Choose the experimental features you want to try

32025R0544

This document is an excerpt from the EUR-Lex website

EUROPA
EUR-Lex home
Implementing regulation - EU - 2025/544 - EN - EUR-Lex

Help

Search tips

Need more search options? Use the Advanced search

Document 32025R0544

Help

Commission Implementing Regulation (EU) 2025/544 of 25 March 2025 amending Implementing Regulation (EU) 2021/403 as regards model animal health certificates and model animal health/official certificates for the entry into the Union of consignments of certain categories of terrestrial animals and germinal products thereof

C/2025/1734

OJ L, 2025/544, 22.4.2025, ELI: http://data.europa.eu/eli/reg_impl/2025/544/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

Legal status of the document In force

ELI: http://data.europa.eu/eli/reg_impl/2025/544/oj

HTML

PDF - authentic OJ

e-signature

How to verify the authenticity of the Official Journal

Official Journal
of the European Union

L series

2025/544

22.4.2025

COMMISSION IMPLEMENTING REGULATION (EU) 2025/544

of 25 March 2025

amending Implementing Regulation (EU) 2021/403 as regards model animal health certificates and model animal health/official certificates for the entry into the Union of consignments of certain categories of terrestrial animals and germinal products thereof

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) 2016/429 of the European Parliament and of the Council of 9 March 2016 on transmissible animal diseases and amending and repealing certain acts in the area of animal health (‘Animal Health Law’) (1), and in particular Articles 238(3), and 239(3), thereof,

Having regard to Regulation (EU) 2017/625 of the European Parliament and of the Council of 15 March 2017 on official controls and other official activities performed to ensure the application of food and feed law, rules on animal health and welfare, plant health and plant protection products, amending Regulations (EC) No 999/2001, (EC) No 396/2005, (EC) No 1069/2009, (EC) No 1107/2009, (EU) No 1151/2012, (EU) No 652/2014, (EU) 2016/429 and (EU) 2016/2031 of the European Parliament and of the Council, Council Regulations (EC) No 1/2005 and (EC) No 1099/2009 and Council Directives 98/58/EC, 1999/74/EC, 2007/43/EC, 2008/119/EC and 2008/120/EC and repealing Regulations (EC) No 854/2004 and (EC) No 882/2004 of the European Parliament and of the Council, Council Directives 89/608/EEC, 89/662/EEC, 90/425/EEC, 91/496/EEC, 96/23/EC, 96/93/EC and 97/78/EC and Council Decision 92/438/EEC (Official Controls Regulation) (2), and in particular Article 90, first paragraph, point (a) and Article 126(3) thereof,

Having regard to Commission Delegated Regulation (EU) 2023/905 of 27 February 2023 supplementing Regulation (EU) 2019/6 of the European Parliament and of the Council as regards the application of the prohibition of use of certain antimicrobial medicinal products in animals or products of animal origin exported from third countries into the Union (3), and in particular Article 6 thereof,

Whereas:

(1)

Commission Implementing Regulation (EU) 2021/403 (4) establishes, among other things, model certificates in the form of animal health certificates or animal health/official certificates for the entry into the Union of consignments of certain categories of terrestrial animals and germinal products thereof.

(2)

Article 14, point (e), of Implementing Regulation (EU) 2021/403 provides that the animal health/official certificate to be used for the entry into Northern Ireland of ovine and caprine animals from Great Britain is to correspond to the model ‘OV/CAP-X-NI’ set out in Chapter 4a of Annex II to that Implementing Regulation. That model was applicable until 31 December 2024, and therefore that point and that model should now be deleted.

(3)

In addition, Chapters 1 (model ‘BOV-X’), 2 (model ‘BOV-Y’), 4 (model ‘OV/CAP-X’), 5 (model ‘OV/CAP-Y’), 7 (model ‘SUI-X’), 8 (model ‘SUI-Y’), 12 (model ‘CAM-CER’), 13 (model ‘EQUI-X’), 14 (model ‘EQUI-Y’), 22 (model ‘BPP’), 23 (model ‘BPR’), 29 (model ‘SP’), 30 (model ‘SR’) and 31 (model ‘POU-LT20’) of Annex II to Implementing Regulation (EU) 2021/403 set out model animal health certificates or animal health/official certificates for the entry into the Union of consignments of certain categories of terrestrial animals. Commission Implementing Regulation (EU) 2024/2598 (5) lays down the list of third countries or regions thereof authorised for the entry into the Union of certain animals and products of animal origin intended for human consumption in accordance with Regulation (EU) 2017/625 as regards the application of the prohibition on the use of certain antimicrobial medicinal products. The attestation as regards Delegated Regulation (EU) 2023/905 in those model certificates should therefore be amended to include a reference to that list in Implementing Regulation (EU) 2024/2598. It is therefore necessary to amend those model certificates accordingly.

(4)

Chapter 4 (model ‘OV/CAP-X’) of Annex II to Implementing Regulation (EU) 2021/403 sets out the model animal health/official certificate for the entry into the Union of ovine and caprine animals. The amendment to Chapter E, points (5)(b) and (6)(b), of Annex IX to Regulation (EC) No 999/2001 of the European Parliament and of the Council (6) by Commission Regulation (EU) 2024/887 (7) concerning caprine animals genetically resistant to classical scrapie strains should be reflected in point II.2.12 of that model certificate. It is therefore necessary to amend that model certificate accordingly.

(5)

Point II.1.11.4 of model certificate in Chapter 18 (model ‘CONFINED-RUM’) and point II.1.11.5 of model certificate in Chapter 21 (model ‘CONFINED-HIPPO’) of Annex II to Implementing Regulation (EU) 2021/403 should be aligned to reflect the diseases referred to in Article 33, point (b), of Delegated Regulation (EU) 2020/692. The references to infection with Brucella abortus, B. melitensis and B. suis and infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae, M. tuberculosis) should therefore be deleted from those points. Those model certificates should therefore be amended accordingly.

(6)

Chapters 22 (model ‘BPP’), 23 (model ‘BPR’), 24 (model ‘DOC’), 25 (model ‘DOR’), 26 (model ‘HEP’), 27 (model ‘HER’), 29, (model ‘SP’), 30 (model ‘SR’), 31 (model ‘POU-LT20’) and 32 (model ‘HE-LT20’) of Annex II to Implementing Regulation (EU) 2021/403 set out the model certificates for the entry into the Union of certain categories of poultry, ratites and germinal products thereof. In the relevant points of those model certificates, an alternative certification option regarding infection with Newcastle disease virus should be added for consignments from zones with the entry ‘N’ in column 4 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404. Those model certificates should therefore be amended accordingly.

(7)

Chapters 48 (model ‘OV/CAP-SEM-A-ENTRY’) and 50 (model ‘OV/CAP-OOCYTES-EMB-A-ENTRY’) of Annex II to Implementing Regulation (EU) 2021/403 set out model animal health certificates for the entry into the Union of certain consignments of semen, oocytes and embryos of ovine and caprine animals. The amendment to Chapter H, points (2)(a) and (b), of Annex IX to Regulation (EC) No 999/2001 by Regulation (EU) 2024/887 concerning donor caprine animals genetically resistant to classical scrapie strains should be reflected in the alternatives in point II.4.13.2 of model ‘OV/CAP-SEM-A-ENTRY’ and the alternatives in point II.4.9.2 of model ‘OV/CAP-OOCYTES-EMB-A-ENTRY’. Those model certificates should therefore be amended accordingly.

(8)

In the interests of clarity and consistency of Union rules, the model certificates set out in Annex II to Implementing Regulation (EU) 2021/403 should be updated, including updating references, notes and structural elements, and replaced by the model certificates set out in the Annex to this Regulation. Implementing Regulation (EU) 2021/403 should therefore be amended accordingly.

(9)

In order to avoid any disruption to trade as regards the entry into the Union of consignments of certain categories of terrestrial animals and germinal products thereof due to the amendments made to Annex II to Implementing Regulation (EU) 2021/403 by this Regulation, the use of animal health certificates or animal health/official certificates issued in accordance with Implementing Regulation (EU) 2021/403 as applicable prior to the amendments made by this Regulation, should continue to be authorised during a transitional period, subject to certain conditions.

(10)	The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

HAS ADOPTED THIS REGULATION:

Article 1

Implementing Regulation (EU) 2021/403 is amended as follows:

(1)	Article 14, point (e), is deleted;

(2)	Annex II is replaced by the text set out in the Annex to this Regulation.

Article 2

For a transitional period until 12 February 2026, the use of animal health certificates or animal health/official certificates issued in accordance with the models set out in Annex II to Implementing Regulation (EU) 2021/403, as applicable before the amendments made to that Implementing Regulation by this Regulation, shall continue to be authorised for the entry into the Union of consignments of certain categories of terrestrial animals and germinal products thereof provided that those certificates were issued no later than 12 November 2025.

Article 3

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 25 March 2025.

For the Commission

The President

Ursula VON DER LEYEN

(1) OJ L 84, 31.3.2016, p. 1, ELI: http://data.europa.eu/eli/reg/2016/429/oj.

(2) OJ L 95, 7.4.2017, p. 1, ELI: http://data.europa.eu/eli/reg/2017/625/oj.

(3) OJ L 116, 4.5.2023, p. 1, ELI: http://data.europa.eu/eli/reg_del/2023/905/oj.

(4) Commission Implementing Regulation (EU) 2021/403 of 24 March 2021 laying down rules for the application of Regulations (EU) 2016/429 and (EU) 2017/625 of the European Parliament and of the Council as regards model animal health certificates and model animal health/official certificates, for the entry into the Union and movements between Member States of consignments of certain categories of terrestrial animals and germinal products thereof, official certification regarding such certificates and repealing Decision 2010/470/EU (OJ L 113, 31.3.2021, p. 1, ELI: http://data.europa.eu/eli/reg_impl/2021/403/oj).

(5) Commission Implementing Regulation (EU) 2024/2598 of 4 October 2024 laying down the list of third countries or regions thereof authorised for the entry into the Union of certain animals and products of animal origin intended for human consumption in accordance with Regulation (EU) 2017/625 of the European Parliament and of the Council as regards the application of the prohibition of use of certain antimicrobial medicinal products (OJ L 2024/2598, 7.10.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/2598/oj).

(6) Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies (OJ L 147 31.5.2001, p. 1, ELI: http://data.europa.eu/eli/reg/2001/999/oj).

(7) Commission Regulation (EU) 2024/887 of 22 March 2024 amending Annexes IV, VIII, and IX to Regulation (EC) No 999/2001 of the European Parliament and of the Council as regards animal feeding, placing on the market and importation into the Union (OJ L, 2024/887, 25.3.2024, ELI: http://data.europa.eu/eli/reg/2024/887/oj).

ANNEX

‘ANNEX II

Annex II contains the following model animal health certificates and animal health/official certificates and declarations for the entry into the Union and transit through the Union:

MODEL

Ungulates

BOV-X

Chapter 1: Model animal health/official certificate for the entry into the Union of bovine animals

BOV-Y

Chapter 2: Model animal health/official certificate for the entry into the Union of bovine animals intended for slaughter

BOV-X-TRANSIT-RU

Chapter 3: Model animal health certificate for the entry into the Union of bovine animals intended for transit from the region of Kaliningrad to other regions of Russia via the territory of Lithuania

OV/CAP-X

Chapter 4: Model animal health/official certificate for the entry into the Union of ovine and caprine animals

OV/CAP-Y

Chapter 5: Model animal health/official certificate for the entry into the Union of ovine and caprine animals intended for slaughter

ENTRY-EVENTS

Chapter 6: Model animal health certificate for the entry into the Union of certain ungulates which originate in the Union, are moved to a third country or territory for their participation in events, exhibitions, displays and shows and are then moved back to the Union

SUI-X

Chapter 7: Model animal health/official certificate for the entry into the Union of porcine animals and animals of the family Tayassuidae

SUI-Y

Chapter 8: Model animal health/official certificate for the entry into the Union of porcine animals intended for slaughter

RUM

Chapter 9: Model animal health/official certificate for the entry into the Union of animals of the families Antilocapridae, Bovidae (other than bovine, ovine and caprine animals), Giraffidae, Moschidae and Tragulidae

RHINO

Chapter 10: Model animal health certificate for the entry into the Union of animals of the families Tapiridae, Rhinocerotidae and Elephantidae

HIPPO

Chapter 11: Model animal health certificate for the entry into the Union of animals of the family Hippopotamidae

CAM-CER

Chapter 12: Model animal health/official certificate for the entry into the Union of camelid and cervid animals

Equine animals

EQUI-X

Chapter 13: Model animal health/official certificate and model declaration for the entry into the Union of an equine animal

EQUI-Y

Chapter 14: Model animal health/official certificate and model declaration for the entry into the Union of equine animals intended for slaughter

EQUI-RE-ENTRY-30

Chapter 15: Model animal health certificate and model declaration for the re-entry into the Union of a registered horse for racing, competition and cultural events after temporary export for a period of not more than 30 days

EQUI-RE-ENTRY-90-COMP

Chapter 16: Model animal health certificate and model declaration for the re-entry into the Union of a registered horse for competition after temporary export for a period of not more than 90 days to participate in equestrian events organised under the auspices of the Fédération Equestre Internationale (FEI)

EQUI- RE-ENTRY-90-RACE

Chapter 17: Model animal health certificate and model declaration for the re-entry into the Union of a registered horse for racing after temporary export for a period of not more than 90 days to participate in specific race events in the United Arab Emirates, Australia, Bahrain, Canada, Hong Kong, Japan, Qatar, Saudi Arabia, Singapore or the United States

Ungulates intended for a confined establishment

CONFINED-RUM

Chapter 18: Model animal health certificate for the entry into the Union of animals listed in Chapter 18, Section 1, of Annex II to Commission Implementing Regulation (EU) 2021/403 that are originating from and intended for a confined establishment

CONFINED-SUI

Chapter 19: Model animal health certificate for the entry into the Union of animals listed in Chapter 19, Section 1, of Annex II to Commission Implementing Regulation (EU) 2021/403 that are originating from and intended for a confined establishment

CONFINED-TRE

Chapter 20: Model animal health certificate for the entry into the Union of animals listed in Chapter 20, Section 1, of Annex II to Commission Implementing Regulation (EU) 2021/403 that are originating from and intended for a confined establishment

CONFINED-HIPPO

Chapter 21: Model animal health certificate for the entry into the Union of animals of the family of Hippopotamidae that are originating from and intended for a confined establishment

Birds and germinal products thereof

BPP

Chapter 22: Model animal health/official certificate for the entry into the Union of breeding poultry other than ratites and productive poultry other than ratites

BPR

Chapter 23: Model animal health/official certificate for the entry into the Union of breeding ratites and productive ratites

DOC

Chapter 24: Model animal health/official certificate for the entry into the Union of day-old chicks other than ratites

DOR

Chapter 25: Model animal health certificate for the entry into the Union of day-old chicks of ratites

HEP

Chapter 26: Model animal health/official certificate for the entry into the Union of hatching eggs of poultry other than ratites

HER

Chapter 27: Model animal health certificate for the entry into the Union of hatching eggs of ratites

SPF

Chapter 28: Model animal health certificate for the entry into the Union of specified pathogen-free eggs

Chapter 29: Model animal health/official certificate for the entry into the Union of poultry, other than ratites, intended for slaughter

Chapter 30: Model animal health/official certificate for the entry into the Union of ratites intended for slaughter

POU-LT20

Chapter 31: Model animal health/official certificate for the entry into the Union of less than 20 heads of poultry other than ratites

HE-LT20

Chapter 32: Model animal health/official certificate for the entry into the Union of less than 20 hatching eggs of poultry other than ratites

CAPTIVE-BIRDS, OTHER THAN RACING PIGEONS

Chapter 33: Model animal health certificate for the entry into the Union of captive birds, other than racing pigeons immediately released after entry

RACING PIGEONS-IMMEDIATE RELEASE

Chapter 34: Model animal health certificate for the entry into the Union of racing pigeons immediately released after entry

HE-CAPTIVE-BIRDS

Chapter 35: Model animal health certificate for the entry into the Union of hatching eggs of captive birds

Bees

QUE

Chapter 36: Model animal health certificate for the entry into the Union of queen honeybees

BBEE

Chapter 37: Model animal health certificate for the entry into the Union of bumble bees

Dogs, cats and ferrets

CANIS-FELIS-FERRETS

Chapter 38: Model animal health certificate for the entry into the Union of dogs, cats and ferrets

Germinal products of bovine animals

BOV-SEM-A-ENTRY

Chapter 39: Model animal health certificate for the entry into the Union of consignments of semen of bovine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021, dispatched from the semen collection centre where the semen was collected

BOV-SEM-B-ENTRY

Chapter 40: Model animal health certificate for the entry into the Union of consignments of stocks of semen of bovine animals collected, processed and stored in accordance with Council Directive 88/407/EEC as amended by Council Directive 2003/43/EC, after 31 December 2004 and before 21 April 2021, dispatched after 20 April 2021 from the semen collection centre where the semen was collected

BOV-SEM-C-ENTRY

Chapter 41: Model animal health certificate for the entry into the Union of consignments of stocks of semen of bovine animals collected, processed and stored in accordance with Council Directive 88/407/EEC as amended by Council Directive 93/60/EEC, before 1 January 2005, dispatched after 20 April 2021 from the semen collection centre where the semen was collected

BOV-OOCYTES-EMB-A-ENTRY

Chapter 42: Model animal health certificate for the entry into the Union of consignments of oocytes and embryos of bovine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021, dispatched by the embryo collection or production team by which the oocytes or embryos were collected or produced

BOV-in-vivo-EMB-B-ENTRY

Chapter 43: Model animal health certificate for the entry into the Union of consignments of stocks of in vivo derived embryos of bovine animals collected, processed and stored in accordance with Council Directive 89/556/EEC before 21 April 2021, dispatched after 20 April 2021 by the embryo collection team by which the embryos were collected

BOV-in-vitro-EMB-C-ENTRY

Chapter 44: Model animal health certificate for the entry into the Union of consignments of stocks of in vitro produced embryos of bovine animals produced, processed and stored in accordance with Council Directive 89/556/EEC before 21 April 2021, conceived using semen complying with requirements of Council Directive 88/407/EEC, dispatched after 20 April 2021 by the embryo production team by which the embryos were produced

BOV-in-vitro-EMB-D-ENTRY

Chapter 45: Model animal health certificate for the entry into the Union of consignments of stocks of in vitro produced embryos of bovine animals produced, processed and stored in accordance with Council Directive 89/556/EEC before 21 April 2021, conceived using semen coming from semen collection or storage centres approved by the competent authority of the exporting third country or territory, dispatched after 20 April 2021 by the embryo production team by which the embryos were produced

BOV-GP-PROCESSING-ENTRY

Chapter 46: Model animal health certificate for the entry into the Union of consignments of germinal products listed below, dispatched after 20 April 2021 from the germinal product processing establishment:

—	semen of bovine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of semen of bovine animals collected, processed and stored in accordance with Council Directive 88/407/EEC as amended by Council Directive 2003/43/EC, after 31 December 2004 and before 21 April 2021;

—	stocks of semen of bovine animals collected, processed and stored in accordance with Directive 88/407/EEC as amended by Council Directive 93/60/EEC, before 1 January 2005;

—	oocytes and embryos of bovine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of in vivo derived embryos of bovine animals collected, processed and stored in accordance with Council Directive 89/556/EEC before 21 April 2021;

—	stocks of in vitro produced embryos of bovine animals produced, processed and stored in accordance with Directive 89/556/EEC before 21 April 2021, and conceived using semen complying with requirements of Directive 88/407/EEC;

—

stocks of in vitro produced embryos of bovine animals produced, processed and stored in accordance with Directive 89/556/EEC before 21 April 2021, and conceived using semen coming from semen collection or storage centres approved by the competent authority of the exporting third country or territory.

BOV-GP-STORAGE-ENTRY

Chapter 47: Model animal health certificate for the entry into the Union of consignments of germinal products listed below, dispatched after 20 April 2021 from the germinal product storage centre:

—	semen of bovine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of semen of bovine animals collected, processed and stored in accordance with Council Directive 88/407/EEC as amended by Council Directive 2003/43/EC, after 31 December 2004 and before 21 April 2021;

—	stocks of semen of bovine animals collected, processed and stored in accordance with Directive 88/407/EEC as amended by Council Directive 93/60/EEC, before 1 January 2005;

—	oocytes and embryos of bovine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of in vivo derived embryos of bovine animals collected, processed and stored in accordance with Council Directive 89/556/EEC before 21 April 2021;

—	stocks of in vitro produced embryos of bovine animals produced, processed and stored in accordance with Directive 89/556/EEC before 21 April 2021, and conceived using semen complying with requirements of Directive 88/407/EEC;

—

Germinal products of ovine and caprine animals

OV/CAP-SEM-A-ENTRY

Chapter 48: Model animal health certificate for the entry into the Union of consignments of semen of ovine and caprine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021, dispatched from the semen collection centre where the semen was collected

OV/CAP-SEM-B-ENTRY

Chapter 49: Model animal health certificate for the entry into the Union of consignments of stocks of semen of ovine and caprine animals collected, processed and stored in accordance with Council Directive 92/65/EEC before 21 April 2021, dispatched after 20 April 2021 from the semen collection centre where the semen was collected

OV/CAP-OOCYTES-EMB-A-ENTRY

Chapter 50: Model animal health certificate for the entry into the Union of consignments of oocytes and embryos of ovine and caprine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021, dispatched by the embryo collection or production team by which the oocytes or embryos were collected or produced

OV/CAP-OOCYTES-EMB-B-ENTRY

Chapter 51: Model animal health certificate for the entry into the Union of consignments of oocytes and embryos of ovine and caprine animals collected or produced, processed and stored in accordance with Council Directive 92/65/EEC before 21 April 2021, dispatched after 20 April 2021 by the embryo collection or production team by which the oocytes or embryos were collected or produced

OV/CAP-GP-PROCESSING-ENTRY

Chapter 52: Model animal health certificate for the entry into the Union of consignments of germinal products listed below, dispatched after 20 April 2021 from the germinal product processing establishment:

—	semen of ovine and caprine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of semen of ovine and caprine animals collected, processed and stored in accordance with Council Directive 92/65/EEC before 21 April 2021;

—	oocytes and embryos of ovine and caprine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of oocytes and embryos of ovine and caprine animals collected or produced, processed and stored in accordance with Directive 92/65/EEC before 21 April 2021.

OV/CAP-GP-STORAGE-ENTRY

Chapter 53: Model animal health certificate for the entry into the Union of consignments of germinal products listed below, dispatched after 20 April 2021 from the germinal product storage centre:

—	semen of ovine and caprine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of semen of ovine and caprine animals collected, processed and stored in accordance with Council Directive 92/65/EEC before 21 April 2021;

—	oocytes and embryos of ovine and caprine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of oocytes and embryos of ovine and caprine animals collected or produced, processed and stored in accordance with Directive 92/65/EEC before 21 April 2021.

Germinal products of porcine animals

POR-SEM-A-ENTRY

Chapter 54: Model animal health certificate for the entry into the Union of consignments of semen of porcine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021, dispatched from the semen collection centre where the semen was collected

POR-SEM-B-ENTRY

Chapter 55: Model animal health certificate for the entry into the Union of consignments of stocks of semen of porcine animals collected, processed and stored in accordance with Council Directive 90/429/EEC before 21 April 2021, dispatched after 20 April 2021 from the semen collection centre where the semen was collected

POR-OOCYTES-EMB-ENTRY

Chapter 56: Model animal health certificate for the entry into the Union of consignments of oocytes and embryos of porcine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021, dispatched by the embryo collection or production team by which the oocytes or embryos were collected or produced

POR-GP-PROCESSING-ENTRY

Chapter 57: Model animal health certificate for the entry into the Union of consignments of germinal products listed below, dispatched after 20 April 2021 from the germinal product processing establishment:

—	semen of porcine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of semen of porcine animals collected, processed and stored in accordance with Council Directive 90/429/EEC before 21 April 2021;

—	oocytes and embryos of porcine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021.

POR-GP-STORAGE-ENTRY

Chapter 58: Model animal health certificate for the entry into the Union of consignments of germinal products listed below, dispatched after 20 April 2021 from the germinal product storage centre:

—	semen of porcine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of semen of porcine animals collected, processed and stored in accordance with Council Directive 90/429/EEC before 21 April 2021;

—	oocytes and embryos of porcine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021.

Germinal products of equine animals

EQUI-SEM-A-ENTRY

Chapter 59: Model animal health certificate for the entry into the Union of consignments of semen of equine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021, dispatched from the semen collection centre where the semen was collected

EQUI-SEM-B-ENTRY

Chapter 60: Model animal health certificate for the entry into the Union of consignments of stocks of semen of equine animals collected, processed and stored in accordance with Council Directive 92/65/EEC after 30 September 2014 and before 21 April 2021, dispatched after 20 April 2021 from the semen collection centre where the semen was collected

EQUI-SEM-C-ENTRY

Chapter 61: Model animal health certificate for the entry into the Union of consignments of stocks of semen of equine animals collected, processed and stored in accordance with Council Directive 92/65/EEC after 31 August 2010 and before 1 October 2014, dispatched after 20 April 2021 from the semen collection centre where the semen was collected

EQUI-SEM-D-ENTRY

Chapter 62: Model animal health certificate for the entry into the Union of consignments of stocks of semen of equine animals collected, processed and stored in accordance with Council Directive 92/65/EEC before 1 September 2010, dispatched after 20 April 2021 from the semen collection centre where the semen was collected

EQUI-OOCYTES-EMB-A-ENTRY

Chapter 63: Model animal health certificate for the entry into the Union of consignments of oocytes and embryos of equine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021, dispatched by the embryo collection or production team by which the oocytes or embryos were collected or produced

EQUI-OOCYTES-EMB-B-ENTRY

Chapter 64: Model animal health certificate for the entry into the Union of consignments of stocks of oocytes and embryos of equine animals collected or produced, processed and stored in accordance with Council Directive 92/65/EEC after 30 September 2014 and before 21 April 2021, dispatched after 20 April 2021 by the embryo collection or production team by which the oocytes or embryos were collected or produced

EQUI-OOCYTES-EMB-C-ENTRY

Chapter 65: Model animal health certificate for the entry into the Union of consignments of stocks of oocytes and embryos of equine animals collected or produced, processed and stored in accordance with Council Directive 92/65/EEC after 31 August 2010 and before 1 October 2014, dispatched after 20 April 2021 by the embryo collection or production team by which the oocytes or embryos were collected or produced

EQUI-GP-PROCESSING-ENTRY

Chapter 66: Model animal health certificate for the entry into the Union of consignments of germinal products listed below, dispatched after 20 April 2021 from the germinal product processing establishment:

—	semen of equine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of semen of equine animals collected, processed and stored in accordance with Council Directive 92/65/EEC after 30 September 2014 and before 21 April 2021;

—	stocks of semen of equine animals collected, processed and stored in accordance with Directive 92/65/EEC after 31 August 2010 and before 1 October 2014;

—	stocks of semen of equine animals collected, processed and stored in accordance with Directive 92/65/EEC before 1 September 2010;

—	oocytes and embryos of equine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of oocytes and embryos of equine animals collected or produced, processed and stored in accordance with Directive 92/65/EEC after 30 September 2014 and before 21 April 2021;

—	stocks of oocytes and embryos of equine animals collected, processed and stored in accordance with Directive 92/65/EEC after 31 August 2010 and before 1 October 2014.

EQUI-GP-STORAGE-ENTRY

Chapter 67: Model animal health certificate for the entry into the Union of consignments of germinal products listed below, dispatched after 20 April 2021 from the germinal product storage centre:

—	semen of equine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of semen of equine animals collected, processed and stored in accordance with Council Directive 92/65/EEC after 30 September 2014 and before 21 April 2021;

—	stocks of semen of equine animals collected, processed and stored in accordance with Directive 92/65/EEC after 31 August 2010 and before 1 October 2014;

—	stocks of semen of equine animals collected, processed and stored in accordance with Directive 92/65/EEC before 1 September 2010;

—	oocytes and embryos of equine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of oocytes and embryos of equine animals collected or produced, processed and stored in accordance with Directive 92/65/EEC after 30 September 2014 and before 21 April 2021;

—	stocks of oocytes and embryos of equine animals collected, processed and stored in accordance with Directive 92/65/EEC after 31 August 2010 and before 1 October 2014.

Germinal products of certain categories of terrestrial animals

GP-CONFINED-ENTRY

Chapter 68: Model animal health certificate for the entry into the Union of consignments of semen, oocytes and embryos of terrestrial animals kept at confined establishments which were collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692

CHAPTER 1

MODEL ANIMAL HEALTH/OFFICIAL CERTIFICATE FOR THE ENTRY INTO THE UNION OF BOVINE ANIMALS (MODEL “BOV-X”)

Part I: Description of consignment

COUNTRY

Animal health/official certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
	☐ Further keeping
				☐ Travelling circus/animal acts
		☐ Quarantine establishment	☐ Exhibition

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category	Sex	Identification system	Identification number	Age	Quantity

Part II: Certification

COUNTRY

Certificate model BOV-X

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

(1) [II.1.

Public health attestation (Delete when the Union is not the final destination of the animals)

I, the undersigned official veterinarian, hereby certify, that the animals described in in Part I:

II.1.1.

have not received:

(a)	any stilbene or thyrostatic substances;

(b)	oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other than therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC);

II.1.2.

fulfil the guarantees provided by the control plan submitted in accordance with Article 6(2) of Commission Delegated Regulation (EU) 2022/2292, and the third country or region thereof of their origin is listed in Annex –I to Commission Implementing Regulation (EU) 2021/405 and marked with an “X” for the category “bovine”;

II.1.3.

with regard to bovine spongiform encephalopathy (BSE):

(a)

the animals are identified by a permanent identification system enabling them to be traced back to the dam and herd of origin, and they are not:

(i)	BSE cases;

(ii)	bovine animals which, during their first year of life, were reared with BSE cases during their first year of life, and which an investigation has shown that they have consumed the same potentially contaminated feed during that period; or

(iii)

if the results of the investigation referred to in point (ii) are inconclusive, bovine animals which, during their first year of life, were reared with BSE cases during their first year of life, or were born in the same herd as, and within 12 months preceding or following the date of the birth of, the BSE cases;

(1) either

[(b)

(i)	the animals were born and continuously reared in a country or region thereof or countries or regions thereof classified in accordance with Commission Decision 2007/453/EC as countries or regions thereof posing a negligible BSE risk;

(ii)

if there have been BSE indigenous cases in the country or region thereof concerned, the animals were born after the date from which the ban on the feeding of ruminants with meat-and-bone meal and greaves derived from ruminants, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health, was effectively enforced, or they were born after the date of birth of the last BSE indigenous case if born after the date of the feed ban.]]

(1) or

[(b)

(i)	the country or region thereof of origin of the animals is classified in accordance with Decision 2007/453/EC as a country or region thereof posing a controlled BSE risk;

(ii)

the animals were born after the date from which the ban on the feeding of ruminants with meat-and-bone meal and greaves derived from ruminants, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health, was effectively enforced, or they were born after the date of birth of the last BSE indigenous case if born after the date of the feed ban.]]

(1) or

[(b)

(i)	the country or region thereof of origin of the animals is classified in accordance with Decision 2007/453/EC as a country or region thereof posing an undetermined BSE risk;

(ii)	the feeding of ruminants with meat-and-bone meal and greaves from ruminants, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health, has been banned and the ban has been effectively enforced in the country or region thereof of origin;

(iii)

the animals were born at least 2 years after the date from which the ban on the feeding of ruminants with meat-and-bone meal and greaves derived from ruminants, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health, was effectively enforced, or they were born after the date of birth of the last BSE indigenous case if born after the date of the feed ban.]]

(1) (15) [II.1.a.

Attestation as regards Commission Delegated Regulation (EU) 2023/905 (Delete when the Union is not the final destination of the animals)

I, the undersigned official veterinarian, hereby certify that the animals described in Part I have not been administered antimicrobial medicinal products for growth promotion or yield increase or antimicrobial medicinal products containing an antimicrobial that is included in the list of antimicrobials reserved for the treatment of certain infections in humans laid down in Commission Implementing Regulation (EU) 2022/1255, as set out in Article 3 of Delegated Regulation (EU) 2023/905 and originate from a third country or region thereof listed in the Annex to Commission Implementing Regulation (EU) 2024/2598.]

II.2.

Animal health attestation

I, the undersigned official veterinarian, hereby certify that the animals described in Part I:

II.2.1.

come from the zone with code __-__ (2) which, at the date of issue of this animal health/official certificate is authorised for the entry into the Union of bovine animals and listed in Part 1 of Annex II to Commission Implementing Regulation (EU) 2021/404;

II.2.2.

have remained continuously:

(a)	in the zone referred to in point II.2.1 since birth or for at least 6 months prior to the date of their dispatch to the Union, and

(b)	in the establishment of origin since birth or for at least 40 days prior to the date of their dispatch to the Union, into which during this period no bovine animals and no animals of other species listed for the same diseases as bovine animals have been introduced;

II.2.3.

had no contact with animals of a lower health status since birth or for at least 30 days prior to the date of their dispatch to the Union;

II.2.4.

are not to be killed under a national programme for the eradication of diseases, including the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

(1) either

[II.2.5.

have been dispatched to the Union directly from their establishment of origin without passing through any other establishment;]

(1) or

[II.2.5.

have undergone one single assembly operation in the zone of origin fulfilling the following requirements:

(a)

the assembly operation took place in an establishment:

(i)	approved for conducting assembly operations of ungulates by the competent authority in the third country or territory in accordance with Article 5 of Commission Delegated Regulation (EU) 2019/2035;

(ii)	which has a unique approval number assigned by the competent authority of the third country or territory;

(iii)

listed for that purpose by the competent authority of the third country or territory of dispatch with the information set out in Article 21 of Delegated Regulation (EU) 2019/2035;

(iv)	fulfilling the requirements provided for in Article 8 of Delegated Regulation (EU) 2020/692;

(b)	the assembly operation in the assembly centre took no longer than 6 days;]

II.2.6.

have not been unloaded in any place that does not comply with the requirements laid down in point II.2.11 since the date of dispatch from their establishment of origin until the date of loading for dispatch to the Union and during that period they have not been in contact with animals of a lower health status;

II.2.7.

are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy) (3) in a means of transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority of the third country or territory and constructed in such a way that:

(a)	animals cannot escape or fall out;

(b)	visual inspection of the space where animals are kept is possible;

(c)	the escape of animal excrements, litter or feed is prevented or minimized;

II.2.8.

have been subjected to a clinical inspection within the last 24 hours prior to the time of loading for dispatch to the Union, carried out by an official veterinarian in the third country or territory, of origin, or zone thereof, who did not detect signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.2.9.

have not been vaccinated against:

(a)

foot and mouth disease, infection with Rift Valley fever virus, infection with Mycoplasma mycoides subsp. mycoides SC (Contagious bovine pleuropneumonia), infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) and infection with Brucella abortus, B. melitensis and B. suis; and

(b)	infection with bluetongue virus (serotypes 1-24) with a live vaccine during the last 60 days prior to the date of their dispatch to the Union;

II.2.10.

come from a zone:

II.2.10.1.

in which:

(a)

foot and mouth disease has not been reported

(1) either

[for at least 24 months prior to the date of dispatch of the animals to the Union;]

(1) (4) or

[since __/__/____ (dd/mm/yyyy);]

(b)	vaccination against foot and mouth disease has not been carried out for at least 12 months prior to the date of dispatch of the animals to the Union, and no animals vaccinated against foot and mouth disease have been introduced during that period;

II.2.10.2.

in which infection with lumpy skin disease virus has not been reported for at least 12 months prior to the date of dispatch of the animals to the Union;

II.2.10.3.

in which infection with rinderpest virus, infection with Rift Valley fever virus and infection with Mycoplasma mycoides subsp. mycoides SC (Contagious bovine pleuropneumonia) has not been reported for at least 12 months prior to the date of dispatch of the animals to the Union and during that period:

(a)	vaccination against these diseases has not been carried out;

(b)	the animals vaccinated against those diseases have not been introduced.

(1) (5) either

[II.2.10.4.

which is free from infection with bluetongue virus (serotypes 1-24);]

(1) or

[II.2.10.4.

which is seasonally free from infection with bluetongue virus (serotypes 1-24)

(1) (6) either

[for at least 60 days prior to the date of dispatch of the animals to the Union;]

(1) (6) or

[for at least 28 days prior to the date of dispatch of the animals to the Union and the animals have been subjected to a serological test in accordance with Article 9, point (b), of Delegated Regulation (EU) 2020/692, with negative results, carried out on samples collected at least 28 days following the date of entry of the animals into the seasonally free zone;]

(1) (6) or

[for at least 14 days prior to the date of dispatch of the animals to the Union and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of entry of the animals in the seasonally free zone;]

(1) or

[II.2.10.4.

which is not free from infection with bluetongue virus (serotypes 1-24) and the animals have been vaccinated against all the serotypes (1-24) of bluetongue virus reported in that zone during the last 2 years prior to the date of dispatch of the animals to the Union and are still within the immunity period guaranteed in the specifications of the vaccine, and

(1) either

[have been vaccinated more than 60 days prior to the date of dispatch of the animals to the Union;]]

(1) or

[have been vaccinated with an inactivated vaccine and were subjected to a PCR test, with negative results on samples collected at least 14 days after the date of onset of the immunity protection set in the specifications of the vaccine;]]

(1) or

[II.2.10.4.

which is not free from infection with bluetongue virus (serotypes 1-24) and the animals have been subjected with positive results to a serological test able to detect specific antibodies against all serotypes (1-24) of bluetongue virus reported in that zone during the last 2 years prior to the date of dispatch of the animals to the Union, and

(1) either

[the serological test has been carried out on samples collected at least 60 days prior to the date of dispatch of the animals to the Union;]]

(1) or

[the serological test has been carried out on samples collected at least 30 days prior to the date of dispatch of the animals to the Union and the animals were subjected to a PCR test, with negative results, carried out on samples collected not earlier than 14 days prior to the date of dispatch of the animals to the Union;]]

(1) (7) either

[II.2.10.5.

which is free from enzootic bovine leukosis;]

(1) or

[II.2.10.5.

which is not free from enzootic bovine leukosis and the disease has not been reported in the establishment of origin of the animals during at least 24 months prior to the date of dispatch of the animals to the Union, and:

[II.2.10.5.1.

the animals of the consignment over 24 months of age

(1) either

[have been kept in isolation from the other bovine animals kept in the same establishment prior to the date of dispatch of the animals to the Union and during the period of isolation have been subjected to a laboratory examination for enzootic bovine leukosis using one of the diagnostic methods referred to in Article 9, point (b)(i), of Delegated Regulation (EU) 2020/692, with negative results, carried out on samples taken on two occasions at an interval of at least 4 months;]]

(1) or

[have been subjected to a laboratory examination for enzootic bovine leukosis using one of the diagnostic methods referred to in Article 9, point (b)(i), of Delegated Regulation (EU) 2020/692, with negative results, carried out on a sample taken during the last 30 days prior to the date of their dispatch to the Union and all bovine animals over 24 months of age kept in the establishment of origin have been subjected to a laboratory examination for enzootic bovine leukosis with one of the diagnostic methods referred to in Article 9, point (b)(i), of Delegated Regulation (EU) 2020/692, carried out, with negative results, on samples taken on two occasions at an interval of not less than 4 months during the last 12 months prior to the date of dispatch of the animals to the Union;]]

(1) [II.2.10.5.2.

the animals of the consignment younger than 24 months of age were born to dams which have been subjected to a laboratory examination for enzootic bovine leukosis with one of the diagnostic methods referred to in Article 9, point (b)(i), of Delegated Regulation (EU) 2020/692, with negative results, carried out on samples taken on two occasions at an interval of not less than 4 months during the last 12 months prior to the date of dispatch of the animals to the Union;]]

II.2.11.

come from an establishment:

II.2.11.1.

which is registered by and under the control of the competent authority of the third country or territory of origin and has a system in place to maintain for at least 3 years following the date of dispatch of the animals to the Union the up-to-date records containing information regarding:

(a)	the species, categories, number and identification of animals on the establishment;

(b)	movements of animals into and out of the establishment;

(c)	mortality in the establishment;

II.2.11.2.

which receives regular animal health visits from a veterinarian for the purpose of the detection of, and information on, signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at a frequency that is proportional to the risk posed by the establishment;

II.2.11.3.

which was not subject to national restriction measures for animal health reasons, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the date of dispatch of the animals to the Union;

II.2.11.4.

in and around which, in an area of 10 km radius, including where appropriate the territory of a neighbouring country, none of the following listed diseases has been reported for at least 30 days prior to the date of dispatch of the animals to the Union: foot and mouth disease, infection with rinderpest virus, infection with Rift Valley fever virus, infection with Mycoplasma mycoides subsp. mycoides SC (Contagious bovine pleuropneumonia) and infection with lumpy skin disease virus;

(1) either

[II.2.11.5.

in and around which, in an area of 150 km radius, including where appropriate the territory of a neighbouring country, epizootic haemorrhagic disease has not been reported for at least 2 years prior to the date of dispatch of the animals to the Union;]

(1) (8) or

[II.2.11.5.

which is located in a zone seasonally free of epizootic haemorrhagic disease;]

II.2.11.6.

which is free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) as regards bovine animals (9), and

(1) (10) either

[located in a zone free from the disease where vaccination against that disease is not practised;]

(1) or

[the animals have been tested with one of the diagnostic methods provided for in Article 9, point (b)(i), of Delegated Regulation (EU) 2020/692 for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis), with negative results, during the last 30 days prior to the date of dispatch of the animals to the Union;]

(1) or

[the animals are less than 6 weeks old;]

II.2.11.7.

which is free from infection with Brucella abortus, B. melitensis and B. suis as regards bovine animals (9), and

(1) (11) either

[located in a zone free from the disease where vaccination against that disease is not practised;]

(1) or

[the animals have been tested with one of the diagnostic methods provided for in Article 9, point (b)(i), of Delegated Regulation (EU) 2020/692 for infection with Brucella abortus, B. melitensis and B. suis, with negative results, on a sample taken during the last 30 days prior to the date of dispatch of the animals to the Union, and in the case of post-parturient females, the test is carried out on a sample taken at least 30 days after the date of parturition;]

(1) or

[the animals are less than 12 months old;]

(1) or

[the animals are castrated;]

II.2.11.8.

in which infection with rabies virus has not been reported for at least 30 days prior to dispatch of the animals to the Union;

II.2.11.9.

in which anthrax has not been reported for at least 15 days prior to the date of dispatch of the animals to the Union;

(1) either

[II.2.11.10.

in which surra (Trypanosoma evansi) has not been reported for at least 2 years prior to the date of dispatch of the animals to the Union;]

(1) or

[II.2.11.10.

in which surra (Trypanosoma evansi) has not been reported for at least 30 days prior to the date of dispatch of the animals to the Union and when the disease was reported in the establishment of origin during the last 2 years prior to the date of dispatch of the animals to the Union, the affected establishment remained under restriction until the date on which the infected animals were removed from the establishment and the remaining animals on the establishment were subjected with negative result to a test for surra as described in Article 9, point (b)(i), of Delegated Regulation (EU) 2020/692 carried out on samples taken at least 6 months after the date on which the infected animals were removed from the establishment.]

(1) (12) [II.2.12.

have not been vaccinated against infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, and

(1) (13) either

[originate from a third country or territory, or zone thereof free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis;]]

(1) or

[have been kept in quarantine for at least 30 days prior to the date of their dispatch to the Union and have undergone a serological test for the detection of antibodies against whole bovine herpes virus-1 (BoHV-1) with one of the diagnostic methods referred to in Article 9, point (b)(i), of Delegated Regulation (EU) 2020/692, with negative results, on a sample taken within the last 15 days prior to the date of dispatch of the animals to the Union;]]

(1) (12) [II.2.13.

have not been vaccinated against bovine viral diarrhoea, and

(1) (14) either

[originate from a third country or territory, or zone thereof free from bovine viral diarrhoea.]]

(1) or

[have been tested for bovine viral diarrhoea virus antigen or genome using one of the diagnostic methods provided for in Part 6 of Annex I to Commission Delegated Regulation (EU) 2020/688 with negative results, and

(1) either

[have been kept in a quarantine establishment for at least 21 days prior to the date of their dispatch to the Union.]]]

(1) or

[are pregnant dams and have been kept in a quarantine establishment for at least 21 days prior to the date of their dispatch to the Union and have been subjected to a serological test for the detection of antibodies against bovine viral diarrhoea virus using one of the diagnostic methods provided for in Part 6 of Annex I to Delegated Regulation (EU) 2020/688 with negative results carried out on samples taken not less than 21 days after the date of commencement of the quarantine.]]]

(1) or

[have been subjected to a serological test for the detection of antibodies against bovine viral diarrhoea virus using one of the diagnostic methods provided for in Part 6 of Annex I to Delegated Regulation (EU) 2020/688, with positive results, carried out on samples taken prior to the date of their dispatch to the Union.]]]

(1) or

[are pregnant dams that have been subjected to a serological test for the detection of antibodies against bovine viral diarrhoea virus using one of the diagnostic methods provided for in Part 6 of Annex I to Delegated Regulation (EU) 2020/688 with positive results, carried out on samples taken prior to the date of insemination preceding current gestation.]]]

Notes:

This animal health/official certificate is intended for the entry into the Union of bovine animals, including when the Union is not the final destination of the animals.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health/official certificate include the United Kingdom in respect of Northern Ireland.

This animal health/official certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.

Part I:

Box reference I.27

“Identification system and identification number”: Specify the means of identification and the individual identification codes of the animals in accordance with Article 21(1) of Delegated Regulation (EU) 2020/692; or, for the zones with an entry “ID” in column 6 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404, in accordance with Article 21(5) of Delegated Regulation (EU) 2020/692.

Part II:

(1)	Delete if not applicable.

(2)	Code of the zone as it appears in column 2 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(3)	Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.2.1 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of those animals from that zone.

(4)	Only for the zones with an opening date in column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(5)	For the zones with an entry “BTV” in column 7 of the table in of Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(6)	For the zones with an entry “SF-BTV” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(7)	For the zones with an entry “EBL” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(8)	For the zones with an entry “SF-EHD” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(9)	In accordance with Article 10 of Delegated Regulation (EU) 2020/692.

(10)	For the zones with an entry “TB” for bovine animals in column 7 of the table in Part 1 of Annex II, to Implementing Regulation (EU) 2021/404.

(11)	For the zones with an entry “BRU” for bovine animals in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(12)

Only applicable when the Member State of destination or Switzerland, in accordance with the Agreement between the European Community and the Swiss Confederation on trade in agricultural products (OJ L 114, 30.4.2002, p. 132), either has disease-free status or an approved eradication programme for the diseases mentioned in points II.2.12 and II.2.13 (infectious bovine rhinotracheitis/infectious pustular vulvovaginitis and bovine viral diarrhoea).

(13)	For the zones with an entry “IBR” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(14)	For the zones with an entry “BVD” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(15)	Applicable to consignments entering the Union as from 3 September 2026.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 2

MODEL ANIMAL HEALTH/OFFICIAL CERTIFICATE FOR THE ENTRY INTO THE UNION OF BOVINE ANIMALS INTENDED FOR SLAUGHTER (MODEL “BOV-Y”)

Part I: Description of consignment

COUNTRY

Animal health/official certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No	Seal No
I.20	Certified as or for

	☐ Slaughter

I.21			I.22	☐ For internal market
			I.23

I.24

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category	Sex	Identification system	Identification number	Age	Quantity

Part II: Certification

COUNTRY

Certificate model BOV-Y

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

II.1.

Public health attestation

I, the undersigned official veterinarian, hereby certify, that the animals described in Part I:

II.1.1.

have not received:

(a)	any stilbene or thyrostatic substances;

(b)	oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other than therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC);

II.1.2.

II.1.3.

with regard to bovine spongiform encephalopathy (BSE),

(a)

the animals are identified by a permanent identification system enabling them to be traced back to the dam and herd of origin, and they are not:

(i)	BSE cases;

(ii)	bovine animals which, during their first year of life, were reared with BSE cases during their first year of life, and which an investigation has shown that they have consumed the same potentially contaminated feed during that period, or

(iii)

(1) either

[(b)

(i)	the animals were born and continuously reared in a country or region thereof or countries or regions thereof classified in accordance with Commission Decision 2007/453/EC as countries or regions posing a negligible BSE risk;

(ii)

if there have been BSE indigenous cases in the country concerned, the animals were born after the date from which the ban on the feeding of ruminants with meat-and-bone meal and greaves derived from ruminants, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health, was effectively enforced, or they were born after the date of birth of the last BSE indigenous case if born after the date of the feed ban.]

(1) or

[(b)

(i)	the country or region thereof of origin of the animals is classified in accordance with Decision 2007/453/EC as a country or region thereof posing a controlled BSE risk;

(ii)

(1) or

[(b)

(i)	the country or region thereof of origin of the animals is classified in accordance with Decision 2007/453/EC as a country or region posing an undetermined BSE risk;

(ii)	the feeding of ruminants with meat-and-bone meal and greaves from ruminants, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health, has been banned and the ban has been effectively enforced in the country or region thereof of origin;

(iii)

(1) (13) [II.1a.

Attestation as regards Commission Delegated Regulation (EU) 2023/905

I, the undersigned official veterinarian, hereby certify that the animals described in Part I have not been administered antimicrobial medicinal products for growth promotion or yield increase or antimicrobial medicinal products containing an antimicrobial that is included in the list of antimicrobials reserved for the treatment of certain infections in humans laid down in Commission Implementing Regulation (EU) 2022/1255, as set out in Article 3 of Commission Delegated Regulation (EU) 2023/905 and originate from a third country or region thereof listed in the Annex to Commission Implementing Regulation (EU) 2024/2598.]

II.2.

Animal health attestation

I, the undersigned official veterinarian, hereby certify that the animals described in Part I:

II.2.1.

come from the zone with code __-__ (2) which, at the date of issue of this animal health/official certificate is authorised for the entry into the Union of bovine animals intended for slaughter and is listed in Part 1 of Annex II to Commission Implementing Regulation (EU) 2021/404;

II.2.2.

are intended for slaughter in the Union;

II.2.3.

have remained continuously:

(a)	in the zone referred to in point II.2.1 since birth or for at least 3 months prior to the date of their dispatch to the Union, and

(b)	in the establishment of origin since birth or for at least 40 days prior to the date of their dispatch to the Union, into which during this period no bovine animals and no animals of other species listed for the same diseases as bovine animals have been introduced;

II.2.4.

had no contact with animals of a lower health status since birth or for at least 30 days prior to the date of their dispatch to the Union;

II.2.5.

(1) either

[II.2.6.

have been dispatched to the Union directly from the establishment of origin without passing through any other establishment;]

(1) or

[II.2.6.

have undergone one single assembly operation in the zone of origin fulfilling the following requirements:

(a)

the assembly operation took place in an establishment:

(i)	approved for conducting assembly operations of ungulates by the competent authority in the third country or territory in accordance with Article 5 of Commission Delegated Regulation (EU) 2019/2035;

(ii)	which has a unique approval number assigned by the competent authority of the third country or territory;

(iii)

listed for that purpose by the competent authority of the third country or territory of dispatch, including the information set out in Article 21 of Delegated Regulation (EU) 2019/2035;

(iv)	fulfilling the requirements provided for in Article 8 of Commission Delegated Regulation (EU) 2020/692;

(b)	the assembly operation in the assembly centre took no longer than 6 days;]

II.2.7.

have not been unloaded in any place that does not comply with the requirements laid down in point II.2.12 since the date of their dispatch from their establishment of origin until the date of loading for dispatch to the Union and during that period they have not been in contact with animals of a lower health status;

II.2.8.

(a)	animals cannot escape or fall out;

(b)	visual inspection of the space where animals are kept is possible;

(c)	the escape of animal excrements, litter or feed is prevented or minimized;

II.2.9.

II.2.10.

have not been vaccinated against:

(a)

(b)	infection with bluetongue virus (serotypes 1-24) with a live vaccine during the last 60 days prior to the date of their dispatch to the Union;

II.2.11.

come from a zone

II.2.11.1.

in which:

(a)

foot and mouth disease has not been reported

(1) either

[for at least 24 months prior to the date of dispatch of the animals to the Union;]

(1) (4) or

[since __/__/____ (dd/mm/yyyy);]

(b)	vaccination against foot and mouth disease has not been carried out for at least 12 months prior to the date of dispatch of the animals to the Union, and no animals vaccinated against foot and mouth disease have been introduced during that period;

II.2.11.2.

in which infection with lumpy skin disease virus has not been reported for at least 12 months prior to the date of dispatch of the animals to the Union;

II.2.11.3.

(a)	vaccination against these diseases has not been carried out, and

(b)	the animals vaccinated against these diseases have not been introduced;

(1) (5) either

[II.2.11.4.

which is free from infection with bluetongue virus (serotypes 1-24);]

(1) or

[II.2.11.4.

which is seasonally free from infection with bluetongue virus (serotypes 1-24)

(1) (6) either

[for at least 60 days prior to the date of dispatch of the animals to the Union;]

(1) (6) or

(1) or

[II.2.11.4.

which is not free from infection with bluetongue virus (serotypes 1-24) and the animals have been vaccinated against all the serotypes (1- 24) of bluetongue virus reported in that zone during the last 2 years prior to the date of dispatch of the animals to the Union and are still within the immunity period guaranteed in the specifications of the vaccine, and

(1) either

[have been vaccinated more than 60 days prior to the date of dispatch of the animals to the Union;]]

(1) or

[II.2.11.4.

(1) either

[the serological test has been carried out on samples collected at least 60 days prior to the date of dispatch of the animals to the Union;]]

(1) or

(1) (7) either

[II.2.11.5.

which is free from enzootic bovine leukosis;]

(1) or

[II.2.11.5.

[II.2.11.5.1.

the animals of the consignment over 24 months of age

(1) either

[have been kept in isolation from the other bovine animals kept in the same establishment prior to the date of dispatch to the Union and during the period of isolation have been subjected to a laboratory examination for enzootic bovine leukosis using one of the diagnostic methods referred to in Article 9, point (b)(i), of Delegated Regulation (EU) 2020/692, with negative results, carried out on samples taken on two occasions at an interval of at least 4 months;]]

(1) or

(1) [II.2.11.5.2.

II.2.12.

come from an establishment:

II.2.12.1.

(a)	the species, categories, number and identification of animals on the establishment;

(b)	movements of animals into and out of the establishment;

(c)	mortality in the establishment;

II.2.12.2.

II.2.12.3.

II.2.12.4.

(1) either

[II.2.12.5.

(1) (8) or

[II.2.12.5.

which is located in a zone seasonally free of epizootic haemorrhagic disease;]

(1) (9) [II.2.12.6.

which is free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) as regards bovine animals;]

(1) (9) [II.2.12.7.

which is free from infection with Brucella abortus, B. melitensis and B. suis as regards bovine animals;]

II.2.12.8.

in which infection with rabies virus has not been reported for at least 30 days prior to the date of dispatch of the animals to the Union;

II.2.12.9.

in which anthrax has not been reported for at least 15 days prior to the date of dispatch of the animals to the Union;

(1) either

[II.2.12.10.

in which surra (Trypanosoma evansi) has not been reported for at least 2 years prior to the date of dispatch of the animals to the Union;]

(1) or

[II.2.12.10.

in which surra (Trypanosoma evansi) has not been reported for at least 30 days prior to the date of dispatch of the animals to the Union and when the disease was reported in the establishment of origin during the last 2 years prior to the date of dispatch of the animals to the Union, the affected establishment remained under restriction until the date on which the infected animals were removed from the establishment and the date on which the remaining animals on the establishment were subjected with negative result to a test for surra as described in Article 9, point (b)(i), of Delegated Regulation (EU) 2020/692 carried out on samples taken at least 6 months after the date on which the infected animals were removed from the establishment;]

(1) (10) [II.2.13.

have not been vaccinated against infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, and

(1) (11) either

[originate from a third country or territory or zone thereof free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis;]]

(1) or

(1) (10) [II.2.14.

have not been vaccinated against bovine viral diarrhoea, and

(1) (12) either

[originate from a third country or territory, or zone thereof free from bovine viral diarrhoea.]]

(1) or

(1) either

[have been kept in a quarantine establishment for at least 21 days prior to the date of their dispatch to the Union.]]]

(1) or

[are pregnant dams that have been subjected to a serological test for the detection of antibodies against bovine viral diarrhoea virus using one of the diagnostic methods provided for in Part 6 of Annex I to Delegated Regulation (EU) 2020/688, with positive results, carried out on samples taken prior to the date of insemination preceding the date of current gestation.]]

Notes:

This animal health/official certificate is intended for the entry of bovine animals that will be slaughtered in the Union.

Part I:

Box reference I.27

Part II:

(1)	Delete if not applicable.

(2)	Code of the zone as it appears in column 2 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(3)	Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.2.1 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of those animals from that zone.

(4)	Only for the zones with an opening date in column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(5)	For the zones with an entry “BTV” in column 7 of the table in Part 1 of Annex I to Implementing Regulation (EU) 2021/404.

(6)	For the zones with an entry “SF-BTV” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(7)	For the zones with an entry “EBL” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(8)	For the zones with an entry “SF-EHD” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(9)	In accordance with Article 10 of Delegated Regulation (EU) 2020/692.

(10)

Only applicable when the Member State of destination or Switzerland, in accordance with the Agreement between the European Community and the Swiss Confederation on trade in agricultural products (OJ L 114, 30.4.2002, p.132), either have disease-free status or an approved eradication programme for the diseases mentioned in points II.2.12 and II.2.13 (infectious bovine rhinotracheitis/infectious pustular vulvovaginitis and bovine viral diarrhoea).

(11)	For the zones with an entry “IBR” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(12)	For the zones with an entry “BVD” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(13)	Applicable to consignments entering the Union as from 3 September 2026.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 3

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF BOVINE ANIMALS INTENDED FOR TRANSIT FROM THE REGION OF KALININGRAD TO OTHER REGIONS OF RUSSIA VIA THE TERRITORY OF LITHUANIA (MODEL “BOV-X-TRANSIT-RU”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No	Seal No
I.20	Certified as or for

I.21	☐ For transit		I.22
	Third country	ISO country code	I.23

I.24

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category	Sex	Identification system	Identification number	Age	Quantity

Part II: Certification

COUNTRY

Certificate model BOV-X-TRANSIT-RU

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

II.1.

Animal health attestation

I, the undersigned official veterinarian, hereby certify that the animals described in Part I:

II.1.1.

come from the zone with code RU-2 (2) which, at the date of issuing this animal health certificate is listed in Part 1 of Annex XXII to Commission Implementing Regulation (EU) 2021/404 for transit of bovine animals through the Union under specific conditions;

(1) either

[II.1.2.

originate from the Union and they were introduced from the Union into the zone with code RU-2 on _____/___/____ (dd/mm/yyyy) and, since that date, they have been kept in facilities where only animals that originate from the Union are kept;]

(1) or

[II.1.2.

have remained in the zone with code RU-2 since birth, or for at least 6 months prior to the date of dispatch to Russia via the Union and without contact with imported animals for the last 30 days prior the date of their dispatch to Russia via the Union;]

II.1.3.

had no contact with animals not complying with the animal health requirements as described in this animal health certificate;

II.1.4.

II.1.5.

have not been unloaded in any place that does not comply with the requirements laid down in point II.1.10 since the date of dispatch from their establishment of origin until the date of their dispatch to Russia via the Union and during that period they have not been in contact with animals of a lower health status;

II.1.6.

are loaded for dispatch to Russia via the Union on ___/___/____ (dd/mm/yyyy) (3) in a means of transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority of the third country or territory and constructed in such a way that:

(a)	animals cannot escape or fall out;

(b)	visual inspection of the space where animals are kept is possible;

(c)	the escape of animal excrements, litter or feed is prevented or minimized;

II.1.7.

have been subjected to a clinical inspection within the last 24 hours prior to the time of loading for dispatch to Russia via the Union, carried out by an official veterinarian, who did not detect signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.1.8.

have not been vaccinated against:

(a)	foot and mouth disease, infection with Rift Valley fever virus, infection with Mycoplasma mycoides subsp. mycoides SC (Contagious bovine pleuropneumonia), and

(b)	infection with bluetongue virus (serotypes 1-24) with a live vaccine during the 60 days prior to the date of their dispatch to Russia via the Union;

II.1.9.

come from the zone described in point II.1.1:

II.1.9.1.

in which:

(a)

foot and mouth disease has not been reported

(1) either

[for at least 24 months prior to the date of dispatch to Russia via the Union;]

(1) (4) or

[since __/__/____ (dd/mm/yyyy);]

(b)	vaccination against foot and mouth disease has not been carried out for at least 12 months prior to the date of dispatch of the animals to Russia via the Union, and no animals vaccinated against foot and mouth disease have been introduced during that period;

II.1.9.2.

in which infection with lumpy skin disease virus has not been reported for at least 12 months prior to the date of dispatch to Russia via the Union;

II.1.9.3.

(a)	vaccination against these diseases has not been carried out, and

(b)	the animals vaccinated against these diseases have not been introduced;

(1) (5) either

[II.1.9.4.

which is free from infection with bluetongue virus (serotypes 1-24);]

(1) or

[II.1.9.4.

which is not free from infection with bluetongue virus (serotypes 1-24) and the animals have been vaccinated against all the serotypes (1-24) of bluetongue virus reported in that zone during the last 2 years prior to the date of dispatch to Russia via the Union and are still within the immunity period guaranteed in the specifications of the vaccine and have been vaccinated more than 60 days prior to the date of dispatch of the animals to Russia via the Union;]

II.1.10.

come from the establishment described under box reference I.11 [where they have remained since birth or for at least 40 days prior to the date of dispatch to Russia via the Union, and] (6):

II.1.10.1.

II.1.10.2.

in and around which, in an area of 10 km radius none of the following listed diseases has been reported for at least 30 days prior to the date of dispatch of the animals to Russia via the Union: foot and mouth disease, infection with rinderpest virus, infection with Rift Valley fever virus, infection with Mycoplasma mycoides subsp. mycoides SC (Contagious bovine pleuropneumonia) and infection with lumpy skin disease virus;

II.1.10.3.

in and around which, in an area of 150 km radius, including where appropriate the territory of a neighbouring country, epizootic haemorrhagic disease has not been reported for at least 60 days prior to the date of dispatch of the animals to Russia via the Union.

Notes:

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.

Part I:

Box reference I.27

Part II:

(1)	Delete if not applicable.

(2)	Code of the zone as it appears in column 2 of the table in Part 1 of Annex XXII to Implementing Regulation (EU) 2021/404.

(3)	Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.1.1 for transit to Russia through the Union, or in a period when restriction measures have been adopted by the Union against such transit of those animals from that zone.

(4)	Only for the zones with an opening date in column 8 of the table in Part 1 of Annex XXII to Implementing Regulation (EU) 2021/404.

(5)	For the zones with an entry “BTV” in column 7 of the table in Part 1 of Annex XXII to Implementing Regulation (EU) 2021/404.

(6)	Delete the text in square brackets if the second option of point II.1.2 is deleted.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 4

MODEL ANIMAL HEALTH/OFFICIAL CERTIFICATE FOR THE ENTRY INTO THE UNION OF OVINE AND CAPRINE ANIMALS (MODEL “OV/CAP-X”)

Part I: Description of consignment

COUNTRY

Animal health/official certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
	☐ Further keeping
				☐ Travelling circus/animal acts
		☐ Quarantine establishment	☐ Exhibition

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

Total net weight/gross weight (kg)

I.27	Description of consignment
CN code	Species	Subspecies/Category	Sex	Identification system	Identification number	Age	Quantity

Part II: Certification

COUNTRY

Certificate model OV/CAP-X

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

(1) [II.1.

Public health attestation (Delete when the Union is not the final destination of the animals)

I, the undersigned official veterinarian, hereby certify, that the animals described in Part I:

II.1.1.

have not received:

(a)	any stilbene or thyrostatic substances;

(b)	oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other than therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC);

II.1.2.

(1) (12) [II.1.a.

Attestation as regards Commission Delegated Regulation (EU) 2023/905 (Delete when the Union is not the final destination of the animals)

I, the undersigned official veterinarian, hereby certify that the animals described in Part I have not been administered antimicrobial medicinal products for growth promotion or yield increase or antimicrobial medicinal products containing an antimicrobial that is included in the list of antimicrobials reserved for the treatment of certain infections in humans laid down in Commission Implementing Regulation (EU) 2022/1255, as set out in Article 3 of Commission Delegated Regulation (EU) 2023/905 and originate from a third country or region thereof listed in the Annex to Commission Implementing Regulation (EU) 2024/2598.]

II.2.

Animal health attestation

I, the undersigned official veterinarian, hereby certify that the animals described in Part I:

II.2.1.

come from the zone with code __-__ (2) which, at the date of issue of this animal health/official certificate is authorised for the entry into the Union of ovine and caprine animals and listed in Part 1 of Annex I to Commission Implementing Regulation (EU) 2021/404;

II.2.2.

have remained continuously:

(a)	in the zone referred to in point II.2.1 since birth or for at least 6 months prior to the date of their dispatch to the Union, and

(b)	in the establishment of origin since birth or for at least 40 days prior to the date of their dispatch to the Union, into which during that period no ovine and caprine animals and no animals of other species listed for the same diseases as ovine and caprine animals have been introduced;

II.2.3.

had no contact with animals of a lower health status since birth or for at least 30 days prior to the date of their dispatch to the Union;

II.2.4.

are not to be killed under a national programme for the eradication of diseases, including the listed diseases referred to in Annex I of Commission Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

(1) either

[II.2.5.

have been dispatched to the Union directly from the establishment of origin without passing through any other establishment;]

(1) or

[II.2.5.

have undergone one single assembly operation in the zone of origin fulfilling the following requirements:

(a)

the assembly operation took place in an establishment:

(i)	approved for conducting assembly operations of ungulates by the competent authority in the third country or territory in accordance with Article 5 of Commission Delegated Regulation (EU) 2019/2035;

(ii)	which has a unique approval number assigned by the competent authority of the third country or territory;

(iii)

listed for that purpose by the competent authority of the third country or territory of dispatch, including the information set out in Article 21 of Delegated Regulation (EU) 2019/2035;

(iv)	fulfilling the requirements provided for in Article 8 of Delegated Regulation (EU) 2020/692;

(b)	the assembly operation in the assembly centre took no longer than 6 days;]

II.2.6.

have not been unloaded in any place that does not comply with the requirements laid down in point II.2.11 since the date of dispatch from their establishment of origin until the date of loading for dispatch to the Union and during that period have not been in contact with animals of a lower health status;

II.2.7.

are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy) (3) in a means of transport which was cleaned and disinfected prior to loading for dispatch with a disinfectant authorised by the competent authority in the third country or territory and constructed in such a way that:

(a)	animals cannot escape or fall out;

(b)	visual inspection of the space where animals are kept is possible;

(c)	the escape of animal excrements, litter or feed is prevented or minimized;

II.2.8.

been subjected to a clinical inspection within the last 24 hours prior to the time of loading for dispatch to the Union, carried out by an official veterinarian in the third country or territory of origin, or zone thereof, who did not detect signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.2.9.

have not been vaccinated against:

(a)

foot and mouth disease, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox, contagious caprine pleuropneumonia, infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) and infection with Brucella abortus, B. melitensis and B. suis, and

(b)	infection with bluetongue virus (serotypes 1-24) with a live vaccine during the last 60 days prior to the date of their dispatch to the Union;

II.2.10.

come from a zone:

II.2.10.1.

in which:

(a)

foot and mouth disease has not been reported

(1) either

[for at least 24 months prior to the date of dispatch to the Union;]

(1) (4) or

[since __/__/____ (dd/mm/yyyy);]

(b)	vaccination against foot and mouth disease has not been carried out for at least 12 months prior to the date of dispatch of the animals to the Union, and no animals vaccinated against foot and mouth disease have been introduced during that period;

II.2.10.2.

in which infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia has not been reported for at least 12 months prior to the date of dispatch of the animals to the Union and during that period:

(a)	vaccination against these diseases has not been carried out, and

(b)	animals vaccinated against these diseases have not been introduced;

(1) (5) either

[II.2.10.3.

which is free from infection with bluetongue virus (serotypes 1-24);]

(1) or

[II.2.10.3.

which is seasonally free from infection with bluetongue virus (serotypes 1-24)

(1) (6) either

[for at least 60 days prior to the date of dispatch of the animals to the Union;]]

(1) (6) or

[for at least 28 days prior to the date of dispatch of the animals to the Union and the animals have been subjected to a serological test in accordance with Article 9, point (b), of Commission Delegated Regulation (EU) 2020/692, with negative results, carried out on samples collected at least 28 days following the date of entry of the animals into the seasonally free zone;]]

(1) (6) or

(1) or

[II.2.10.3.

(1) either

[have been vaccinated more than 60 days prior to the date of dispatch of the animals to the Union;]]

(1) or

[II.2.10.3.

(1) either

[the serological test has been carried out on samples collected at least 60 days prior to the date of dispatch of the animals to the Union;]]

(1) or

II.2.11.

come from an establishment:

II.2.11.1.

(a)	the species, categories, number and identification of animals on the establishment;

(b)	movements of animals into and out of the establishment;

(c)	mortality in the establishment;

II.2.11.2.

II.2.11.3.

II.2.11.4.

in and around which, in an area of 10 km radius, including where appropriate the territory of a neighbouring country, none of the following listed diseases has been reported for at least 30 days prior to the date of dispatch of the animals to the Union: foot and mouth disease, infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia;

(1) either

[II.2.11.5.

(1) (7) or

[II.2.11.5.

which is located in a zone seasonally free of epizootic haemorrhagic disease;]

(1) (8) either

[II.2.11.6.

in which infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has not been reported for a at least 42 days prior to the date of dispatch of the animals to the Union;]

(1) (9) or

[II.2.11.6.

which is subjected to surveillance to detect infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in caprine animals in accordance with the procedures set out in Part 1, points (1) and (2), of Annex II to Commission Delegated Regulation (EU) 2020/688 for at least 12 months prior to the date of dispatch to the Union of the animals described in Part I and during that period:

(a)	only caprine animals from establishments applying such surveillance have been introduced therein;

(1) either

[(b)	infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has not been reported in caprine animals kept therein;]]

(1) or

[(b)	infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has been reported in caprine animals kept therein and measures were taken in accordance with Part 1, point 3, of Annex II to Delegated Regulation (EU) 2020/688;]]

(10) II.2.11.7.

which is free from infection with Brucella abortus, B. melitensis and B. suis as regards ovine and caprine animals; and

(1) (11) either

[in a zone free from the disease as regards ovine and caprine animals where vaccination against that disease is not practised;]

(1) or

[the animals have been tested with one of the diagnostic methods provided for in Article 9, point (b)(i), of Delegated Regulation (EU) 2020/692 for infection with Brucella abortus, B. melitensis and B. suis, with negative results, on a sample taken during the last 30 days prior to the date of dispatch to the Union, and in the case of post-parturient females, the test is carried out on a sample taken at least 30 days after the date of parturition;]

(1) or

[the animals are less than 6 months old;]

(1) or

[the animals are castrated;]

II.2.11.8.

in which rabies has not been reported for at least 30 days prior to the date of dispatch of the animals to the Union;

II.2.11.9.

in which anthrax has not been reported for at least 15 days prior to the date of dispatch of the animals to the Union;

(1) either

[II.2.11.10.

in which surra (Trypanosoma evansi) has not been reported for at least 2 years prior to the date of dispatch of the animals to the Union;]

(1) or

[II.2.11.10.

in which surra (Trypanosoma evansi) has not been reported for at least 30 days prior to the date of dispatch of the animals to the Union and where that disease was reported in the establishment of origin during the last 2 years prior to the date of dispatch of the animals to the Union, the affected establishment remained under restrictions until the date on which the infected animals were removed from the establishment and the date on which the remaining animals on the establishment were subjected with negative results to a test for surra as described in Article 9, point (b)(i), of Delegated Regulation (EU) 2020/692 carried out on samples taken at least 6 months after the date on which the infected animals were removed from the establishment;]

(1) (9) [II.2.11.11.

in which Burkholderia mallei (glanders) has not been reported for at least 6 months prior to the date of dispatch of the animals to the Union;]

II.2.12.

comply with the following conditions as regards classical scrapie:

II.2.12.1.

have been kept continuously since birth in a country where the following conditions are fulfilled:

(a)	classical scrapie is compulsorily notifiable;

(b)	an awareness, surveillance and monitoring system is in place;

(c)	ovine and caprine animals affected with classical scrapie are killed and completely destroyed;

(d)

the feeding to ovine and caprine animals of meat-and-bone meal or greaves of ruminant origin, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health, has been banned and effectively enforced in the whole country for at least 7 years prior to the date of issuing of this animal health/official certificate;

(1) either

[II.2.12.2.

are intended for production and they are destined for a Member State other than a Member State with a negligible risk status for classical scrapie approved in accordance with Chapter A, Section A, point 2.2, of Annex VIII to Regulation (EC) No 999/2001, or other than a Member State which is listed in Chapter A, Section A, point 3.2, of Annex VIII to Regulation (EC) No 999/2001 as having an approved national scrapie control programme;]

(1) or

[II.2.12.2.

are intended for breeding and they are destined for a Member State other than a Member State with a negligible risk status for classical scrapie approved in accordance with Chapter A, Section A, point 2.2, of Annex VIII to Regulation (EC) No 999/2001, or other than a Member State which is listed in Chapter A, Section A, point 3.2, of Annex VIII to Regulation (EC) No 999/2001 as having an approved national scrapie control programme, and

(1) either

[come from a holding or holdings that have complied with the requirements laid down in Chapter A, Section A, point 1.3, of Annex VIII to Regulation (EC) No 999/2001;]]

(1) or

[are ovine animals of the ARR/ARR prion protein genotype or caprine animals carrying at least one of the K222, D146 or S146 alleles, and they come from a holding or holdings where no official movement restriction has been imposed due to BSE or classical scrapie for the last 2 years prior to the date of issuing of this animal health/official certificate;]]

(1) or

[II.2.12.2.

are destined for a Member State with a negligible risk status for classical scrapie approved in accordance with Chapter A, Section A, point 2.2, of Annex VIII to Regulation (EC) No 999/2001, or for a Member State listed in Chapter A, Section A, point 3.2, of Annex VIII to Regulation (EC) No 999/2001 as having an approved national scrapie control programme, and

(1) either

[come from a holding or holdings that have complied with the requirements laid down in Chapter A, Section A, point 1.2, of Annex VIII to Regulation (EC) No 999/2001;]]

(1) or

(1) [II.2.13.

include uncastrated males of ovine animals, which have remained during the period of at least 30 days prior to the date of their dispatch to the Union in an establishment where ovine epididymitis (Brucella ovis) has not been reported during the last 12 months prior to the date of their dispatch to the Union and have been subjected to a serological test for ovine epididymitis (Brucella ovis), with negative results, during the last 30 days prior to the date of their dispatch to the Union.]

Notes:

This animal health/official certificate is intended for the entry into the Union of ovine and caprine animals, including when the Union is not the final destination of the animals.

Part I:

Box reference I.27

Part II:

(1)	Delete if not applicable.

(2)	Code of the zone as it appears in column 2 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(3)	Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.2.1 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of those animals from that zone.

(4)	Only for the zones with an opening date in column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(5)	For the zones with an entry “BTV” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(6)	For the zones with an entry “SF-BTV” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(7)	For the zones with an entry “SF-EHD” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(8)	Only for ovine animals.

(9)	Only for caprine animals.

(10)	In accordance with Article 10 of Delegated Regulation (EU) 2020/692.

(11)	For the zones with an entry “BRU” for ovine and caprine animals in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(12)	Applicable to consignments entering the Union as from 3 September 2026.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 5

MODEL ANIMAL HEALTH/OFFICIAL CERTIFICATE FOR THE ENTRY INTO THE UNION OF OVINE AND CAPRINE ANIMALS INTENDED FOR SLAUGHTER (MODEL “OV/CAP-Y”)

Part I: Description of consignment

COUNTRY

Animal health/official certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No	Seal No
I.20	Certified as or for

	☐ Slaughter

I.21			I.22	☐ For internal market
			I.23

I.24

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category	Sex	Identification system	Identification number	Age	Quantity

Part II: Certification

COUNTRY

Certificate model OV/CAP-Y

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

II.1.

Public health attestation

I, the undersigned official veterinarian, hereby certify, that the animals described in Part I:

II.1.1.

have not received:

(a)	any stilbene or thyrostatic substances;

(b)	oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other than therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC);

II.1.2.

(1) (11) [II.1a.

Attestation as regards Commission Delegated Regulation (EU) 2023/905

I, the undersigned official veterinarian, hereby certify that the animals described in Part I have not been administered antimicrobial medicinal products for growth promotion or yield increase or antimicrobial medicinal products containing an antimicrobial that is included in the list of antimicrobials reserved for the treatment of certain infections in humans laid down in Commission Implementing Regulation (EU) 2022/1255, as set out in Article 3 of Commission Delegated Regulation (EU) 2023/905 and originate from a third country or region thereof listed in the Annex to Commission Implementing Regulation (EU) 2024/2598.]

II.2.

Animal health attestation

I, the undersigned official veterinarian, hereby certify that the animals described in Part I:

II.2.1.

come from the zone with code __-__ (2) which, at the date of issuing this animal health/official certificate is authorised for the entry into the Union of ovine and caprine animals and is listed in Part 1 of Annex I to Commission Implementing Regulation (EU) 2021/404;

II.2.2.

are intended for slaughter in the Union;

II.2.3.

have remained continuously:

(a)	in the zone referred to in point II.2.1 since birth or for at least 3 months prior to the date of their dispatch to the Union, and

(b)	in the establishment of origin since birth or for at least 40 days prior to the date of their dispatch to the Union, into which during this period no ovine and caprine animals and no animals of other species listed for the same diseases as ovine and caprine animals have been introduced;

II.2.4.

had no contact with animals of a lower health status since birth or for at least 30 days prior to the date of their dispatch to the Union;

II.2.5.

(1) either

[II.2.6.

have been dispatched to the Union directly from the establishment of origin without passing through any other establishment;]

(1) or

[II.2.6.

have undergone one single assembly operation in the zone of origin fulfilling the following requirements:

(a)

the assembly operation took place in an establishment:

(i)	approved for conducting assembly operations of ungulates by the competent authority in the third country or territory in accordance with Article 5 of Commission Delegated Regulation (EU) 2019/2035;

(ii)	which has a unique approval number assigned by the competent authority of the third country or territory;

(iii)

listed for that purpose by the competent authority of the third country or territory of dispatch, including the information set out in Article 21 of Delegated Regulation (EU) 2019/2035;

(iv)	fulfilling the requirements provided for in Article 8 of Delegated Regulation (EU) 2020/692;

(b)	the assembly operation in the assembly centre took no longer than 6 days;]

II.2.7.

have not been unloaded in any place that does not comply with the requirements laid down in point II.2.12 since the date of dispatch from their establishment of origin until the date of their dispatch to the Union and during that period have not been in contact with animals of a lower health status;

II.2.8.

are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy) (3) in a means of transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority in the third country or territory and constructed in such a way that:

(a)	animals cannot escape or fall out;

(b)	visual inspection of the space where animals are kept is possible;

(c)	the escape of animal excrements, litter or feed is prevented or minimized;

II.2.9.

II.2.10.

have not been vaccinated against:

(i)

(ii)	infection with bluetongue virus (serotypes 1-24) with a live vaccine during the last 60 days prior to the date of their dispatch to the Union;

II.2.11.

come from a zone:

II.2.11.1.

in which:

(a)

foot and mouth disease has not been reported

(1) either

[for at least 24 months prior to the date of their dispatch to the Union;]

(1) (4) or

[since __/__/____ (dd/mm/yyyy);]

(b)	vaccination against foot and mouth disease has not been carried out for at least 12 months prior to the date of dispatch of the animals to the Union, and no animals vaccinated against foot and mouth disease have been introduced during that period;

II.2.11.2.

(a)	vaccination against these diseases has not been carried out, and

(b)	animals vaccinated against these diseases have not been introduced;

(1) (5) either

[II.2.11.3.

which is free from infection with bluetongue virus (serotypes 1-24);]

(1) or

[II.2.11.3.

which is seasonally free from infection with bluetongue virus (serotypes 1-24)

(1) (6) either

[for at least 60 days prior to the date of dispatch of the animals to the Union;]]

(1) (6) or

(1) or

[II.2.11.3.

(1) either

[have been vaccinated more than 60 days prior to the date of dispatch of the animals to the Union;]]

(1) or

[II.2.11.3.

(1) either

[the serological test has been carried out on samples collected at least 60 days prior to the date of dispatch of the animals to the Union;]]

(1) or

II.2.12.

come from an establishment:

II.2.12.1.

(a)	the species, categories, number and identification of animals on the establishment;

(b)	movements of animals into and out of the establishment;

(c)	mortality in the establishment;

II.2.12.2.

II.2.12.3.

II.2.12.4.

in and around which, in an area of 10 km radius, including where appropriate the territory of a neighbouring country, none of the following listed diseases has been reported for at least 30 days prior to the date of dispatch of the animals to the Union: foot and mouth disease, infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia;

(1) either

[II.2.12.5.

(1) (7) or

[II.2.12.5.

which is located in a zone seasonally free of epizootic haemorrhagic disease;]

(1) (8) either

[II.2.12.6.

in which infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has not been reported for the last 42 days prior to the date of dispatch of the animals to the Union;]

(1) (9) or

[II.2.12.6.

which is subjected to surveillance to detect infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in caprine animals in accordance with the procedures in Part 1, points 1 and 2, of Annex II to Commission Delegated Regulation (EU) 2020/688 during at least 12 months prior to the date of dispatch to the Union of the animals described in Part I and during that period:

(a)	only caprine animals from establishments applying such surveillance have been introduced therein;

(1) either

[(b)	infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has not been reported in caprine animals kept therein;]]

(1) or

[(b)	infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has been reported in caprine animals kept therein and measures were taken in accordance with Part 1, point 3, of Annex II to Delegated Regulation (EU) 2020/688;]]

II.2.12.7.

which is free from infection with Brucella abortus, B. melitensis and B. suis as regards ovine and caprine animals (10);

II.2.12.8.

in which rabies has not been reported for at least 30 days prior to dispatch of the animals to the Union;

II.2.12.9.

in which anthrax has not been reported for at least 15 days prior to the date of dispatch of the animals to the Union;

(1) either

[II.2.12.10.

in which surra (Trypanosoma evansi) has not been reported for at least 2 years prior to the date of dispatch of the animals to the Union;]

(1) or

[II.2.12.10.

in which surra (Trypanosoma evansi) has not been reported for at least 30 days prior to the date of dispatch of the animals to the Union, and when the disease was reported in the establishment of origin during the last 2 years prior to the date of dispatch of the animals to the Union, the affected establishment remained under restriction until the date on which the infected animals were removed from the establishment and the date on which the remaining animals on the establishment were subjected with negative result to a test for surra as described in Article 9, point (b)(i), of Delegated Regulation (EU) 2020/692 carried out on samples taken at least 6 months after the date on which the infected animals were removed from the establishment;]

(1) (9) [II.2.12.11.

in which Burkholderia mallei (glanders) has not been reported for at least 6 months prior to the date of dispatch of the animals to the Union;]

II.2.13.

have been kept continuously since birth in a country where the following conditions as regards classical scrapie are fulfilled:

(a)	classical scrapie is compulsorily notifiable;

(b)	an awareness, surveillance and monitoring system is in place;

(c)	ovine and caprine animals affected with classical scrapie are killed and completely destroyed;

(d)

(1) [II.2.14.

include uncastrated males of ovine animals, which have remained during the period of at least 30 days prior to their dispatch to the Union in an establishment where ovine epididymitis (Brucella ovis) has not been reported during the last 12 months prior to the date of their dispatch to the Union and have been subjected to a serological test for ovine epididymitis (Brucella ovis), with negative results, during the last 30 days prior to the date of their dispatch to the Union.]

Notes:

This animal health/official certificate is intended for the entry of ovine and caprine animals that will be slaughtered in the Union.

Part I:

Box reference I.27

Part II:

(1)	Delete if not applicable.

(2)	Code of the zone as it appears in column 2 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(3)	Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.2.1 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of those animals from that zone.

(4)	Only for the zones with an opening date in column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(5)	For the zones with an entry “BTV” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(6)	For the zones with an entry “SF-BTV” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(7)	For zones with entry “SF-EHD” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(8)	Only for ovine animals.

(9)	Only for caprine animals.

(10)	In accordance with Article 10 of Delegated Regulation (EU) 2020/692.

(11)	Applicable to consignments entering the Union as from 3 September 2026.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 6

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CERTAIN UNGULATES WHICH ORIGINATE IN THE UNION, ARE MOVED TO A THIRD COUNTRY OR TERRITORY FOR THEIR PARTICIPATION IN EVENTS, EXHIBITIONS, DISPLAYS AND SHOWS AND ARE THEN MOVED BACK TO THE UNION (MODEL “ENTRY-EVENTS”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No	Seal No
I.20	Certified as or for
	☐ Further keeping

I.21		I.22	☐ For internal market
		I.23

I.24

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category	Sex	Identification system	Identification number	Age	Quantity

Part II: Certification

COUNTRY

Certificate model ENTRY-EVENTS

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

II.1.

Animal health attestation

I, the undersigned official veterinarian, hereby certify, that the ungulates described in Part I:

II.2.1.

are [bovine animals] (1) [ovine animals] (1) [caprine animals] (1)which originate from the Union and were moved on _____/___/____ (dd/mm/yyyy) (2) to participate in an event, exhibition, display or show that took place in an establishment:

(a)	located in the zone with code __-__ (3) (4) which, at the date of dispatch of the animals from the Union was authorised for the entry into the Union of the species of animals of that consignment and listed in Part 1 of Annex II to Commission Implementing Regulation (EU) 2021/404 accordingly;

(b)	that complies with the requirements applicable to conduct assembly operations of ungulates laid down in Article 20(2), point (b), of Commission Delegated Regulation (EU) 2020/692;

(c)	which, for the entire duration of the event, kept only bovine, ovine or caprine animals that were in compliance with all the relevant requirements for the entry into the Union provided for in Union legislation upon the date of arrival at the establishment;

II.2.2.

were dispatched directly from their establishment of origin in the Union to the establishment referred to in point II.2.1 without passing through any other establishment or any other third country or territory;

II.2.3.

are loaded for direct dispatch to the Union on ___/___/____ (dd/mm/yyyy) (5) in a means of transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority of the third country or territory and constructed in such a way that:

(a)	animals cannot escape or fall out;

(b)	visual inspection of the space where animals are kept is possible;

(c)	the escape of animal excrements, litter or feed is prevented or minimized;

II.2.4.

have been subjected to a clinical inspection within the last 24 hours prior to the time of loading for dispatch to the Union, carried out by an official veterinarian in the third country or territory of origin, or zone thereof, who did not detect signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.2.5.

have had no contact with other animals of a lower health status from the time of loading for dispatch from the Union to the establishment referred to in point II.2.1 and for all the duration of the event until the date of loading for dispatch to the Union.

Notes:

This animal health certificate is intended for the entry into the Union of certain ungulates which originate in the Union, are moved to a third country or territory for their participation in events, exhibitions, displays and shows and are then moved back to the Union. This animal health certificate is only for the third countries or territories, or zones thereof with the entry “EVENTS” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.27

Part II:

(1)	Delete if not applicable.

(2)

Date of dispatch from the Union shall not be prior to the date of authorisation of the zone for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of those animals from that zone. It shall not be prior to the date of approval of the event for which the ungulate is being transported.

(3)	Code of the zone as it appears in column 2 of the table in Part 1 of Annex II, to Implementing Regulation (EU) 2021/404.

(4)	Only for the zones with an entry “EVENTS” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(5)	Date of dispatch for the return to the Union: The period between that date and the date of loading for dispatch from the Union shall not exceed 15 days.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 7

MODEL ANIMAL HEALTH/OFFICIAL CERTIFICATE FOR THE ENTRY INTO THE UNION OF PORCINE ANIMALS AND ANIMALS OF THE FAMILY TAYASSUIDAE (MODEL “SUI-X”)

Part I: Description of consignment

COUNTRY

Animal health/official certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
	☐ Further keeping
				☐ Travelling circus/animal acts
		☐ Quarantine establishment	☐ Exhibition

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category	Sex	Identification system	Identification number	Age	Quantity

Part II: Certification

COUNTRY

Certificate model SUI-X

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

(1) [II.1.

Public health attestation (Delete when the Union is not the final destination of the animals)

I, the undersigned official veterinarian, hereby certify, that the animals described in Part I:

II.1.1.

have not received:

(a)	any stilbene or thyrostatic substances;

(b)	oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other than therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC);

II.1.2.

(1) (2) (10) [II.1.3.

are domestic porcine animals either coming from a holding officially recognised as applying controlled housing conditions in accordance with Article 8 of Commission Implementing Regulation (EU) 2015/1375 or are not weaned and less than 5 weeks of age.]]

(1) (11) [II.1.a.

Attestation as regards Commission Delegated Regulation (EU) 2023/905 (Delete when the Union is not the final destination of the animals)

I, the undersigned official veterinarian, hereby certify that the animals described in Part I have not been administered antimicrobial medicinal products for growth promotion or yield increase or antimicrobial medicinal products containing an antimicrobial that is included in the list of antimicrobials reserved for the treatment of certain infections in humans laid down in Commission Implementing Regulation (EU) 2022/1255, as set out in Article 3 of Commission Delegated Regulation (EU) 2023/905 and originate from a third country or region thereof listed in the Annex to Commission Implementing Regulation (EU) 2024/2598.]

II.2.

Animal health attestation

I, the undersigned official veterinarian, hereby certify, that the animals described in Part I:

II.2.1.

come from the zone with code __-__ (2) which, at the date of issue of this animal health/official certificate is authorised for the entry into the Union of animals of the families Suidae and Tayassuidae and listed in Part 1 of Annex II to Commission Implementing Regulation (EU) 2021/404;

II.2.2.

have remained continuously:

(a)	in the zone referred to in point II.2.1 since birth or for at least 6 months immediately prior to the date of their dispatch to the Union, and

(b)

in the establishment of origin since birth or for at least 40 days prior to the date of their dispatch to the Union, into which during this period no animals of the families Suidae and Tayassuidae and no animals of other species listed for the same diseases as animals of the families Suidae and Tayassuidae have been introduced;

II.2.3.

had no contact with animals of a lower health status since birth or for at least 30 days prior to the date of their dispatch to the Union;

II.2.4.

(1) either

[II.2.5.

have been dispatched to the Union directly from the establishment of origin without passing through any other establishment;]

(1) (3) or

[II.2.5.

have undergone one single assembly operation in the zone of origin fulfilling the following requirements:

(a)

the assembly operation took place in an establishment:

(i)	approved for conducting assembly operations of ungulates by the competent authority in the third country or territory in accordance with Article 5 of Commission Delegated Regulation (EU) 2019/2035;

(ii)	which has a unique approval number assigned by the competent authority of the third country or territory;

(iii)

listed for that purpose by the competent authority of the third country or territory of dispatch, including the information set out in Article 21 of Delegated Regulation (EU) 2019/2035;

(iv)	fulfilling the requirements provided for in Article 8 of Delegated Regulation (EU) 2020/692;

(b)	the assembly operation in the assembly centre took no longer than 6 days;]

II.2.6.

have not been unloaded in any place that does not comply with the requirements laid down in point II.2.11 since the date of their dispatch from their establishment of origin until the date of their dispatch to the Union and during that period they have not been in contact with animals of a lower health status;

II.2.7.

are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy) (4) in a means of transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority in the third country or territory and constructed in such a way that:

(a)	animals cannot escape or fall out;

(b)	visual inspection of the space where animals are kept is possible;

(c)	the escape of animal excrements, litter or feed is prevented or minimized;

II.2.8.

have been subjected to a clinical inspection within the last 24 hours prior to the time of loading for dispatch to the Union, carried out by an official veterinarian in the third country or territory of origin, or zone thereof, who did not detect signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.2.9.

have not been vaccinated against foot and mouth disease and classical swine fever;

II.2.10.

come from a zone in which:

II.2.10.1.

foot and mouth disease has not been reported

(1) either

[for at least 24 months prior to the date of their dispatch to the Union;]

(1) (5) or

[since ___/___/____ (dd/mm/yyyy);]

and in which vaccination against foot and mouth disease has not been carried out for at least 12 months prior to the date of dispatch of the animals to the Union and no animals vaccinated against the disease have been introduced during that period;

II.2.10.2.

infection with rinderpest virus has not been reported for at least 12 months prior to the date of dispatch of the animals to the Union and in which vaccination against this disease has not been carried out for at least 12 months prior to the date of dispatch of the animals to the Union and no animals vaccinated against the disease have been introduced during that period;

II.2.10.3.

classical swine fever has not been reported

(1) either

[for at least 24 months prior to the date of dispatch of the animals to the Union;]

(1) (6) or

[since ___/___/____ (dd/mm/yyyy) and the animals of the consignment have been subjected to a test for the detection of classical swine fever, with a negative result, carried out within the last 30 days prior to the date of dispatch of the animals to the Union;]

and in which vaccination against classical swine fever has not been carried out for at least 12 months prior to the date of dispatch of the animals to the Union and no animals vaccinated against the disease have been introduced during that period

(1) (7) [II.2.10.4.

African swine fever has not been reported for at least 12 months prior to the date of dispatch of the animals to the Union;]

II.2.11.

come from an establishment:

II.2.11.1.

(a)	the species, categories, number and identification of animals on the establishment;

(b)	movements of animals into and out of the establishment;

(c)	mortality in the establishment;

II.2.11.2.

II.2.11.3.

II.2.11.4.

II.2.11.5.

[in which infection with Brucella abortus, B. melitensis and B. suis has not been reported for at least 42 days prior to the date of dispatch of the animals to the Union and in which during the last 12 months prior to the date of their dispatch to the Union

(1) either

[biosecurity and risk mitigating measures, including housing conditions and feeding systems, have been applied as necessary to prevent transmission of infection with Brucella abortus, B. melitensis and B. suis from wild animals of listed species to porcine animals kept on the establishment and only porcine animals from establishments applying equivalent biosecurity measures have been introduced;]]

(1) or

[surveillance for infection with Brucella abortus, B. melitensis and B. suis has been carried out on the porcine animals kept on the establishment in accordance with Annex III to Commission Delegated Regulation (EU) 2020/688, and during that period:

(a)

only porcine animals from establishments applying such surveillance or biosecurity measures, including housing conditions and feeding systems, necessary to prevent transmission of infection with Brucella abortus, B. melitensis and B. suis from wild animals of listed species to porcine animals kept on the establishments, have been introduced, and

(b)	in the case where infection with Brucella abortus, B. melitensis and B. suis has been reported in porcine animals kept therein, measures were taken in accordance with Part 1, point 3, of Annex II to Delegated Regulation (EU) 2020/688;]]

II.2.11.6.

in which infection with Aujeszky’s disease virus has not been reported for at least 30 days prior to the date of dispatch of the animals to the Union;

II.2.11.7.

in which anthrax has not been reported for at least 15 days prior to the date of dispatch of the animals to the Union;

(1) (7) [II.2.11.8.

in which rabies has not been reported for at least 30 days prior to the date of dispatch of the animals to the Union;]

(1) (8) [II.2.12.

(1) (9) either

[originate from a third country or territory, or zone thereof free from infection with Aujeszky’s disease virus.]]

(1) (7) or

[meet the following requirements:

(a)	have not been vaccinated against infection with Aujeszky’s disease virus;

(b)	were kept in an approved quarantine establishment for at least 30 days;

(c)

were subjected to a serological test for the detection of antibodies against whole Aujeszky’s disease virus with the diagnostic method provided for in Part 7 of Annex I to Delegated Regulation (EU) 2020/688, with a negative result, carried out on samples taken on two occasions at an interval of not less than 30 days, the last sample taken during the period of 15 days prior to the date of dispatch to the Union.]]

Notes:

This animal health/official certificate is intended for the entry into the Union of porcine animals and animals of the family Tayassuidae, including when the Union is not the final destination of those animals.

Part I:

Box reference I.27

Part II:

(1)	Delete if not applicable.

(2)	Code of the zone as it appears in column 2 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(3)	Only possible for porcine animals.

(4)	Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.2.1 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of those animals from that zone.

(5)	Only for the zones with an opening date in column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(6)	For the zones with an entry “CSF” in column 6 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404

(7)	Only applicable to ungulates of the family Suidae.

(8)

Only applicable when the Member State of destination or Switzerland, in accordance with the Agreement between the European Community and the Swiss Confederation on trade in agricultural products (OJ L 114, 30.4.2002, p.132), either have disease-free status or an approved eradication programme for the disease mentioned in point II.2.12 (infection with Aujeszky’s disease virus).

(9)	For the zones with an entry “ADV” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404 recognised free from infection with Aujeszky’s disease virus and fulfilling the requirements laid down in Delegated Regulation (EU) 2020/689.

(10)	Only for third countries or territories listed in Article 13(2) of Implementing Regulation (EU) 2015/1375.

(11)	Applicable to consignments entering the Union as from 3 September 2026.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 8

MODEL ANIMAL HEALTH/OFFICIAL CERTIFICATE FOR THE ENTRY INTO THE UNION OF PORCINE ANIMALS INTENDED FOR SLAUGHTER (MODEL “SUI-Y”)

Part I: Description of consignment

COUNTRY

Animal health/official certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No	Seal No
I.20	Certified as or for

	☐ Slaughter

I.21			I.22	☐ For internal market
			I.23

I.24

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category	Sex	Identification system	Identification number	Age	Quantity

Part II: Certification

COUNTRY

Certificate model SUI-Y

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

II.1.

Public health attestation

I, the undersigned official veterinarian, hereby certify, that the animals described in Part I:

II.1.1.

have not received:

(a)	any stilbene or thyrostatic substances;

(b)	oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other than therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC);

II.1.2.

(1) (2) (10) [II.1.3.

(1) (11) [II.1a.

Attestation as regards Commission Delegated Regulation (EU) 2023/905

I, the undersigned official veterinarian, hereby certify that the animals described in Part I have not been administered antimicrobial medicinal products for growth promotion or yield increase or antimicrobial medicinal products containing an antimicrobial that is included in the list of antimicrobials reserved for the treatment of certain infections in humans laid down in Commission Implementing Regulation (EU) 2022/1255, as set out in Article 3 of Commission Delegated Regulation (EU) 2023/905 and originate from a third country or region thereof listed in the Annex to Commission Implementing Regulation (EU) 2024/2598.]

II.2.

Animal health attestation

I, the undersigned official veterinarian, hereby certify, that the animals described in Part I:

II.2.1.

come from the zone with code __-__ (2) which, at the date of issue of this animal health/official certificate is authorised for the entry into the Union of porcine animals intended for slaughter and listed in Part 1 of Annex II to Commission Implementing Regulation (EU) 2021/404;

II.2.2.

are intended for slaughter in the Union;

II.2.3.

have remained continuously:

(a)	in the zone referred to in point II.2.1 since birth or for at least 3 months prior to the date of their dispatch to the Union, and

(b)	in the establishment of origin since birth or for at least 40 days prior to the date of their dispatch to the Union, into which during this period no porcine animals and no animals of other species listed for the same diseases as porcine animals have been introduced;

II.2.4.

had no contact with animals of a lower health status since birth or for at least 30 days prior to the date of their dispatch to the Union;

II.2.5.

(1) either

[II.2.6.

have been dispatched to the Union directly from the establishment of origin without passing through any other establishment;]

(1) (3) or

[II.2.6.

have undergone one single assembly operation in the zone of origin fulfilling the following requirements:

(a)

the assembly operation took place in an establishment:

(i)	approved for conducting assembly operations of ungulates by the competent authority in the third country or territory in accordance with Article 5 of Commission Delegated Regulation (EU) 2019/2035;

(ii)	which has a unique approval number assigned by the competent authority of the third country or territory;

(iii)

listed for that purpose by the competent authority of the third country or territory of dispatch, including the information set out in Article 21 of Delegated Regulation (EU) 2019/2035;

(iv)	fulfilling the requirements provided for in Article 8 of Delegated Regulation (EU) 2020/692;

(b)	the assembly operation in the assembly centre took no longer than 6 days;]

II.2.7.

have not been unloaded in any place that does not comply with the requirements laid down in point II.2.12 since the date of dispatch from their establishment of origin until the date of dispatch to the Union and during that period they have not been in contact with animals of a lower health status;

II.2.8.

(a)	animals cannot escape or fall out;

(b)	visual inspection of the space where animals are kept is possible;

(c)	the escape of animal excrements, litter or feed is prevented or minimized;

II.2.9.

have been subjected to a clinical inspection within the last 24 hours prior to the time of loading for dispatch to the Union, carried out by an official veterinarian in the third country or territory of origin, or zone thereof, who did not detect signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.2.10.

have not been vaccinated against foot and mouth disease and classical swine fever;

II.2.11.

come from a zone in which:

II.2.11.1.

foot and mouth disease has not been reported

(1) either

[for at least 24 months prior to the date of dispatch of the animals to the Union;]

(1) (5) or

[since ___/___/____ (dd/mm/yyyy);]

II.2.11.2.

II.2.11.3.

classical swine fever has not been reported

(1) either

[for at least 24 months prior to the date of dispatch of the animals to the Union;]

(1) (6) or

[since ___/___/____ (dd/mm/yyyy) and the animals have been subjected to a test for the detection of classical swine fever, with a negative result, carried out within the last 30 days prior to the date of their dispatch to the Union;]

(1) (7) [II.2.11.4.

African swine fever has not been reported for at least 12 months prior to the date of dispatch of the animals to the Union;]

II.2.12.

come from an establishment:

II.2.12.1.

(a)	the species, categories, number and identification of animals on the establishment;

(b)	movements of animals into and out of the establishment;

(c)	mortality in the establishment;

II.2.12.2.

II.2.12.3.

II.2.12.4.

(1) either

[II.2.12.5.

in which infection with Brucella abortus, B. melitensis and B. suis has not been reported for at least 42 days prior to dispatch of the animals to the Union and in which during the last 12 months prior to the date of dispatch of the animals to the Union the biosecurity and risk mitigating measures, including housing conditions and feeding systems, have been applied as necessary to prevent transmission of infection with Brucella abortus, B. melitensis and B. suis from wild animals of listed species to porcine animals kept in the establishment and only porcine animals from establishments applying equivalent biosecurity measures have been introduced;]

(1) or

[II.2.12.5.

in which infection with Brucella abortus, B. melitensis and B. suis has not been reported for at least 42 days prior to dispatch of the animals to the Union and in which during the last 12 months prior to the date of dispatch of the animals to the Union a surveillance for infection with Brucella abortus, B. melitensis and B. suis has been carried out on the porcine animals kept in the establishment in accordance with Annex III to Commission Delegated Regulation (EU) 2020/688, and during that period:

(a)

(b)	in the case where infection with Brucella abortus, B. melitensis and B. suis has been reported in porcine animals kept therein, measures were taken in accordance with Part 1, point 3, of Annex II to Delegated Regulation (EU) 2020/688;]

II.2.12.6.

in which infection with Aujeszky’s disease virus has not been reported for at least 30 days prior to the date of dispatch of the animals to the Union;

II.2.12.7.

in which anthrax has not been reported for at least 15 days prior to the date of dispatch of the animals to the Union;

(1) (7) [II.2.12.8.

in which rabies has not been reported for at least 30 days prior to the date of dispatch of the animals to the Union;]

(1) (8) [(1) (9) either

[II.2.13.

originate from a third country or territory, or zone thereof free from infection with Aujeszky’s disease virus.]

(1) (7) or

[II.2.13.

meet the following requirements:

(a)	have not been vaccinated against infection with Aujeszky’s disease virus;

(b)	were kept in an approved quarantine establishment for at least 30 days;

(c)

Notes:

This animal health/official certificate is intended for porcine animals and animals of the family Tayassuidae that will be slaughtered in the Union.

Part I:

Box reference I.27

Part II:

(1)	Delete if not applicable.

(2)	Code of the zone as it appears in column 2 of the table in Part 1 of Annex II to Commission Implementing Regulation (EU) 2021/404.

(3)	Only possible for porcine animals.

(4)	Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.2.1 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of those animals from that zone.

(5)	Only for the zones with an opening date in column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(6)	For the zones with an entry “CSF” in column 6 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(7)	Only applicable to ungulates of the family Suidae.

(8)

Only applicable when the Member State of destination or Switzerland, in accordance with the Agreement between the European Community and the Swiss Confederation on trade in agricultural products (OJ L 114, 30.4.2002, p.132), either have disease-free status or an approved eradication programme for the disease mentioned in point II.2.13 (infection with Aujeszky’s disease virus).

(9)	For the zones with an entry “ADV” in column 7 of the table in Part 1 of Annex II to Regulation (EU) 2021/404 recognised free from infection with Aujeszky’s disease virus and fulfilling the requirements laid down in Delegated Regulation (EU) 2020/689.

(10)	Only for third countries or territories listed in Article 13(2) of Implementing Regulation (EU) 2015/1375.

(11)	Applicable to consignments entering the Union as from 3 September 2026.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 9

MODEL ANIMAL HEALTH/OFFICIAL CERTIFICATE FOR THE ENTRY INTO THE UNION OF ANIMALS OF THE FAMILIES ANTILOCAPRIDAE, BOVIDAE (OTHER THAN BOVINE, OVINE AND CAPRINE ANIMALS), GIRAFFIDAE, MOSCHIDAE AND TRAGULIDAE (MODEL “RUM”)

Part I: Description of consignment

COUNTRY

Animal health/official certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
	☐ Further keeping
				☐ Travelling circus/animal acts
		☐ Quarantine establishment	☐ Exhibition

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category	Sex	Identification system	Identification number	Age	Quantity

Part II: Certification

COUNTRY

Certificate model RUM

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

(1) [II.1.

Public health attestation (Delete when the Union is not the final destination of the animals)

I, the undersigned official veterinarian, hereby certify, that the animals described in Part I:

II.1.1.

have not received:

(a)	any stilbene or thyrostatic substances;

(b)	oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other than therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC);

II.1.2.

II.2.

Animal health attestation

I, the undersigned official veterinarian, hereby certify, that the animals described in Part I:

II.2.1.

come from the zone with code __-__ (2) which, at the date of issue of this animal health/official certificate is authorised for the entry into the Union of ungulates of the families Antilocapridae, Bovidae, Giraffidae, Moschidae, Tragulidae and listed in Part 1 of Annex II to Commission Implementing Regulation (EU) 2021/404;

II.2.2.

have remained continuously:

(a)	in the zone referred to in point II.2.1 since birth or for at least 6 months prior to the date of their dispatch to the Union, and

(b)

in the establishment of origin since birth or for at least 40 days prior to the date of their dispatch to the Union, into which during that period no ungulates of the families of Antilocapridae, Bovidae, Giraffidae, Moschidae, Tragulidae and no animals of other species listed for the same diseases as ungulates of the families Antilocapridae, Bovidae, Giraffidae, Moschidae, Tragulidae have been introduced;

II.2.3.

had no contact with animals of a lower health status since birth or for at least 6 months prior to the date of their dispatch to the Union;

II.2.4.

II.2.5.

have been dispatched to the Union directly from the establishment of origin without passing through any other establishment;

II.2.6.

II.2.7.

are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy) (3) in a means of transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority in the third country or territory and constructed in such a way that:

(a)	animals cannot escape or fall out;

(b)	visual inspection of the space where animals are kept is possible;

(c)	the escape of animal excrements, litter or feed is prevented or minimized;

II.2.8.

have been subjected to a clinical inspection within the last 24 hours prior to the time of loading for dispatch to the Union, carried out by an official veterinarian in the third country or territory of origin, or zone thereof, who did not detect signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.2.9.

have not been vaccinated against:

(a)

foot and mouth disease, infection with rinderpest virus, infection with Rift Valley fever virus, infection with Mycoplasma mycoides subsp. mycoides SC (contagious bovine pleuropneumonia), contagious caprine pleuropneumonia, infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis), infection with Brucella abortus, B. melitensis and B. suis, and:

(b)	infection with bluetongue virus (serotypes 1-24) with a live vaccine during the last 60 days prior to the date of their dispatch to the Union;

II.2.10.

come from a zone:

II.2.10.1.

in which:

(a)

foot and mouth disease has not been reported

(1) either

[for at least 24 months prior to the date of their dispatch to the Union;]

(1) (4) or

[since __/__/____ (dd/mm/yyyy);]

(b)	vaccination against foot and mouth disease has not been carried out for at least 12 months prior to the date of their dispatch to the Union, and no animals vaccinated against foot and mouth disease have been introduced during that period;

II.2.10.2.

in which infection with rinderpest virus, [infection with Rift Valley fever virus] (1) (5), [infection with Mycoplasma mycoides subsp. mycoides SC (contagious bovine pleuropneumonia)] (1) (6) [and contagious caprine pleuropneumonia] (1) (7) has not been reported for the last 12 months prior to the date of their dispatch to the Union and during that period:

(a)	vaccination against these diseases has not been carried out, and

(b)	animals vaccinated against these diseases have not been introduced;

(1) (8) either

[II.2.10.3.

which is free from infection with bluetongue virus (serotypes 1-24);]

(1) or

[II.2.10.3.

which is seasonally free from infection with bluetongue virus (serotypes 1-24)

(1) (9) either

[for at least 60 days prior to the date of their dispatch to the Union;]

(1) (9) or

[for at least 28 days prior to the date of their dispatch to the Union and the animals have been subjected to a serological test in accordance with Article 9, point (b), of Delegated Regulation (EU) 2020/692, with negative results, carried out on samples collected at least 28 days following the date of entry of the animals into the seasonally free zone;]

(1) (9) or

[for at least 14 days prior to the date of their dispatch to the Union and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of entry of the animals in the seasonally free zone;]

(1) or

[II.2.10.3.

(1) either

[have been vaccinated more than 60 days prior to the date of their dispatch to the Union;]]

(1) or

[II.2.10.3.

(1) either

[the serological test has been carried out on samples collected at least 60 days prior to the date of their dispatch to the Union;]]

(1) or

II.2.11.

come from an establishment:

II.2.11.1.

(a)	the species, categories, number and identification of animals on the establishment;

(b)	movements of animals into and out of the establishment;

(c)	mortality in the establishment;

II.2.11.2.

which receives regular animal health visits from a veterinarian for the purpose of the detection of, and information on, signs indicative of occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at a frequency that is proportional to the risk posed by the establishment;

II.2.11.3.

II.2.11.4.

in and around which, in an area of 10 km radius, including where appropriate the territory of a neighbouring country, none of the following listed diseases has been reported for at least 30 days prior to the date of dispatch of the animals to the Union: foot and mouth disease, infection with rinderpest virus, [infection with Rift Valley fever virus,] (1) (5) [infection with Mycoplasma mycoides subsp. mycoides SC (contagious bovine pleuropneumonia),] (1) (6) [contagious caprine pleuropneumonia] (1) (7);

(1) either

[II.2.11.5.

in and around which, including where appropriate the territory of a neighbouring country, epizootic haemorrhagic disease has not been reported for at least 2 years prior to the date of dispatch of the animals to the Union in an area of 150 km radius;]

(1) (10) or

[II.2.11.5.

which is located in a zone seasonally free of epizootic haemorrhagic disease;]

II.2.11.6.

in which infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has not been reported in kept animals of listed species for at least 42 days prior to the date of dispatch of the animals to the Union;

II.2.11.7.

in which infection with Brucella abortus, B. melitensis and B. suis has not been reported in kept animals of listed species for at least 42 days prior to the date of dispatch of the animals to the Union;

II.2.11.8.

in which anthrax has not been reported for at least 15 days prior to the date of dispatch of the animals to the Union;

II.2.11.9.

in which surra (Trypanosoma evansi) has not been reported for at least 30 days prior to the date of dispatch of the animals to the Union and if the disease was reported in the establishment of origin during the last 2 years prior to the date of dispatch of the animals to the Union, the affected establishment remained under restriction until the date on which the infected animals were removed from the establishment and the remaining animals on the establishment were subjected with negative result to a test for surra as described in Part 3 of Annex I to Commission Delegated Regulation (EU) 2020/688 carried out on samples taken at least 6 months after the date on which the infected animals were removed from the establishment;

(1) (11) [II.2.11.10.

in which rabies has not been reported for at least 30 days prior to the date of dispatch of the animals to the Union.]

Notes:

This animal health/official certificate is intended for the entry into the Union of animals of the families Antilocapridae, Bovidae (other than bovine, ovine and caprine animals), Giraffidae, Moschidae and Tragulidae, including when the Union is not the final destination of those animals.

Part I:

Box reference I.27

Part II:

(1)	Delete if not applicable.

(2)	Code of the zone as it appears in column 2 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(3)	Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.2.1 for the entry into the Union, or in a period where restriction measures have been adopted by the Union against entry into the Union of those animals from that zone.

(4)	Only for the zones with an opening date in column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(5)	Not applicable to ungulates of the family Tragulidae.

(6)	Only applicable to ungulates of the species Syncerus caffer.

(7)	Only applicable to ungulates of the species Gazella spp.

(8)	For the zones with an entry “BTV” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404

(9)	For the zones with an entry “SF-BTV” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(10)	For the zones with an entry “SF-EHD” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(11)	Only applicable to ungulates of the family Bovidae.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 10

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF ANIMALS OF THE FAMILIES TAPIRIDAE, RHINOCEROTIDAE AND ELEPHANTIDAE (MODEL “RHINO”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
	☐ Further keeping
				☐ Travelling circus/animal acts
		☐ Quarantine establishment	☐ Exhibition

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category	Sex	Identification system	Identification number	Age	Quantity

Part II: Certification

COUNTRY

Certificate model RHINO

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

II.1.

Animal health attestation

I, the undersigned official veterinarian, hereby certify, that the animals described in Part I:

II.1.1.

come from the zone with code __-__ (2) which, at the date of issue of this certificate is authorised for the entry into the Union of animals of the families Tapiridae, Rhinocerotidae and Elephantidae and listed in Part 1 of Annex II to Commission Implementing Regulation (EU) 2021/404;

II.1.2.

have remained continuously:

(a)	in the zone referred to in point II.1.1 since birth or for at least 6 months prior to the date of their dispatch to the Union, and

(b)	in the establishment of origin since birth or for at least 40 days prior to the date of their dispatch to the Union, in which no animals have been introduced during that period;

II.1.3.

had no contact with animals of a lower health status since birth or for at least 6 months prior to the date of their dispatch to the Union;

II.1.4.

are not to be killed under a national programme for the eradication of diseases, including listed diseases and emerging diseases;

II.1.5.

have been dispatched to the Union directly from the establishment of origin without passing through any other establishment;

II.1.6.

have not been unloaded in any place that does not comply with the requirements laid down in point II.1.11 since the date of their dispatch from their establishment of origin until the date of their dispatch to the Union and during that period they have not been in contact with animals of a lower health status;

II.1.7.

are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy) (3) in a means of transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority in the third country or territory and constructed in such a way that:

(a)	animals cannot escape or fall out;

(b)	visual inspection of the space where animals are kept is possible;

(c)	the escape of animal excrements, litter or feed is prevented or minimized;

II.1.8.

have been subjected with negative result to a clinical inspection, carried out by an official veterinarian in the third country or territory of origin, or zone thereof within the last 24 hours prior to the time of loading for dispatch to the Union for the purpose of detection of signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.1.9.

have not been vaccinated against [foot and mouth disease and] (1) (4) infection with Rift Valley fever virus;

II.1.10.

come from a zone:

[II.1.10.1.

in which:

(a)

foot and mouth disease has not been reported

(1) either

[for at least 24 months prior to the date of their dispatch to the Union;]

(1) (5) or

[since __/__/____ (dd/mm/yyyy);]

(b)	vaccination against foot and mouth disease has not been carried out for at least 12 months prior to the date of their dispatch to the Union, and no animals vaccinated against foot and mouth disease have been introduced during that period;] (1) (4)

II.1.10.2.

in which infection with Rift Valley fever virus has not been reported for at least 12 months prior to the date of their dispatch to the Union and during that period:

(a)	vaccination against the disease has not been carried out, and

(b)	animals vaccinated against the disease have not been introduced;

II.1.11.

come from an establishment:

II.1.11.1.

which is registered by and under the control of the competent authority of the third country or territory of origin and has a system in place to maintain for at least 3 years up to date following the date of dispatch of the animals to the Union the records containing information regarding:

(a)	the species, categories, number and identification of animals on the establishment;

(b)	movements of animals into and out of the establishment;

(c)	mortality in the establishment;

II.1.11.2.

II.1.11.3.

which was not subject to national restriction measures for animal health reasons, including listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the date of dispatch of the animals to the Union;

II.1.11.4.

in and around which, including where appropriate the territory of a neighbouring country, none of the following listed diseases has been reported for at least 30 days prior to the date of dispatch of the animals to the Union in an area of 10 km radius: [foot and mouth disease and] (1) (4) infection with Rift Valley fever virus;

II.1.11.5.

in which anthrax has not been reported for at least 15 days prior to the date of dispatch of the animals to the Union.

Notes:

This animal health certificate is intended for the entry into the Union of animals of the families Tapiridae, Rhinocerotidae and Elephantidae, including when the Union is not the final destination of those animals.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.27

Part II:

(1)	Delete if not applicable.

(2)	Code of the zone as it appears in column 2 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(3)	Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.1.1 for the entry into the Union, or in a period where restriction measures have been adopted by the Union against entry into the Union of those animals from that zone.

(4)	Only applicable to animals of the family Elephantidae.

(5)	Only for the zones with an opening date in column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 11

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF ANIMALS OF THE FAMILY HIPPOPOTAMIDAE (MODEL “HIPPO”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
	☐ Further keeping
				☐ Travelling circus/animal acts
		☐ Quarantine establishment	☐ Exhibition

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category	Sex	Identification system	Identification number	Age	Quantity

Part II: Certification

COUNTRY

Certificate model HIPPO

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

II.1.

Animal health attestation

I, the undersigned official veterinarian, hereby certify, that the animals described in Part I:

II.1.1.

come from the zone with code __-__ (2) which, at the date of issue of this animal health certificate is authorised for the entry into the Union of animals of the family Hippopotamidae and listed in Part 1 of Annex II to Commission Implementing Regulation (EU) 2021/404;

II.1.2.

have remained continuously:

(a)	in the zone referred to in point II.1.1 since birth or for at least 6 months prior to the date of dispatch of the animals to the Union, and

(b)

in the establishment of origin since birth or for at least 40 days prior to the date of dispatch of the animals to the Union, into which during that period no animals of the family Hippopotamidae and no animals of other species listed for the same diseases as animals of the family Hippopotamidae have been introduced;

II.1.3.

had no contact with animals of a lower health status since birth or for at least 6 months prior to the date of dispatch of the animals to the Union;

II.1.4.

II.1.5.

have been dispatched to the Union directly from the establishment of origin without passing through any other establishment;

II.1.6.

II.1.7.

are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy) (3) in a means of transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority in the third country or territory and constructed in such a way that:

(a)	animals cannot escape or fall out;

(b)	visual inspection of the space where animals are kept is possible;

(c)	the escape of animal excrements, litter or feed is prevented or minimized;

II.1.8.

have been subjected to a clinical inspection within the last 24 hours prior to the time of loading for dispatch to the Union, carried out by an official veterinarian in the third country or territory of origin, or zone thereof, who did not detect signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.1.9.

have not been vaccinated against foot and mouth disease, infection with rinderpest virus, infection with Rift Valley fever virus, infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) and infection with Brucella abortus, B. melitensis and B. suis;

II.1.10.

come from a zone:

II.1.10.1.

in which:

(a)

foot and mouth disease has not been reported

(1) either

[for at least 24 months prior to the date of dispatch of the animals to the Union;]

(1) (4) or

[since __/__/____ (dd/mm/yyyy);]

(b)	vaccination against foot and mouth disease has not been carried out for at least 12 months prior to the date of dispatch of the animals to the Union, and no animals vaccinated against foot and mouth disease have been introduced during that period;

II.1.10.2.

in which infection with rinderpest virus and infection with Rift Valley fever virus has not been reported for at least 12 months prior to the date of dispatch of the animals to the Union and during that period:

(a)	vaccination against these diseases has not been carried out; and

(b)	animals vaccinated against these diseases have not been introduced;

II.1.11.

come from an establishment:

II.1.11.1.

(a)	the species, categories, number and identification of animals on the establishment;

(b)	movements of animals into and out of the establishment;

(c)	mortality in the establishment;

II.1.11.2.

II.1.11.3.

II.1.11.4.

II.1.11.5.

II.1.11.6.

II.1.11.7.

in which anthrax has not been reported for at least 15 days prior to the date of dispatch of the animals to the Union.

(1) either

[II.1.11.8.

in which surra (Trypanosoma evansi) has not been reported for at least 2 years prior to the date of dispatch of the animals to the Union.]

(1) or

[II.1.11.8.

Notes:

This animal health certificate is intended for the entry into the Union of animals of the family Hippopotamidae, including when the Union is not the final destination of those animals.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.27

Part II:

(1)	Delete if not applicable.

(2)	Code of the zone as it appears in column 2 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(3)	Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.1.1 for the entry into the Union, or in a period where restriction measures have been adopted by the Union against entry into the Union of those animals from that zone.

(4)	Only for the zones with an opening date in column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 12

MODEL ANIMAL HEALTH/OFFICIAL CERTIFICATE FOR THE ENTRY INTO THE UNION OF CAMELID AND CERVID ANIMALS (MODEL “CAM-CER”)

Part I: Description of consignment

COUNTRY

Animal health/official certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
	☐ Further keeping
				☐ Travelling circus/animal acts
		☐ Quarantine establishment	☐ Exhibition

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category	Sex	Identification system	Identification number	Age	Quantity

Part II: Certification

COUNTRY

Certificate model CAM-CER

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

(1) [II.1.

Public health attestation (Delete when the Union is not the final destination of the animals)

I, the undersigned official veterinarian, hereby certify, that the animals described in Part I:

II.1.1.

have not received:

(a)	any stilbene or thyrostatic substances;

(b)	oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other than therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC);

II.1.2.

(1) (10) [II.1a.

Attestation as regards Commission Delegated Regulation (EU) 2023/905 (Delete when the Union is not the final destination of the animals)

II.2.

Animal health attestation

I, the undersigned official veterinarian, hereby certify, that the animals described in Part I:

II.2.1.

come from the zone with code __-__ (2) which, at the date of issuing this animal health/official certificate is authorised for the entry into the Union of camelid and cervid animals and listed in Part 1 of Annex II to Commission Implementing Regulation (EU) 2021/404;

II.2.2.

have remained continuously:

(a)	in the zone referred to in point II.2.1 since birth or for at least 6 months prior to the date of their dispatch to the Union, and

(b)	in the establishment of origin since birth or for at least 40 days prior to the date of their dispatch to the Union, in which no animals have been introduced during that period;

II.2.3.

had no contact with animals of a lower health status since birth or for at least 6 months prior to the date of their dispatch to the Union;

II.2.4.

II.2.5.

have been dispatched to the Union directly from the establishment of origin without passing through any other establishment;

II.2.6.

II.2.7.

are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy) (3) in a means of transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority in the third country or territory and constructed in such a way that:

(a)	animals cannot escape or fall out;

(b)	visual inspection of the space where animals are kept is possible;

(c)	the escape of animal excrements, litter or feed is prevented or minimized;

II.2.8.

have been subjected to a clinical inspection within the last 24 hours prior to the time of loading for dispatch to the Union, carried out by an official veterinarian in the third country or territory of origin, or zone thereof, who did not detect signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.2.9.

have not been vaccinated against:

(a)	foot and mouth disease, infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis), infection with Brucella abortus, B. melitensis and B. suis;

(b)	infection with bluetongue virus (serotypes 1-24) with a live vaccine during the last 60 days prior to their dispatch to the Union;

II.2.10.

come from a zone:

II.2.10.1.

in which:

(a)

foot and mouth disease has not been reported

(1) either

[for at least 24 months prior to the date of their dispatch to the Union;]

(1) (4) or

[since __/__/____ (dd/mm/yyyy);]

(b)	vaccination against foot and mouth disease has not been carried out for at least 12 months prior to the date of dispatch to the Union, and no animals vaccinated against foot and mouth disease have been introduced during that period;

II.2.10.2.

in which infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus has not been reported for at least 12 months prior to the date of dispatch of the animals to the Union and during that period:

(a)	vaccination against these diseases has not been carried out, and

(b)	animals vaccinated against these diseases have not been introduced;

(1) (5) either

[II.2.10.3.

which is free from infection with bluetongue virus (serotypes 1-24);]

(1) or

[II.2.10.3.

which is seasonally free from infection with bluetongue virus (serotypes 1-24)

(1) (6) either

[for at least 60 days prior to the date of dispatch of the animals to the Union;]

(1) (6) or

(1) or

[II.2.10.3.

which is not free from infection with bluetongue virus (serotypes 1-24) and the animals have been vaccinated against all the serotypes (1-24) of bluetongue virus reported in that zone for at least 2 years prior to the date of dispatch of the animals to the Union and are still within the immunity period guaranteed in the specifications of the vaccine, and

(1) either

[have been vaccinated more than 60 days prior to the date of their dispatch to the Union;]]

(1) or

[II.2.10.3.

(1) either

[the serological test has been carried out on samples collected at least 60 days prior to the date of dispatch of the animals to the Union;]]

(1) or

II.2.11.

come from an establishment:

II.2.11.1.

(a)	the species, categories, number and identification of animals on the establishment;

(b)	movements of animals into and out of the establishment;

(c)	mortality in the establishment;

II.2.11.2.

II.2.11.3.

II.2.11.4.

in and around which, in an area of 10 km radius, including where appropriate the territory of a neighbouring country, none of the following listed diseases has been reported for at least 30 days prior to the date of dispatch of the animals to the Union: foot and mouth disease, infection with Rift Valley fever virus and infection with peste des petits ruminants virus;

(1) either

[II.2.11.5.

(1) (7) or

[II.2.11.5.

which is located in a zone seasonally free of epizootic haemorrhagic disease;]

II.2.11.6.

which is subjected to surveillance to detect infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in the animals of the same species as the animals described in Part I in accordance with the procedures in Part 2, points (1) and (2), or Part 3 of Annex II to Commission Delegated Regulation (EU) 2020/688 for at least 12 months prior to the date of dispatch of the animals described in Part I to the Union and during that period:

(a)	only animals from establishments applying such surveillance have been introduced therein;

(1) either

[(b)	infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has not been reported in the animals of the same species kept therein;]

(1) or

[(b)

infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has been reported in the animals of the same species as the animals described in Part I kept therein and measures were taken in accordance with Part 2, point (3), or Part 3 of Annex II to Delegated Regulation (EU) 2020/688;]

II.2.11.7.

in which infection with Brucella abortus, B. melitensis and B. suis in the animals of the same species as the animals described in Part I has not been reported for at least 42 days prior to the date of dispatch of the animals to the Union, and the animals described in Part I have been subjected to a test for the detection of infection with Brucella abortus, B. melitensis and B. suis with one of the diagnostic methods provided for in Part 1 of Annex I to Delegated Regulation (EU) 2020/688, with negative results, carried out on a sample taken during the last 30 days prior to the date of their dispatch to the Union, and in the case of post-parturient females, taken at least 30 days after the date of parturition;

II.2.11.8.

in which rabies has not been reported for at least 30 days prior to the date of dispatch of the animals to the Union;

II.2.11.9.

in which anthrax has not been reported for at least 15 days prior to the date of dispatch of the animals to the Union;

II.2.11.10.

in which surra (Trypanosoma evansi) has not been reported for at least 30 days prior to the date of dispatch of the animals to the Union and if the disease was reported in the establishment of origin during the last 2 years prior to the date of dispatch of the animals to the Union, the affected establishment remained under restriction until the date on which the infected animals were removed from the establishment and the remaining animals on the establishment were subjected with negative result to a test for surra as described in Part 3 of Annex I to Delegated Regulation (EU) 2020/688 carried out on samples taken at least 6 months after the date on which the infected animals were removed from the establishment;

(1) (8) [II.2.11.11.

in which, if an infection with Burkholderia mallei (glanders) has been reported during the last 3 years prior to the date of dispatch of the animals to the Union, and following the last outbreak, the establishment remained under movement restrictions by the competent authority until:

(a)	the date on which the infected animals have been killed and destroyed; and

(b)

the date on which the remaining animals were subjected to a test carried out as described in Chapter 3.5.11, point 3.1, of the WOAH Terrestrial Manual (version adopted 2015) with negative results on samples taken at least 6 months after the date on which the infected animals were killed and destroyed and the establishment cleaned and disinfected;]

(1) (9) [II.2.12.

originate from an establishment in which infectious bovine rhinotracheitis/infectious pustular vulvovaginitis has not been reported in camelid animals for at least 30 days prior to the date of dispatch of the animals to the Union.]

Notes:

This animal health/official certificate is intended for the entry into the Union of camelid and cervid animals, including when the Union is not the final destination of those animals.

Part I:

Box reference I.27

Part II:

(1)	Delete if not applicable.

(2)	Code of the zone as it appears in column 2 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(3)	Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.2.1 for the entry into the Union, or in a period where restriction measures have been adopted by the Union against entry into the Union of those animals from that zone.

(4)	Only for the zones with an opening date in column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404

(5)	For the zones with an entry “BTV” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(6)	For the zones with an entry “SF-BTV” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(7)	For the zones with an entry “SF-EHD” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(8)	Only applicable for ungulates of the family Camelidae.

(9)

Only applicable when the Member State of destination or Switzerland, in accordance with the Agreement between the European Community and the Swiss Confederation on trade in agricultural products (OJ L 114, 30.4.2002, p.132), either have disease-free status for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis in bovine animals or an approved eradication programme.

(10)	Applicable to consignments entering the Union as from 3 September 2026.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 13

MODEL ANIMAL HEALTH/OFFICIAL CERTIFICATE AND MODEL DECLARATION FOR THE ENTRY INTO THE UNION OF AN EQUINE ANIMAL (MODEL “EQUI-X”)

Part I: Description of consignment

COUNTRY

Animal health/official certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for

	☐ Further keeping	☐ Registered equine animal	☐ Registered horse

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category	Sex	Identification system	Identification number	Age

Part II Certification

COUNTRY

Certificate model EQUI-X

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

II. Animal health attestation

I, the undersigned official veterinarian, hereby certify that:

II.1.

The equine animal described in Part I:

II.1.1.

is not intended for slaughter for human consumption and not intended for slaughter in the framework of the eradication of infectious or contagious diseases transmissible to equine animals, and

(1) either

[is a registered equine animal, as defined in Article 2, point (12), of Commission Delegated Regulation (EU) 2020/692;]

(1) or

[is a registered horse as defined in Article 2, point (12), of Delegated Regulation (EU) 2020/692;]

(1) or

[is an equine animal other than a registered equine animal or a registered horse;]

II.1.2.

has not shown signs or symptoms of diseases listed for equine animals in Commission Implementing Regulation (EU) 2018/1882 during the clinical examination carried out on ___/___/____ (dd/mm/yyyy) (2), this date being within the last 24 hours or, in the case of a registered equine animal, within the last 48 hours or on the last working day prior to the date of dispatch of the animal to the Union from the registered establishment;

II.1.3.

meets the requirements attested in points II.2 to II.5, and where applicable in point II.6, of this animal health/official certificate;

II.1.4.

is accompanied by a written declaration, signed by the operator responsible for the animal, which is attached to this animal health/official certificate.

II.2.

Attestation on third country or territory, or zone thereof and in establishment of dispatch

II.2.1.

The equine animal described in Part I is dispatched from … (insert name of third country or territory, or zone thereof), a third country or territory, or zone thereof, which on the date of issuing this animal health/official certificate has the code __-__ (3) and is assigned to Sanitary Group … (3).

II.2.2.

The equine animal described in Part I comes from a third country or territory, or zone thereof in which there has been no clinical, serological (in unvaccinated equine animals) or epidemiological evidence of African horse sickness during the last 24 months prior to the date of dispatch of the animal to the Union, and there has been no vaccination against African horse sickness during the last 12 months prior to the date of dispatch of the animal to the Union.

II.2.3.

The equine animal described in Part I comes from an establishment situated in a third country or territory, or zone thereof in which

(1) either

[infection with Burkholderia mallei (glanders) has not been reported during the last 36 months prior to the date of dispatch of the animal to the Union.]

(1) or

[a surveillance programme for infection with Burkholderia mallei (glanders) recognised by the Union (2) has been carried out during the last 36 months prior to the date of dispatch of the animal to the Union, and

(1) either

[infection with Burkholderia mallei (glanders) has not been reported in the establishment of dispatch during the last 36 months prior to the date of dispatch of the animal to the Union.]]

(1) or

[infection with Burkholderia mallei (glanders) has been reported in the establishment during the last 36 months prior to the date of dispatch of the animal to the Union and following the date of last outbreak, the establishment has remained under movement restrictions

(1) either

[until the date on which the remaining equine animals in the establishment have been subjected to a complement fixation test for infection with Burkholderia mallei (glanders) (4), carried out, with negative results at a serum dilution of 1 in 5, on samples taken at least 6 months after the date on which the infected animals have been killed and destroyed.]]]

(1) or

[for at least 30 days after the date on which the last animal of listed species on the establishment was killed and destroyed, and the establishment was cleaned and disinfected.]]]

II.2.4.

The equine animal described in Part I comes from an establishment situated in a third country or territory, or zone thereof in which

(1) either

[surra has not been reported during the last 24 month prior to the date of dispatch of the animal to the Union.]

(1) or

[a surveillance programme for surra recognised by the Union (2) has been carried out during the last 24 months prior to the date of dispatch of the animal to the Union, and

(1) either

[surra has not been reported in the establishment during the last 24 months prior to the date of dispatch of the animal to the Union.]]

(1) or

[surra has been reported in the establishment during the last 24 months prior to the date of dispatch of the animal to the Union, and following the last outbreak, the establishment has remained under movement restrictions

(1) either

[until the date on which the remaining animals in the establishment have been subjected to an enzyme-linked immunosorbent assay (ELISA) for trypanosomosis or card agglutination test for trypanosomosis (CATT) at a serum dilution of 1 in 4 (4) carried out, with negative results, on samples taken at least 6 months after the date on which the last infected animal has been removed from the establishment.]]]

(1) or

[for at least 30 days after the date on which the last animal of listed species on the establishment was either killed and destroyed or slaughtered, and the establishment was cleaned and disinfected.]]]

II.2.5.

The equine animal described in Part I comes from an establishment situated in a third country or territory, or zone thereof in which

(1) either

[dourine has not been reported during the last 24 months prior to the date of dispatch of the animal to the Union.]

(1) or

[a surveillance programme for dourine recognised by the Union (2) has been carried out during the last 24 months prior to the date of dispatch of the animal to the Union, and

(1) either

[dourine has not been reported in the establishment during the last 24 months prior to the date of dispatch of the animal to the Union.]]

(1) or

[dourine has been reported in the establishment during the last 24 months prior to the date of dispatch of the animal to the Union, and following the last outbreak, the establishment has remained under movement restrictions

(1) either

[until the date on which the remaining equine animals in the establishment, except castrated male equine animals, have been subjected to a complement fixation test for dourine, carried out with negative results at a serum dilution of 1 in 5 (4) on samples taken at least 6 months after the date on which the infected animals have been killed and destroyed or slaughtered, or the date on which the infected entire male equine animals have been castrated.]]]

(1) or

II.2.6.

The equine animal described in Part I comes from an establishment in which

(1) either

[equine infectious anaemia has not been reported during the last 12 months prior to the date of dispatch of the animal to the Union.]

(1) or

[equine infectious anaemia has been reported during the last 12 months prior to the date of dispatch of the animal to the Union and following the last outbreak, the establishment has remained under movement restrictions

(1) either

[until the date on which the remaining equine animals in the establishment have been subjected to an agar gel immuno-diffusion test (AGID or Coggins test) or ELISA (4) for equine infectious anaemia carried out, with negative results, on samples taken on two occasions with a minimum interval of 90 days following the date on which the infected animals have been killed and destroyed, or slaughtered, and the establishment was cleaned and disinfected.]]

(1) or

II.2.7.

The equine animal described in Part I comes from an establishment in which:

II.2.7.1.

infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to the date of dispatch of the animal to the Union;

II.2.7.2.

anthrax in ungulates has not been reported during the last 15 days prior to the date of dispatch of the animal to the Union.

II.2.8.

To the best of my knowledge and as declared by the operator, the equine animal described in Part I has not been in contact with kept animals of listed species which did not comply with the requirements referred to in points II.2.2 to II.2.7.1 during the last 30 days prior to the date of dispatch of the animal to the Union, and with the requirement referred to in point II.2.7.2 during the last 15 days prior to the date of dispatch of the animal to the Union.

II.3.

Attestation of residence and isolation prior to dispatch to the Union

(1) either

[II.3.1.

During the last 40 days prior to the date of its dispatch to the Union, or since birth if it is less than 40 days of age, the equine animal described in Part I has been continuously resident in the third country or territory, or zone thereof of dispatch or entered the third country or territory, or zone thereof of dispatch from a Member State of the European Union or Norway.]

(1) or

[II.3.1.

During the last 40 days prior to the date of its dispatch to the Union, or since birth if it is less than 40 days of age, the registered horse described in Part I

(1) either

[has been continuously resident in the third country or territory, or zone thereof of dispatch.]

(1) or

[entered the third country or territory, or zone thereof of dispatch on one or more occasions from:

(1) either

[a Member State of the European Union or Norway;]]]

(1) and/or

[a third country or territory, or zone thereof authorised for the entry into the Union of registered horses, and from which it was introduced into the third country or territory, or zone thereof of dispatch under conditions at least as strict as those required in accordance with Union legislation for the entry of registered horses from that third country or territory, or zone thereof directly to the Union, and which is:

(1) either

[assigned to the same Sanitary Group … (3) as the third country or territory, or zone thereof of dispatch;]]]]

(1) and/or

[assigned to Sanitary Group A, B or C;]]]]

(1) and/or

[the United Arab Emirates, Bahrain, China (5) (6), South Korea, Hong Kong, Japan, Macao or Singapore.]]]]

(1) either

[II.3.2.

The equine animal described in Part I is dispatched from a third country or territory, or zone thereof assigned to Sanitary Group A, B, C, D or G, and

(1) either

[during the last 30 days prior to the date of its dispatch to the Union, or since birth if it is less than 30 days of age or since entry from a Member State of the Union or Norway,

(1) either

[it has been kept apart from other equine animals, except in case of a foal at foot of his mother, in an establishment situated in a third country or territory, or zone thereof assigned to Sanitary Group A.]]]

(1) or

[it has been kept in pre-export isolation from other equine animals, except in case of a foal at foot of his mother, in an establishment situated in a third country or territory, or zone thereof assigned to Sanitary Group B, C, D or G.]]]

(1) or

[it is a registered horse which has been kept in establishments under official veterinary supervision during the last 30 days prior to the date of its dispatch to the Union, or since birth if it is less than 30 days of age, or since entry in accordance with point II.3.1 from a Member State of the European Union, Norway or a third country or territory, or zone thereof which is assigned to Sanitary Group A, B, C, D, E or G.]]

(1) (7) or

[II.3.2.

The equine animal described in Part I is dispatched from a third country or territory, or zone thereof assigned to Sanitary Group E, and

(1) either

[during the last 40 days prior to the date of its dispatch to the Union, or since birth if it is less than 40 days of age, or since the date of entry in accordance with point II.3.1 from a Member State of the European Union, Norway or a third country or territory, or zone thereof which is assigned to Sanitary Group A, B, C, D, E or G, it has been kept

(1) either

[in isolation in a vector-protected establishment.]]]

(1) or

[in an establishment under official veterinary supervision, and the country or territory, or zone thereof of dispatch is recognised by the World Organisation for Animal Health (WOAH) as officially free of African horse sickness.]]]

(1) or

[is a registered horse which has been kept during the last 30 days prior to the date of its dispatch, or since birth if it is less than 30 days of age, or since the date of entry in accordance with point II.3.1 from a Member State of the European Union, Norway or a third country or territory, or zone thereof which is assigned to Sanitary Group A, B, C, D, E or G, in the establishments under official veterinary supervision, and the third country or territory, or zone thereof of dispatch to the Union is recognised by the WOAH as officially free of African horse sickness.]]

(1) (7) or

[II.3.2.

The registered horse described in Part I is dispatched from a third country or territory, or zone thereof assigned to Sanitary Group F, and

(1) either

[during the last 40 days prior to the date of dispatch it has been kept in isolation in a vector-protected establishment.]]

(1) or

[during the last 14 days prior to the date of dispatch to the Union it has been kept in isolation in a vector-protected establishment and constant monitoring of the vector protection has proven absence of insect vectors inside the vector-protected establishment.]]

II.4.

Attestation of vaccination and health tests

(1) either

[II.4.1.

The equine animal described in Part I was not vaccinated against African horse sickness in the third country or territory, or zone thereof of dispatch and there is no information suggesting previous vaccination.]

(1) or

[II.4.1.

The equine animal described in Part I was vaccinated against African horse sickness more than 12 months prior to the date of its dispatch to the Union.]

(1) (7) or

[II.4.1.

The registered horse described in Part I was vaccinated against African horse sickness not more than 24 months and at least 40 days prior to the date of introduction into the vector-protected establishment situated in a third country or territory, or zone thereof assigned to Sanitary Group F, and this vaccination consisted of a complete primary course of vaccination against African horse sickness, or a revaccination within the period of validity of the previous vaccination, by administration according to manufacturer's instructions of a registered vaccine which is protective against the circulating serotypes of the African horse sickness virus, and the last vaccination was applied on ___/___/____ (dd/mm/yyyy).]

II.4.2.

The equine animal described in Part I has not been vaccinated against Venezuelan equine encephalomyelitis during the last 60 days prior to the date of its dispatch to the Union, and

(1) either

[it comes from an establishment situated in a third country or territory in which Venezuelan equine encephalomyelitis has not been reported during the last 24 months prior to the date of its dispatch to the Union.]

(1) or

[it comes from an establishment in which Venezuelan equine encephalomyelitis has not been reported during the last 6 months prior to the date of its dispatch to the Union and during the last 21 days prior to the date of dispatch of the animal described in Part I to the Union, all equine animals in the establishment have remained clinically healthy, and

(1) either

[the equine animal described in Part I has been kept protected from attacks by insect vectors in a vector-protected establishment, in which any equine animal that showed a rise in daily taken body temperature has been subjected with negative result to a virus isolation test for Venezuelan equine encephalomyelitis (4); and the equine animal described in Part I

(1) either

[was vaccinated against Venezuelan equine encephalomyelitis with a complete primary course and revaccinated according to manufacturer's recommendations not less than 60 days and not more than 12 months prior to the date of dispatch of the animal to the Union.]]]

(1) or

[was subjected to a haemagglutination inhibition test for Venezuelan equine encephalomyelitis (4), carried out, with negative result, on a sample taken not less than 14 days after the date of commencement of isolation in the vector-protected establishment.]]]

(1) or

[the body temperature of the equine animal described in Part I has been taken daily, either without a rise or the animal has been subjected to a virus isolation test for Venezuelan equine encephalomyelitis with negative result, and the equine animal described in Part I has been subjected to:

(a)

a haemagglutination inhibition test for Venezuelan equine encephalomyelitis (4), without an increase in antibody titre, carried out on paired samples taken on two occasions with an interval of 21 days, the second of which was taken during the last 10 days prior to the date of its dispatch to the Union, and

(b)	a reverse transcription-polymerase chain reaction (RT-PCR) for the detection of Venezuelan equine encephalomyelitis virus genome (4), with negative result, carried out on a sample taken within the last 48 hours prior to its dispatch to the Union, and

(c)	protection from vector attacks during the period after the date of sampling until loading for dispatch to the Union, by combined use of approved insect repellents and insecticides on the animal and disinsectization of the stable and the means in which it is transported.]]

(1) (7) either

[II.4.3.

The equine animal described in Part I is dispatched to the Union from Iceland, which is certified as officially free from equine infectious anaemia, where it was continuously resident since birth, and did not come into contact with equine animals which have entered Iceland from other third countries or territories.]

(1) or

[II.4.3.

The equine animal described in Part I was subjected with negative result to an agar gel immunodiffusion test (AGID or Coggins test) or to an ELISA for equine infectious anaemia (4) carried out on a blood sample taken on ___/___/____ (dd/mm/yyyy), this being within

(1) either

[the last 30 days prior to the date of its dispatch to the Union.]]

(1) (7) or

[the last 90 days prior to the date of its dispatch to the Union from a third country or territory, or zone thereof assigned to Sanitary Group A.]]

(1) [II.4.4.

The equine animal described in Part I is dispatched from a third country or territory, or zone thereof assigned to Sanitary Group B, D or E, or from China, or from a third country or territory in which infection with Burkholderia mallei (glanders) has been reported during the last 36 months prior to the date of its dispatch to the Union, and the equine animal was subjected to a complement fixation test for infection with Burkholderia mallei (glanders) (4) carried out with negative result at a serum dilution of 1 in 5 on a blood sample taken on ___/___/____ (dd/mm/yyyy), within the last 30 day prior to the date of its dispatch to the Union.]

(1) [II.4.5.

The equine animal described in Part I is an uncastrated male or female equine animal older than 270 days dispatched from a third country or territory, or zone thereof assigned to Sanitary Group B, D, E or F, or from China, or from a third country or territory in which dourine has been reported during the last 24 months prior to the date of its dispatch to the Union, and the equine animal was subjected to a complement fixation test for dourine (4) carried out with negative result at a serum dilution of 1 in 5 on a blood sample taken on ___/___/____ (dd/mm/yyyy), within the last 30 days prior to the date of its dispatch to the Union, and the equine animal described in Part I has not been used for breeding during 30 days prior to and after the date the sample was taken.]

(1) [II.4.6.

The equine animal described in Part I is dispatched to the Union from a third country or territory, or zone thereof assigned to Sanitary Group E, or from Bolivia, Brazil, Uruguay, or from a third country or territory in which surra was reported during the last 24 months prior to the date of its dispatch to the Union; and the equine animal was subjected to a card agglutination test for trypanosomosis (CATT) (4) carried out with negative result at a serum dilution of 1 in 4 on a blood sample taken on ___/___/____ (dd/mm/yyyy), within the last 30 days prior to the date of its dispatch to the Union.]

(1) (7) [II.4.7.

The equine animal described in Part I is dispatched to the Union from a third country or territory, or zone thereof which is assigned to Sanitary Group E, and

(3) either

[was subjected to an indirect ELISA or a blocking ELISA for African horse sickness (8), which was carried out by the same laboratory on the same day on blood samples taken on two occasions with an interval of between 21 and 30 days, on ___/___/____ (dd/mm/yyyy) and on ___/___/____ (dd/mm/yyyy), the second of which was taken within the last 10 days prior to the date of its dispatch to the Union,

(3) either

[with negative results in each case.]]]

(3) or

[with a positive result in the first sample, and

(3) either

[the second sample was subsequently tested with negative result in a real-time RT-PCR (8).]]]]

(3) or

[the two samples were tested without more than a two-fold increase in antibody titre in a virus neutralisation test as described in the latest edition of the WOAH Terrestrial Manual for Diagnostic Tests and Vaccines.]]]]

(1) or

[was subjected to an indirect ELISA or a blocking ELISA for African horse sickness (8) with negative result on a blood sample taken on ___/___/____ (dd/mm/yyyy), within the last 21 days prior to the date of its dispatch to the Union, and the third country or territory of dispatch is recognised by the WOAH as officially free of African horse sickness.]]

(1) or

[is a registered horse not vaccinated against African horse sickness and dispatched to the Union from a third country or territory, or zone thereof which is recognised by the WOAH as officially free of African horse sickness.]]

(1) (7) [II.4.8.

The equine animal described in Part I is dispatched to the Union from a third country or territory, or zone thereof assigned to Sanitary Group F, and

(1) either

[was subjected to an indirect ELISA or a blocking ELISA for African horse sickness (8) carried out by the same laboratory on the same day on blood samples taken on two occasions with an interval of between 21 and 30 days, on ___/___/____ (dd/mm/yyyy) and on ___/___/____ (dd/mm/yyyy), the first sample not taken less than 7 days after the date of introduction into the vector-protected establishment, the second sample taken within the last 10 days prior to the date of its dispatch to the Union,

(1) either

[with negative results in each case.]]]

(1) or

[with a positive result in the first sample, and

(1) either

[the second sample was subsequently tested with negative result in a real-time RT-PCR (8).]]]]

(1) or

[was subjected to an indirect ELISA or a blocking ELISA and a real-time RT-PCR for African horse sickness (8) carried out with negative result in each case on a blood sample taken on ___/___/____ (dd/mm/yyyy) not less than 28 days after the date of introduction into the vector-protected establishment and within the last 10 days prior to the date of its dispatch to the Union.]]

(1) or

[was subjected to a real-time RT-PCR for African horse sickness (8), carried out with negative result on a blood sample taken on ___/___/____ (dd/mm/yyyy) not less than 14 days after the date of introduction into the vector-protected establishment and not more than 72 hours prior to its dispatch to the Union.]]

II.5.

Attestation of the transport conditions

(1) (7) either

[II.5.1.

The equine animal described in Part I is dispatched to the Union from a third country or territory, or zone thereof assigned to Sanitary Group A, B, C, D, E or G and arrangements have been made to transport it directly to the Union, without subjecting the animal to any assembly operation and without coming into contact with other equine animals not complying with at least the same health requirements as described in this animal health/official certificate.]

(1) (7) or

[II.5.1.

The animal is dispatched to the Union from a third country or territory, or zone thereof which is assigned to Sanitary Group F and arrangements have been made to transport it directly from the vector-protected establishment without coming into contact with other equine animals not complying with at least the same health requirements as described in this animal health/official certificate

(1) either

[to the airport under vector-protected conditions and arrangements have been made for the aircraft to be cleansed and disinfected in advance with a disinfectant officially recognised in the third country or territory of dispatch.]]

(1) or

[to a sea port in that country or territory, or zone thereof under vector-protected conditions and arrangements have been made to transport it on a vessel which is scheduled directly to a port in the Union without calling into a port situated in a third country or territory, or zone thereof not approved for the entry into the Union of equine animals, in stalls which were cleansed and disinfected in advance with a disinfectant officially recognised in the third country or territory of dispatch.]]

II.5.2.

Arrangements have been made and verified to prevent any contact with other equine animals not complying with at least the same health requirements as described in this animal health/official certificate during the period from the date of certification until the date of dispatch of the animal to the Union.

II.5.3.

The transport vehicles or containers in which the animal is going to be loaded were cleaned and disinfected before loading of the animal for dispatch to the Union with a disinfectant officially recognised in the third country or territory of dispatch and are so constructed that faeces, urine, litter or fodder cannot escape during transportation.

(1) (9) [II.6.

Public health attestation (Delete when the Union is not the final destination of the animals)

I, the undersigned official veterinarian, hereby certify, that the equine animal described in Part I:

II.6.1.

in the third country or territory of dispatch of the consignment to the Union has not received:

(a)	prohibited substances listed in Table 2 of the Annex to Commission Regulation (EU) No 37/2010;

(b)	any stilbene or thyrostatic substances;

(c)	oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other than therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC);

II.6.2.

fulfils the guarantees provided by the control plan submitted and approved in accordance with Article 6(2) of Commission Delegated Regulation (EU) 2022/2292 and it has been dispatched from a third country or region thereof listed in Annex –I to Commission Implementing Regulation (EU) 2021/405 and marked with an “X” for the category “equine”.]

(1) (10) [II.6a.

Attestation as regards Commission Delegated Regulation (EU) 2023/905 (Delete when the Union is not the final destination of the animals)

I, the undersigned official veterinarian, hereby certify that the animal described in Part I has not been administered antimicrobial medicinal products for growth promotion or yield increase or antimicrobial medicinal products containing an antimicrobial that is included in the list of antimicrobials reserved for the treatment of certain infections in humans laid down in Commission Implementing Regulation (EU) 2022/1255, as set out in Article 3 of Delegated Regulation (EU) 2023/905 and originates from a third country or region thereof listed in the Annex to Commission Implementing Regulation (EU) 2024/2598.]

Notes:

This animal health/official certificate is intended for the entry into the Union of an equine animal, including when the Union is not the final destination of the animal.

Part I:

Box reference I.6	:	Provide the information on the operator responsible for the animal.
Box reference I.8	:	Provide the code of the third country or territory, or zone thereof of dispatch to the Union as appearing in column 2 of the table in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2021/404.
Box reference I.27	:	“Identification system”: The animal shall be individually identified with one of the methods of identification laid down in Article 21(2), point (a), of Delegated Regulation (EU) 2020/692, or be identified by an alternative method provided it is recorded in the identification document (passport) of the animal as referred to in Article 21(2), point (b)(i), of Delegated Regulation (EU) 2020/692. Specify the identification system and the anatomic place used on the animal. If a passport accompanies the animal, its number shall be stated and the name of the competent authority which validated it.

Part II:

(1)	Delete if not applicable.

(2)

The animal health/official certificate shall be issued within the last 10 days prior to the date of arrival of the consignment at the border control post; in the case of transport by sea, the period may be extended by an additional period corresponding to the duration of the journey by sea.

The entry into the Union shall not be allowed when the animal was loaded either prior to the date of authorisation for the entry into the Union from the respective third country or territory, or zone thereof referred to in point II.2.1, or during a period where restrictive measures have been adopted by the Union against the entry into the Union of equine animals from that third country or territory, or zone thereof. Check against columns 8 and 9 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.

(3)	Code of the third country or territory, or zone thereof and the Sanitary Group as appearing respectively in columns 2 and 3 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.

(4)	Tests for glanders, surra, dourine, equine infectious anaemia and Venezuelan equine encephalomyelitis described by the European Union Reference Laboratory for Equine Diseases other than African horse sickness: https://sitesv2.anses.fr/en/minisite/equine-diseases/sop.

(5)	Zone of the third country or territory authorised for the entry into the Union as appearing respectively in columns 2 and 5 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.

(6)	Only authorised if the third country or territory of dispatch is assigned to Sanitary Group G.

(7)	Statements that relate entirely and exclusively to a Sanitary Group different from the Sanitary Group to which the third country or territory, or zone thereof of dispatch to the Union is assigned, may be left out, provided that the numbering of the subsequent statements is maintained.

(8)	Tests for African horse sickness described by the European Union Reference Laboratory for African horse sickness: https://www.mapa.gob.es/en/ganaderia/temas/laboratorios-sanidad-genetica/referencia-ue/ .

(9)

By deleting this point, the equine animal, if intended for free circulation in accordance with the customs procedures laid down in Regulation (EU) No 952/2013 of the European Parliament and of the Council, will be excluded from slaughter for human consumption in the identification document issued in accordance with Union animal health rules.

(10)	Applicable to consignments entering the Union as from 3 September 2026.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

Declaration by the operator responsible for the entry into the Union of the consignment of an equine animal

Identification of the animal (1)

Species (scientific name)

…

Identification system

…

Identification number

…

Age

…

Sex

…

I, the undersigned operator of the equine animal described above, hereby declare, that:

(a)

the equine animal

(2) either

[has remained in … (insert name of third country or territory, or zone thereof of dispatch to the Union) during at least 40 days prior to the date of dispatch to the Union, or since birth, or since the entry from a Member State the European Union or Norway;]

(2) or

[entered … (insert name of third country or territory, or zone thereof of dispatch to the Union) during the required residence period of at least 40 days prior to the date of dispatch to the Union:

(i)	on ___/___/____ (dd/mm/yyyy) from … (insert name of third country or territory from where the equine animal entered the third country or territory, or zone thereof of dispatch to the Union)

(ii)	on ___/___/____ (dd/mm/yyyy) from … (insert name of third country or territory from where the equine animal entered the third country, territory or zone thereof of dispatch to the Union)

(iii)

on ___/___/____ (dd/mm/yyyy) from … (insert name of third country or territory from where the equine animal entered the third country or territory or zone thereof of dispatch to the Union);]

(b)	during the last 15 days prior to the date of dispatch to the Union the equine animal has not been in contact with animals suffering from infectious or contagious diseases transmissible to equine animals;

(c)	the conditions for residence and isolation prior to dispatch to the Union as applicable in accordance with point II.3 of the accompanying animal health/official certificate for the third country or territory, or zone thereof of dispatch to the Union are fulfilled;

(d)	the conditions for the transport as applicable in accordance with point II.5 of the accompanying animal health/official certificate for the third country or territory, or zone thereof of dispatch to the Union are fulfilled;

(e)	I am aware of the animal health and veterinary certification requirements for the movement of equine animals from one Member State of the European Union to another laid down in Commission Delegated Regulation (EU) 2020/688;

(f)

the equine animal is scheduled to leave the European Union on ___/___/____ (dd/mm/yyyy) at the border post of … (insert name and place of border post of exit) or otherwise will be subject to the identification and registration rules applicable in accordance with Commission Delegated Regulation (EU) 2019/2035.

Name and address of the operator …

Date … (dd/mm/yyyy)

…

(Signature)

(1)

Identification system: The animal shall be individually identified with one of the methods of identification laid down in Article 21(2), point (a), of Commission Delegated Regulation (EU) 2020/692, or be identified by an alternative method provided it is recorded in identification document (passport) of the animal as referred to in Article 21(2), point (b)(i), of Delegated Regulation (EU) 2020/692. Specify the identification system (such as ear tag, transponder) and the anatomic place used on the animal.

If a passport accompanies the animal, its number shall be stated and the name of the competent authority which validated it.

Age: Date of birth (dd/mm/yyyy).

Sex (M = male, F = female, C = castrated).

(2)	Delete if not applicable.

CHAPTER 14

MODEL ANIMAL HEALTH/OFFICIAL CERTIFICATE AND MODEL DECLARATION FOR THE ENTRY INTO THE UNION OF EQUINE ANIMALS INTENDED FOR SLAUGHTER (MODEL “EQUI-Y”)

Part I: Description of consignment

COUNTRY

Animal health/official certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No	Seal No
I.20	Certified as or for

	☐ Slaughter

I.21			I.22	☐ For internal market
			I.23

I.24

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category	Identification system	Identification number	Quantity
Slaughterhouse

Part II: Certification

COUNTRY

EQUI-Y

Entry – equine animals intended for slaughter

II.a

Certificate reference

II.b

IMSOC reference

II. Animal health attestation

I, the undersigned official veterinarian, hereby certify that:

II.1.

The equine animals (1) of the consignment described in Part I:

II.1.1.

are intended for slaughter for human consumption and are not intended for slaughter in the framework of the eradication of infectious or contagious diseases transmissible to equine animals;

II.1.2.

have not shown signs or symptoms of diseases listed for equine animals in Commission Implementing Regulation (EU) 2018/1882 during the clinical examination carried out on ___/___/____ (dd/mm/yyyy) (2), this date being within the last 24 hours prior to dispatch to the Union

(3) either

[from the registered establishment of origin in the third country or territory, or zone thereof of dispatch;]

(3) or

[from the establishment approved for conducting assembly operations of equine animals by the competent authority in the third country or territory of dispatch in accordance with requirements at least as stringent as those laid down in Article 5 of Commission Delegated Regulation (EU) 2019/2035;]

II.1.3.

meet the requirements attested in points II.2 to II.6 of this animal health/official certificate, including in case of dispatch from an establishment approved for assembly operations;

II.1.4.

are accompanied by a written declaration, signed by the operator responsible for the consignment of animals, which is attached to this animal health/official certificate.

II.2.

Attestation on third country or territory, or zone thereof and in establishment of dispatch

II.2.1.

The equine animals described in Part I are dispatched from … (insert name of third country or territory, or zone thereof), a third country or territory, or zone thereof, which on the date of issuing this animal health/official certificate has the code __-__ (4) and is assigned to Sanitary Group … (4).

II.2.2.

The equine animals described in Part I are dispatched from a third country or territory, or zone thereof in which there has been no clinical, serological (in unvaccinated equine animals) or epidemiological evidence of African horse sickness during the last 24 months prior to the date of dispatch of the consignment to the Union, and there has been no vaccination against African horse sickness during the last 12 months prior to the date of dispatch of the consignment to the Union.

II.2.3.

The equine animals described in Part I come from an establishment of origin situated in a third country or territory, or zone thereof in which

(3) either

[infection with Burkholderia mallei (glanders) has not been reported during the last 36 months prior to the date of dispatch of the consignment to the Union.]

(3) or

(3) either

[infection with Burkholderia mallei (glanders) has not been reported in the establishment of origin during the last 36 months prior to the date of dispatch of the consignment to the Union.]

(3) or

[infection with Burkholderia mallei (glanders) has been reported in the establishment of origin during the last 36 months prior to the date of dispatch of the consignment to the Union and following the last outbreak, the establishment has remained under movement restrictions

(3) either

[until the date on which the remaining equine animals in the establishment have been subjected to a complement fixation test for infection with Burkholderia mallei (glanders) (5), carried out, with negative results at a serum dilution of 1 in 5, on samples taken at least 6 months after the date on which the infected animals have been killed and destroyed.]]]

(3) or

[for at least 30 days after the date on which the last equine animal on the establishment was killed and destroyed, and the establishment was cleaned and disinfected.]]]

II.2.4.

The equine animals described in Part I come from an establishment of origin situated in a country or territory, or zone thereof in which

(3) either

[surra has not been reported during the last 24 months prior to the date of dispatch of the consignment to the Union.]

(3) or

[a surveillance programme for surra recognised by the Union (2) has been carried out during the last 24 months prior to the date of dispatch of the consignment to the Union, and

(3) either

[surra has not been reported in the establishment of origin during the last 24 months prior to the date of dispatch of the consignment to the Union.]

(3) or

[surra has been reported in the establishment of origin during the last 24 months prior to the date of dispatch of the consignment to the Union, and following the last outbreak, the establishment has remained under movement restrictions

(3) either

[until the date on which the remaining animals in the establishment have been subjected to an enzyme-linked immunosorbent assay (ELISA) for trypanosomosis or card agglutination test for trypanosomosis (CATT) at a serum dilution of 1 in 4 (5) carried out, with negative results, on samples taken at least 6 months after the date on which the last infected animal has been removed from the establishment.]]]

(3) or

II.2.5.

The equine animals described in Part I come from an establishment of origin situated in a third country or territory, or zone thereof in which

(3) either

[dourine has not been reported during the last 24 months prior to the date of dispatch of the consignment to the Union.]

(3) or

[a surveillance programme for dourine recognised by the Union (2) has been carried out during the last 24 months prior to the date of dispatch of the consignment to the Union, and

(3) either

[dourine has not been reported in the establishment of origin during the last 24 months prior to the date of dispatch of the consignment to the Union.]

(3) or

[dourine has been reported in the establishment of origin during the last 24 months prior to the date of dispatch of the consignment to the Union, and following the last outbreak, the establishment has remained under movement restrictions

(3) either

[until the date on which the remaining equine animals in the establishment, except castrated male equine animals, have been subjected to a complement fixation test for dourine, carried out with negative results at a serum dilution of 1 in 5 (5) on samples taken at least 6 months after the date on which the infected animals have been killed and destroyed or slaughtered, or the date on which the infected entire male equine animals have been castrated.]]]

(3) or

[for at least 30 days after the date of cleaning and disinfection of the establishment, and after the date on which the last equine animal on the establishment was either killed and destroyed or slaughtered.]]]

II.2.6.

The equine animals described in Part I come from an establishment of origin in which

(3) either

[equine infectious anaemia has not been reported during the last 12 months prior to the date of dispatch of the consignment to the Union.]

(3) or

[equine infectious anaemia has been reported during the last 12 months prior to the date of dispatch of the consignment to the Union and following the last outbreak, the establishment has remained under movement restrictions

(3) either

[until the date on which the remaining equine animals in the establishment have been subjected to an agar gel immuno-diffusion test (AGID or Coggins test) or ELISA (5) for equine infectious anaemia carried out, with negative results, on samples taken on two occasions with a minimum interval of 90 days following the date on which the infected animals have been killed and destroyed or slaughtered, and the establishment was cleaned and disinfected.]]

(3) or

[for at least 30 days after the date on which the last equine animal on the establishment was either killed and destroyed or slaughtered, and the establishment was cleaned and disinfected.]]

II.2.7.

The equine animals described in Part I come from an establishment of origin in which:

II.2.7.1.

infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to the date of dispatch of the consignment to the Union;

II.2.7.2.

anthrax in ungulates has not been reported during the last 15 days prior to the date of dispatch of the consignment to the Union.

II.2.8.

To the best of my knowledge and as declared by the operator of the consignment, the equine animals described in Part I have not been in contact with kept animals of listed species which did not comply with the requirements referred to in points II.2.2 to II.2.7.1 during the last 30 days prior to the date of dispatch of the consignment to the Union, and with the requirement referred to in point II.2.7.2 during the last 15 days prior to the dispatch of the consignment to the Union.

II.3.

Attestation of residence and isolation prior to dispatch to the Union

II.3.1.

The equine animals described in Part I have been resident in the third country or territory, or zone thereof of dispatch during the last 90 days prior to the date of dispatch of the consignment to the Union.

(3) either

[II.3.2.

The equine animals described in Part I are dispatched from a third country or territory, or zone thereof assigned to Sanitary Group A, B, C, D, or G, and during the last 30 days prior to the date of dispatch from the establishment of origin have been kept in pre-export isolation.]

(3) (6) or

[II.3.2.

The equine animals described in Part I are dispatched from a third country or territory, or zone thereof assigned to Sanitary Group E, and during the last 40 days prior to the date of dispatch from the establishment of origin, have been kept

(3) either

[in isolation in a vector-protected establishment.]]

(3) or

[in an establishment of origin under official veterinary supervision, and the third country or territory, or zone thereof of dispatch is recognised by the World Organisation for Animal Health (WOAH) as officially free of African horse sickness.]]

(3) [II.3.3.

Immediately prior to their dispatch from the third country or territory, or zone thereof of dispatch, the equine animals of the consignment described in Part I have been kept in the establishment approved for assembly operations referred to in point II.1.2 for not more than 6 days after the date of dispatch from their respective establishments of origin. In the approved establishment, which complies with the requirements for establishments referred to in point II.2, the animals have been kept under conditions that effectively protect their health status and without coming into contact with equine animals not complying with the requirements in points II.2, II.3.1, II.3.2 and II.4 of this animal health/official certificate.]

II.4.

Attestation of vaccination and health tests

II.4.1.

The equine animals described in Part I were not vaccinated against African horse sickness in the country, territory or zone thereof of dispatch and there is no information suggesting previous vaccination.

II.4.2.

The equine animals described in Part I have not been vaccinated against Venezuelan equine encephalomyelitis during the last 60 days prior to the date of dispatch of the consignment to the Union, and come from an establishment situated in a third country or territory, or zone thereof in which Venezuelan equine encephalomyelitis has not been reported during the last 24 months prior to the date of dispatch of the consignment to the Union.

(3) either

[II.4.3.

The equine animals described in Part I are dispatched from Iceland, which is certified as officially free from equine infectious anaemia, where they have been continuously resident since birth, and did not come into contact with equine animals which have entered Iceland from other third countries or territories.]

(3) or

[II.4.3.

The equine animals described in Part I were subjected with negative result in each case to an agar gel immunodiffusion test (AGID or Coggins test) or to an ELISA for equine infectious anaemia (5) carried out on a blood sample taken on ___/___/____ (dd/mm/yyyy), within the last 30 days prior to the date of dispatch of the consignment to the Union.]

(3) [II.4.4.

The equine animals described in Part I are dispatched from a third country or territory, or zone thereof assigned to Sanitary Group B, D or E, or from a third country or territory in which infection with Burkholderia mallei (glanders) has been reported during the last 36 months prior to the date of dispatch of the consignment to the Union, and the equine animals were subjected to a complement fixation test for infection with Burkholderia mallei (glanders) (5) carried out with negative result in each case at a serum dilution of 1 in 5 on a blood sample taken on ___/___/____ (dd/mm/yyyy), within the last 30 days prior to the date of dispatch of the consignment to the Union.]

(3) [II.4.5.

The equine animals described in Part I are uncastrated male or female equine animals older than 270 days dispatched from a third country or territory, or zone thereof assigned to Sanitary Group B, D or E, or from a third country in which dourine has been reported during the last 24 months prior to the date of dispatch of the consignment to the Union, and the equine animals were subjected to a complement fixation test for dourine (5) carried out with negative result in each case at a serum dilution of 1 in 5 on a blood sample taken on ___/___/____ (dd/mm/yyyy), within the last 30 days prior to the date of dispatch of the consignment to the Union.]

(3) [II.4.6.

The equine animals described in Part I are dispatched from a third country or territory, or zone thereof which is assigned to Sanitary Group E, or from Bolivia, Brazil, Uruguay, or from a third country or territory in which surra was reported during the last 24 months prior to the date of dispatch of the consignment to the Union, and the equine animals were subjected to a card agglutination test for trypanosomosis (CATT) (5) carried out with negative result in each case at a serum dilution of 1 in 4 on a blood sample taken on ___/___/____ (dd/mm/yyyy), within the last 30 days prior to the date of dispatch of the consignment to the Union.]

(3) (6) [II.4.7.

The equine animals described in Part I are dispatched to the Union from a third country or territory, or zone thereof which is assigned to Sanitary Group E, and

(3) either

[were subjected to an indirect ELISA or a blocking ELISA for African horse sickness (7), which was carried out with negative results in each case by the same laboratory on the same day on blood samples taken on two occasions with an interval of between 21 and 30 days, on ___/___/____ (dd/mm/yyyy) and on ___/___/____ (dd/mm/yyyy), the second of which was taken within the last 10 days prior to the date of dispatch of the consignment to the Union.]]

(3) or

[were subjected to an indirect ELISA or a blocking ELISA for African horse sickness (7) with negative result on a blood sample taken on ___/___/____ (dd/mm/yyyy), within the last 21 days prior to the date of dispatch of the consignment to the Union, and the third country or territory of dispatch is recognised by the WOAH as officially free of African horse sickness.]]

II.5.

Attestation of the transport conditions

II.5.1.

Arrangements have been made to transport this consignment of animals directly to the Union, without subjecting the animals after the date of certification to any further assembly operation outside the Union and without coming into contact with other equine animals not complying with at least the same health requirements as described in this animal health/official certificate.

II.5.2.

II.5.3.

The transport vehicles or containers in which the animals are going to be loaded were cleaned and disinfected before loading with a disinfectant officially recognised in the third country or territory of dispatch of the consignment to the Union and they are so constructed that faeces, urine, litter or fodder cannot escape during transportation.

II.6.

Public health attestation

I, the undersigned official veterinarian, hereby certify, that the equine animals described in Part I:

II.6.1.

in the third country or territory of dispatch of the consignment to the Union have not received:

(a)	prohibited substances listed in Table 2 of the Annex to Commission Regulation (EU) No 37/2010;

(b)	any stilbene or thyrostatic substances;

(c)	oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other than therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC);

II.6.2.

fulfil the guarantees provided by the control plan submitted and approved in accordance with Article 6(2) of Commission Delegated Regulation (EU) 2022/2292, and have been dispatched from a third country or region thereof listed in Annex –I to Commission Implementing Regulation (EU) 2021/405 and marked with an “X” for the category “equine”.

(3) (8) [II.6a.

Attestation as regards Commission Delegated Regulation (EU) 2023/905

Notes:

This animal health/official certificate is intended for the entry of equine animals that will be slaughtered in the Union.

Part I:

Box reference I.6	:	Provide the information on the operator responsible for the consignment.
Box reference I.8	:	Provide the code of the third country or territory, or zone thereof of dispatch as appearing in column 2 of the table in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2021/404.
Box reference I.27	:	“Identification system”: The animals shall be individually identified with one of the methods of identification laid down in Article 21(2), point (a), of Delegated Regulation (EU) 2020/692 which permits to link the animals to the animal health/official certificate. Specify the identification system and the anatomic place used on the animals.

Part II:

(1)	There can be one or more equine animals in the consignment.

(2)

The entry into the Union shall not be allowed when the animals were loaded either prior to the date of authorisation for the entry into the Union from the respective third country or territory, or zone thereof referred to in point II.2.1, or during a period where restrictive measures have been adopted by the Union against the entry into the Union of equine animals from that third country or territory, or zone thereof. Check against columns 8 and 9 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.

(3)	Delete if not applicable.

(4)	Code of the third country or territory, or zone thereof and the Sanitary Group as appearing respectively in columns 2 and 3 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.

(5)	Tests for glanders, surra, dourine, equine infectious anaemia and Venezuelan equine encephalomyelitis described by the European Union Reference Laboratory for Equine Diseases other than African horse sickness: https://sitesv2.anses.fr/en/minisite/equine-diseases/sop.

(6)	Statements that relate entirely and exclusively to a Sanitary Group different from the Sanitary Group to which the third country or territory, or zone thereof of dispatch is assigned, may be left out, provided that the numbering of the subsequent statements is maintained.

(7)	Tests for African horse sickness described by the European Union Reference Laboratory for African horse sickness: https://www.mapa.gob.es/en/ganaderia/temas/laboratorios-sanidad-genetica/referencia-ue/ .

(8)	Applicable to consignments entering the Union as from 3 September 2026.

Official veterinarian
Name (in capital letters)	Qualification and title
Date	Signature
Stamp

Declaration by the operator responsible for the entry into the Union of the consignment of equine animals intended for slaughter

Identification of the animals (1)

Total number

…

Species (scientific name)

…

Identification system

…

Identification number(s)

…

Quantity

…

I, the undersigned operator of the consignment of equine animals intended for slaughter described above, hereby declare, that:

(a)	the animals have remained in the third country or territory, or zone thereof of dispatch for at least 90 days prior to the date of their dispatch to the Union;

(b)	during the last 15 days prior to the date of their dispatch to the Union the animals have not been in contact with animals suffering from infectious or contagious diseases transmissible to equine animals;

(c)	the conditions for residence and isolation prior to dispatch to the Union as applicable in accordance with point II.3 of the accompanying animal health/official certificate for the third country or territory, or zone thereof of dispatch to the Union are fulfilled;

(d)	the conditions for the transport as applicable in accordance with point II.5 of the accompanying animal health/official certificate for the third country or territory, or zone thereof of dispatch to the Union are fulfilled;

(e)

the animals will be sent

(2) either

[directly from the establishment of origin to the slaughterhouse of destination without coming into contact with other equine animals not of the same health status;]

(2) or

[from the establishment approved for assembly operations on equine animals to the slaughterhouse of destination without coming into contact with other equine animals not of the same health status;]

Name and address of the operator …

Date … (dd/mm/yyyy)

…

(Signature)

(1)

Identification system: The animals shall be individually identified with one of the methods of identification laid down in Article 21(2), point (a), of Commission Delegated Regulation (EU) 2020/692 which permits to link the animals to the animal health/official certificate. Specify the identification system (such as ear tag, transponder) and the anatomic place used on the animals.

(2)	Delete if not applicable.

CHAPTER 15

MODEL ANIMAL HEALTH CERTIFICATE AND MODEL DECLARATION FOR THE RE-ENTRY INTO THE UNION OF A REGISTERED HORSE FOR RACING, COMPETITION AND CULTURAL EVENTS AFTER TEMPORARY EXPORT FOR A PERIOD OF NOT MORE THAN 30 DAYS (MODEL “EQUI-RE-ENTRY-30”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No	Seal No
I.20	Certified as or for

		☐ Registered horse

I.21			I.22
			I.23	☐ For re-entry

I.24

I.25

Total quantity

I.26

Part II: Certification

COUNTRY

Certificate model EQUI-RE-ENTRY-30

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

II. Animal health attestation

I, the undersigned official veterinarian, hereby certify that:

II.1.

The equine animal described in Part I:

II.1.1.

is a registered horse as defined in Article 2, point (30), of Commission Delegated Regulation (EU) 2019/2035, not intended for slaughter in the framework of the eradication of a disease transmissible to equine animals;

II.1.2.

has not shown signs or symptoms of diseases listed for equine animals in Commission Implementing Regulation (EU) 2018/1882 during the clinical examination carried out on ___/___/____ (dd/mm/yyyy) (1), this being within the last 48 hours or on the last working day prior to the date of its dispatch to the Union from the registered establishment;

II.1.3.

meets the requirements attested in points II.2 to II.3 of this animal health certificate;

II.1.4.

is accompanied by a written declaration, signed by the operator responsible for the animal, which is attached to this animal health certificate.

II.2.

Attestation on third country or territory, or zone thereof and in establishment of dispatch

II.2.1.

The equine animal is dispatched from … (insert name of third country or territory, or zone thereof), a third country or territory, or zone thereof which on the date of issuing this animal health certificate has the code __-__ (2) and is assigned to Sanitary Group … (2).

II.2.2.

The equine animal described in Part I comes from a third country or territory, or zone thereof in which there has been no clinical, serological (in unvaccinated equine animals) or epidemiological evidence of African horse sickness during the last 24 months prior to the date of dispatch of the animal to the Union and there has been no vaccination against African horse sickness during the last 12 months prior to the date of its dispatch to the Union.

II.2.3.

The equine animal described in Part I comes from an establishment situated in a third country or territory, or zone thereof in which

(3) either

[infection with Burkholderia mallei (glanders) has not been reported during the last 36 months prior to the date of dispatch of the animal to the Union.]

(3) or

[a surveillance programme for infection with Burkholderia mallei (glanders) recognised by the Union (1)has been carried out during the last 36 months prior to the date of dispatch of the animal to the Union, and

(3) either

[infection with Burkholderia mallei (glanders) has not been reported in the establishment of dispatch during the last 36 months prior to the date of dispatch of the animal to the Union.]]

(3) or

[infection with Burkholderia mallei (glanders) has been reported in the establishment during the last 36 months prior to the date of dispatch of the animal to the Union and following the last outbreak, the establishment has remained under movement restrictions

(3) either

(3) or

[for at least 30 days after the date on which the last equine animal on the establishment was killed and destroyed, and the establishment was cleaned and disinfected.]]]

II.2.4.

The equine animal described in Part I comes from an establishment situated in a third country or territory, or zone thereof in which

(3) either

[surra has not been reported during the last 24 months prior to the date of dispatch of the animal to the Union.]

(3) or

[a surveillance programme for surra recognised by the Union (1)has been carried out during the last 24 months prior to the date of dispatch of the animal to the Union, and

(3) either

[surra has not been reported in the establishment during the last 24 months prior to the date of dispatch of the animal to the Union.]]

(3) or

(3) either

(3) or

II.2.5.

The equine animal described in Part I comes from an establishment situated in a third country or territory, or zone thereof in which

(3) either

[dourine has not been reported during the last 24 months prior to the date of dispatch of the animal to the Union.]

(3) or

[a surveillance programme for dourine recognised by the Union (1)has been carried out during the last 24 months prior to the date of dispatch of the animal, and

(3) either

[dourine has not been reported in the establishment during the last 24 months prior to the date of dispatch of the animal to the Union.]]

(3) or

(3) either

(3) or

[for at least 30 days after the date on which the last equine animal on the establishment was either killed and destroyed or slaughtered, and the establishment was cleaned and disinfected.]]]

II.2.6.

The equine animal described in Part I has not been vaccinated against Venezuelan equine encephalomyelitis during the last 60 days prior to the date of its dispatch to the Union, and

(3) either

(3) or

(3) either

(3) or

(a)

(b)	a reverse transcription-polymerase chain reaction (RT-PCR) for the detection of Venezuelan equine encephalomyelitis virus genome (4), with negative result, carried out on a sample taken within the last 48 hours prior to its dispatch to the Union, and

(c)	protection from vector attacks during the period after the date of sampling until loading for dispatch to the Union, by combined use of approved insect repellents and insecticides on the animal and disinsectization of the stable and the means in which it is transported.]]

II.2.7.

The equine animal described in Part I comes from an establishment in which

(3) either

[equine infectious anaemia has not been reported during the last 12 months prior to the date of dispatch of the animal to the Union.]

(3) or

(3) either

[until the date on which the remaining equine animals in the establishment have been subjected to an agar gel immuno-diffusion test (AGID or Coggins test) or ELISA (4) for equine infectious anaemia carried out, with negative results, on samples taken on two occasions with a minimum interval of 90 days following the date on which the infected animals have been killed and destroyed or slaughtered, and the establishment was cleaned and disinfected.]]

(3) or

[for at least 30 days after the date on which the last equine animal on the establishment was either killed and destroyed or slaughtered, and the establishment was cleaned and disinfected.]]

II.2.8.

The equine animal described in Part I comes from an establishment in which:

II.2.8.1.

infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to the date of dispatch of the animal to the Union;

II.2.8.2.

anthrax in ungulates has not been reported during the last 15 days prior to the date of dispatch of the animal to the Union.

II.2.9.

To the best of my knowledge and as declared by the operator, the equine animal described in Part I has not been in contact with kept animals of listed species which did not comply with the requirements referred to in points II.2.2 to II.2.8.1 during the last 30 days prior to the date of dispatch of the animal to the Union, and with the requirement referred to in point II.2.8.2 during the last 15 days prior to the date of dispatch of the animal to the Union.

II.3.

Attestation of residence and isolation prior to dispatch to the Union

II.3.1.

The equine animal described in Part I was introduced into the third country or territory, or zone thereof of dispatch on ___/___/____ (dd/mm/yyyy)

(3) either

[directly from the Member State of the European Union … (insert name of Member State).]

(3) or

[from the third country or territory, or zone thereof … (insert name of third country or territory, or zone thereof) authorised for the entry of registered horses into the Union, under conditions at least as strict as those set out in this animal health certificate.]

II.3.2.

The equine animal described in Part I exited from the Union less than 30 days ago, and since the date of exit from the Union it was never in a third country or territory, or zone thereof (2) other than those of the same Sanitary Group as the third country or territory, or zone thereof of dispatch, and was a resident in the establishments under official veterinary supervision, accommodated in separated stables without coming into contact with equine animals of lower health status, except during racing, competition or the cultural event.

Notes:

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.6

Provide the information on the operator responsible for the animal.

Box reference I.8

Provide the code of the third country or territory, or zone thereof of dispatch as appearing in column 2 of the table in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2021/404.

Box reference I.27

“Identification system”: The animal shall be individually identified with one of the means of identification defined in point (a), (c), (e), or (g) of Annex III to Delegated Regulation (EU) 2019/2035, or be identified by an alternative method in accordance with Article 62 of that Delegated Regulation (for example, brand) provided it is recorded in its identification document (passport). Specify the identification system and the anatomic place used on the animal. The number of the accompanying passport or the Unique Code, if no passport number is available, shall be stated and the name of the competent authority which validated it.

“Age”: Date of birth (dd/mm/yyyy).

“Sex”: M = male, F = female, C = castrated.

Part II:

(1)

The animal health certificate shall be issued within the last 10 days prior to the date of arrival of the consignment at the border control post; in the case of transport by sea, the period may be extended by an additional period corresponding to the duration of the journey by sea.

(2)	Code of the third country or territory, or zone thereof and the Sanitary Group as appearing respectively in columns 2 and 3 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.

(3)	Delete if not applicable.

(4)	Tests for glanders, surra, dourine, equine infectious anaemia and Venezuelan equine encephalomyelitis described by the European Union Reference Laboratory for Equine Diseases other than African horse sickness: https://sitesv2.anses.fr/en/minisite/equine-diseases/sop.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

Declaration by the operator responsible for the re-entry into the Union after temporary export of a registered horse for racing, competition and cultural events

Identification of the animal (1)

Species (scientific name)

Equus caballus

Identification system

…

Identification number

…

Age

…

Sex

…

I, the undersigned operator of the registered horse described above, hereby declare, that:

(a)

the registered horse

(2) either

[was temporarily exported from the Union to the third country or territory, or zone thereof of dispatch to the Union on ___/___/____ (dd/mm/yyyy) less than 30 days prior to the date of issue of this declaration;]

(2) or

[entered the third country or territory, or zone thereof of dispatch on ___/___/____ (dd/mm/yyyy) from … (insert name of third country or territory, or zone thereof from where the registered horse has entered the third country or territory, or zone thereof of dispatch);]

(b)	during the last15 days prior to the date of dispatch to the Union the registered horse has not been in contact with the animals suffering from infectious or contagious diseases transmissible to equine animals;

(c)	the transportation will be effected in such a way that health and welfare of the registered horse can be protected effectively at all stages of the journey;

(d)	the conditions for residence and pre-export isolation as applicable in accordance with point II.3 of the accompanying animal health certificate for the third country or territory, or zone thereof of dispatch are fulfilled.

Name and address of the operator …

Date … (dd/mm/yyyy)

…

(Signature)

(1)

Identification system: The animal shall be individually identified with one of the means of identification defined in point (a), (c), (e), or (g) of Annex III to Commission Delegated Regulation (EU) 2019/2035, or be identified by an alternative method in accordance with Article 62 of that Delegated Regulation provided it is recorded in its identification document (passport). Specify the identification system (such as tattoo, brand, transponder etc.) and the anatomic place used on the animal.

The number of the accompanying passport or the Unique Code, if no passport number is available, shall be stated and the name of the competent authority which validated the passport.

Age: Date of birth (dd/mm/yyyy).

Sex (M = male, F = female, C = castrated).

(2)	Delete if not applicable.

CHAPTER 16

MODEL ANIMAL HEALTH CERTIFICATE AND MODEL DECLARATION FOR THE RE-ENTRY INTO THE UNION OF A REGISTERED HORSE FOR COMPETITION AFTER TEMPORARY EXPORT FOR A PERIOD OF NOT MORE THAN 90 DAYS TO PARTICIPATE IN EQUESTRIAN EVENTS ORGANISED UNDER THE AUSPICES OF THE FÉDÉRATION EQUESTRE INTERNATIONALE (FEI) (MODEL “EQUI-RE-ENTRY-90-COMP”)

(Test event in preparation of the Olympic Games, Olympic Games, Paralympics, World Equestrian Games/World Championship, Asian Equestrian Games, American Equestrian Games (including the Pan American Games, South American Games, Central American and Caribbean Games), the show jumping 5* in Mexico, the United States and China, the show jumping and dressage in the United Arab Emirates)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No	Seal No
I.20	Certified as or for
		☐ Registered horse

I.21			I.22
			I.23	☐ For re-entry

I.24

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category	Sex	Identification system	Identification number	Age

Part II Certification

COUNTRY

Certificate model EQUI-RE-ENTRY-90-COMP

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

II. Animal health attestation

I, the undersigned official veterinarian, hereby certify that:

II.1.

The equine animal described in Part I:

II.1.1.

II.1.2.

has not shown signs or symptoms of diseases listed for equine animals in Commission Implementing Regulation (EU) 2018/1882 during the clinical examination carried out on ___/___/____ (dd/mm/yyyy) (1), this being within the last 48 hours or on the last working day prior to the date of its dispatch from the registered establishment;

II.1.3.

meets the requirements attested in points II.2 to II.3 of this animal health certificate;

II.1.4.

is accompanied by a written declaration, signed by the operator responsible for the animal, which is attached to this animal health certificate.

II.2.

Attestation on third country or territory, or zone thereof and in establishment of dispatch

II.2.1.

II.2.2.

The equine animal described in Part I comes from a third country or territory, or zone thereof in which there has been no clinical, serological (in unvaccinated equine animals) or epidemiological evidence of African horse sickness during the last 24 months prior to the date of dispatch of the animal to the Union and there has been no vaccination against African horse sickness during the last 12 months prior to the date of its dispatch to the Union.

II.2.3.

The equine animal described in Part I comes from an establishment situated in a third country or territory, or zone thereof in which

(3) either

[infection with Burkholderia mallei (glanders) has not been reported during the last 36 months prior to the date of dispatch of the animal to the Union.]

(3) or

(3) either

[infection with Burkholderia mallei (glanders) has not been reported in the establishment of dispatch during the last 36 months prior to the date of dispatch of the animal to the Union.]]

(3) or

[infection with Burkholderia mallei (glanders) has been reported in the establishment during the last 36 months prior to the date of dispatch of the animal to the Union and following the last outbreak, the establishment has remained under movement restrictions

(3) either

[until the date on which the remaining equine animals in the establishment have been subjected to a complement fixation test for infection with Burkholderia mallei (glanders)(4), carried out, with negative results at a serum dilution of 1 in 5, on samples taken at least 6 months after the date on which the infected animals have been killed and destroyed.]]]

(3) or

[for at least 30 days after the date on which the last equine animal on the establishment was killed and destroyed, and the establishment was cleaned and disinfected.]]]

II.2.4.

The equine animal described in Part I comes from an establishment situated in a third country or territory, or zone thereof in which

(3) either

[surra has not been reported during the last 24 months prior to the date of dispatch of the animal to the Union.]

(3) or

[a surveillance programme for surra recognised by the Union (1)has been carried out during the last 24 months prior to the date of dispatch of the animal to the Union, and

(3) either

[surra has not been reported in the establishment during the last 24 months prior to the date of dispatch of the animal to the Union.]]

(3) or

(3) either

(3) or

II.2.5.

The equine animal described in Part I comes from an establishment situated in a third country or territory, or zone thereof in which

(3) either

[dourine has not been reported during the last 24 months prior to the date of dispatch of the animal to the Union.]

(3) or

[a surveillance programme for dourine recognised by the Union (1)has been carried out during the last 24 months prior to the date of dispatch of the animal to the Union, and

(3) either

[dourine has not been reported in the establishment during the last 24 months prior to the date of dispatch of the animal to the Union.]]

(3) or

(3) either

(3) or

[for at least 30 days after the date on which the last equine animal on the establishment was either killed and destroyed or slaughtered, and the establishment was cleaned and disinfected.]]]

II.2.6.

The equine animal described in Part I has not been vaccinated against Venezuelan equine encephalomyelitis during the last 60 days prior to the date of its dispatch to the Union, and

(3) either

(3) or

(3) either

(3) or

(a)

(b)	a reverse transcription-polymerase chain reaction (RT-PCR) for the detection of Venezuelan equine encephalomyelitis virus genome (4), with negative result, carried out on a sample taken within the last 48 hours prior to its dispatch to the Union, and

(c)	protection from vector attacks during the period after the date of sampling until loading for dispatch to the Union, by combined use of approved insect repellents and insecticides on the animal and disinsectization of the stable and the means in which it is transported.]]

II.2.7.

The equine animal described in Part I comes from an establishment in which

(3) either

[equine infectious anaemia has not been reported during the last 12 months prior to the date of dispatch of the animal to the Union.]

(3) or

(3) either

[until the date on which the remaining equine animals in the establishment have been subjected to an agar gel immuno-diffusion test (AGID or Coggins test) or ELISA (4) for equine infectious anaemia carried out, with negative results, on samples taken on two occasions with a minimum interval of 90 days following the date on which the infected animals have been killed and destroyed or slaughtered, and the establishment was cleaned and disinfected.]]

(3) or

[for at least 30 days after the date on which the last equine animal on the establishment was either killed and destroyed or slaughtered, and the establishment was cleaned and disinfected.]]

II.2.8.

The equine animal described in Part I comes from an establishment in which:

II.2.8.1.

infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to the date of dispatch of the animal to the Union;

II.2.8.2.

anthrax in ungulates has not been reported during the last 15 days prior to the date of dispatch of the animal to the Union.

II.2.9.

To the best of my knowledge and as declared by the operator, the equine animal described in Part I has not been in contact with kept animals of listed species which did not comply with the requirements referred to in points II.2.2 to II.2.8.1 during the last 30 days prior to the date of dispatch of the animal to the Union, and with the requirement referred to in point II.2.8.2 during the last 15 days prior to the date of dispatch of the animal to the Union.

II.3.

Attestation of residence and isolation prior to dispatch to the Union

II.3.1.

The equine animal described in Part I was introduced into the third country or territory, or zone thereof of dispatch on ___/___/____ (dd/mm/yyyy)

(3) either

[directly from the Member State of the European Union … (insert name of a Member State).]

(3) or

[from a third country or territory, or zone thereof … (insert name of third country or territory, or zone thereof) authorised for the entry of equine animals into the Union, under conditions at least as strict as those set out in this animal health certificate.]

II.3.2.

The equine animal exited from the European Union

(3) either

[less than 30 days ago, and since the date of exit from the European Union has never been in a third country or territory, or zone thereof (1) other than those of the same Sanitary Group as the third country or territory, or zone thereof of dispatch to the European Union, and has been a resident in the establishments under official veterinary supervision, accommodated in separated stables without coming into contact with equine animals of lower health status except during competition and has taken part in or was stabled together with horses participating in the show jumping (Concours de Saut International 5*)

(3) either

[in the Metropolitan area of Mexico City, Mexico;]

(3) and/or

[in the Unites States;]

(3) or

[in Shanghai, China;]]

(3) or

[less than 60 days ago, and since the date of exit from the European Union has never been in a third country or territory, or zone thereof (1) other than those of the same Sanitary Group as the third country or territory, or zone thereof of dispatch, and has been a resident in the establishments under official veterinary supervision, accommodated in separated stables without coming into contact with equine animals of lower health status except during competition and has taken part in or was stabled together with horses participating in

(3) either

[the Asian Games in … (insert place).]]

(3) or

[the American Games (5) in … (insert place).]]

(3) or

[less than 90 days ago, and since the date of exit from the European Union has never been in a third country or territory, or zone thereof (1) other than those of the same Sanitary Group as the third country or territory, or zone thereof of dispatch to the European Union, and has been a resident in the establishments under official veterinary supervision, accommodated in separated stables without coming into contact with equine animals of lower health status except during competition and has taken part in or was stabled together with horses participating in

(3) either

[the test event for the Olympic Games in … (insert place).]]

(3) or

[the Olympic Games in … (insert place).]]

(3) or

[the Paralympics in … (insert place).]]

(3) or

[the World Equestrian Games/World Championships in … (insert place).]]

(3) or

[the show jumping (Concours de Saut International) or dressage (Concours de Dressage International) in the United Arab Emirates.]]

Notes:

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.6

Provide the information on the operator responsible for the animal.

Box reference I.8

Provide the code of the third country or territory, or zone thereof of dispatch as appearing in column 2 of the table in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2021/404.

Box reference I.27

“Identification system”: The animal shall be individually identified with one of the means of identification defined in point (a), (c), (e), or (g) of Annex III to Delegated Regulation (EU) 2019/2035, or be identified by an alternative method in accordance with Article 62 of that Regulation (for example, brand) provided it is recorded in its identification document (passport). Specify the identification system and the anatomic place used on the animal. The number of the accompanying passport or the Unique Code, if no passport number is available, shall be stated and the name of the competent authority which validated it.

“Age”: Date of birth (dd/mm/yyyy).

“Sex”: (M = male, F = female, C = castrated.

Part II:

(1)

(2)	Code of the third country or territory, or zone thereof and the Sanitary Group as appearing respectively in columns 2 and 3 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.

(3)	Delete if not applicable.

(4)	Tests for glanders, surra, dourine, equine infectious anaemia and Venezuelan equine encephalomyelitis described by the European Union Reference Laboratory for Equine Diseases other than African horse sickness: https://sitesv2.anses.fr/en/minisite/equine-diseases/sop.

(5)	Including the Pan American Games, South American Games, Central American and Caribbean Games.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

Declaration by the operator responsible for the re-entry into the Union after temporary export of a registered horse for racing, competition and cultural events

Identification of the animal (1)

Species (scientific name)

Equus caballus

Identification system

…

Identification number

…

Age

…

Sex

…

I, the undersigned operator of the registered horse described above, hereby declare, that:

(a)

the registered horse

(2) either

[was temporarily exported from the Union to the third country or territory, or zone thereof of dispatch to the Union on ___/___/____ (dd/mm/yyyy) less than 90 days prior to the date of issue of this declaration;]

(2) or

[entered the third country or territory, or zone thereof of dispatch to the Union on ___/___/____ (dd/mm/yyyy) from … (insert name of third country or territory, or zone thereof from where the registered horse entered the third country or territory, or zone thereof of dispatch to the Union);]

(b)

the registered horse has been temporarily exported from the Union to take part in

(2) either

[the Asian Games in … (insert place);]

(2) or

[the American Games in … (insert place);]

(2) or

[the test event for the Olympic Games in … (insert place);]

(2) or

[the Olympic Games in … (insert place);]

(2) or

[the Paralympics in … (insert place);]

(2) or

[the World Equestrian Games in … (insert place);]

(2) or

[the show jumping (Concours de Saut International 5* in

(2) either

[the Metropolitan area of Mexico City, Mexico;]]

(2) and/or

[the Unites States;]]

(2) or

[Shanghai, China;]]

(2) or

[the show jumping (Concours de Saut International) or dressage (Concours de Dressage International) in the United Arab Emirates;]

(c)	during the last 15 days prior to the date of dispatch to the Union the registered horse has not been in contact with animals suffering from infectious or contagious diseases transmissible to equine animals;

(d)	the transportation will be effected in such a way that health and welfare of the registered horse can be protected effectively at all stages of the journey;

(e)	the conditions for residence and pre-export isolation as applicable in accordance with point II.3 of the accompanying animal health certificate for the third country or territory, or zone thereof of dispatch to the Union are fulfilled.

Name and address of the operator …

Date … (dd/mm/yyyy)

…

(Signature)

(1)

The number of the accompanying passport or the Unique Code, if no passport number is available, shall be stated and the name of the competent authority which validated the passport.

Age: Date of birth (dd/mm/yyyy).

Sex (M = male, F = female, C = castrated).

(2)	Delete if not applicable.

CHAPTER 17

MODEL ANIMAL HEALTH CERTIFICATE AND MODEL DECLARATION FOR THE RE-ENTRY INTO THE UNION OF A REGISTERED HORSE FOR RACING AFTER TEMPORARY EXPORT FOR A PERIOD OF NOT MORE THAN 90 DAYS TO PARTICIPATE IN SPECIFIC RACE EVENTS IN THE UNITED ARAB EMIRATES, AUSTRALIA, BAHRAIN, CANADA, HONG KONG, JAPAN, QATAR, SAUDI ARABIA, SINGAPORE OR THE UNITED STATES (MODEL “EQUI-RE-ENTRY-90-RACE”)

(International Group/Grade meetings, the Dubai Racing World-Cup, the Melbourne Cup, the Bahrain Turf Series, the Hong Kong International Races, the Japan Cup and the Saudi Cup)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No	Seal No
I.20	Certified as or for
		☐ Registered horse

I.21			I.22
			I.23	☐ For re-entry

I.24

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category	Sex	Identification system	Identification number	Age

Part II: Certification

COUNTRY

Certificate model EQUI-RE-ENTRY-90-RACE

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

II. Animal health attestation

I, the undersigned official veterinarian, hereby certify that:

II.1.

The equine animal described in Part I:

II.1.1.

II.1.2.

has not shown signs or symptoms of diseases listed for equine animals in Commission Implementing Regulation (EU) 2018/1882 during the clinical examination carried out on ___/___/____ (dd/mm/yyyy) (1), this being within the last 48 hours or on the last working day prior to the date of its dispatch to the Union from the registered establishment;

II.1.3.

meets the requirements attested in points II.2 to II.3 of this animal health certificate;

II.1.4.

is accompanied by a written declaration, signed by the operator responsible for the animal, which is attached to this animal health certificate.

II.2.

Attestation on third country or territory, or zone thereof and in establishment of dispatch

II.2.1.

The equine animal is dispatched from … (insert name of the third country or territory, or zone thereof), a third country or territory, or zone thereof which on the date of issuing this animal health certificate has the code __-__ (2) and is assigned to Sanitary Group … (2).

II.2.2.

The equine animal described in Part I comes from a third country or territory, or zone thereof in which there has been no clinical, serological (in unvaccinated equine animals) or epidemiological evidence of African horse sickness during the last 24 months prior to the date of dispatch of the animal to the Union and there has been no vaccination against African horse sickness during the last12 months prior to the date of its dispatch to the Union.

II.2.3.

The equine animal described in Part I comes from an establishment situated in a third country or territory, or zone thereof in which

(3) either

[infection with Burkholderia mallei (glanders) has not been reported during the last 36 months prior to the date of dispatch of the animal to the Union.]

(3) or

[a surveillance programme for infection with Burkholderia mallei (glanders) recognised by the Union (1)has been carried out during the last 36 months prior to the date of its dispatch to the Union, and

(3) either

[infection with Burkholderia mallei (glanders) has not been reported in the establishment of dispatch during the last 36 months prior to the date of dispatch of the animal to the Union.]]

(3) or

[infection with Burkholderia mallei (glanders) has been reported in the establishment during the last 36 months prior to the date of dispatch of the animal and following the last outbreak, the establishment has remained under movement restrictions

(3) either

(3) or

[for at least 30 days after the date on which the last equine animal on the establishment was killed and destroyed, and the establishment was cleaned and disinfected.]]]

II.2.4.

The equine animal described in Part I comes from an establishment situated in a third country or territory, or zone thereof in which

(3) either

[surra has not been reported during the last 24 months prior to the date of dispatch of the animal to the Union.]

(3) or

[a surveillance programme for surra recognised by the Union (1)has been carried out during the last 24 months prior to the date of dispatch of the animal to the Union, and

(3) either

[surra has not been reported in the establishment during the last 24 months prior to the date of dispatch of the animal to the Union.]]

(3) or

(3) either

(3) or

II.2.5.

The equine animal described in Part I comes from an establishment situated in a third country or territory, or zone thereof in which

(3) either

[dourine has not been reported during the last 24 months prior to the date of dispatch of the animal to the Union.]

(3) or

[a surveillance programme for dourine recognised by the Union (1)has been carried out during the last 24 months prior to the date of dispatch of the animal to the Union, and

(3) either

[dourine has not been reported in the establishment during the last 24 months prior to the date of dispatch of the animal to the Union.]]

(3) or

(3) either

[until the date on which the remaining equine animals in the establishment, except castrated male equine animals, have been subjected to a complement fixation test for dourine, carried out with negative results at a serum dilution of 1 in 5 (4) on samples taken at least 6 months after the date the infected animals have been killed and destroyed or slaughtered, or the date on which the infected entire male equine animals have been castrated.]]]

(3) or

[for at least 30 days after the date on which the last equine animal on the establishment was either killed and destroyed or slaughtered, and the establishment was cleaned and disinfected.]]]

II.2.6.

The equine animal described in Part I has not been vaccinated against Venezuelan equine encephalomyelitis during the last 60 days prior to the date of its dispatch to the Union, and

(3) either

(3) or

(3) either

(3) or

(a)

(b)	a reverse transcription-polymerase chain reaction (RT-PCR) for the detection of Venezuelan equine encephalomyelitis virus genome (4), with negative result, carried out on a sample taken within the last 48 hours prior to its dispatch to the Union, and

(c)	protection from vector attacks during the period after the date of sampling until loading for dispatch to the Union, by combined use of approved insect repellents and insecticides on the animal and disinsectization of the stable and the means in which it is transported.]]

II.2.7.

The equine animal described in Part I comes from an establishment in which

(3) either

[equine infectious anaemia has not been reported during the last 12 months prior to the date of dispatch of the animal to the Union.]

(3) or

(3) either

[until the date on which the remaining equine animals in the establishment have been subjected to an agar gel immuno-diffusion test (AGID or Coggins test) or ELISA (4) for equine infectious anaemia carried out, with negative results, on samples taken on two occasions with a minimum interval of 90 days following the date on which the infected animals have been killed and destroyed or slaughtered, and the establishment was cleaned and disinfected.]]

(3) or

[for at least 30 days after the date on which the last equine animal on the establishment was either killed and destroyed or slaughtered, and the establishment was cleaned and disinfected.]]

II.2.8.

The equine animal described in Part I comes from an establishment in which:

II.2.8.1.

infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to the date of dispatch of the animal to the Union;

II.2.8.2.

anthrax in ungulates has not been reported during the last 15 days prior to the date of dispatch of the animal to the Union.

II.2.9.

To the best of my knowledge and as declared by the operator, the equine animal described in Part I has not been in contact with kept animals of listed species which did not comply with the requirements referred to in points II.2.2 to II.2.8.1 during the last 30 days prior to the date of dispatch of the animal to the Union, and with the requirement referred to in point II.2.8.2 during the last 15 days prior to the date of dispatch of the animal to the Union.

II.3.

Attestation of residence and isolation prior to dispatch to the Union

II.3.1.

The equine animal described in Part I was introduced into the third country or territory, or zone thereof of dispatch to the European Union on ___/___/____ (dd/mm/yyyy)

(3) either

[directly from the Member State of the European Union … (insert name of a Member State) for the participation in

(3) either

[The Dubai Racing World-Cup;]]

(3) or

[The Melbourne Cup;]]

(3) or

[The Bahrain Turf Series;]]

(3) or

[The Hong Kong International Races;]]

(3) or

[The Japan Cup;]]

(3) or

[The Saudi Cup;]]

(3) or

[International Group/Grade meetings in the United Arab Emirates (3), Australia (3), Bahrain (3), Canada (3), Hong Kong (3), Japan (3), Qatar (3), Singapore (3), the United States (3).]]

(3) or

[from the United Arab Emirates (3), Australia (3), Bahrain (3), Canada (3), Hong Kong (3), Japan (3), Qatar (3), Singapore (3) or the United States (3) for the participation in International Group/Grade meetings in the third country or territory of dispatch, or from Australia (3) for the participation in the Melbourne Cup.]

II.3.2.

As far as can be ascertained and based on the declaration of the operator of the horse accompanying this animal health certificate, the equine animal was:

(a)	not continuously outside the European Union for more than 90 days, including the date of scheduled return in accordance with this animal health certificate;

(b)	not outside the third country or territory of dispatch to the European Union or in case of International Group/Grade meetings or the Melbourne Cup outside the United Arab Emirates, Australia, Bahrain, Canada, Hong Kong, Japan, Qatar, Singapore or the United States;

(c)	resident in the establishments under official veterinary supervision, accommodated in separated stables without coming into contact with equine animals of lower health status except during racing.

II.3.3.

The equine animal entered the third country or territory of dispatch to the European Union under animal health conditions at least as strict as those laid down in this animal health certificate.

Notes:

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.6

Provide the information on the operator responsible for the animal.

Box reference I.8

Provide the code of the third country or territory, or zone thereof of dispatch to the Union as appearing in column 2 of the table in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2021/404.

Box reference I.27

“Identification system”: The animal shall be individually identified with one of the means of identification defined in point (a), (c), (e), or (g) of Annex III to Delegated Regulation (EU) 2019/2035, or be identified by an alternative method in accordance with Article 62 of that Regulation (for example, brand) provided it is recorded in its identification document (passport). Specify the identification system and the anatomic place used on the animal. The number of the accompanying passport or the Unique Code, if no passport number is available, shall be stated and the name of the competent authority which validated it.

“Age”: Date of birth (dd/mm/yyyy).

“Sex”: M = male, F = female, C = castrated.

Part II:

(1)

(2)	Code of the third country or territory, or zone thereof and the Sanitary Group as appearing respectively in columns 2 and 3 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404.

(3)	Delete if not applicable.

(4)	Tests for glanders, surra, dourine, equine infectious anaemia and Venezuelan equine encephalomyelitis described by the European Union Reference Laboratory for Equine Diseases other than African horse sickness: https://sitesv2.anses.fr/en/minisite/equine-diseases/sop.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

Declaration by the operator responsible for the re-entry into the Union after temporary export of a registered horse for racing

Identification of the animal (1)

Species (scientific name)

Equus caballus

Identification system

…

Identification number

…

Age

…

Sex

…

I, the undersigned operator of the registered horse described above, hereby declare, that:

(a)

the registered horse

(2) either

(2) or

(b)

the registered horse has been temporarily exported from the Union to take part in

(2) either

[The Dubai Racing World-Cup;]

(2) or

[The Bahrain Turf Series;]

(2) or

[The Melbourne Cup;]

(2) or

[The Hong Kong International Races;]

(2) or

[The Japan Cup;]

(2) or

[The Saudi Cup;]

(2) or

[International Group/Grade meetings in the United Arab Emirates (2), Australia (2), Bahrain (2), Canada (2), Hong Kong (2), Japan (2), Qatar (2), Singapore (2) or the United States (2); or the Melbourne Cup in Australia (2);]

(c)	during the last 15 days prior to the date of dispatch to the Union the registered horse has not been in contact with animals suffering from infectious or contagious diseases transmissible to equine animals;

(d)	the transportation will be effected in such a way that health and welfare of the registered horse can be protected effectively at all stages of the journey;

(e)	the conditions for residence and pre-export isolation as applicable in accordance with point II.3 of the accompanying animal health certificate for the third country or territory, or zone thereof of dispatch to the Union are fulfilled.

Name and address of the operator …

Date … (dd/mm/yyyy)

…

(Signature)

(1)

The number of the accompanying passport or the Unique Code, if no passport number is available, shall be stated and the name of the competent authority which validated the passport.

Age: Date of birth (dd/mm/yyyy).

Sex (M = male, F = female, C = castrated).

(2)	Delete if not applicable.

CHAPTER 18

(MODEL “CONFINED-RUM”)

Section 1

List of animals originating from and intended for a confined establishment covered by the model “CONFINED-RUM” set out in Section 2

Order	Family	Genera/species
Artiodactyla	Antilocapridae	Antilocapra ssp.
	Bovidae	Addax ssp., Aepyceros ssp., Alcelaphus ssp., Ammodorcas ssp., Ammotragus ssp., Antidorcas ssp., Antilope ssp., Bison ssp., Bos ssp. (including Bibos, Novibos, Poephagus), Boselaphus ssp., Bubalus ssp. (including anoa), Budorcas ssp., Capra ssp., Cephalophus ssp., Connochaetes ssp., Damaliscus ssp. (including Beatragus), Dorcatragus ssp., Gazella ssp., Hemitragus ssp., Hippotragus ssp., Kobus ssp., Litocranius ssp., Madoqua ssp., Naemorhedus ssp. (including Nemorhaedus and Capricornis), Neotragus ssp., Oreamnos ssp., Oreotragus ssp., Oryx ssp., Ourebia ssp., Ovibos ssp., Ovis ssp., Patholops ssp., Pelea ssp., Procapra ssp., Pseudois ssp., Pseudoryx ssp., Raphicerus ssp., Redunca ssp., Rupicapra ssp., Saiga ssp., Sigmoceros-Alcelaphus ssp., Sylvicapra ssp., Syncerus ssp., Taurotragus ssp., Tetracerus ssp., Tragelaphus ssp. (including Boocerus).
	Camelidae	Camelus ssp., Lama ssp., Vicugna ssp.
	Cervidae	Alces ssp., Axis-Hyelaphus ssp., Blastocerus ssp., Capreolus ssp., Cervus-Rucervus ssp., Dama ssp., Elaphurus ssp., Hippocamelus ssp., Hydropotes ssp., Mazama ssp., Megamuntiacus ssp., Muntiacus ssp., Odocoileus ssp., Ozotoceros ssp., Pudu ssp., Rangifer ssp.
	Giraffidae	Giraffa ssp., Okapia ssp.
	Moschidae	Moschus ssp.
	Tragulidae	Hyemoschus ssp., Tragulus-Moschiola ssp.

Section 2

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF ANIMALS LISTED IN CHAPTER 18, SECTION 1, OF ANNEX II TO COMMISSION IMPLEMENTING REGULATION (EU) 2021/403 THAT ARE ORIGINATING FROM AND INTENDED FOR A CONFINED ESTABLISHMENT (MODEL “CONFINED-RUM”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Confined establishment

I.21			I.22	☐ For internal market
			I.23

I.24

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category	Sex	Identification system	Identification number	Age	Quantity

					Approval or registration number of plant/establishment/centre

Part II: Certification

COUNTRY

Certificate model CONFINED-RUM

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify, that the animals described in Part I:

II.1.1.

come from the zone with code __-__ (2) which, at the date of issue of this animal health certificate is authorised for the entry into the Union of animals of the families Antilocapridae, Bovidae, Camelidae, Cervidae, Giraffidae, Moschidae, Tragulidae intended for confined establishments and listed in Part 1 of Annex III to Commission Implementing Regulation (EU) 2021/404;

II.1.2.

have remained continuously in the establishment of origin since birth, or for the last 6 months prior to the date of their dispatch to the Union;

II.1.3.

have not been in contact with animals of a lower health status for the last 30 days prior to the date of their dispatch to the Union, or since birth, if the animals are less than 30 days of age, and during their transport from the confined establishment of origin to the place of their dispatch to the Union;

II.1.4.

II.1.5.

have been dispatched to the Union directly from the establishment of origin without passing through any other establishment;

II.1.6.

have not been unloaded in any place that does not comply with the requirements laid down in point II.1.11 since the date of dispatch from their establishment of origin until the date of their dispatch to the Union and during that period they have not been in contact with animals of a lower health status;

II.1.7.

are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy) (3) in a means of transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority in the third country or territory and constructed in such a way that:

(a)	animals cannot escape or fall out;

(b)	visual inspection of the space where animals are kept is possible;

(c)	the escape of animal excrements, litter or feed is prevented or minimized;

II.1.8.

have been subjected to a clinical inspection within the last 24 hours prior to the time of loading for their dispatch to the Union, carried out by an official veterinarian in the third country or territory of origin, or zone thereof, who did not detect signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.1.9.

have not been vaccinated against foot and mouth disease and infection with rinderpest virus;

(1) [II.1.10.

have been vaccinated against

(1)	[anthrax on ___/___/____ (dd/mm/yyyy) with the following vaccine(s): … … (name of vaccine(s) used);]]

(1)	[rabies on ___/___/____ (dd/mm/yyyy) with the following vaccine(s): … … (name of vaccine(s) used);]]

II.1.11.

come from a confined establishment:

II.1.11.1.

which is approved by the competent authority in accordance with the conditions set out in Article 30 of Delegated Regulation (EU) 2020/692;

II.1.11.2.

II.1.11.3.

in which at the date of issue of this animal health certificate the following diseases have not been reported for the last 6 months: foot and mouth disease, infection with rinderpest virus, infection with Brucella abortus, B. melitensis and B. suis, infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae, M. tuberculosis), infection with bluetongue virus (serotypes 1-24), [infection with Rift Valley fever virus,] (1) (4) [infection with Mycoplasma mycoides subsp. mycoides SC (contagious bovine pleuropneumonia),] (1) (5) [infection with peste des petits ruminants virus,] (1) (6) [sheep pox and goat pox,] (1) (7) [contagious caprine pleuropneumonia,] (1) (8) [infection with lumpy skin disease virus,] (1) (9) [infection with Burkholderia mallei (glanders),] (1) (10) [rabies] (1) (11);

II.1.11.4.

in which at the date of issue of this animal health certificate surra (Trypanosoma evansi) and anthrax have not been reported for the last [30 days] (1) (12) [180 days] (1) (13);

II.1.11.5.

around which, in an area of 10 km radius, including where appropriate the territory of a neighbouring country, none of the following listed diseases has been reported for at least 30 days prior to the date of dispatch of the animals to the Union: foot and mouth disease, infection with rinderpest virus, [infection with Mycoplasma mycoides subsp. mycoides SC (contagious bovine pleuropneumonia),] (1) (5) [infection with peste des petits ruminants virus,] (1) (6) [sheep pox and goat pox,] (1) (7) [contagious caprine pleuropneumonia,] (1) (8) [infection with Burkholderia mallei (glanders),] (1) (10) [rabies] (1) (11);

II.1.11.6.

around which, in an area of 150 km radius, including where appropriate the territory of a neighbouring country, none of the following listed diseases has been reported for at least 30 days prior to the date of dispatch of the animals to the Union: infection with bluetongue virus (serotypes 1-24), infection with epizootic haemorrhagic disease virus,[infection with Rift Valley fever virus,] (1) (4) [infection with lumpy skin disease virus,] (1) (9);

(1) either

[II.1.12.

come from a zone in which at the date of issue of this animal health certificate foot and mouth disease has not been reported for the last 12 months;]

(1) or

[II.1.12.

have been subjected to a virological and a serological test for evidence of foot and mouth disease virus infection carried out in accordance with one of the prescribed tests for international trade laid down in the World Organisation for Animal Health (WOAH) Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (WOAH Terrestrial Manual), with negative results, on samples taken within the last 10 days prior to the date of dispatch of the animals to the Union;]

(1) either

[II.1.13.

come from a zone in which at the date of issue of this animal health certificate infection with Rift Valley fever virus has not been reported for the last 48 months;]

(1) or

[II.1.13.

have:

(a)	been kept in quarantine in a vector-protected facility in the confined establishment for at least 30 days prior to the date of their dispatch to the Union;

(b)	showed no disease symptoms of infection with Rift Valley fever virus for at least 30 days prior to the date of their dispatch to the Union;

(c)	been protected from vectors when transported between the vector-protected facility referred to in point (a) and the place of their loading for dispatch to the Union;

(d)

undergone a virus neutralisation test with negative results for evidence of infection with Rift Valley fever virus in accordance with the WOAH Terrestrial Manual, carried out firstly on samples taken at the date of commencement of the quarantine period and secondly on samples taken at least 42 days from that date and during the last 10 days prior to the date of their dispatch to the Union;]

(1) either

[II.1.14.

have not been vaccinated against infection with Brucella abortus, B. melitensis and B. suis and come from a zone in which at the date of issue of this animal health certificate this disease has not been reported for the last 12 months;]

(1) or

[II.1.14.

have undergone a test as laid down and prescribed for international trade by the WOAH Terrestrial Manual, on samples taken during the last 30 days prior to the date of dispatch of the animals to the Union;]

(1) or

[II.1.14.

are castrated males of any age;]

(1) either

[II.1.15.

come from a zone in which at the date of issue of this animal health certificate infection with bluetongue virus (serotypes 1-24) has not been reported for the last 24 months;]

(1) or

[II.1.15.

have been kept in quarantine in a vector-protected facility in the confined establishment for at least 30 days prior to the date of their dispatch to the Union and have undergone a serology test for infection with bluetongue virus (1-24) and infection with epizootic haemorrhagic disease virus carried out in accordance with the WOAH Terrestrial Manual with negative results, carried out at least 28 days after the date of introduction of the animals into the confined establishment;]

(1) or

[II.1.15.

have been kept in quarantine in a vector-protected facility in the confined establishment for at least 30 days prior to the date of their dispatch to the Union and have undergone a PCR test for infection with bluetongue virus (1-24) and infection with epizootic haemorrhagic disease virus in accordance with the WOAH Terrestrial Manual, with negative results, carried out at least 14 days after the date of introduction into the confined establishment;]

(1) or

[II.1.15.

come from a seasonally free zone and have undergone during the free season a serology test for infection with bluetongue virus (1-24) and infection with epizootic haemorrhagic disease virus according to the WOAH Terrestrial Manual, with negative results, carried out on samples taken at least 28 days after the date of introduction of the animals into the confined establishment;]

(1) or

[II.1.15.

come from a seasonally free zone and have undergone during the free season a PCR test for infection with bluetongue virus (1-24) and infection with epizootic haemorrhagic disease virus in accordance with the WOAH Terrestrial Manual, with negative results, carried out on samples taken at least 14 days after the date of introduction of the animals into the confined establishment;]

II.1.16.

have been treated at least twice during the last 40 days prior to the date of their dispatch to the Union against internal and external parasites with the following product(s): …

… . Specify the active ingredients and the doses of the products used … .

Notes:

This animal health certificate is intended for the entry into the Union of animals from third countries listed in Part 1 of Annex III to Implementing Regulation (EU) 2021/404 that are originating from and intended for a confined establishment.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.27

“Identification system and identification number”: Specify the means of identification and the individual identification codes of the animals in accordance with Article 21(1) or Article 21(3) of Delegated Regulation (EU) 2020/692, or, for the zones with an entry “ID” in column 6 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404, in accordance with Article 21(5) of Delegated Regulation (EU) 2020/692.

Part II:

(1)	Delete if not applicable.

(2)	Code of the zone as it appears in column 2 of the table in Part 1 of Annex III to Implementing Regulation (EU) 2021/404.

(3)	Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.1.1 for the entry into the Union, or in a period where restriction measures have been adopted by the Union against entry into the Union of those animals from that zone.

(4)	Not applicable to animals of the family Tragulidae.

(5)	Only applicable to bovine animals and Syncerus caffer.

(6)	Only applicable to ovine animals, caprine animals, camelid animals and cervid animals.

(7)	Only applicable to ovine and caprine animals.

(8)	Only applicable to caprine animals and Gazella spp.

(9)	Only applicable to bovine animals.

(10)	Only applicable to caprine animals and camelid animals.

(11)	Only applicable to animals of the family Bovidae, camelid animals and cervid animals.

(12)	Not applicable to camelid animals.

(13)	Only applicable to camelid animals.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 19

(MODEL “CONFINED-SUI”)

Section 1

List of animals originating from and intended for a confined establishment covered by the model “CONFINED-SUI” set out in Section 2

Order	Family	Genera/species
Artiodactyla	Suidae	Babyrousa ssp., Hylochoerus ssp., Phacochoerus ssp., Potamochoerus ssp., Sus ssp.
Artiodactyla	Tayassuidae	Catagonus ssp., Pecari-Tayassu ssp.

Section 2

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF ANIMALS LISTED IN CHAPTER 19, SECTION 1, OF ANNEX II TO COMMISSION IMPLEMENTING REGULATION (EU) 2021/403 THAT ARE ORIGINATING FROM AND INTENDED FOR A CONFINED ESTABLISHMENT (MODEL “CONFINED-SUI”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Confined establishment

I.21			I.22	☐ For internal market
			I.23

I.24

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category	Sex	Identification system	Identification number	Age	Quantity
					Approval or registration number of plant/establishment/centre

Part II: Certification

COUNTRY

Certificate model CONFINED-SUI

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify, that the animals described in Part I:

II.1.1.

come from the zone with code __-__ (2) which, at the date of issue of this animal health certificate is authorised for the entry into the Union of animals of the families Suidae and Tayassuidae intended for confined establishments and listed in Part 1 of Annex III to Commission Implementing Regulation (EU) 2021/404;

II.1.2.

have remained continuously in the establishment of origin since birth or for at least 6 months prior to the date of their dispatch to the Union;

II.1.3.

II.1.4.

II.1.5.

have been dispatched to the Union directly from the establishment of origin without passing through any other establishment;

II.1.6.

II.1.7.

are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy) (3) in a means of transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority in the third country or territory and constructed in such a way that:

(a)	animals cannot escape or fall out;

(b)	visual inspection of the space where animals are kept is possible;

(c)	the escape of animal excrements, litter or feed is prevented or minimized;

II.1.8.

have been subjected to a clinical inspection within the last 24 hours prior to the time of their loading for dispatch to the Union, carried out by an official veterinarian in the third country or territory of origin, or zone thereof, who did not detect signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.1.9.

have not been vaccinated against foot and mouth disease and infection with rinderpest virus;

(1) [II.1.10.

have been vaccinated against

(1)	[anthrax on ___/___/____ (dd/mm/yyyy) with the following vaccine(s): … … (name of vaccine(s) used);]

(1)	[rabies on ___/___/____ (dd/mm/yyyy) with the following vaccine(s): … … (name of vaccine(s) used);]]

II.1.11.

come from a confined establishment:

II.1.11.1.

which is approved by the competent authority in accordance with the conditions set out in Article 30 of Delegated Regulation (EU) 2020/692;

II.1.11.2.

II.1.11.3.

II.1.11.4.

in which at the date of issue of this animal health certificate surra (Trypanosoma evansi) and anthrax have not been reported for the last 30 days;

II.1.11.5.

around which, in an area of 10 km radius, including where appropriate the territory of a neighbouring country, none of the following listed diseases has been reported for the last 12 months prior to the date of dispatch of the animals to the Union: foot and mouth disease, infection with rinderpest virus, classical swine fever, rabies [, African swine fever] (1) (4);

(1) either

[II.1.12.

come from a zone in which at the date of issue of this animal health certificate foot and mouth disease has not been reported for the last 12 months;]

(1) or

[II.1.12.

have been subjected to a virological and a serological test for evidence of foot and mouth disease virus infection carried out in accordance with one of the prescribed tests for international trade laid down in the WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (WOAH Terrestrial Manual), with negative results, on samples taken within the last 10 days prior to the date of dispatch of the animals to the Union;]

(1) either

[II.1.13.

come from a zone in which at the date of issue of this animal health certificate classical swine fever has not been reported for the last 12 months;]

(1) or

[II.1.13.

have undergone a virology and serology test for the detection of classical swine fever in accordance with the test prescribed for international trade in the WOAH Terrestrial Manual, carried out on samples taken during the last 30 days prior to the date of dispatch of the animals to the Union;]

(1) (4) [(1) either

[II.1.14.

come from a zone in which at the date of issue of this animal health certificate African swine fever has not been reported for the last 12 months;]]

(1) or

[II.1.14.

have undergone a virology and serology test for the detection of African swine fever and in accordance with the test prescribed for international trade in the WOAH Terrestrial Manual, carried out on samples taken during the last 30 days prior to the date of dispatch of the animals to the Union;]]

(1) either

[II.1.15.

(1) or

[II.1.15.

(1) or

[II.1.15.

are castrated males of any age;]

II.1.16.

have been treated at least twice during the last 40 days prior to the date of dispatch of the animals to the Union against internal and external parasites with the following product(s): … . Specify the active ingredients and the doses of the products used … .

Notes:

This animal health certificate is intended for the entry into the Union of animals from third countries listed in Part 1 of Annex III to Commission Implementing Regulation (EU) 2021/404 that are originating from and intended for a confined establishment.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.27

“Identification system and identification number”: Specify the means of identification and the individual identification codes of the animals in accordance with Article 21(1) or (3) of Delegated Regulation (EU) 2020/692; or, for the zones with an entry “ID” in column 6 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404, in accordance with Article 21(5) of Delegated Regulation (EU) 2020/692.

Part II:

(1)	Delete if not applicable.

(2)	Code of the zone as it appears in column 2 of the table in Part 1 of Annex III to Implementing Regulation (EU) 2021/404.

(3)	Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.1.1 for the entry into the Union, or in a period where restriction measures have been adopted by the Union against entry into the Union of those animals from that zone.

(4)	Not applicable to animals of the family Tayassuidae.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 20

(MODEL “CONFINED-TRE”)

Section 1

List of animals originating from and intended for a confined establishment covered by model “CONFINED-TRE” set out in Section 2

Order	Family	Genera/species
Perissodactyla	Tapiridae	Tapirus ssp.
Perissodactyla	Rhinocerotidae	Ceratotherium ssp., Dicerorhinus ssp., Diceros ssp., Rhinoceros ssp.
Proboscidea	Elephantidae	Elephas ssp., Loxodonta ssp.

Section 2

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF ANIMALS LISTED IN CHAPTER 20, SECTION 1, OF ANNEX II TO COMMISSION IMPLEMENTING REGULATION (EU) 2021/403 THAT ARE ORIGINATING FROM AND INTENDED FOR A CONFINED ESTABLISHMENT (MODEL “CONFINED-TRE”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Confined establishment

I.21			I.22	☐ For internal market
			I.23

I.24

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category	Sex	Identification system	Identification number	Age	Quantity
					Approval or registration number of plant/establishment/centre

Part II: Certification

COUNTRY

Certificate model CONFINED-TRE

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify, that the animals described in Part I:

II.1.1.

come from the zone with code __-__ (2) which, at the date of issue of this animal health certificate is authorised for the entry into the Union of animals of the families Tapiridae, Rhinocerotidae and Elephantidae intended for confined establishments and listed in Part 1 of Annex III to Commission Implementing Regulation (EU) 2021/404;

II.1.2.

have remained continuously in the establishment of origin since birth, or for at least 6 months prior to the date of their dispatch to the Union;

II.1.3.

II.1.4.

II.1.5.

have been dispatched to the Union directly from the establishment of origin without passing through any other establishment;

II.1.6.

II.1.7.

are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy) (3) in a means of transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority in the third country or territory and constructed in such a way that:

(a)	animals cannot escape or fall out;

(b)	visual inspection of the space where animals are kept is possible;

(c)	the escape of animal excrements, litter or feed is prevented or minimized;

II.1.8.

have been subjected to a clinical inspection within the last 24 hours prior to the time of loading for dispatch to the Union, carried out by an official veterinarian in the third country or territory of origin, or zone thereof, who did not detect signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.1.9.

have not been vaccinated against foot and mouth disease and infection with rinderpest virus;

(1) [II.1.10.

have been vaccinated against

(1)	[anthrax on ___/___/____ (dd/mm/yyyy) with the following vaccine(s): … … (name of vaccine(s) used);]]

(1)	[rabies on ___/___/____ (dd/mm/yyyy) with the following vaccine(s) … … (name of vaccine(s) used);]]

II.1.11.

come from a confined establishment:

II.1.11.1.

which is approved by the competent authority in accordance with the conditions set out in Article 30 of Delegated Regulation (EU) 2020/692;

II.1.11.2.

II.1.11.3.

in which at the date of issue of this animal health certificate the following diseases have not been reported for the last 6 months: infection with rinderpest virus, infection with Rift Valley fever virus [, foot and mouth disease] (1) (4);

II.1.11.4.

in which at the date of issue of this animal health certificate anthrax has not been reported for the last 30 days;

(1) (4) [II.1.11.5.

around which, in an area of 10 km radius, including where appropriate the territory of a neighbouring country, foot and mouth disease has not been reported for the last 30 days prior to the date of dispatch of the animals to the Union;]

II.1.11.6.

around which, in an area of 150 km radius, including where appropriate the territory of a neighbouring country, infection with Rift Valley fever virus has not been reported for the last 30 days prior to the date of dispatch of the animals to the Union;

(1) (4) [(1) either

[II.1.12.

come from a zone in which at the date of issue of this animal health certificate foot and mouth disease has not been reported for the last 12 months;]]

(1) or

[II.1.12.

have been subjected to a virological and a serological test for evidence of foot and mouth disease virus infection carried out in accordance with one of the prescribed tests for international trade laid down in the WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (WOAH Terrestrial Manual), with negative results, on samples taken within the last 10 days prior to the date of dispatch of the animals to the Union;]]

(1) either

[II.1.13.

come from a zone in which at the date of issue of this animal health certificate infection with Rift Valley fever virus has not been reported for the last 48 months;]

(1) or

[II.1.13.

have:

(a)	been kept in quarantine in a vector-protected facility in the confined establishment for at least 30 days prior to the date of dispatch of the animals to the Union;

(b)	showed no disease symptoms of infection with Rift Valley fever virus for at least 30 days prior to the date of dispatch of the animals to the Union;

(c)	been protected from vectors when transported between the vector-protected facility referred to in point (a) and the place of loading for their dispatch to the Union;

(d)

II.1.14.

have been treated at least twice during the last 40 days prior to the date of their dispatch to the Union against internal and external parasites with the following product(s): …

… . Specify the active ingredients and the doses of the products used … .

Notes:

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.27

“Identification system and identification number”: Specify the means of identification and the individual identification codes of the animals in accordance with Article 21(1) or Article 21(3) of Delegated Regulation (EU) 2020/692; or, for the zones with an entry “ID” in column 6 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404, in accordance with Article 21(5) of Delegated Regulation (EU) 2020/692.

Part II:

(1)	Delete if not applicable.

(2)	Code of the zone as it appears in column 2 of the table in Part 1 of Annex III to Implementing Regulation (EU) 2021/404.

(3)	Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.1.1 for the entry into the Union, or in a period where restriction measures have been adopted by the Union against entry into the Union of those animals from that zone.

(4)	Only applicable to animals of the family Elephantidae.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 21

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF ANIMALS OF THE FAMILY OF HIPPOPOTAMIDAE THAT ARE ORIGINATING FROM AND INTENDED FOR A CONFINED ESTABLISHMENT (MODEL “CONFINED-HIPPO”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Confined establishment

I.21			I.22	☐ For internal market
			I.23

I.24

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category	Sex	Identification system	Identification number	Age	Quantity
					Approval or registration number of plant/establishment/centre

Part II: Certification

COUNTRY

Certificate model CONFINED-HIPPO

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify that the animals described in Part I:

II.1.1.

come from the zone with code __-__ (2) which, at the date of issue of this animal health certificate is authorised for the entry into the Union of animals of the family Hippopotamidae intended for confined establishments and listed in Part 1 of Annex III to Commission Implementing Regulation (EU) 2021/404;

II.1.2.

have remained continuously in the establishment of origin since birth, or for at least 6 months prior to the date of their dispatch to the Union;

II.1.3.

II.1.4.

II.1.5.

have been dispatched to the Union directly from the establishment of origin without passing through any other establishment;

II.1.6.

II.1.7.

are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy) (3) in a means of transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority in the third country or territory and constructed in such a way that:

(a)	animals cannot escape or fall out;

(b)	visual inspection of the space where animals are kept is possible;

(c)	the escape of animal excrements, litter or feed is prevented or minimized;

II.1.8.

II.1.9.

have not been vaccinated against foot and mouth disease and infection with rinderpest virus;

(1) [II.1.10.

have been vaccinated against

(1)	[anthrax on ___/___/____ (dd/mm/yyyy) with the following vaccine(s): … … (name of vaccine(s) used);]]

(1)	[rabies on ___/___/____ (dd/mm/yyyy) with the following vaccine(s): … … (name of vaccine(s) used);]]

II.1.11.

come from a confined establishment:

II.1.11.1.

which is approved by the competent authority in accordance with the conditions set out in Article 30 of Delegated Regulation (EU) 2020/692;

II.1.11.2.

II.1.11.3.

in which at the date of issue of this animal health certificate the following diseases have not been reported for the last 6 months:

(a)	foot and mouth disease,

(b)	infection with rinderpest virus,

(c)	infection with Rift Valley fever virus,

(d)	infection with Brucella abortus, B. melitensis and B. suis,

(e)	infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae, M. tuberculosis);

II.1.11.4.

in which at the date of issue of this animal health certificate surra (Trypanosoma evansi) and anthrax have not been reported for the last 30 days prior to the date of dispatch of the animals to the Union;

II.1.11.5.

(a)	foot and mouth disease,

(b)	infection with rinderpest virus;

II.1.11.6.

(1) either

[II.1.12.

come from a zone in which at the date of issue of this animal health certificate foot and mouth disease has not been reported for the last 12 months;]

(1) or

[II.1.12.

have been subjected to a virological and a serological test for evidence of foot and mouth disease virus infection carried out in accordance with one of the prescribed tests for international trade laid down in the WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (WOAH Terrestrial Manual), with negative results, on samples taken within the last 10 days prior to the date of dispatch of the animals to the Union;]

(1) either

[II.1.13.

come from a zone in which at the date of issue of this animal health certificate infection with Rift Valley fever virus has not been reported for the last 48 months;]

(1) or

[II.1.13.

have:

(a)	been kept in quarantine in a vector-protected facility in the confined establishment for at least 30 days prior to the date of their dispatch to the Union;

(b)	showed no disease symptoms of infection with Rift Valley fever virus for at least 30 days prior to the date of their dispatch to the Union;

(c)	been protected from vectors when transported between the vector-protected facility referred to in point (a) and the place of their loading for dispatch to the Union;

(d)

(1) either

[II.1.14.

(1) or

[II.1.14.

have undergone a test as laid down and prescribed for international trade by the WOAH Terrestrial Manual, on samples taken during the last 30 days prior to the date of their dispatch to the Union;]

(1) or

[II.1.14.

are castrated males of any age;]

II.1.15.

have been treated at least twice during the last 40 days prior to the date of their dispatch to the Union against internal and external parasites with the following product(s): …

…. Specify the active ingredients and the doses of the products used … .

Notes:

This animal health certificate is intended for the entry into the Union of animals of the family Hippopotamidae that are originating from and intended for a confined establishment.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.27

“Identification system and identification number”: Specify the means of identification and the individual identification codes of the animals in accordance with Article 21(1) or Article 21(3) of Delegated Regulation (EU) 2020/692; or, for the zones with an entry “ID” in column 6 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404, in accordance with Article 21(5) of Delegated Regulation (EU) 2020/692.

Part II:

(1)	Delete if not applicable.

(2)	Code of the zone as it appears in column 2 of the table in Part 1 of Annex III to Implementing Regulation (EU) 2021/404.

(3)	Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.1.1 for the entry into the Union, or in a period where restriction measures have been adopted by the Union against entry into the Union of those animals from that zone.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 22

MODEL ANIMAL HEALTH/OFFICIAL CERTIFICATE FOR THE ENTRY INTO THE UNION OF BREEDING POULTRY OTHER THAN RATITES AND PRODUCTIVE POULTRY OTHER THAN RATITES (MODEL “BPP”)

Part I: Description of consignment

COUNTRY

Animal health/official certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No	Seal No
I.20	Certified as or for
	☐ Further keeping

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

Total net weight/gross weight (kg)

I.27	Description of consignment
CN code	Species	Subspecies/Category	Quantity

Part II: Certification

COUNTRY

Certificate model BPP

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

(3) [II.1.

Public health attestation (Delete when the Union is not the final destination of the animals)

I, the undersigned official veterinarian, hereby certify the following as regards the [breeding poultry (6) other than ratites] (3) [productive poultry (7) other than ratites] (3) of the consignment described in Part I:

(1) (3) [II.1.1.

The Salmonella control programme referred to in Article 10 of Regulation (EC) No 2160/2003 of the European Parliament and of the Council and the specific requirements for the use of antimicrobials and vaccines in Commission Regulation (EC) No 1177/2006, have been applied to the flock of origin and that flock has been tested for Salmonella serotypes of public health significance:

Identification of the flock	Age of the birds	Date of last sampling of the flock from which the testing result is known [dd/mm/yyyy]	Result of all testing in the flock (2)
			positive	negative

For reasons other than the Salmonella control programme, within the last 3 weeks prior to the date of the entry into the Union

(3) either

[antimicrobials were not administered to the breeding and productive poultry other than ratites;]]]

(3) (4) or

[the following antimicrobials were administered to the breeding and productive poultry other than ratites: … ;]]]

(1) (3) [II.1.2.

If breeding poultry, neither Salmonella Enteritidis nor Salmonella Typhimurium were detected within the control programme referred to in point II.1.1.]]

(3) (5) [II.1.3.

If the Member State of destination is Finland or Sweden

(3) either

[the breeding poultry has tested negative for Salmonella in accordance with the rules laid down in Commission Decision 2003/644/EC.]]]

(3) or

[the laying hens (productive poultry reared in view to producing eggs for consumption) have tested negative in accordance with the rules laid down in Commission Decision 2004/235/EC.]]]

(3) (19) [II.1.a.

Attestation as regards Commission Delegated Regulation (EU) 2023/905 (Delete when the Union is not the final destination of the animals)

II.2.

Animal health attestation

I, the undersigned official veterinarian, hereby certify, that the [breeding poultry (6) other than ratites] (3) [productive poultry (7) other than ratites] (3) of the consignment described in Part I:

II.2.1.

come from the zone with code __-__ (8) which, at the date of issue of this animal health/official certificate:

(a)	is authorised and listed in Part 1, Section B, of Annex V to Commission Implementing Regulation (EU) 2021/404 for the entry into the Union of breeding poultry other than ratites and productive poultry other than ratites;

(b)	carries out a disease surveillance programme for highly pathogenic avian influenza in accordance with Article 37, point (a), of Commission Delegated Regulation (EU) 2020/692;

(c)	is considered free from highly pathogenic avian influenza in accordance with Article 38 of Delegated Regulation (EU) 2020/692;

(3) either

[(d)	is considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692;]

(3) (9) or

[(d)	is not considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692, and they originate from establishment(s) located in an area within that zone not placed under official restrictions due to an outbreak of that disease;]

II.2.2.

come from the zone referred to in point II.2.1, in which:

(3) either

[(a)	vaccination against highly pathogenic avian influenza is not carried out;]

(3) (10) or

[(a)	vaccination against highly pathogenic avian influenza is carried out in accordance with a vaccination programme that complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692;]

(3) either

[(b)	vaccination against infection with Newcastle disease virus with vaccines which do not comply with both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692 is prohibited;]

(3) (11) or

[(b)

vaccination against infection with Newcastle disease virus with vaccines which comply only with the general criteria of Annex XV to Delegated Regulation (EU) 2020/692 is not prohibited, and the birds:

(i)	have not been vaccinated with such vaccines for at least 12 months prior to the date of loading of the consignment for dispatch to the Union;

(ii)

come from a flock or flocks which underwent a virus isolation test (12) for infection with Newcastle disease virus carried out on a random sample of cloacal swabs from at least 60 birds in each flock, taken not earlier than 2 weeks prior to the date of loading of the consignment for dispatch to the Union, and in which no avian paramyxoviruses with an ICPI of more than 0,4 were found;

(iii)

were kept in isolation under official surveillance on the establishment of origin during the 2 weeks referred to in point (ii);

(iv)	during the last 60 days prior to the date of loading of the consignment for dispatch to the Union, were not in contact with the birds which do not fulfil the conditions referred to in points (i) and (ii);]

II.2.3.

have remained in the zone referred to in point II.2.1 for a continuous period of at least

(3) (13) either

[3 months immediately prior to the date of loading of the consignment for dispatch to the Union or since the date of hatching where they are less than 3 months of age;]

(3) (14) or

[6 weeks immediately prior to the date of loading of the consignment for dispatch to the Union or since the date of hatching where they are less than 6 weeks of age;]

and where they were introduced into the zone referred to in point II.2.1, that introduction took place under animal health requirements at least as stringent as those for the entry into the Union of breeding poultry other than ratites and productive poultry other than ratites laid down in Regulation (EU) 2016/429 of the European Parliament and of the Council and Delegated Regulation (EU) 2020/692, and from a third country or territory, or zone thereof listed in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 or a Member State;

II.2.4.

come from the establishment, indicated in box I.11, approved by the competent authority of the third country or territory of origin in accordance with the requirements which are at least as stringent as those laid down in Article 8 of Commission Delegated Regulation (EU) 2019/2035, and:

(a)	the approval of which has not been suspended or withdrawn;

(b)	which is under the control of the competent authority of the third country or territory of origin and has a system in place to maintain and to keep records in accordance with Article 8 of Delegated Regulation (EU) 2020/692;

(c)

(d)	which was not subject to national restriction measures for animal health reasons, including for the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the date of loading of the consignment for dispatch to the Union;

(e)

within a 10 km radius of which, including, where appropriate, the territory of a neighbouring country, there has been no outbreak of highly pathogenic avian influenza or infection with Newcastle disease virus for at least 30 days prior to the date of loading of the consignment for dispatch to the Union;

(f)	in which no confirmed case of infection with low pathogenic avian influenza viruses has been reported for at least 21 days prior to the date of loading of the consignment for dispatch to the Union;

(g)

in which

(3) either

[infection with Salmonella Pullorum, S. Gallinarum or S. arizonae was not confirmed during the last 12 months prior to date of loading of the consignment for dispatch to the Union;]

(3) or

[infection with Salmonella Pullorum, S. Gallinarum or S. arizonae was confirmed during the last 12 months prior to date of loading of the consignment for dispatch to the Union and the measures provided for in Article 44, point (d), of Delegated Regulation (EU) 2020/692 have been applied;]

(h)

in which

(3) either

[avian mycoplasmosis (Mycoplasma gallisepticum and M. meleagridis) was not confirmed during the last 12 months prior to date of loading of the consignment for dispatch to the Union;]

(3) or

[avian mycoplasmosis (Mycoplasma gallisepticum and M. meleagridis) was confirmed during the last 12 months prior to date of loading of the consignment for dispatch to the Union and the measures provided for in Article 44, point (e), of Delegated Regulation (EU) 2020/692 have been applied;]

II.2.5.

come from a flock which:

(a)	has not been vaccinated against highly pathogenic avian influenza;

(3) either

[(b)	has not been vaccinated against infection with Newcastle disease virus within the last 12 months prior to the date of loading of the consignment for dispatch to the Union;]

(3) or

[(b)

has been vaccinated against infection with Newcastle disease virus within the last 12 months prior to the date of loading of the consignment for dispatch to the Union, with vaccines that comply with both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692;

(15)

Identification of the flock	Age of the birds	Date of vaccination	Name and type of virus strain used	Batch number of the vaccine	Name of the vaccine	Manufacturer of the vaccine

]

(c)	underwent a disease surveillance programme that meets the requirements set out in Annex II to Delegated Regulation (EU) 2019/2035 and was found not to be infected or showed any grounds for suspecting any infection, by the following agents

(3) either

[Salmonella Pullorum, Salmonella Gallinarum and Mycoplasma gallisepticum (in case of Gallus gallus);]

(3) or

[Salmonella arizonae (serogroup O:18(k)), Salmonella Pullorum and Salmonella Gallinarum, Mycoplasma meleagridis and Mycoplasma gallisepticum (in case of Meleagris gallopavo);]

(3) or

[Salmonella Pullorum and Salmonella Gallinarum (in case of Numida meleagris, Coturnix coturnix, Phasianus colchicus, Perdix perdix and Anas spp);]

(d)

has been subjected to a clinical inspection (16) within the last 24 hours prior to the time of loading of the consignment for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.2.6.

have remained in the establishment indicated in box I.11 since the date of hatching or for a continuous period of at least

(3) (13) either

[6 weeks immediately prior to the date of loading of the consignment for dispatch to the Union;]

(3) (14) or

[30 days immediately prior to the date of loading of the consignment for dispatch to the Union;]

II.2.7.

had no contact with other birds of a lower health status since the date of hatching or for a continuous period of at least

(3) (13) either

[6 weeks immediately prior to the date of loading of the consignment for dispatch to the Union;]

(3) (14) or

[30 days immediately prior to the date of loading of the consignment for dispatch to the Union;]

II.2.8.

are not to be killed under a national programme for the eradication of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.2.9.

have been subjected to a clinical inspection (16) on ___/___/____ (dd/mm/yyyy) within the last 24 hours prior to the time of loading of the consignment for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.2.10.

are loaded for dispatch to the Union in the containers which:

(a)

are constructed in such a way that:

(i)	birds cannot escape or fall out;

(ii)	visual inspection of the space where birds are kept is possible;

(iii)

the escape of animal excrements, litter, feed or feathers is prevented or minimized;

(b)	contain only birds of the same species and category coming from the same establishment;

(c)

are

(3) either

[unused and purpose-designed disposable containers to be destroyed after first use;]

(3) or

[cleaned and disinfected and dried or allowed to dry prior to loading of the consignment;]

(d)	are closed in accordance with the instructions of the competent authority of the third country or territory of origin to avoid any possibility of substitution of the content;

(e)	bear the information set out in Point 1 of Annex XVI to Delegated Regulation (EU) 2020/692 relevant for breeding poultry and productive poultry;

II.2.11.

are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy) (17) in a means of transport which is constructed in accordance with point II.2.10(a) and was cleaned and disinfected prior to loading of the consignment with a disinfectant authorised by the competent authority of the third country or territory of origin;

(3) (18) [II.2.12.

are intended for a Member State which has been granted the status free from infection with Newcastle disease virus without vaccination in accordance with Article 66 of Commission Delegated Regulation (EU) 2020/689, and:

(a)	have not been vaccinated against infection with Newcastle disease virus;

(b)

were kept in isolation for at least 14 days prior to the date of loading of the consignment for dispatch to the Union in the establishment of origin or quarantine establishment under the supervision of an official veterinarian, where:

(i)	no bird was vaccinated against infection with Newcastle disease virus during at least 21 days prior to the date of loading of the consignment for dispatch to the Union;

(ii)	no other birds have entered into the establishment during that period;

(iii)

no vaccination has been carried out;

(c)

have tested (12) negative to serological tests to detect antibodies against Newcastle disease virus, performed on blood samples at a level which gives 95% confidence of detecting infection at 5% prevalence and which were taken during at least 14 days prior to the date of loading of the consignment for dispatch to the Union.]

Notes:

This animal health/official certificate is intended for the entry into the Union of breeding poultry other than ratites and productive poultry, other than ratites including when the Union is not the final destination of those animals.

Part I:

Box reference I.8

Provide the code of the zone as it appears in column 2 of the table in Part 1 of Annex V to Implementing Regulation (EU) 2021/404.

Box reference I.27

Description of consignment:

“CN code”: Indicate the appropriate Harmonised System (HS) code(s) of the World Customs Organisation under the following headings: 0105 or 0106 39 .

“Category”: Select one of the following: Pure line/grandparents/parents/laying pullets/others.

Part II:

(1)	This guarantee applies only for poultry belonging to the species of Gallus gallus and turkeys.

(2)

If any of the results were positive for the serotypes below during the life of the flock, indicate as positive:

(a)	flocks of breeding poultry: Salmonella Hadar, Salmonella Virchow and Salmonella Infantis;

(b)	flocks of productive poultry: Salmonella Enteritidis and Salmonella Typhimurium.

(3)	Delete if not applicable.

(4)	Complete if appropriate: indicate the name and active substance of antimicrobials used.

(5)	Delete if consignment is not intended for Finland or Sweden.

(6)	“Breeding poultry” means poultry 72 hours old or more, intended for the production of hatching eggs, as defined in Article 2 of Delegated Regulation (EU) 2020/692.

(7)	“Productive poultry” means poultry 72 hours old or more, reared for the production of meat, eggs for consumption or other products or for restocking supplies of game birds, as defined in Article 2 of Delegated Regulation (EU) 2020/692.

(8)	Code of the zone as it appears in column 2 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

(9)	Only for the zones with the entry “N” in column 4 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

(10)

This applies only to the zones in which vaccination against highly pathogenic avian influenza is carried out in accordance with a vaccination programme that complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692, and which are listed in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 with an entry “A” in column 5 of the table.

(11)

This guarantee is required only for poultry coming from zones in which the use of vaccines against infection with Newcastle disease virus which comply only with the general criteria of Annex XV to Delegated Regulation (EU) 2020/692 is not prohibited, in accordance with Article 37, point (e)(ii), thereof, and which are listed in the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 with an entry “B” in column 5 of that table.

(12)

Tests shall have been carried out on samples taken by or under the control of the competent authority of the third country or territory of origin and testing shall have been carried out in an official laboratory designated in accordance with Article 37 of Regulation (EU) 2017/625 of the European Parliament and of the Council.

(13)	Applicable for breeding poultry and productive poultry for the production of meat, eggs for consumption or other products.

(14)	Applicable for productive poultry for restocking supplies of game birds.

(15)	To be completed when the birds were vaccinated against infection with Newcastle disease virus.

(16)	The clinical inspection shall have been carried out by an official veterinarian of the third country or territory of origin.

(17)	The date of loading shall not be prior to the date of authorisation of the zone referred to in point II.2.1 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of that poultry from that zone.

(18)	This guarantee is required only for consignments intended for the Member State or zone thereof which has been granted the status free from infection with Newcastle disease virus without vaccination in accordance with Article 66 of Delegated Regulation (EU) 2020/689.

(19)	Applicable to consignments entering the Union as from 3 September 2026.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 23

MODEL ANIMAL HEALTH/OFFICIAL CERTIFICATE FOR THE ENTRY INTO THE UNION OF BREEDING RATITES AND PRODUCTIVE RATITES (MODEL “BPR”)

Part I: Description of consignment

COUNTRY

Animal health/official certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No	Seal No
I.20	Certified as or for
	☐ Further keeping

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23	☐ For re-entry

I.24

Total number of packages

I.25

Total quantity

I.26

Total net weight/gross weight (kg)

I.27	Description of consignment
CN code	Species	Subspecies/Category	Identification system	Identification number	Quantity

Part II: Certification

COUNTRY

Certificate model BPR

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

II.1.

Animal health attestation

I, the undersigned official veterinarian, hereby certify that the [breeding ratites (1)] (2) [productive ratites (3)] (2) of the consignment described in Part I:

II.1.1.

come from the zone with code __-__ (4) which, at the date of issue of this animal health/official certificate:

(a)	is authorised and listed in Part 1, Section B, of Annex V to Commission Implementing Regulation (EU) 2021/404 for the entry into the Union of breeding ratites and productive ratites;

(b)	carries out a disease surveillance programme for highly pathogenic avian influenza in accordance with Article 37, point (a), of Commission Delegated Regulation (EU) 2020/692;

(c)	is considered free from highly pathogenic avian influenza in accordance with Article 38 of Delegated Regulation (EU) 2020/692;

II.1.2.

come from the zone referred to in point II.1.1, which at the date of issue of this animal health/official certificate

(2) either

[is considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692;]

(2) (5) or

[is not considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692, and they originate from establishment(s) located in an area within that zone not placed under official restrictions due to an outbreak of that disease;]

(2) (6) or

[is not considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692, and the birds:

(a)	have been placed under official surveillance for at least 21 days prior to the date of loading of the consignment for dispatch to the Union;

(b)	have been kept in complete isolation during the period referred to in point (a), away from direct or indirect contact with other birds, in facilities approved by the competent authority of the third country or territory of origin for that purpose;

(c)

have undergone a virus detection test (7) for infection with Newcastle disease virus:

(i)	which was carried out on cloacal swabs or faeces samples collected from each ratite within 7 to 10 days from the date on which the ratites were placed under official surveillance referred to in point (a);

(ii)	in which no avian paramyxovirus type 1 isolates with an Intracerebral Pathogenicity Index (ICPI) of more than 0,4 have been found;

(iii)

with favourable results being available for all birds in the consignment prior to the date on which they left the facilities referred to in point (b) for dispatch to the Union;

(d)	come from flocks in which surveillance for infection with Newcastle disease virus was carried out under a statistically based sampling plan which produced negative results for at least 6 months immediately prior to loading of the consignment for dispatch to the Union;]

II.1.3.

come from the zone referred to in point II.1.1, in which:

(2) either

[(a)	vaccination against highly pathogenic avian influenza is not carried out;]

(2) (8) or

[(a)	vaccination against highly pathogenic avian influenza is carried out in accordance with a vaccination programme that complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692;]

(2) either

[(b)	vaccination against infection with Newcastle disease virus with vaccines which do not comply with both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692 is prohibited;]

(2) (9) or

[(b)

(i)	have not been vaccinated with such vaccines for at least 12 months prior to the date of loading of the consignment for dispatch to the Union;

(ii)

come from a flock or flocks which underwent a virus isolation test (7) for infection with Newcastle disease virus carried out on a random sample of cloacal swabs from at least 60 birds in each flock, taken not earlier than 2 weeks prior to the date of loading of the consignment for dispatch to the Union, and in which no avian paramyxoviruses with an ICPI of more than 0,4 were found;

(iii)

were kept in isolation under official surveillance on the establishment of origin during the 2 weeks referred to in point (ii);

(iv)	during the last 60 days prior to the date of loading of the consignment for dispatch to the Union, were not in contact with poultry which do not fulfil the conditions referred to in points (i) and (ii);]

II.1.4.

have remained in the zone referred to in point II.1.1 for a continuous period of at least 3 months immediately prior to the date of loading of the consignment for dispatch to the Union or since the date of hatching where they are less than 3 months of age; and where they were introduced into the zone referred to in point II.1.1, that introduction took place under animal health requirements at least as stringent as those for the entry into the Union of breeding ratites and productive ratites laid down in Regulation (EU) 2016/429 of the European Parliament and of the Council and Delegated Regulation (EU) 2020/692, and from a third country or territory, or zone thereof listed in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 or a Member State;

II.1.5.

come from the establishment, indicated in box I.11, approved by the competent authority of the third country or territory of origin in accordance with requirements which are at least as stringent as those laid down in Article 8 of Commission Delegated Regulation (EU) 2019/2035, and:

(a)	the approval of which has not been suspended or withdrawn;

(b)	which is under the control of the competent authority of the third country or territory of origin and has a system in place to maintain and to keep records in accordance with Article 8 of Delegated Regulation (EU) 2020/692;

(c)

(d)	which was not subject to national restriction measures for animal health reasons, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the date of loading of the consignment for dispatch to the Union;

(e)

(f)	in which no confirmed case of infection with low pathogenic avian influenza viruses has been reported for at least 21 days prior to the date of loading of the consignment for dispatch to the Union;

II.1.6.

come from a flock which:

(a)	has not been vaccinated against highly pathogenic avian influenza;

(2) either

[(b)	has not been vaccinated against infection with Newcastle disease virus within the last 12 months prior to the date of loading of the consignment for dispatch to the Union;]

(2) or

[(b)

(10)

Identification of the flock	Age of the birds	Date of vaccination	Name and type of virus strain used	Batch number of the vaccine	Name of the vaccine	Manufacturer of the vaccine

]

(c)

has been subjected to a clinical inspection (11) within the last 24 hours prior to the time of loading of the consignment for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.1.7.

have remained in the establishment indicated in box I.11 since the date of hatching or for a continuous period of at least 6 weeks immediately prior to the date of loading of the consignment for dispatch to the Union;

II.1.8.

had no contact with other birds of a lower health status since the date of hatching or for a continuous period of at least 6 weeks immediately prior to the date of loading of the consignment for dispatch to the Union;

II.1.9.

II.1.10.

have been subjected to a clinical inspection (11) on ___/___/____ (dd/mm/yyyy), within the last 24 hours prior to the time of loading of the consignment for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.1.11.

are loaded for dispatch to the Union in the containers which:

(a)

are constructed in such a way that:

(i)	birds cannot escape or fall out;

(ii)	visual inspection of the space where birds are kept is possible;

(iii)

the escape of animal excrements, litter, feed or feathers is prevented or minimized;

(b)	contain only birds of the same species and category coming from the same establishment;

(c)

are

(2) either

[unused and purpose-designed disposable containers to be destroyed after first use;]

(2) or

[cleaned and disinfected and dried or allowed to dry prior to loading of the consignment for dispatch to the Union;]

(d)	are closed in accordance with the instructions of the competent authority of the third country or territory of origin to avoid any possibility of substitution of the content;

(e)	bear the information set out in point 1 of Annex XVI to Delegated Regulation (EU) 2020/692 relevant for breeding poultry and productive poultry;

II.1.12.

are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy) (12) in a means of transport which is constructed in accordance with point II.1.11(a), and was cleaned and disinfected prior to loading of the consignment for dispatch to the Union with a disinfectant authorised by the competent authority of the third country or territory of origin;

(2) (13) [II.1.13.

are intended for a Member State or zone thereof which has been granted the status free from infection with Newcastle disease virus without vaccination in accordance with Article 66 of Commission Delegated Regulation (EU) 2020/689, and:

(a)	have not been vaccinated against infection with Newcastle disease virus;

(b)

(i)	no bird was vaccinated against infection with Newcastle disease virus during the last 21 days prior to the date of loading of the consignment for dispatch to the Union;

(ii)	no other birds have entered into the establishment during that period;

(iii)

no vaccination has been carried out;

(c)

have tested (7) negative to serological tests to detect antibodies against Newcastle disease virus, performed on blood samples at a level which gives 95% confidence of detecting infection at 5% prevalence and which were taken during at least 14 days prior to the date of loading of the consignment for dispatch to the Union.]

(2) (14) [II.2.

Attestation as regards Commission Delegated Regulation (EU) 2023/905 (Delete when the Union is not the final destination of the animals)

I, the undersigned official veterinarian, hereby certify that the [breeding ratites] (2) [productive ratites] (2) have not been administered antimicrobial medicinal products for growth promotion or yield increase or antimicrobial medicinal products containing an antimicrobial that is included in the list of antimicrobials reserved for the treatment of certain infections in humans laid down in Commission Implementing Regulation (EU) 2022/1255, as set out in Article 3 of Delegated Regulation (EU) 2023/905 and originate from a third country or region thereof listed in the Annex to Commission Implementing Regulation (EU) 2024/2598.]

Notes:

This animal health/official certificate is intended for the entry into the Union of breeding ratites or productive ratites, including when the Union is not the final destination of those animals.

Part I:

Box reference I.8

Provide the code of the zone as it appears in column 2 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

Box reference I.27

Description of consignment:

“CN code”: Indicate the appropriate Harmonised System (HS) code(s) of the World Customs Organisation under the following headings: 0106 39 .

“Identification system”: The animal shall be individually identified by neck-tags or an injectable transponder in accordance with Article 43 of Delegated Regulation (EU) 2020/692.

“Category”: select one of the following: Pure line/grandparents/parents/others.

“Identification number”: Indicate the identification number, which shall include the code of the third country or territory of origin conforming with ISO standards in accordance with Article 43 of Delegated Regulation (EU) 2020/692.

Part II:

(1)	“Breeding ratites” means ratites 72 hours old or more, intended for the production of hatching eggs, as defined in Delegated Regulation (EU) 2020/692.

(2)	Delete if not applicable.

(3)	“Productive ratites” means ratites 72 hours old or more, reared for the production of meat, eggs for consumption or other products, as defined in Delegated Regulation (EU) 2020/692.

(4)	Code of the zone as it appears in column 2 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

(5)	Only for the zones with the entry “N” in column 4 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

(6)

This guarantee is required only for the consignments from zones which are not considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692 and which are listed in the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 with an entry “C” in column 5 of that table.

(7)

(8)

This applies only to the zones in which vaccination against highly pathogenic avian influenza is carried out in accordance with a vaccination programme that complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692, and which are listed in the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 with an entry “A” in column 5 of that table.

(9)

This guarantee is required only for poultry coming from the zones in which the use of vaccines against infection with Newcastle disease virus which comply only with the general criteria of Annex XV to Delegated Regulation (EU) 2020/692 is not prohibited, in accordance with Article 37, point (e)(ii), thereof, and which are listed in the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 with an entry “B” in column 6 of that table.

(10)	To be completed when the birds were vaccinated against infection with Newcastle disease virus.

(11)	The clinical inspection shall have been carried out by an official veterinarian of the third country or territory of origin.

(12)	The date of loading shall not be prior to the date of authorisation of the zone referred to in point II.1.1 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of those ratites from that zone.

(13)	This guarantee is required only for the consignments intended for a Member State or zone thereof which has been granted the status free from infection with Newcastle disease virus without vaccination in accordance with Article 66 of Delegated Regulation (EU) 2020/689.

(14)	Applicable to consignments entering the Union as from 3 September 2026.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 24

MODEL ANIMAL HEALTH/OFFICIAL CERTIFICATE FOR THE ENTRY INTO THE UNION OF DAY-OLD CHICKS OTHER THAN RATITES (MODEL “DOC”)

Part I: Description of consignment

COUNTRY

Animal health/official certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No	Seal No
I.20	Certified as or for
	☐ Further keeping

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

Total net weight/gross weight (kg)

I.27	Description of consignment
CN code	Species	Subspecies/Category	Quantity

Part II: Certification

COUNTRY

Certificate model DOC

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

(3) [II.1.

Public health attestation (Delete when the Union is not the final destination of the animals)

I, the undersigned official veterinarian, hereby certify, the following as regards the day-old chicks (6) other than ratites of the consignment described in Part I:

(1) (3) [II.1.1.

The Salmonella control programme referred to in Article 10 of Regulation (EC) No 2160/2003 and the specific requirements for the use of antimicrobials and vaccines in Commission Regulation (EC) No 1177/2006, have been applied to the parent flock of origin and that parent flock has been tested for Salmonella serotypes of public health significance:

Identification of the flock	Age of the birds	Date of last sampling of the flock from which the testing result is known[dd/mm/yyyy]	Result of all testing in the flock (2)
			positive	negative

The specific requirements for the use of antimicrobials and vaccines in Regulation (EC) No 1177/2006 have been applied to the day-old chicks.

For reasons other than the Salmonella control programme

(3) either

[antimicrobials were not administered to the day-old chicks (including in-ovo injection).]]]

(3) (4) or

[the following antimicrobials were administered to the day-old chicks (including in-ovo injection): … .]]]

(1) (3) [II.1.2.

If the day-old chicks are intended for breeding, neither Salmonella Enteritidis nor Salmonella Typhimurium were detected within the control programme referred to in point II.1.1.]]

(3) (5) [II.1.3.

If the Member State of destination is Finland or Sweden, the day-old chicks for introduction into flocks of breeding poultry or flocks of productive poultry come from flocks which have tested negative for Salmonella in accordance with the rules laid down in Commission Decision 2003/644/EC.]]

II.2.

Animal health attestation

I, the undersigned official veterinarian, hereby certify, that the day-old chicks (6) other than ratites of the consignment described in Part I:

II.2.1.

have hatched in the zone with code __-__ (7) which, at the date of issue of this animal health/official certificate:

(a)	is authorised and listed in Part 1, Section B, of Annex V to Commission Implementing Regulation (EU) 2021/404 for the entry into the Union of day-old chicks other than ratites;

(b)	carries out a disease surveillance programme for highly pathogenic avian influenza in accordance with Article 37, point (a), of Commission Delegated Regulation (EU) 2020/692;

(c)	is considered free from highly pathogenic avian influenza in accordance with Article 38 of Delegated Regulation (EU) 2020/692;

(3) either

[(d)	is considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692;]

(3) (8) or

[(d)	is not considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692, and they originate from establishment(s) located in an area within that zone not placed under official restrictions due to an outbreak of that disease;]

II.2.2.

come from the zone referred to in point II.2.1, in which:

(3) either

[(a)	vaccination against highly pathogenic avian influenza is not carried out;]

(3) (9) or

[(a)	vaccination against highly pathogenic avian influenza is carried out in accordance with a vaccination programme that complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692;]

(3) either

[(b)	vaccination against infection with Newcastle disease virus with vaccines which do not comply with both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692 is prohibited;]

(3) (10) or

[(b)

(i)	have not been vaccinated with such vaccines;

(ii)

come from flocks which:

(1)	have not been vaccinated with such vaccines for at least 12 months prior to the date of loading of the consignment for dispatch to the Union;

(2)

underwent a virus isolation test (11) for infection with Newcastle disease virus carried out on a random sample of cloacal swabs taken from at least 60 birds in each flock, not earlier than 2 weeks prior to the date of loading of the consignment for dispatch to the Union, and in which no avian paramyxoviruses with an ICPI of more than 0,4 were found;

(3)	were kept in isolation under official surveillance on the establishment of origin during the last 2 weeks prior to the date of loading of the consignment for dispatch to the Union;

(4)	during the last 60 days prior to the date of loading of the consignment for dispatch to the Union, were not in contact with poultry which do not fulfil the conditions referred to in points (1) and (2);

(iii)

come from hatching eggs which have not been in contact in the hatchery or during transport thereto with poultry or hatching eggs not meeting the requirements referred to in point (ii);]

II.2.3.

come from a hatchery, indicated in box I.11, approved by the competent authority of the third country or territory of origin in accordance with requirements which are at least as stringent as those laid down in Article 7 of Commission Delegated Regulation (EU) 2019/2035, and:

(a)	the approval of which has not been suspended or withdrawn;

(b)	which is under the control of the competent authority of the third country or territory of origin and has a system in place to maintain and to keep records in accordance with Article 8 of Delegated Regulation (EU) 2020/692;

(c)

(d)	which was not subject to national restriction measures for animal health reasons, including for the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the time of loading of the consignment of dispatch to the Union;

(e)

II.2.4.

come from a flock which:

(a)

has remained in zone referred to in point II.2.1 for a continuous period of at least 3 months immediately prior to the date of collection of the eggs from which the day-old chicks have hatched; and where the flock was introduced into the zone referred to in point II.2.1, that introduction took place under animal health requirements at least as stringent as those for the entry into the Union of breeding poultry other than ratites and productive poultry other than ratites laid down in Regulation (EU) 2016/429 of the European Parliament and of the Council and Delegated Regulation (EU) 2020/692, and from a third country or territory, or zone thereof listed in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 or a Member State;

(b)

has been kept for a continuous period of at least 6 weeks immediately prior to the date of collection of the eggs from which the day-old chicks have hatched in an establishment:

(i)

approved by the competent authority of the third country or territory of origin in accordance with requirements which are at least as stringent as those laid down in Article 8 of Delegated Regulation (EU) 2019/2035;

(12)

Name of establishment	Address	Approval number

(ii)	the approval of which has not been suspended or withdrawn at the date of dispatch of the hatching eggs, from which the day-old chicks have hatched, to the hatchery;

(iii)

in which no confirmed case of infection with low pathogenic avian influenza viruses has been reported for at least 21 days prior to the date of collection of the hatching eggs, from which the day-old chicks have hatched;

(iv)

in which

(3) either

[infection with Salmonella Pullorum, S. Gallinarum or S. arizonae was not confirmed during the last 12 months prior to date of loading of the consignment for dispatch to the Union;]

(3) or

[infection with Salmonella Pullorum, S. Gallinarum or S. arizonae was confirmed during the last 12 months prior to date of loading of the consignment for dispatch to the Union and the measures provided for in Article 46, point (d), of Delegated Regulation (EU) 2020/692 have been applied;]

(v)

in which

(3) either

[avian mycoplasmosis (Mycoplasma gallisepticum and M. meleagridis) was not confirmed during the last 12 months prior to date of loading of the consignment for dispatch to the Union;]

(3) or

[avian mycoplasmosis (Mycoplasma gallisepticum and M. meleagridis) was confirmed during the last 12 months prior to date of loading of the consignment for dispatch to the Union and the measures provided for in Article 46, point (e), of Delegated Regulation (EU) 2020/692 have been applied;]

(3) either

[(c)	has not been vaccinated against highly pathogenic avian influenza;]

(3) (9) or

[(c)	has been vaccinated against highly pathogenic avian influenza in accordance with a vaccination programme which complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692;]

(3) either

[(d)	has not been vaccinated against infection with Newcastle disease virus within the last 12 months prior to the date of loading of the consignment for dispatch to the Union;]

(3) or

[(d)

(13)

Identification of the flock	Age of the birds	Date of vaccination	Name and type of virus strain used	Batch number of the vaccine	Name of the vaccine	Manufacturer of the vaccine

]

(e)	underwent a disease surveillance programme that meets the requirements set out in Annex II to Delegated Regulation (EU) 2019/2035 and was found not to be infected or showed any grounds for suspecting any infection, by the following agents

(3) either

[Salmonella Pullorum, Salmonella Gallinarum and Mycoplasma gallisepticum (in case of Gallus gallus);]

(3) or

[Salmonella arizonae (serogroup O:18(k)), Salmonella Pullorum and Salmonella Gallinarum, Mycoplasma meleagridis and Mycoplasma gallisepticum (in case of Meleagris gallopavo);]

(3) or

[Salmonella Pullorum and Salmonella Gallinarum (in case of Numida meleagris, Coturnix coturnix, Phasianus colchicus, Perdix perdix and Anas spp);]

II.2.5.

come from hatching eggs which:

(a)	comply with the requirements for the entry into the Union laid down in Title 2 of Part III of Delegated Regulation (EU) 2020/692;

(b)	prior to the date of their dispatch to the hatchery, have been marked in accordance with the instructions of the competent authority of the third country or territory of origin;

(c)	have been disinfected in accordance with the instructions of the competent authority of the third country or territory of origin;

(d)	have had no contact in the hatchery or during transport thereto with poultry or hatching eggs of lower health status, captive birds or wild birds;

II.2.6.

have remained:

(a)	in the third country or territory, or zone thereof referred to in point II.2.1 since the date of hatching;

(b)	in the establishment indicated in box I.11 since the date of hatching;

(14) [II.2.7.

have had no contact with other birds of a lower health status since the date of hatching;]

II.2.8.

have not been vaccinated against highly pathogenic avian influenza;

II.2.9.

(14) [II.2.10.

hatched on ___/___/____ (dd/mm/yyyy);

(14) [II.2.11.

were subjected to a clinical inspection (15) on ___/___/____ (dd/mm/yyyy), within the period of 24 hours prior to the time of loading of this consignment for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.2.12.

are loaded for dispatch to the Union in the containers which:

(a)

are constructed in such a way that:

(i)	the birds cannot escape or fall out;

(ii)	visual inspection of the space where birds are kept is possible;

(iii)

the escape of bird excrements, litter, feed or feathers is prevented or minimized;

(b)	contain only poultry of the same species and category coming from the same establishment;

(c)	are disposable, clean and used for the first time;

(d)	are closed in accordance with the instructions of the competent authority of the third country or territory of origin to avoid any possibility of substitution of the content;

(e)	bear the information set out in Point 3 of Annex XVI to Delegated Regulation (EU) 2020/692 relevant for day-old chicks;

II.2.13.

are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy) (16) in a means of transport which is constructed in accordance with point II.2.12(a), and was cleaned and disinfected prior to loading of the consignment for dispatch to the Union with a disinfectant authorised by the competent authority of the third country or territory of origin;

(3) (17) [II.2.14.

(a)	have not been vaccinated against infection with Newcastle disease virus;

(b)

come from hatching eggs coming from flocks which

(3) either

[have not been vaccinated against infection with Newcastle disease virus;]

(3) or

[have been vaccinated against infection with Newcastle disease virus with an inactivated vaccine;]

(3) or

[have been vaccinated against infection with Newcastle disease virus with a live vaccine at the latest within the last 60 days prior to the date of collection of the eggs;]

(c)	come from a hatchery where working practices ensure that the hatching eggs from which the day-old chicks have hatched, were incubated at the completely separate times and locations from the eggs not satisfying the requirements referred to in point (b).]

Notes:

This animal health/official certificate is intended for the entry into the Union of day-old chicks other than ratites, including when the Union is not the final destination of those animals.

Part I:

Box reference I.8

Provide the code of the zone as it appears in column 2 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

Box reference I.27

Description of consignment:

“CN code”: Indicate the appropriate Harmonised System (HS) code(s) of the World Customs Organisation under the following headings: 0105 or 0106 39 .

“Category”: Select one of the following: Pure line/grandparents/parents/laying stock/broilers/others.

Part II:

(1)	This guarantee applies only for day-old chicks belonging to the species of Gallus gallus and turkeys.

(2)

If any of the results were positive for the serotypes below during the life of the flock, indicate as positive:

(a)	flocks of breeding poultry: Salmonella Hadar, Salmonella Virchow and Salmonella Infantis;

(b)	flocks of productive poultry: Salmonella Enteritidis and Salmonella Typhimurium.

(3)	Delete if not applicable.

(4)	Keep if appropriate: indicate the name and active substance of antimicrobials used.

(5)	Delete if consignment is not intended for Finland or Sweden.

(6)	“Day-old chicks” means poultry less than 72 hours old, as defined in Article 2 of Delegated Regulation (EU) 2020/692.

(7)	Code of the zone as it appears in column 2 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

(8)	Only for the zones with the entry “N” in column 4 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

(9)

This applies only to the zones in which vaccination against highly pathogenic avian influenza is carried out in accordance with a vaccination programme that complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692, and which are listed in in the table Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 with an entry “A” in column 5 of that table.

(10)

This guarantee is required only for the poultry coming from the zones in which the use of vaccines against infection with Newcastle disease virus which comply only with the general criteria of Annex XV to Delegated Regulation (EU) 2020/692 is not prohibited, in accordance with Article 37, point (e)(ii), thereof, and which are listed in the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 with an entry “B” in column 5 of that table.

(11)

(12)	Indicate the name, address and approval number of the establishment were the flock of origin of the day-old chicks was kept during the 6 weeks immediately prior to the date of collection of the eggs from which the day-old chicks have hatched.

(13)	To be completed when the birds were vaccinated against infection with Newcastle disease virus.

(14)	Delete if Part III “Supplementary health information” is completed.

(15)	The clinical inspection shall have been carried out by an official veterinarian of the third country or territory of origin.

(16)	The date of loading shall not be prior to the date of authorisation of the zone referred to in point II.2.1 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of those day-old chicks from that zone.

(17)

This guarantee is required only for the consignments intended for a Member State or zone thereof which has been granted the status free from infection with Newcastle disease virus without vaccination in accordance with Article 66 of Delegated Regulation (EU) 2020/689.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

(18) (19) III.

Supplementary health information concerning animal health/official certificate reference number (box I.2)

…

I, the undersigned official veterinarian, hereby certify, that:

(a)	the health conditions of Part II of this animal health/official certificates continue to be met;

(b)

the day-old chicks described in this animal health/official certificate:

(i)	have hatched on ___/___/____. (dd/mm/yyyy);

(ii)

have been subjected to a clinical inspection (17) on __/__/__ (dd/mm/yyyy), within the last 24 hours prior to the time of loading of the consignment for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

(iii)

had no contact with other birds of a lower health status since the date of hatching.

(18)	This Part shall only be used if points II.2.7, II.2.10 and II.2.11 have been deleted.

(19)	This Part can be on a separate sheet provided it is attached to Part II of the animal health/official certificate.

(20)	The clinical inspection shall have been carried out by an official veterinarian of the third country or territory of origin.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 25

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF DAY-OLD CHICKS OF RATITES (MODEL “DOR”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No	Seal No
I.20	Certified as or for
	☐ Further keeping

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23	☐ For re-entry

I.24

Total number of packages

I.25

Total quantity

I.26

Total net weight/gross weight (kg)

I.27	Description of consignment
CN code	Species	Subspecies/Category	Quantity

Part II: Certification

COUNTRY

Certificate model DOR

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

II.1.

Animal health attestation

I, the undersigned official veterinarian, hereby certify that the day-old chicks (1) of ratites of the consignment described in this animal health certificate:

II.1.1.

have hatched on the zone with code __-__ (2) which, at the date of issue of this animal health certificate:

(a)	is authorised and listed in Part 1, Section B, of Annex V to Commission Implementing Regulation (EU) 2021/404 for the entry into the Union of day-old chicks of ratites;

(b)	carries out a disease surveillance programme for highly pathogenic avian influenza in accordance with Article 37, point (a), of Commission Delegated Regulation (EU) 2020/692;

(c)	is considered free from highly pathogenic avian influenza in accordance with Article 38 of Delegated Regulation (EU) 2020/692;

II.1.2.

come from the zone referred to in point II.1.1, which at the date of issue of this animal health certificate

(3) either

[is considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692;]

(3) (4) or

(3) (5) or

[is not considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692 and the day-old chicks of the consignment come from flocks:

(a)	which have been placed in isolation under official surveillance for at least 30 days prior to the date of laying of the hatching eggs from which the day-old chicks of this consignment have hatched;

(b)

which have undergone a virus detection test (6) for infection with Newcastle disease virus:

(i)	which was carried out on cloacal swabs or faeces samples collected from each ratite within 7 to 10 days from the date on which the ratites were placed under official surveillance referred to in point (a);

(ii)	in which no avian paramyxovirus type 1 isolates with an Intracerebral Pathogenicity Index (ICPI) of more than 0,4 have been found;

(iii)

with favourable results being available for all birds prior to the date on which the day-old chicks of this consignment left the hatchery for dispatch to the Union;

(c)	in which surveillance for infection with Newcastle disease virus was carried out under a statistically based sampling plan which produced negative results for at least 6 months immediately prior to the date of loading of this consignment for dispatch to the Union;

(d)	which have not been in contact with poultry which do not fulfil the guarantees referred to in points (a), (b) and (c) during the last 30 days prior to the date of laying and during the period of laying of the hatching eggs from which the day-old chicks of this consignment have hatched;]

II.1.3.

come from the zone referred to in point II.1.1, in which:

(3) either

[(a)	vaccination against highly pathogenic avian influenza is not carried out;]

(3) (7) or

[(a)	vaccination against highly pathogenic avian influenza is carried out in accordance with a vaccination programme that complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692;]

(3) either

[(b)	vaccination against infection with Newcastle disease virus with vaccines which do not comply with both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692 is prohibited;]

(3) (8) or

[(b)

(i)	have not been vaccinated with such vaccines;

(ii)

come from flocks which:

(1)	have not been vaccinated with such vaccines for at least 12 months prior to the date of loading of the consignment for dispatch to the Union;

(2)

underwent a virus isolation test (6) for infection with Newcastle disease virus carried out on a random sample of cloacal swabs taken from at least 60 birds in each flock, not earlier than 2 weeks prior to the date of loading of the consignment for dispatch to the Union, and in which no avian paramyxoviruses with an ICPI of more than 0,4 were found;

(3)	were kept in isolation under official surveillance on the establishment of origin during the last 2 weeks prior to the date of loading of the consignment for dispatch to the Union;

(4)	during the last 60 days prior to the date of loading of the consignment for dispatch to the Union, were not in contact with other birds which do not fulfil the conditions referred to in points (1) and (2);

(iii)

come from hatching eggs which have not been in contact in the hatchery or during transport thereto with poultry or hatching eggs not meeting the requirements referred to in point (ii);]

II.1.4.

(a)	the approval of which has not been suspended or withdrawn;

(b)	which is under the control of the competent authority of the third country or territory of origin and has a system in place to maintain and to keep records in accordance with Article 8 of Delegated Regulation (EU) 2020/692;

(c)

(d)	which was not subject to national restriction measures for animal health reasons, including for the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the date of loading of the consignment for dispatch to the Union;

(e)

II.1.5.

come from a flock which:

(a)

has remained in the zone referred to in point II.1.1 for a continuous period of at least 3 months immediately prior to the date of collection of the eggs from which the day-old chicks of the consignment have hatched; and where the flock was introduced into the zone referred to in point II.1.1, that introduction took place under animal health requirements at least as stringent as those for the entry into the Union of breeding ratites and productive ratites laid down in Regulation (EU) 2016/429 of the European Parliament and of the Council and Delegated Regulation (EU) 2020/692, and from a third country or territory, or zone thereof listed in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 or a Member State;

(b)

has been kept for a continuous period of at least 6 weeks immediately prior to the date of collection of the eggs from which the day-old chicks of the consignment have hatched in the establishments:

(i)

approved by the competent authority of the third country or territory of origin in accordance with requirements which are at least as stringent as those laid down in Article 8 of Commission Delegated Regulation (EU) 2019/2035;

(9)

Name of establishment	Address	Approval number

(ii)	the approval of which has not been suspended or withdrawn at the date of the hatching eggs, from which the day-old chicks of the consignment have hatched, were dispatched to the hatchery;

(iii)

(3) either

[(c)	has not been vaccinated against highly pathogenic avian influenza;]

(3) (7) or

[(c)	has been vaccinated against highly pathogenic avian influenza in accordance with a vaccination programme which complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692;]

(3) either

[(d)	has not been vaccinated against infection with Newcastle disease virus within the last 12 months prior to the date of loading of the consignment for dispatch to the Union;]

(3) or

[(d)

(10)

Identification of the flock	Age of the birds	Date of vaccination	Name and type of virus strain used	Batch number of the vaccine	Name of the vaccine	Manufacturer of the vaccine

]

II.1.6.

come from hatching eggs which:

(a)	comply with the requirements for the entry into the Union laid down in Title 2 of Part III of Delegated Regulation (EU) 2020/692;

(b)	prior to the date of their dispatch to the hatchery, have been marked in accordance with the instructions of the competent authority of the third country or territory of origin;

(c)	have been disinfected in accordance with the instructions of the competent authority of the third country or territory of origin;

(d)	have had no contact in the hatchery or during transport thereto with poultry or hatching eggs of lower health status, captive birds or wild birds;

II.1.7.

have remained:

(a)	in the zone referred to in point II.1.2 since the date of hatching;

(b)	in the establishment indicated in box I.11 since the date of hatching;

II.1.8.

had no contact with other birds of a lower health status since the date of hatching;

II.1.9.

have not been vaccinated against highly pathogenic avian influenza;

II.1.10.

II.1.11.

have hatched on ___/___/____ (dd/mm/yyyy);

II.1.12.

have been subjected to a clinical inspection (11) on ___/___/____ (dd/mm/yyyy), within the last 24 hours prior to the time of loading of this consignment for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.1.13.

are loaded for dispatch to the Union in the containers which:

(a)

are constructed in such a way that:

(i)	birds cannot escape or fall out;

(ii)	visual inspection of the space where birds are kept is possible;

(iii)

the escape of animal excrements, litter, feed or feathers is prevented or minimized;

(b)	contain only birds of the same species and category coming from the same establishment;

(c)	are disposable, clean and used for the first time;

(d)	are closed in accordance with the instructions of the competent authority of the third country or territory of origin to avoid any possibility of substitution of the content;

(e)	bear the information set out in Point 3 of Annex XVI to Delegated Regulation (EU) 2020/692 relevant for day-old chicks;

II.1.14.

are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy) (12) in a means of transport which is constructed in accordance with point II.1.13(a) and was cleaned and disinfected prior to loading of the consignment for dispatch to the Union with a disinfectant authorised by the competent authority of the third country or territory of origin;

(3) (13) [II.1.15.

(a)	have not been vaccinated against infection with Newcastle disease virus;

(b)

come from hatching eggs coming from flocks which

(3) either

[have not been vaccinated against infection with Newcastle disease virus;]

(3) or

[have been vaccinated against infection with Newcastle disease virus with an inactivated vaccine;]

(3) or

[have been vaccinated against infection with Newcastle disease virus with a live vaccine at the latest 60 days prior to the date of collection of the eggs;]

(c)	come from a hatchery where working practices ensure that the hatching eggs from which the day-old chicks of the consignment have hatched, were incubated at the completely separate times and locations from the eggs not satisfying the requirements referred to in point (b).]

Notes:

This animal health certificate is intended for the entry into the Union of day-old chicks of ratites, including when the Union is not the final destination of those animals.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.8

Provide the code of the third country or territory, or zone thereof as it appears in column 2 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

Box reference I.27

“CN code”: Indicate the appropriate Harmonised System (HS) code(s) of the World Customs Organisation under the following headings: 0106 39 .

“Category”: Select one of the following: Pure line/grandparents/parents/others.

Part II:

(1)	“Day-old chicks” means poultry less than 72 hours old, as defined in Article 2 of Delegated Regulation (EU) 2020/692.

(2)	Code of the zone as it appears in column 2 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

(3)	Delete if not applicable.

(4)	Only for the zones with the entry “N” in column 4 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

(5)

This guarantee is required only for the consignments from the zones which are not considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692 and which are listed in the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 with an entry “C” in column 5 of that table.

(6)

(7)

This applies only to the zones in which vaccination against highly pathogenic avian influenza is carried out in accordance with a vaccination programme that complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692, and which are listed in the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 with an entry “A” in column 5 of that table.

(8)

This guarantee is required only for the day-old chicks coming from the zones in which the use of vaccines against infection with Newcastle disease virus which comply only with the general criteria of Annex XV to Delegated Regulation (EU) 2020/692 is not prohibited, in accordance with Article 37, point (e)(ii), thereof, and which are listed in the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 with an entry “B” in column 5 of that table.

(9)	Indicate the name, address and approval number of the establishment were the flock of origin of the day-old chicks was kept during the 6 weeks immediately prior to the date of collection of the eggs from which the day-old chicks have hatched.

(10)	To be completed when the birds were vaccinated against infection with Newcastle disease virus.

(11)	The clinical inspection shall have been carried out by an official veterinarian of the third country or territory of origin.

(12)	The date of loading shall not be prior to the date of authorisation of the zone referred to in point II.1.1 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of those day-old chicks from that zone.

(13)	This guarantee is required only for the consignments intended for a Member State or zone thereof which has been granted the status free from infection with Newcastle disease virus without vaccination in accordance with Article 66 of Commission Delegated Regulation (EU) 2020/689.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 26

MODEL ANIMAL HEALTH/OFFICIAL CERTIFICATE FOR THE ENTRY INTO THE UNION OF HATCHING EGGS OF POULTRY OTHER THAN RATITES (MODEL “HEP”)

Part I: Description of consignment

COUNTRY

Animal health/official certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

Total net weight/gross weight (kg)

I.27	Description of consignment
CN code	Species	Subspecies/Category	Identification system	Identification number	Quantity

Part II: Certification

COUNTRY

Certificate model HEP

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

(3) [II.1.

Public health attestation (Delete when the Union is not the final destination of the hatching eggs)

I, the undersigned official veterinarian, hereby certify, the following as regards the hatching eggs (1) of poultry other than ratites of the consignment described in Part I:

(3) (15) [II.1.1.

Identification of the flock	Age of the birds	Date of last sampling of the flock from which the testing result is known[dd/mm/yyyy]	Result of all testing in the flock (16)
			Positive	Negative

]]

(3) (16) [II.1.2.

Neither Salmonella Enteritidis nor Salmonella Typhimurium were detected within the control programme referred to in point II.1.1.]]

(3) (17) [II.1.3.

If the Member State of destination is Finland or Sweden, the hatching eggs come from flocks which have tested negative for Salmonella in accordance with the rules laid down in Commission Decision 2003/644/EC.]]

II.2.

Animal health attestation

I, the undersigned official veterinarian, hereby certify, that the hatching eggs (1) of poultry other than ratites of the consignment described in Part I:

II.2.1.

come from the zone with code __-__ (2) which, at the date of issue of this animal health/official certificate:

(a)	is authorised and listed in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2021/404 for the entry into the Union of hatching eggs of poultry other than ratites;

(b)	carries out a disease surveillance programme for highly pathogenic avian influenza in accordance with Article 105, point (a), of Commission Delegated Regulation (EU) 2020/692;

(c)	is considered free from highly pathogenic avian influenza in accordance with Article 38 of Delegated Regulation (EU) 2020/692;

(3) either

[(d)	is considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692;]

(3) (4) or

[(d)	is not considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692, and they originate from establishment(s) located in an area within that zone not placed under official restrictions due to an outbreak of that disease;]

II.2.2.

come from the zone referred to in point II.2.1, in which:

(3) either

[(a)	vaccination against highly pathogenic avian influenza is not carried out;]

(3) (5) or

[(a)	vaccination against highly pathogenic avian influenza is carried out in accordance with a vaccination programme that complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692;]

(3) either

[(b)	vaccination against infection with Newcastle disease virus with vaccines which do not comply with both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692 is prohibited;]

(3) (6) or

[(b)

(i)

come from flocks which:

(1)	have not been vaccinated with such vaccines for at least 12 months prior to the date of loading of the consignment for dispatch to the Union;

(2)

underwent a virus isolation test (7) for infection with Newcastle disease virus carried out on a random sample of cloacal swabs taken from at least 60 birds in each flock, not earlier than 2 weeks prior to the date of loading of the consignment for dispatch to the Union, and in which no avian paramyxoviruses with an ICPI of more than 0,4 were found;

(3)	were kept in isolation under official surveillance on the establishment of origin during the last 2 weeks prior to the date of loading of the consignment for dispatch to the Union;

(4)	during the last 60 days prior to the date of loading of the consignment for dispatch to the Union, were not in contact with poultry which do not fulfil the conditions referred to in points (1) and (2);

(ii)	have not been in contact in the hatchery or during transport thereto with poultry or hatching eggs not meeting the requirements referred to in point (i);]

II.2.3.

come from the establishment, indicated in box I.11:

(3) (8) either

[(a)

which is approved by the competent authority of the third country or territory of origin in accordance with requirements which are at least as stringent as those laid down in Article 7 of Commission Delegated Regulation (EU) 2019/2035 and the approval of which has not been suspended or withdrawn at the date of collection of the hatching eggs;]

(3) (9) or

[(a)

which is approved by the competent authority of the third country or territory of origin in accordance with requirements which are at least as stringent as those laid down in Article 8 of Delegated Regulation (EU) 2019/2035 and the approval of which has not been suspended or withdrawn at the date of collection of the hatching eggs;]

(b)	which is under the control of the competent authority of the third country or territory of origin and has a system in place to maintain and to keep records in accordance with Article 8 of Delegated Regulation (EU) 2020/692;

(c)

which receives regular animal health visits from a veterinarian for the purpose of the detection of, and information on, signs indicative the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at a frequency that is proportional to the risk posed by the establishment;

(d)	which was not subject to national restriction measures for animal health reasons, including for the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the date of loading of the consignment for dispatch to the Union;

(e)

II.2.4.

come from a flock which:

(a)

has remained in zone referred to in point II.2.1 for a continuous period of at least 3 months immediately prior to the date of loading of the consignment for dispatch to the Union; and where the flock was introduced into the zone referred to in point II.2.1, that introduction took place under animal health requirements that are at least as stringent as those for the entry into the Union of breeding poultry other than ratites and productive poultry other than ratites laid down in Regulation (EU) 2016/429 of the European Parliament and of the Council and Delegated Regulation (EU) 2020/692, and from a third country or territory, or zone thereof listed in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 or a Member State;

(b)

has been kept for a continuous period of at least 6 weeks immediately prior to the date of loading of the consignment for dispatch to the Union in an establishment:

(i)	in which no confirmed case of infection with low pathogenic avian influenza viruses has been reported for at least 21 days prior to the date of collection of the hatching eggs;

(ii)

in which

(3) either

[infection with Salmonella Pullorum, S. Gallinarum or S. arizonae was not confirmed during the last 12 months prior to date of collection of the hatching eggs for dispatch to the Union;]

(3) or

[infection with Salmonella Pullorum, S. Gallinarum or S. arizonae was confirmed during the last 12 months prior to date of collection of the hatching eggs for dispatch to the Union and the measures provided for in Article 107, point (d), of Delegated Regulation (EU) 2020/692 have been applied;]

(iii)

in which

(3) either

[avian mycoplasmosis (Mycoplasma gallisepticum and M. meleagridis) was not confirmed during the last 12 months prior to date of collection of the hatching eggs for dispatch to the Union;]

(3) or

[avian mycoplasmosis (Mycoplasma gallisepticum and M. meleagridis) was confirmed during the last 12 months prior to date of collection of the hatching eggs for dispatch to the Union and the measures provided for in Article 107, point (e), of Delegated Regulation (EU) 2020/692 have been applied;]

(8) [(iv)

(10)

Name of establishment	Address	Approval number

(v)	the approval of which has not been suspended or withdrawn at the date of collection of the hatching eggs;

(vi)

(vii)

which is under the control of the competent authority of the third country or territory of origin and has a system in place to maintain and to keep records in accordance with Article 8 of Delegated Regulation (EU) 2020/692;

(viii)

(ix)	which was not subject to national restriction measures for animal health reasons, including for the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the date of loading of the consignment for dispatch to the Union;]

(3) either

[(c)	has not been vaccinated against highly pathogenic avian influenza;]

(3) (5) or

[(c)	has been vaccinated against highly pathogenic avian influenza in accordance with a vaccination programme which complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692;]

(3) either

[(d)	has not been vaccinated against infection with Newcastle disease virus within the last 12 months prior to the date of loading of the consignment for dispatch to the Union;]

(3) or

[(d)

(11)

Identification of the flock	Age of the birds	Date of vaccination	Name and type of virus strain used	Batch number of the vaccine	Name of the vaccine	Manufacturer of the vaccine

]

(e)	underwent a disease surveillance programme that meets the requirements set out in Annex II to Delegated Regulation (EU) 2019/2035 and was found not to be infected or showed any grounds for suspecting any infection, by the following agents

(3) either

[Salmonella Pullorum, Salmonella Gallinarum and Mycoplasma gallisepticum (in case of Gallus gallus);]

(3) or

[Salmonella arizonae (serogroup O:18(k)), Salmonella Pullorum and Salmonella Gallinarum, Mycoplasma meleagridis and Mycoplasma gallisepticum (in case of Meleagris gallopavo);]

(3) or

[Salmonella Pullorum and Salmonella Gallinarum (in case of Numida meleagris, Coturnix coturnix, Phasianus colchicus, Perdix perdix and Anas spp);]

(f)	had no contact with poultry or hatching eggs of a lower health status, or with captive or wild birds for a continuous period of at least 6 weeks immediately prior to the date of loading of the consignment for dispatch to the Union;

(g)	did not show symptoms of transmissible diseases at the date of collection of the hatching eggs;

(h)	had been subjected to

(3) either

[a clinical inspection (12) within the last 72 hours prior to the time of loading of the consignment for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;]

(3) or

[monthly clinical inspections (12), the most recent carried out within the last 31 days prior to the time of loading of the consignment for dispatch to the Union, for the purpose of the detection of signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation 2020/692 relevant for the species and emerging diseases and it showed no disease symptoms or grounds for suspecting the presence of any of those diseases based on those clinical inspections, and on an evaluation of its current health status carried out by an official veterinarian in the third country or territory of origin, or zone thereof, within the last 72 hours prior to the time of loading of the consignment for dispatch to the Union, as assessed by up-to-date information supplied by the operator and by documentary checks of the health and production records kept on the establishment, for the purpose of the detection of signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation 2020/692 relevant for the species and emerging diseases;]

II.2.5.

were:

(3) either

[(a)	not vaccinated against highly pathogenic avian influenza;]

(3) (5) or

[(a)	vaccinated against highly pathogenic avian influenza in accordance with a vaccination programme which complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692;]

(3) either

[(b)	not vaccinated against infection with Newcastle disease virus;]

(3) or

[(b)	vaccinated against infection with Newcastle disease virus with vaccines that comply with the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692;]

(c)	marked using colour ink, with a stamp indicating the unique approval number of the establishment of origin;

(d)	disinfected in accordance with the instructions of the competent authority of the third country or territory of origin;

II.2.6.

were collected [on ___/___/____ (dd/mm/yyyy)] (3) [from ___/___/____ (dd/mm/yyyy) to ___/___/____ (dd/mm/yyyy)] (3); (13)

II.2.7.

are loaded for dispatch to the Union in the containers which:

(a)	are constructed in such a way that the hatching eggs cannot fall out;

(b)	are designed to allow cleaning and disinfection;

(c)	contain only hatching eggs of the same species, category and type coming from the same establishment;

(d)	are closed in accordance with the instructions of the competent authority of the third country or territory of origin to avoid any possibility of substitution of the content;

(e)

are

(3) either

[disposable, clean and used for the first time;]

(3) or

[cleaned and disinfected before the date of loading of the consignment for dispatch to the Union in accordance with the instructions of the competent authority of the third country or territory of origin;]

(f)	bear the information set out in Point 5 of Annex XVI to Delegated Regulation (EU) 2020/692 relevant for hatching eggs of poultry;

II.2.8.

are loaded for dispatch to the Union in a means of transport which is constructed in accordance with points II.1.2.7(a) and (b), and was cleaned and disinfected with a disinfectant authorised by the competent authority of the third country or territory of origin and dried or allowed to dry immediately prior to loading of the consignment for dispatch to the Union;

(3) (14) [II.2.9.

(a)	have not been vaccinated against infection with Newcastle disease virus;

(b)	come from flocks which

(3) either

[have not been vaccinated against infection with Newcastle disease virus.]]

(3) or

[have been vaccinated against infection with Newcastle disease virus with an inactivated vaccine.]]

(3) or

[have been vaccinated against infection with Newcastle disease virus with a live vaccine at the latest 60 days prior to the date of collection of the hatching eggs.]]

Notes:

This animal health/official certificate is intended for the entry into the Union of hatching eggs of poultry other than ratites, including when the Union is not the final destination of those germinal products.

Part I:

Box reference I.8

Provide the code of the zone as it appears in column 2 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

Box reference I.27

“CN code”: Indicate the appropriate Harmonised System (HS) code(s) of the World Customs Organisation under the following heading: 0407 .

“Category”: Select one of the following: Pure line/grandparents/parents/laying pullets/others.

Part II:

(1)	“Hatching eggs” as defined in Article 4 of Regulation (EU) 2016/429.

(2)	Code of the zone as it appears in column 2 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

(3)	Delete if not applicable.

(4)	Only for the zones with the entry “N” in column 4 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

(5)

This applies only to the zones in which vaccination against highly pathogenic avian influenza is carried out in accordance with a vaccination programme that complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692, and which are listed in the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 with an entry “A” in column 5 of that table.

(6)

This guarantee is required only for the hatching eggs coming from the zones in which the use of vaccines against infection with Newcastle disease virus which comply only with the general criteria of Annex XV to Delegated Regulation (EU) 2020/692 is not prohibited, in accordance with Article 37, point (e)(ii) thereof, and which are listed in the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 with an entry “B” in column 5 of that table.

(7)

(8)	Keep in case the hatching eggs are dispatched from a hatchery.

(9)	Keep in case the hatching eggs are dispatched from the establishment of the flock of origin.

(10)	Indicate the name, address and approval number of the establishment were the flock of origin of the hatching eggs was kept during 6 weeks immediately prior to the date of loading of the hatching eggs for dispatch to the Union.

(11)	To be completed when the birds were vaccinated against infection with Newcastle disease virus.

(12)	The clinical inspection shall have been carried out by an official veterinarian of the third country or territory of origin.

(13)	The date(s) of collection shall not be prior to the date of authorisation of the zone referred to in point II.2.1 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of those hatching eggs from that zone.

(14)	This guarantee is required only for the consignments intended for a Member State or zones thereof which has been granted the status free from infection with Newcastle disease virus without vaccination in accordance with Article 66 of Delegated Regulation (EU) 2020/689.

(15)	This guarantee applies only for the hatching eggs belonging to the species of Gallus gallus and turkeys.

(16)	If any of the results were positive for the following serotypes during the life of the parent flock, indicate as positive: Salmonella Hadar, Salmonella Virchow and Salmonella Infantis.

(17)	Delete if the consignment is not intended for Finland or Sweden.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 27

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF HATCHING EGGS OF RATITES (MODEL “HER”)

Part I: Description of consignment

COUNTRY

Animal health/official certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for

		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

Total net weight/gross weight (kg)

Part II: Certification

COUNTRY

Certificate model HER

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

II.1.

Animal health attestation

I, the undersigned official veterinarian, hereby certify that the hatching eggs (1) of ratites of the consignment described in Part I:

II.1.1.

come from the zone with code __-__ (2) which, at the date of issue of this animal health certificate:

(a)	is authorised and listed in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2021/404 for the entry into the Union of hatching eggs of ratites;

(b)	carries out a disease surveillance programme for highly pathogenic avian influenza in accordance with Article 105, point (a), of Commission Delegated Regulation (EU) 2020/692;

(c)	is considered free from highly pathogenic avian influenza in accordance with Article 38 of Delegated Regulation (EU) 2020/692;

II.1.2.

come from the zone referred to in point II.1.1, which at the date of issue of this animal health certificate

(3) either

[is considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692;]

(3) (4) or

(3) (5) or

[is not considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692 and the hatching eggs come from the flocks:

(a)	which have been placed in isolation under official surveillance for at least 30 days prior to the date of laying of the hatching eggs of this consignment;

(b)

which have undergone a virus detection test (6) for infection with Newcastle disease virus:

(i)	which was carried out on cloacal swabs or faeces samples collected from each ratite within 7 to 10 days from the date on which the ratites were placed under official surveillance referred to in point (a);

(ii)	in which no avian paramyxovirus type 1 isolates with an Intracerebral Pathogenicity Index (ICPI) of more than 0,4 have been found;

(iii)

with favourable results being available for all birds prior to the date on which the hatching eggs were loaded for dispatch to the Union;

(c)	in which surveillance for infection with Newcastle disease virus was carried out under a statistically based sampling plan which produced negative results for at least 6 months immediately prior to the date of loading of the consignment for dispatch to the Union;

(d)	have not been kept with poultry which do not fulfil the guarantees under points (a), (b) and (c) during the last 30 days prior to the date of laying and during the period of laying of the hatching eggs of this consignment;]

II.1.3.

come from the zone referred to in point II.1.1, in which:

(3) either

[(a)	vaccination against highly pathogenic avian influenza is not carried out;]

(3) (7) or

[(a)	vaccination against highly pathogenic avian influenza is carried out in accordance with a vaccination programme that complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692;]

(3) either

[(b)	vaccination against infection with Newcastle disease virus with vaccines which do not comply with both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692 is prohibited;]

(3) (8) or

[(b)

(i)

come from the flocks which:

(1)	have not been vaccinated with such vaccines for at least 12 months prior to the date of loading of the consignment for dispatch to the Union;

(2)

(3)	were kept in isolation under official surveillance on the establishment of origin during the last 2 weeks prior to the date of loading of the consignment for dispatch to the Union;

(4)	during the last 60 days prior to the date of loading of the consignment for dispatch to the Union, were not in contact with poultry which do not fulfil the conditions referred to in points (1) and (2);

(ii)	have not been in contact in the hatchery or during transport thereto with poultry or hatching eggs not meeting the requirements referred to in point (i);]

II.1.4.

come from the establishment, indicated in box I.11:

(3) (9) either

[(a)

(3) (10) or

[(a)

which is approved by the competent authority of the third country or territory of origin in accordance with requirements which are at least as stringent as those laid down in Article 8 of Delegated Regulation (EU) 2019/2035 and the approval of which has not been suspended or withdrawn at the date of collection of the hatching eggs;]

(b)	which is under the control of the competent authority of the third country or territory of origin and has a system in place to maintain and to keep records in accordance with Article 8 of Delegated Regulation (EU) 2020/692;

(c)

(d)	which was not subject to national restriction measures for animal health reasons, including for the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the date of loading of the consignment for dispatch to the Union;

(e)

II.1.5.

come from a flock which:

(a)

has remained in zone referred to in point II.1.1 for a continuous period of at least 3 months immediately prior to the date of loading of the consignment for dispatch to the Union; and where the flock was introduced into the zone referred to in point II.1.1, that introduction took place under animal health requirements at least as stringent as those for the entry into the Union of breeding ratites and productive ratites laid down in Regulation (EU) 2016/429 of the European Parliament and of the Council and Delegated Regulation (EU) 2020/692, and from a third country or territory, or zone thereof listed in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 or a Member State;

(b)

has been kept for a continuous period of at least 6 weeks immediately prior to the date of loading of the consignment for dispatch to the Union in an establishment:

(i)	in which no confirmed case of infection with low pathogenic avian influenza viruses has been reported for at least 21 days prior to the date of collection of the hatching eggs;

(9) [(ii)

(11)

Name of establishment	Address	Approval number

(iii)

the approval of which has not been suspended or withdrawn on the date of collection of the hatching eggs;

(iv)

(v)	which is under the control of the competent authority of the third country or territory of origin and has a system in place to maintain and to keep records in accordance with Article 8 of Delegated Regulation (EU) 2020/692;

(vi)

(vii)

which was not subject to national restriction measures for animal health reasons, including for the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the date of loading of the consignment for dispatch to the Union;]

(3) either

[(c)	has not been vaccinated against highly pathogenic avian influenza;]

(3) (6) or

[(c)	has been vaccinated against highly pathogenic avian influenza in accordance with a vaccination programme which complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692;]

(3) either

[(d)	has not been vaccinated against infection with Newcastle disease virus in the last 12 months prior to the date of loading of the consignment for dispatch to the Union;]

(3) or

[(d)

has been vaccinated against infection with Newcastle disease virus in the last 12 months prior to the date of loading of the consignment for dispatch to the Union, with vaccines that comply with both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692;

(12)

Identification of the flock	Age of the birds	Date of vaccination	Name and type of virus strain used	Batch number of the vaccine	Name of the vaccine	Manufacturer of the vaccine

]

(e)	had no contact with poultry or hatching eggs of a lower health status, or with captive or wild birds for a continuous period of at least 6 weeks immediately prior to the date of loading of the consignment for dispatch to the Union;

(f)	did not show symptoms of transmissible diseases at the time of collection of the hatching eggs;

(g)	has been subjected to

(3) either

[a clinical inspection (13) within the last 72 hours prior to the time of loading of the consignment for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;]

(3) or

[monthly clinical inspections (13), the most recent carried out within the last 31 days prior to the time of loading of the consignment for dispatch to the Union, for the purpose of the detection of signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation 2020/692 relevant for the species and emerging diseases and it showed no disease symptoms or grounds for suspecting the presence of any of those diseases based on those clinical inspections, and on an evaluation of its current health status carried out by an official veterinarian in the third country or territory of origin, or zone thereof, within the last 72 hours prior to the time of loading of the consignment for dispatch to the Union, as assessed by up-to-date information supplied by the operator and by documentary checks of the health and production records kept on the establishment, for the purpose of the detection of signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation 2020/692 relevant for the species and emerging diseases;]

II.1.6.

were:

(3) either

[(a)	not vaccinated against highly pathogenic avian influenza;]

(3) (7) or

[(a)	vaccinated against highly pathogenic avian influenza in accordance with a vaccination programme which complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692;]

(3) either

[(b)	not vaccinated against infection with Newcastle disease virus;]

(3) or

[(b)	vaccinated against infection with Newcastle disease virus with vaccines that comply with the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692;]

(c)	marked using colour ink, with a stamp indicating the ISO code of the third country or territory of origin and the unique approval number of the establishment of origin;

(d)	disinfected in accordance with the instructions of the competent authority of the third country or territory of origin;

II.1.7.

were collected [on ___/___/____ (dd/mm/yyyy)] (3) [from ___/___/____ (dd/mm/yyyy) to ___/___/____ (dd/mm/yyyy)] (3) (14) ;

II.1.8.

are loaded for dispatch to the Union in the containers which:

(a)	are constructed in such a way that the hatching eggs cannot fall out;

(b)	are designed to allow cleaning and disinfection;

(c)	contain only hatching eggs of the same species, category and type coming from the same establishment;

(d)	are closed in accordance with the instructions of the competent authority of the third country or territory of origin to avoid any possibility of substitution of the content;

(e)

are

(3) either

[disposable, clean and used for the first time;]

(3) or

[cleaned and disinfected prior to loading of the consignment for dispatch to the Union in accordance with the instructions of the competent authority of the country or territory of origin;]

(f)	bear the information set out in Point 5 of Annex XVI to Delegated Regulation (EU) 2020/692 relevant for hatching eggs of poultry;

II.1.9.

are loaded for dispatch to the Union in a means of transport which is constructed in accordance with points II.1.8(a) and (b) and was cleaned and disinfected with a disinfectant authorised by the competent authority of the third country or territory of origin and dried or allowed to dry immediately prior to loading of the consignment for dispatch to the Union;

(3) (15) [II.1.10.

(a)	have not been vaccinated against infection with Newcastle disease virus;

(b)	come from the flocks which

(3) either

[have not been vaccinated against infection with Newcastle disease virus.]]

(3) or

[have been vaccinated against infection with Newcastle disease virus with an inactivated vaccine.]]

(3) or

[have been vaccinated against infection with Newcastle disease virus with a live vaccine at the latest 60 days prior to the date of collection of the hatching eggs.]]

Notes:

This animal health certificate is intended for the entry into the Union hatching eggs of ratites, including when the Union is not the final destination of those germinal products.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.8

Provide the code of the zone as it appears in column 2 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

Box reference I.27

Description of consignment:

“CN code”: Indicate the appropriate Harmonised System (HS) code(s) of the World Customs Organisation under the following heading: 0407 .

“Category”: Select one of the following: Pure line/grandparents/parents/others.

Part II:

(1)	Hatching eggs as defined in Article 4 of Regulation (EU) 2016/429.

(2)	Code of the zone as it appears in column 2 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

(3)	Delete if not applicable.

(4)	Only for the zones with the entry “N” in column 4 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

(5)

This guarantee is required only for the consignments from the zones which are not considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/689 and which are listed in the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 with an entry “C” in column 5 of that table.

(6)	Tests shall have been carried out on samples taken by or under the control of the competent authority of the third country or territory of origin and testing shall have been carried out in an official laboratory designated in accordance with Article 37 of Regulation (EU) 2017/625.

(7)

This applies only to the zones in which vaccination against highly pathogenic avian influenza is carried out in accordance with a vaccination programme that complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692, and which are listed in the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 with an entry “A” in column 5 of that table.

(8)

This guarantee is required only for hatching eggs coming from the zones in which the use of vaccines against infection with Newcastle disease virus which comply only with the general criteria of Annex XV to Delegated Regulation (EU) 2020/692 is not prohibited, in accordance with Article 37, point (e)(ii), thereof, and which are listed in the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 with an entry “B” in column 5 of that table.

(9)	Keep in case the hatching eggs are dispatched from a hatchery.

(10)	Keep in case the hatching eggs are dispatched from the establishment of the flock of origin.

(11)	Indicate the name, address and approval number of the establishment were the flock of origin of the hatching eggs was kept during the 6 weeks immediately prior to the date of loading of the consignment for dispatch to the Union.

(12)	To be completed when the birds were vaccinated against infection with Newcastle disease virus.

(13)	The clinical inspection shall have been carried out by an official veterinarian of the third country or territory of origin.

(14)	The date(s) of collection shall not be prior to the date of authorisation of the zone referred to in point II.1.1 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of those hatching eggs from that zone.

(15)	This guarantee is required only for the consignments intended for a Member State or zone thereof which has been granted the status free from infection with Newcastle disease virus without vaccination in accordance with Article 66 of Delegated Regulation (EU) 2020/689.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 28

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF SPECIFIED PATHOGEN-FREE EGGS (MODEL “SPF”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for

		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

Total net weight/gross weight (kg)

I.27	Description of consignment
CN code	Species	Subspecies/Category	Identification system	Identification number	Quantity

Part II: Certification

COUNTRY

Certificate model SPF

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

II. Animal health attestation

I, the undersigned official veterinarian, hereby certify, that the specified pathogen-free eggs (1) of the consignment described in Part I:

II.1.

come from the zone with code __-__ (2) which, at the date of issue of this animal health certificate is authorised and listed in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2021/404 for the entry into the Union of specified pathogen-free eggs;

II.2.

come from the establishment, indicated in box I.11, which:

(a)	is under the control of the competent authority of the third country or territory of origin and has a system in place to maintain and to keep records in accordance with Article 8 of Commission Delegated Regulation (EU) 2020/692;

(b)	complies with the conditions described in the European Pharmacopoeia;

(c)	is approved by the competent authority of the third country or territory of origin in accordance with requirements which are at least equivalent to those laid down in Article 8 of Commission Delegated Regulation (EU) 2019/2035, the approval of which has not been suspended or withdrawn;

(d)

receives regular animal health visits from a veterinarian for the purpose of the detection of, and information on, signs indicative the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at a frequency that is proportional to the risk posed by the establishment;

(e)	was not subject to national restriction measures for animal health reasons, including for the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, on the date of loading of the consignment for dispatch to the Union;

II.3.

come from a flock which:

(a)	has been kept for a continuous period of at least 6 weeks prior to the date of collection of the eggs for dispatch to the Union in the establishment referred to in point II.2;

(b)

is free from specified pathogens as described in the European Pharmacopoeia and clinical examinations required for this specific status have been favourable, including negative testing results for highly pathogenic avian influenza, infection with Newcastle disease virus and infection with low pathogenic avian influenza viruses carried out within the last 30 days prior to the date of the collection of the eggs for dispatch to the Union;

(c)	has been clinically examined at least once a week as described in the European Pharmacopoeia and no disease symptoms or ground for suspecting the presence of any disease were detected;

(d)	has had no contact with poultry of a lower health status, or with other birds for at least 6 weeks prior to the date of collection of the eggs for dispatch to the Union;

(e)	did not show symptoms of transmissible diseases on the date of collection of the eggs for dispatch to the Union;

II.4.

were:

(a)	marked using colour ink, with a stamp indicating the ISO code of the third country or territory of origin and the unique approval number of the establishment of origin;

(b)	disinfected in accordance with the instructions of the competent authority of the third country or territory of origin;

II.5.

were collected [on ___/___/____ (dd/mm/yyyy)] (3) [from ___/___/____ (dd/mm/yyyy) to ___/___/____ (dd/mm/yyyy)] (3); (4)

II.6.

are loaded for dispatch to the Union in the containers which:

(a)	are constructed in such a way that the eggs cannot fall out;

(b)	are designed to allow cleaning and disinfection;

(c)	contain only eggs of the same species, category and type coming from the same establishment;

(d)	are closed in accordance with the instructions of the competent authority of the third country or territory of origin to avoid any possibility of substitution of the content;

(e)

are

(3) either

[disposable, clean and used for the first time;]

(3) or

[cleaned and disinfected prior to loading of the consignment for dispatch to the Union in accordance with the instructions of the competent authority of the third country or territory of origin;]

(f)	bear the information set out in Pont 6 of Annex XVI to Delegated Regulation (EU) 2020/692 relevant for specified pathogen-free eggs;

II.7.

are loaded for dispatch to the Union in a means of transport which is constructed in accordance with points II.1.6(a) and (b) and was cleaned and disinfected with a disinfectant authorised by the competent authority of the third country or territory of origin and dried or allowed to dry immediately prior to the date of loading of the consignment for dispatch to the Union.

Notes:

This animal health certificate is intended for the entry into the specified pathogen-free eggs, including when the Union is not the final destination of those products.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.8

Provide the code of the zone as it appears in column 2 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

Box reference I.27

Description of consignment:

“CN code”: Indicate the appropriate Harmonised System (HS) code(s) of the World Customs Organisation under the following heading: 0407 .

Part II:

(1)	Specified pathogen-free eggs as defined in Article 2 of Delegated Regulation (EU) 2020/692.

(2)	Code of the zone as it appears in column 2 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

(3)	Delete if not applicable.

(4)	The date(s) of collection shall not be prior to the date of authorisation of the zone referred to in point II.1 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of those eggs from that zone.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 29

MODEL ANIMAL HEALTH/OFFICIAL CERTIFICATE FOR THE ENTRY INTO THE UNION OF POULTRY, OTHER THAN RATITES, INTENDED FOR SLAUGHTER (MODEL “SP”)

Part I: Description of consignment

COUNTRY

Animal health/official certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No	Seal No
I.20	Certified as or for
	☐ Slaughter

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

Total net weight/gross weight (kg)

I.27	Description of consignment
CN code	Species	Quantity

Part II: Certification

COUNTRY

Certificate model SP

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

(3) [II.1.

Public health attestation (Delete when the Union is not the final destination of the animals)

I, the undersigned official veterinarian, hereby certify, the following as regards the poultry, other than ratites, intended for slaughter (1) of the consignment described in Part I:

II.1.1.

They have not received:

(a)	any stilbene or thyrostatic substances;

(b)	oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other than therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC).

II.1.2.

They fulfil the guarantees provided by the control plan submitted in accordance with Article Article 6(2) of Commission Delegated Regulation (EU) 2022/2292, and the third country or region thereof of their origin is listed in Annex –I to Commission Implementing Regulation (EU) 2021/405, and marked with an “X” for the category “poultry”.]

(3) (12) [II.1.3.

The Salmonella control programme referred to in Article 10 of Regulation (EC) No 2160/2003 and the specific requirements for the use of antimicrobials and vaccines in Commission Regulation (EC) No 1177/2006, have been applied to the flock of origin and that flock has been tested for Salmonella serotypes of public health significance:

Identification of the flock	Age of the birds	Date of last sampling of the flock from which the testing result is known[dd/mm/yyyy]	Result of all testing in the flock (13)
			positive	negative

For reasons other than the Salmonella control programme

(3) either

[antimicrobials were not administered to the poultry intended for slaughter other than ratites.]]]

(3) (13) or

[the following antimicrobials were administered to the poultry intended for slaughter other than ratites: … .]]]

(3) (15) [II.1.4.

If the Member State of destination is Finland or Sweden, the poultry underwent a microbiological test by sampling on the holding of origin and tested Salmonella negative in accordance with the procedures in Decision 95/410/EC pursuant to Article 9(3) of Regulation (EC) No 2160/2003.]]

(3) (16) [II.1.a.

Attestation as regards Commission Delegated Regulation (EU) 2023/905 (Delete when the Union is not the final destination of the animals)

I, the undersigned official veterinarian, hereby certify that the animals described in Part I have not been administered antimicrobial medicinal products for growth promotion or yield increase or antimicrobial medicinal products containing an antimicrobial that is included in the list of antimicrobials reserved for the treatment of certain infections in humans laid down in Commission Implementing Regulation (EU) 2022/1255, as set out in Article 3 of Commission Delegated Regulation (EU) 2023/905 and originate from a third country or region thereof listed in the Annex to Commission Implementing Regulation (EU) 2024/2598.]

II.2.

Animal health attestation

I, the undersigned official veterinarian, hereby certify that the poultry intended for slaughter (1) other than ratites of the consignment described in Part I:

II.2.1.

come from the zone with code __-__ (2) which, at the date of issue of this animal health/official certificate:

(a)	is authorised and listed in Part 1, Section B, of Annex V to Commission Implementing Regulation (EU) 2021/404 for the entry into the Union of poultry intended for slaughter other than ratites;

(b)	carries out a disease surveillance programme for highly pathogenic avian influenza in accordance with Article 37, point (a), of Commission Delegated Regulation (EU) 2020/692;

(c)	is considered free from highly pathogenic avian influenza in accordance with Article 38 of Delegated Regulation (EU) 2020/692;

(3) either

[(d)	is considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692;]

(3) (4) or

[(d)	is not considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692, and they originate from establishment(s) located in an area within that zone not placed under official restrictions due to an outbreak of that disease;]

II.2.2.

come from the zone referred to in point II.2.1, in which:

(3) either

[(a)	vaccination against highly pathogenic avian influenza is not carried out;]

(3) (5) or

[(a)	vaccination against highly pathogenic avian influenza is carried out in accordance with a vaccination programme that complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692;]

(3) either

[(b)	vaccination against infection with Newcastle disease virus with vaccines which do not comply with both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692 is prohibited;]

(3) (6) or

[(b)

(i)	have not been vaccinated with such vaccines for at least 12 months prior to the date of loading of the consignment for dispatch to the Union;

(ii)

come from a flock or flocks which underwent a virus isolation test (7) for infection with Newcastle disease virus not earlier than 2 weeks prior to the date of loading of the consignment for dispatch to the Union, carried out on a random sample of cloacal swabs taken from at least 60 birds in each flock and in which no avian paramyxoviruses with an ICPI of more than 0,4 were found;

(iii)

were kept in isolation under official surveillance on the establishment of origin during the last 2 weeks referred to in point (ii);

(iv)	during the last 60 days prior to the date of loading of the consignment for dispatch to the Union, were not in contact with poultry which do not fulfil the conditions referred to in points (i) and (ii);]

II.2.3.

have remained in the zone referred to in point II.2.1 for a continuous period of at least 6 weeks immediately prior to the date of loading for dispatch to the Union or since the date of hatching where they are less than 6 weeks of age; and where they were introduced into the zone referred to in point II.2.1, that introduction took place under animal health requirements at least as stringent as those for the entry into the Union of poultry intended for slaughter other than ratites laid down in Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692, and from a third country or territory, or zone thereof listed in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 or a Member State;

II.2.4

come from the establishment, indicated in box I.11:

(a)	which is registered by and is under the control of the competent authority of the third country or territory of origin and has a system in place to maintain and to keep records in accordance with Article 8 of Delegated Regulation (EU) 2020/692;

(b)

(c)	which was not subject to national restriction measures for animal health reasons, including for the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the date of loading of the consignment for dispatch to the Union;

(d)

(e)	in which no confirmed case of infection with low pathogenic avian influenza viruses has been reported for at least 21 days prior to the date of loading of the consignment for dispatch to the Union;

II.2.5.

come from a flock which:

(a)	has not been vaccinated against highly pathogenic avian influenza;

(3) either

[(b)	has not been vaccinated against infection with Newcastle disease virus within the last 12 months prior to the date of loading of the consignment for dispatch to the Union;]

(3) or

[(b)

(8)

Identification of the flock	Age of the birds	Date of vaccination	Name and type of virus strain used	Batch number of the vaccine	Name of the vaccine	Manufacturer of the vaccine

]

(c)

has been subjected to a clinical inspection (9) within the last 24 hours prior to the time of loading of the consignment for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.2.6.

have remained in the establishment indicated in box I.11 since the date of hatching or for a continuous period of at least 30 days immediately prior to the date of loading of the consignment for dispatch to the Union;

II.2.7.

had no contact with animals of a lower health status since the date of hatching or for a continuous period of at least 30 days immediately prior to the date of loading of the consignment for dispatch to the Union;

II.2.8

II.2.9.

have been subjected to a clinical inspection (9) on ___/___/____ (dd/mm/yyyy), within the last 24 hours prior to the time of loading of the consignment for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.2.10.

are loaded for dispatch to the Union in the containers which:

(a)

are constructed in such a way that:

(i)	the birds cannot escape or fall out;

(ii)	visual inspection of the space where birds are kept is possible;

(iii)

the escape of bird excrements, litter, feed or feathers is prevented or minimized;

(b)	contain only poultry of the same species and category coming from the same establishment;

(c)

are

(3) either

[unused and purpose-designed disposable containers to be destroyed after first use;]

(3) or

[cleaned and disinfected and dried or allowed to dry prior to loading of the consignment for dispatch to the Union;]

(d)	are closed in accordance with the instructions of the competent authority of the third country or territory of origin to avoid any possibility of substitution of the content;

(e)	bear the information set out in Point 2 of Annex XVI to Delegated Regulation (EU) 2020/692 relevant for poultry intended for slaughter;

II.2.11.

are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy) (10) in a means of transport which is constructed in accordance with point II.2.10(a) and was cleaned and disinfected prior to loading of the consignment for dispatch to the Union with a disinfectant authorised by the competent authority of the third country or territory of origin;

(3) (11) [II.2.12.

(3) either

[have not been vaccinated against infection with Newcastle disease virus and have tested (7) negative to serological tests to detect antibodies against Newcastle disease virus, performed on blood samples at a level which gives 95% confidence of detecting infection at 5% prevalence and which were taken during at least 14 days prior to the date of loading of the consignment for dispatch to the Union.]]

(3) or

[have been vaccinated against infection with Newcastle disease virus but not with a live vaccine during the last 30 days prior to the date of loading of the consignment for dispatch to the Union and tested negative to a virus isolation test (7) for infection with Newcastle disease virus, performed on a random sample of cloacal swabs or faeces samples taken from at least 60 birds within the last 14 days prior to the date of loading of the consignment for dispatch to the Union.]]

Notes:

This animal health/official certificate is intended for the entry into the Union of poultry intended for slaughter other than ratites, including when the Union is not the final destination of those animals.

Part I:

Box reference I.8	:	Provide the code of the zone as it appears in column 2 of the table in Part 1, Section B, of Annex V to Commission Implementing Regulation (EU) 2021/404.
Box reference I.27	:	“CN code”: Indicate the appropriate Harmonised System (HS) code(s) of the World Customs Organisation under the following headings: 0105 or 0106 39 .

Part II:

(1)	“Poultry intended for slaughter” means poultry to be transported directly to a slaughterhouse, as defined in Article 2 of Delegated Regulation (EU) 2020/692.

(2)	Code of the zone as it appears in column 2 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

(3)	Delete if not applicable.

(4)	Only for the zones with the entry “N” in column 4 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

(5)

This applies only to the zones in which vaccination against highly pathogenic avian influenza is carried out in accordance with a vaccination programme that complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692, and which are listed in the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 with an entry “A” in column 5 of that table.

(6)

(7)

(8)	To be completed when the birds were vaccinated against infection with Newcastle disease virus.

(9)	The clinical inspection shall have been carried out by an official veterinarian of the third country or territory of origin.

(10)	The date of loading shall not be prior to the date of authorisation of the zone referred to in point II.2.1 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of that poultry from that zone.

(11)	This guarantee is required only for consignments intended for a Member State which has been granted the status free from infection with Newcastle disease virus without vaccination in accordance with Article 66 of Delegated Regulation (EU) 2020/689.

(12)	This guarantee applies only to the poultry belonging to the species of Gallus gallus and turkeys.

(13)	If any of the results were positive for the following serotypes during the life of the flock, indicate as positive: Salmonella Enteritidis and Salmonella Typhimurium.

(14)	Complete if appropriate: indicate the name and active substance of antimicrobials used.

(15)	Delete if consignment is not intended for Finland or Sweden.

(16)	Applicable to consignments entering the Union as from 3 September 2026.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 30

MODEL ANIMAL HEALTH/OFFICIAL CERTIFICATE FOR THE ENTRY INTO THE UNION OF RATITES INTENDED FOR SLAUGHTER (MODEL “SR”)

Part I: Description of consignment

COUNTRY

Animal health/official certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No	Seal No
I.20	Certified as or for

	☐ Slaughter

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

Total net weight/gross weight (kg)

I.27	Description of consignment
CN code	Species	Quantity

Part II: Certification

COUNTRY

Certificate model SR

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

(3) [II.1.

Public health attestation (Delete when the Union is not the final destination of the animals)

I, the undersigned official veterinarian, hereby certify, that the ratites intended for slaughter (1) of the consignment described in Part I:

II.1.1.

have not received:

(a)	any stilbene or thyrostatic substances;

(b)	oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other than therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC);

II.1.2.

fulfil the guarantees provided by the control plan submitted in accordance with Article 6(2) of Commission Delegated Regulation (EU) 2022/2292, and the third country or region thereof of their origin is listed in Annex –I to Commission Implementing Regulation (EU) 2021/405, and marked with an “X” for the category “farmed game”.]

(3) (13) [II.1.a.

Attestation as regards Commission Delegated Regulation (EU) 2023/905 (Delete when the Union is not the final destination of the animals)

II.2.

Animal health attestation

I, the undersigned official veterinarian, hereby certify, that the ratites intended for slaughter (1) of the consignment described in Part I:

II.2.1.

come from the zone with code __-__ (2) which, at the date of issue of this animal health /official certificate:

(a)	is authorised and listed in Part 1, Section B, of Annex V to Commission Implementing Regulation (EU) 2021/404 for the entry into the Union of ratites intended for slaughter;

(b)	carries out a disease surveillance programme for highly pathogenic avian influenza in accordance with Article 37, point (a), of Commission Delegated Regulation (EU) 2020/692;

(c)	is considered free from highly pathogenic avian influenza in accordance with Article 38 of Delegated Regulation (EU) 2020/692;

II.2.2.

come from the zone referred to in point II.2.1, which at the date of issue of this animal health /official certificate

(3) either

[is considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692;]

(3) (4) or

(3) (5) or

[is not considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692; and the birds;

(a)	have been placed under official surveillance for at least 21 days prior to the date of loading of the consignment for dispatch to the Union;

(b)	have been kept in complete isolation during the period referred to in point (a), away from direct or indirect contact with other birds, in facilities approved by the competent authority of the country or territory of origin for this purpose;

(c)

have undergone a virus detection test (6) for infection with Newcastle disease virus:

(i)	which was carried out within 7 to 10 days from the date on which the birds were placed under official surveillance referred to in point (a) on cloacal swabs or faeces samples collected from each bird;

(ii)	in which no avian paramyxovirus type 1 isolates with an Intracerebral Pathogenicity Index (ICPI) of more than 0,4 have been found;

(iii)

with favourable results being available for all birds of the consignment prior to the date on which they left the facilities referred to in point (b) for dispatch to the Union;

(d)	come from flocks in which surveillance for infection with Newcastle disease virus was carried out under a statistically based sampling plan which produced negative results for at least 6 months immediately prior to the date of loading of the consignment for dispatch to the Union;]

II.2.3.

come from the zone referred to in point II.2.1, in which:

(3) either

[(a)	vaccination against highly pathogenic avian influenza is not carried out;]

(3) (7) or

[(a)	vaccination against highly pathogenic avian influenza is carried out in accordance with a vaccination programme that complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692;]

(3) either

[(b)	vaccination against infection with Newcastle disease virus with vaccines which do not comply with both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692 is prohibited;]

(3) (8) or

[(b)

vaccination against infection with Newcastle disease virus with vaccines which comply only with the general criteria of Annex XV to Delegated Regulation (EU) 2020/692 is not prohibited and the birds:

(i)	have not been vaccinated with such vaccines for at least 12 months prior to the date of loading of the consignment for dispatch to the Union;

(ii)

come from a flock or flocks which underwent a virus isolation test (6) for infection with Newcastle disease virus not earlier than 2 weeks prior to the date of loading of the consignment for dispatch to the Union, carried out on a random sample of cloacal swabs taken from at least 60 birds in each flock and in which no avian paramyxoviruses with an ICPI of more than 0,4 were found;

(iii)

were kept in isolation under official surveillance on the establishment of origin during the last 2 weeks referred to in point (ii);

(iv)	during the last 60 days prior to the date of loading of the consignment for dispatch to the Union, were not in contact with poultry which do not fulfil the conditions referred to in points (i) and (ii);]

II.2.4.

have remained in the zone referred to in point II.2.1 for a continuous period of at least 6 weeks immediately prior to the date of loading for dispatch to the Union or since the date of hatching where they are less than 6 weeks of age, and where they were introduced into the zone referred to in point II.2.1, that introduction took place under animal health requirements at least as stringent as those for the entry into the Union of ratites intended for slaughter laid down in Regulation (EU) 2016/429 of the European Parliament and of the Council and Delegated Regulation (EU) 2020/692, and from a third country or territory, or zone thereof listed in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 or a Member State;

II.2.5.

come from the establishment, indicated in box I.11:

(a)	which is registered by and is under the control of the competent authority of the third country or territory of origin and has a system in place to maintain and to keep records in accordance with Article 8 of Delegated Regulation (EU) 2020/692;

(b)

(c)	which was not subject to national restriction measures for animal health reasons, including for the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the date of loading of the consignment for dispatch to the Union;

(d)

(e)	in which no confirmed case of infection with low pathogenic avian influenza viruses has been reported for at least 21 days prior to the date of loading of the consignment for dispatch to the Union;

II.2.6.

come from a flock which:

(a)	has not been vaccinated against highly pathogenic avian influenza;

(3) either

[(b)	has not been vaccinated against infection with Newcastle disease virus in the last 12 months prior to the date of loading of the consignment for dispatch to the Union;]

(3) or

[(b)

(9)

Identification of the flock	Age of the birds	Date of vaccination	Name and type of virus strain used	Batch number of the vaccine	Name of the vaccine	Manufacturer of the vaccine

]

(c)

has been subjected to a clinical inspection (10) within the last 24 hours prior to the time of loading of the consignment for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.2.7.

II.2.8.

had no contact with other birds of a lower health status since the date of hatching or for a continuous period of at least 30 days immediately prior to the date of loading of the consignment for dispatch to the Union;

II.2.9

II.2.10.

have been subjected to a clinical inspection (10) on ___/___/____ (dd/mm/yyyy), within the last 24 hours prior to the time of loading of the consignment for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.2.11.

are loaded for dispatch to the Union in the containers which:

(a)

are constructed in such a way that:

(i)	the birds cannot escape or fall out;

(ii)	visual inspection of the space where birds are kept is possible;

(iii)

the escape of bird excrements, litter, feed or feathers is prevented or minimized;

(b)	contain only poultry of the same species and category coming from the same establishment;

(c)

are

(3) either

[unused and purpose-designed disposable containers to be destroyed after first use;]

(3) or

[cleaned and disinfected and dried or allowed to dry prior to loading of the consignment for dispatch to the Union;]

(d)	are closed in accordance with the instructions of the competent authority of the third country or territory of origin to avoid any possibility of substitution of the content;

(e)	bear the information set out in Point 2 of Annex XVI to Delegated Regulation (EU) 2020/692 relevant for poultry intended for slaughter;

II.2.12.

are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy) (11) in a means of transport which is constructed in accordance with point II.2.11(a) and was cleaned and disinfected prior to loading of the consignment for dispatch to the Union with a disinfectant authorised by the competent authority of the third country or territory of origin;

(3) (12) [II.2.13.

(3) either

[have not been vaccinated against infection with Newcastle disease virus and have tested (6) negative to serological tests to detect antibodies against Newcastle disease virus, performed on blood samples at a level which gives 95% confidence of detecting infection at 5% prevalence and which were taken during at least 14 days prior to the date of loading of the consignment for dispatch to the Union.]]

(3) or

[have been vaccinated against infection with Newcastle disease virus but not with a live vaccine during the last 30 days prior to the date of loading of the consignment for dispatch to the Union and tested negative to a virus isolation test (6) for infection with Newcastle disease virus, performed on a random sample of cloacal swabs or faeces samples taken from at least 60 birds within the last 14 days prior to the date of loading of the consignment for dispatch to the Union.]]

Notes:

This animal health/official certificate is intended for the entry into the Union of ratites intended for slaughter, including when the Union is not the final destination of those animals.

Part I:

Box reference I.8	:	Provide the code of the third country or territory, or zone thereof as it appears in column 2 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.
Box reference I.27	:	“CN code”: Indicate the appropriate Harmonised System (HS) code(s) of the World Customs Organisation under the following heading: 0106 39 .

Part II:

(1)	“Ratites intended for slaughter” means ratites to be transported directly to a slaughterhouse, as defined in Article 2 of Delegated Regulation (EU) 2020/692.

(2)	Code of the zone as it appears in column 2 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

(3)	Delete if not applicable.

(4)	Only for the zones with the entry “N” in column 4 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

(5)

(6)

(7)

This applies only to the zones in which vaccination against highly pathogenic avian influenza is carried out in accordance with a vaccination programme that complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692, and which are listed in the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 with an entry “A” in column 5 of that table.

(8)

This guarantee is required only for the ratites coming from the zones in which the use of vaccines against infection with Newcastle disease virus which comply only with the general criteria of Annex XV to Delegated Regulation (EU) 2020/692 is not prohibited, in accordance with Article 37, point (e)(ii), thereof, and which are listed in the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 with an entry “B” in column 5 of that table.

(9)	To be completed when the birds were vaccinated against infection with Newcastle disease virus.

(10)	The clinical inspection shall have been carried out by an official veterinarian of the third country or territory of origin.

(11)	The date of loading shall not be prior to the date of authorisation of the zone referred to in point II.2.1 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of those ratites from that zone.

(12)	This guarantee is required only for consignments intended for a Member State or zone thereof which has been granted the status free from infection with Newcastle disease virus without vaccination in accordance with Article 66 of Commission Delegated Regulation (EU) 2020/689.

(13)	Applicable to consignments entering the Union as from 3 September 2026.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 31

MODEL ANIMAL HEALTH/OFFICIAL CERTIFICATE FOR THE ENTRY INTO THE UNION OF LESS THAN 20 HEADS OF POULTRY OTHER THAN RATITES (MODEL “POU-LT20”)

Part I: Description of consignment

COUNTRY

Animal health/official certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No	Seal No
I.20	Certified as or for
	☐ Further keeping
	☐ Slaughter

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

Total net weight/gross weight (kg)

I.27	Description of consignment
CN code	Species	Subspecies/Category	Quantity

Part II: Certification

COUNTRY

Certificate model POU-LT20

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

(2) [II.1.

Public health attestation (Delete when the Union is not the final destination of the animals)

I, the undersigned official veterinarian, hereby certify, the following as regards the [breeding poultry (1), other than ratites] (2) [productive poultry (3), other than ratites] (2) [poultry intended for slaughter (4), other than ratites] (2) [day-old chicks (5), other than ratites] (2) of the consignment described in Part I

II.1.1.

They have not received:

(a)	any stilbene or thyrostatic substances,

(b)	oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other than therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC).

II.1.2.

They fulfil the guarantees provided by the control plan submitted in accordance with Article 6(2) of Commission Delegated Regulation (EU) 2022/2292, and the third country or region thereof of their origin is listed in Annex –I to Commission Implementing Regulation (EU) 2021/405 , and marked with an “X” for the category “poultry”.]

(2) (17) [II.1.3.

The Salmonella control programme referred to in Article 10 of Regulation (EC) No 2160/2003 and the specific requirements for the use of antimicrobials and vaccines in Commission Regulation (EC) No 1177/2006, have been applied to the flock of origin and that flock has been tested for Salmonella serotypes of public health significance:

Identification of the flock	Age of the birds	Date of last sampling of the flock from which the testing result is known [dd/mm/yyyy]	Result of all testing in the flock (18)
			positive	negative

For reasons other than the Salmonella control programme, within the last 3 weeks prior to the date of loading for dispatch to the Union

(2) either

[antimicrobials were not administered to the breeding and productive poultry other than ratites.]]]

(2) (19) or

[the following antimicrobials were administered to the breeding and productive poultry other than ratites: … .]]]

(2) (17) [II.1.4.

If breeding poultry, neither Salmonella Enteritidis nor Salmonella Typhimurium were detected within the control programme referred to in point II.1.3.]]

(2) (20) [II.1.5.

If the Member State of destination is Finland or Sweden

(2) either

[the breeding poultry has tested negative for Salmonella in accordance with the rules laid down in Commission Decision 2003/644/EC.]]]

(2) or

[the laying hens (productive poultry reared in view to producing eggs for consumption) have tested negative in accordance with the rules laid down in Commission Decision 2004/235/EC.]]]

(2) (21) [II.1.a.

Attestation as regards Commission Delegated Regulation (EU) 2023/905 (Delete when the Union is not the final destination of the animals)

II.2.

Animal health attestation

I, the undersigned official veterinarian, hereby certify, that the [breeding poultry (1), other than ratites] (2) [productive poultry (3), other than ratites] (2) [poultry intended for slaughter (4), other than ratites] (2) [day-old chicks (5), other than ratites] (2) of the consignment described in Part I:

II.2.1.

form a single consignment of less than 20 heads of poultry;

II.2.2.

come from the zone with code __-__ (6) which, at the date of issue of this animal health/official certificate:

(a)	is authorised and listed in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2021/404 for the entry into the Union of less than 20 heads of poultry other than ratites;

(b)	carries out a disease surveillance programme for highly pathogenic avian influenza in accordance with Article 37, point (a), of Commission Delegated Regulation (EU) 2020/692;

(c)	is considered free from highly pathogenic avian influenza in accordance with Article 38 of Delegated Regulation (EU) 2020/692;

(2) either

[(d)	is considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692;]

(2) (7) or

[(d)	is not considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692, and they originate from establishment(s) located in an area within that zone not placed under official restrictions due to an outbreak of that disease;]

II.2.3.

come from the zone referred to in point II.2.2, in which

(2) either

[vaccination against highly pathogenic avian influenza is not carried out;]

(2) (8) or

[vaccination against highly pathogenic avian influenza is carried out in accordance with a vaccination programme that complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692;]

(2) either

[II.2.4.

the [breeding poultry, other than ratites] (2) [productive poultry, other than ratites] (2) [poultry intended for slaughter, other than ratites] (2):

II.2.4.1.

come from the zone referred to in point II.2.2, in which

(2) either

[vaccination against infection with Newcastle disease virus with vaccines which do not comply with both the general and specific criteria of Annex XV to Commission Delegated Regulation (EU) 2020/692 is prohibited;]

(2) (9) or

[vaccination against infection with Newcastle disease virus with vaccines which comply only with the general criteria of Annex XV to Delegated Regulation (EU) 2020/692 is not prohibited, and the birds:

(a)	have not been vaccinated with such vaccines for at least 12 months prior to the date of loading of the consignment for dispatch to the Union;

(b)

(c)	were kept in isolation under official surveillance on the establishment of origin during the last 2 weeks referred to in point (b);

(d)	during the last 60 days prior to the date of loading of the consignment for dispatch to the Union, were not in contact with poultry which do not fulfil the conditions referred to in points (a) and (b);]

II.2.4.2.

have remained:

(a)

in the zone referred to in point II.2.2 for a continuous period of at least 3 months immediately prior to the date of loading of the consignment for dispatch to the Union or since the date of hatching where they are less than 3 months of age; and where they were introduced into the zone referred to in point II.2.2, that introduction took place under animal health requirements at least as stringent as those for the entry into the Union of less than 20 heads of poultry other than ratites laid down in Regulation (EU) 2016/429 of the European Parliament and of the Council and Delegated Regulation (EU) 2020/692, and from a third country or territory, or zone thereof listed in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 or a Member State;

(b)	in the establishment indicated in box I.11 for a continuous period of at least 3 weeks immediately prior to the date of loading of the consignment for dispatch to the Union or since the date of hatching where they are less than 3 weeks of age;

(c)	without contact with other birds of a lower health status for a continuous period of at least 3 weeks immediately prior to the date of loading of the consignment for dispatch to the Union or since the date of hatching where they are less than 3 weeks of age;

II.2.4.3.

come from the establishment, indicated in box I.11:

(a)	which is registered by and is under the control of the competent authority of the third country or territory of origin and has a system in place to maintain and to keep records in accordance with Article 8 of Delegated Regulation (EU) 2020/692;

(b)

(c)	which was not subject to national restriction measures for animal health reasons, including for the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, on the date of loading of the consignment for dispatch to the Union;

(d)

(e)	in which no confirmed case of infection with low pathogenic avian influenza viruses has been reported for at least 21 days prior to the date of loading of the consignment for dispatch to the Union;

II.2.4.4.

come from a flock which:

(a)	has not been vaccinated against highly pathogenic avian influenza;

(2) either

[(b)	has not been vaccinated against infection with Newcastle disease virus in the last 12 months prior to the date of loading of the consignment for dispatch to the Union;]

(2) or

[(b)

(10)

Identification of the flock	Age of the birds	Date of vaccination	Name and type of virus strain used	Batch number of the vaccine	Name of the vaccine	Manufacturer of the vaccine

(c)

II.2.4.5.

the birds:

(a)	have not been vaccinated against highly pathogenic avian influenza;

(b)	are not to be killed under a national programme for the eradication of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

(c)

have been subjected to a clinical inspection (11) on ___/___/____ (dd/mm/yyyy) within the last 24 hours prior to the time of loading of the consignment for dispatch to the Union, and show no signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

(d)	tested negative in serological and/or bacteriological tests (12) within the last 30 days prior to the date of loading of the consignment for dispatch to the Union and were found not to be infected or showed any grounds for suspecting any infection, by the following agents

(2) either

[Salmonella Pullorum, Salmonella Gallinarum and Mycoplasma gallisepticum (in case of Gallus gallus);]

(2) or

[Salmonella arizonae (serogroup O:18(k)), Salmonella Pullorum and Salmonella Gallinarum, Mycoplasma meleagridis and Mycoplasma gallisepticum (in case of Meleagris gallopavo);]

(2) or

[Salmonella Pullorum and Salmonella Gallinarum (in case of Numida meleagris, Coturnix coturnix, Phasianus colchicus, Perdix perdix and Anas spp);]

II.2.4.6.

are loaded for dispatch to the Union in the containers which:

(a)

are constructed in such a way that:

(i)	the birds cannot escape or fall out;

(ii)	visual inspection of the space where birds are kept is possible;

(iii)

the escape of bird excrements, litter, feed or feathers is prevented or minimized;

(b)	contain only birds of the same species and category coming from the same establishment;

(c)

are

(2) either

[unused and purpose-designed disposable containers to be destroyed after first use;]

(2) or

[cleaned and disinfected and dried or allowed to dry prior to loading of the consignment for dispatch to the Union;]

(d)	are closed in accordance with the instructions of the competent authority of the third country or territory of origin to avoid any possibility of substitution of the content;

(e)	bear the information set out in Annex XVI to Delegated Regulation (EU) 2020/692 relevant for [breeding poultry and productive poultry] (2) [poultry intended for slaughter] (2);

II.2.4.7.

are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy) (13) in a means of transport which is constructed in accordance with point II.2.4.6(a) and was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority of the third country or territory of origin;

(2) (14) [II.2.4.8.

(2) (15) either

[and:

(a)	have not been vaccinated against infection with Newcastle disease virus;

(b)

(i)	no bird was vaccinated against infection with Newcastle disease virus during at least 21 days prior to the date of loading of the consignment for dispatch to the Union;

(ii)	no other birds have entered into the establishment during that period;

(iii)

no vaccination has been carried out;

(c)

(2) (16) or

[and

(2) either

[have not been vaccinated against infection with Newcastle disease virus and have tested (12) negative to serological tests to detect antibodies against Newcastle disease virus, performed on blood samples at a level which gives 95% confidence of detecting infection at 5% prevalence and which were taken during at least 14 days prior to the date of loading of the consignment for dispatch to the Union.]]]

(2) or

[have been vaccinated against infection with Newcastle disease virus but not with a live vaccine during the last 30 days prior to the date of loading of the consignment for dispatch to the Union and tested negative to a virus isolation test (12) for infection with Newcastle disease virus, performed on a random sample of cloacal swabs or faeces samples taken from at least 60 birds within the last 14 days prior to the date of loading of the consignment for dispatch to the Union.]]]

(2) or

[II.2.4.

the day-old chicks other than ratites:

II.2.4.1.

come from the zone referred to in point II.2.2, in which

(2) either

[vaccination against infection with Newcastle disease virus with vaccines which do not comply with both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692 is prohibited;]

(2) (9) or

(a)	have not been vaccinated with such vaccines;

(b)

come from the flocks which:

(i)	have not been vaccinated with such vaccines for at least 12 months prior to the date of loading of the consignment for dispatch to the Union;

(ii)

underwent a virus isolation test (12) for infection with Newcastle disease virus carried out on a random sample of cloacal swabs taken from at least 60 birds in each flock, not earlier than 2 weeks prior to the date of loading of the consignment for dispatch to the Union, and in which no avian paramyxoviruses with an ICPI of more than 0,4 were found;

(iii)

were kept in isolation under official surveillance on the establishment of origin during the last 2 weeks prior to the date of loading of the consignment for dispatch to the Union;

(iv)	during the last 60 days prior to the date of loading of the consignment for dispatch to the Union, were not in contact with poultry which do not fulfil the conditions referred to in points (i) and (ii);

(c)	come from hatching eggs which have not been in contact in the hatchery or during transport thereto with poultry or hatching eggs not meeting the requirements referred to in point (b);]

II.2.4.2.

have remained:

(a)	in the zone referred to in point II.2.2 since the date of hatching;

(b)	in the establishment indicated in box I.11 since the date of hatching;

(c)	without contact with birds of a lower health status since the date of hatching;

II.2.4.3.

come from the establishment, indicated in box I.11:

(a)	which is registered by and is under the control of the competent authority of the country or territory of origin and has a system in place to maintain and to keep records in accordance with Article 8 of Delegated Regulation (EU) 2020/692;

(b)

(c)	which was not subject to national restriction measures for animal health reasons, including for the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, on the date of loading of the consignment for dispatch to the Union;

(d)

(e)	in which no confirmed case of infection with low pathogenic avian influenza viruses has been reported for at least 21 days prior to the date of loading of the consignment for dispatch to the Union;

II.2.4.4.

come from a flock which:

(a)

has remained in the zone referred to in point II.2.2 for a continuous period of at least 3 months immediately prior to the date of loading of the consignment for dispatch to the Union; and where the flock was introduced into the zone referred to in point II.2.2, that introduction took place under animal health requirements at least as stringent as those for the entry into the Union of breeding poultry other than ratites and productive poultry other than ratites laid down in Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692, and from a third country or territory, or zone thereof listed in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 or a Member State;

(b)

has remained for a continuous period of at least 3 weeks immediately prior to the date of loading of the consignment for dispatch to the Union in an establishment:

(i)	which is registered by and is under the control of the competent authority of the third country or territory of origin and has a system in place to maintain and to keep record, in accordance with Article 8 of Commission Delegated Regulation (EU) 2020/692;

(ii)

(iii)

which was not subject to national restriction measures for animal health reasons, including for the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, on the date of dispatch of the consignment to the Union;

(iv)	in which no confirmed case of infection with low pathogenic avian influenza viruses has been reported for at least 21 days prior to the date of collection of the hatching eggs, from which the day-old chicks have hatched;

(v)

(2) either

[(c)	has not been vaccinated against highly pathogenic avian influenza;]

(2) (8) or

[(c)	has been vaccinated against highly pathogenic avian influenza in accordance with a vaccination programme which complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692;]

(2) either

[(d)	has not been vaccinated against infection with Newcastle disease virus within the last 12 months prior to the date of loading of the consignment for dispatch to the Union;]

(2) or

[(d)

(10)

Identification of the flock	Age of the birds	Date of vaccination	Name and type of virus strain used	Batch number of the vaccine	Name of the vaccine	Manufacturer of the vaccine

(e)

underwent serological and/or bacteriological tests (12) within the last 90 days prior to the date of loading of the consignment for dispatch to the Union at a level which gives 95% confidence of detecting infection at 5% prevalence and was found not to be infected or showed any grounds for suspecting any infection, by the following agents

(2) either

[Salmonella Pullorum, Salmonella Gallinarum and Mycoplasma gallisepticum (in case of Gallus gallus);]

(2) or

[Salmonella arizonae (serogroup O:18(k)), Salmonella Pullorum and Salmonella Gallinarum, Mycoplasma meleagridis and Mycoplasma gallisepticum (in case of Meleagris gallopavo);]

(2) or

[Salmonella Pullorum and Salmonella Gallinarum (in case of Numida meleagris, Coturnix coturnix, Phasianus colchicus, Perdix perdix and Anas spp);]

(f)	had no contact with other birds of a lower health status for a continuous period of at least 3 weeks immediately prior to the date of collection of the hatching eggs from which the day-old chicks have hatched;

(g)

II.2.4.5.

have not been vaccinated against highly pathogenic avian influenza;

II.2.4.6.

II.2.4.7.

II.2.4.8.

come from hatching eggs which prior to the date of incubation, have been disinfected in accordance with the instructions of the competent authority of the third country or territory of origin;

II.2.4.9.

are loaded for dispatch to the Union in the containers which:

(a)

are constructed in such a way that:

(i)	the birds cannot escape or fall out;

(ii)	visual inspection of the space where birds are kept is possible;

(iii)

the escape of bird excrements, litter, feed or feathers is prevented or minimized;

(b)	contain only poultry of the same species and category coming from the same establishment;

(c)	are unused and purpose-designed disposable containers to be destroyed after first use;

(d)	are closed in accordance with the instructions of the competent authority of the third country or territory of origin to avoid any possibility of substitution of the content;

(e)	bear the information set out in Point 3 of Annex XVI to Delegated Regulation (EU) 2020/692 relevant for day-old chicks;

II.2.4.10.

are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy) (13) in a means of transport which is constructed in accordance with point II.2.4.9(a) and was cleaned and disinfected prior to loading of the consignment for dispatch to the Union with a disinfectant authorised by the competent authority of the third country or territory of origin;]

(2) (14) [II.2.4.11.

are intended for a Member State which has been granted the status free from infection with Newcastle disease virus without vaccination in accordance with Artic 66 of Commission Delegated Regulation (EU) 2020/689, and:

(a)	have not been vaccinated against infection with Newcastle disease virus;

(b)

come from hatching eggs coming from flocks which

(2) either

[have not been vaccinated against infection with Newcastle disease virus;]

(2) or

[have been vaccinated against infection with Newcastle disease virus with an inactivated vaccine;]

(2) or

[have been vaccinated against infection with Newcastle disease virus with a live vaccine at the latest 60 days prior to the date of collection of the hatching eggs;]

(c)	come from a hatchery where working practices ensure that the hatching eggs from which the day-old chicks have hatched, were incubated at completely separate times and locations from eggs not satisfying the requirements referred to in point (b).]

Notes:

This animal health/official certificate is intended for the entry into the Union of less than 20 heads of poultry other than ratites, including when the Union is not the final destination of those animals.

Part I:

Box reference I.8

Provide the code of the zone as it appears in column 2 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

Box reference I.27

Description of consignment:

“CN code”: Indicate the appropriate Harmonised System (HS) code(s) of the World Customs Organisation under the following headings: 0105 or 0106 39 .

Part II:

(1)	“Breeding poultry” means poultry 72 hours old or more, intended for the production of hatching eggs, as defined in Article 2 of Delegated Regulation (EU) 2020/692.

(2)	Delete if not applicable.

(3)	“Productive poultry” means poultry 72 hours old or more, reared for the production of meat, eggs for consumption or other products or for restocking supplies of game birds, as defined in Article 2 of Delegated Regulation (EU) 2020/692.

(4)	“Poultry intended for slaughter” means poultry to be transported directly to a slaughterhouse, as defined in Article 2 of Delegated Regulation (EU) 2020/692.

(5)	“Day-old chicks” means poultry less than 72 hours old, as defined in Article 2 of Delegated Regulation (EU) 2020/692.

(6)	Code of the zone as it appears in column 2 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

(7)	Only for the zones with the entry “N” in column 4 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

(8)

This applies only to the zones in which vaccination against highly pathogenic avian influenza is carried out in accordance with a vaccination programme that complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692, and which are listed in the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 with an entry “A” in column 5 of that table.

(9)

(10)	To be completed when the birds were vaccinated against infection with Newcastle disease virus.

(11)	The clinical inspection shall have been carried out by an official veterinarian of the third country or territory of origin.

(12)

(13)	The date of loading shall not be prior to the date of authorisation of the zone referred to in point II.2.2 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of that poultry from that zone.

(14)	This guarantee is required only for consignments intended for a Member State or zone thereof which has been granted the status free from infection with Newcastle disease virus without vaccination in accordance with Article 66 of Delegated Regulation (EU) 2020/689.

(15)	Applicable for breeding poultry and productive poultry.

(16)	Applicable for poultry intended for slaughter.

(17)	This guarantee applies only for the poultry belonging to the species of Gallus gallus and turkeys.

(18)

If any of the results were positive for the serotypes below during the life of the flock, indicate as positive:

(a)	flocks of breeding poultry: Salmonella Hadar, Salmonella Virchow and Salmonella Infantis;

(b)	flocks of productive poultry: Salmonella Enteritidis and Salmonella Typhimurium.

(19)	Complete if appropriate: indicate the name and active substance of antimicrobials used.

(20)	Delete if consignment is not intended for Finland or Sweden.

(21)	Applicable to consignments entering the Union as from 3 September 2026.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 32

MODEL ANIMAL HEALTH/OFFICIAL CERTIFICATE FOR THE ENTRY INTO THE UNION OF LESS THAN 20 HATCHING EGGS OF POULTRY OTHER THAN RATITES (MODEL “HE-LT20”)

Part I: Description of consignment

COUNTRY

Animal health/official certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

Total net weight/gross weight (kg)

I.27	Description of consignment
CN code	Species	Subspecies/Breed/Category	Identification system	Identification number	Quantity

Part II: Certification

COUNTRY

Certificate model HE-LT20

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

(3) [II.1.

Public health attestation (Delete when the Union is not the final destination of the hatching eggs)

I, the undersigned official veterinarian, hereby certify, the following as regards the hatching eggs (1) of poultry other than ratites of the consignment described in Part I:

(3) (13) [II.1.1.

Identification of the flock	Age of the birds	Date of last sampling of the flock from which the testing result is known[dd/mm/yyyy]	Result of all testing in the flock( 14)
			Positive	Negative

]]

(3) (13) [II.1.2.

Neither Salmonella Enteritidis nor Salmonella Typhimurium were detected within the control programme referred to in point II.1.1.]]

(3) (15) [II.1.3.

II.2.

Animal health attestation

I, the undersigned official veterinarian, hereby certify, that the hatching eggs (1) of poultry other than ratites described in Part I:

II.2.1.

form a single consignment of less than 20 hatching eggs;

II.2.2.

come from the zone with code __-__ (2) which, at the date of issue of this animal health/official certificate:

(a)	is authorised and listed in Part 1, Section B, of Annex V to Commission Implementing Regulation (EU) 2021/404 for the entry into the Union of less than 20 hatching eggs of poultry other than ratites;

(b)	carries out a disease surveillance programme for highly pathogenic avian influenza in accordance with Article 105, point (a), of Commission Delegated Regulation (EU) 2020/692;

(c)	is considered free from highly pathogenic avian influenza in accordance with Article 38 of Delegated Regulation (EU) 2020/692;

(3) either

[(d)	is considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692;]

(3) (4) or

[(d)	is not considered free from infection with Newcastle disease virus in accordance with Article 39 of Delegated Regulation (EU) 2020/692, and they originate from establishment(s) located in an area within that zone not placed under official restrictions due to an outbreak of that disease;]

II.2.3.

come from the zone referred to in point II.2.2, in which:

(3) either

[(a)	vaccination against highly pathogenic avian influenza is not carried out;]

(3) (5) or

[(a)	vaccination against highly pathogenic avian influenza is carried out in accordance with a vaccination programme that complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692;]

(3) either

[(b)	vaccination against infection with Newcastle disease virus with vaccines which do not comply with both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692 is prohibited;]

(3) (6) or

[(b)

(i)

come from flocks which:

(1)	have not been vaccinated with such vaccines for at least 12 months prior to the date of loading of the consignment for dispatch to the Union;

(2)

(3)	were kept in isolation under official surveillance on the establishment of origin during the last 2 weeks prior to the date of loading of the consignment for dispatch to the Union;

(4)	during the last 60 days prior to the date of loading of the consignment for dispatch to the Union, were not in contact with poultry which do not fulfil the conditions referred to in points (1) and (2);

(ii)	have not been in contact in the hatchery or during transport thereto with poultry or hatching eggs not meeting the requirements referred to in point (i);]

II.2.4.

come from the establishment, indicated in box I.11:

(a)	which is registered by and is under the control of the competent authority of the third country or territory of origin and has a system in place to maintain and to keep records in accordance with Article 8 of Delegated Regulation (EU) 2020/692;

(b)

(c)	which was not subject to national restriction measures for animal health reasons, including for the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, on the date of loading of the consignment for dispatch to the Union;

(d)

II.2.5.

come from a flock which:

(a)

has remained in zone referred to in point II.2.2 for a continuous period of at least 3 months immediately prior to the date of loading of the consignment for dispatch to the Union and where the flock was introduced into the zone referred to in point II.2.2 , that introduction took place under animal health requirements at least as stringent as those for the entry into the Union of breeding poultry other than ratites and productive poultry other than ratites laid down in Regulation (EU) 2016/429 of the European Parliament and of the Council and Delegated Regulation (EU) 2020/692, and from a third country or territory, or zone thereof listed in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 or a Member State;

(b)

has been kept for a continuous period of at least 3 weeks immediately prior to the date of loading of the consignment for dispatch to the Union in an establishment:

(i)	in which no confirmed case of infection with low pathogenic avian influenza viruses has been reported for at least 21 days prior to the date of collection of the hatching eggs;

(3) (8) [(ii)

which is registered by and is under the control of the competent authority of the third country or territory of origin and has a system in place to maintain and to keep records in accordance with Article 8 of Delegated Regulation (EU) 2020/692;

(iii)

(iv)

which was not subject to national restriction measures for animal health reasons, including for the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, on the date of loading of the consignment for dispatch to the Union;

(v)

(3) either

[(c)	has not been vaccinated against highly pathogenic avian influenza;]

(3) (5) or

[(c)	has been vaccinated against highly pathogenic avian influenza in accordance with a vaccination programme which complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692;]

(3) either

[(d)	has not been vaccinated against infection with Newcastle disease virus within the last 12 months prior to the date of loading of the consignment for dispatch to the Union;]

(3) or

[(d)

(9)

Identification of the flock	Age of the birds	Date of vaccination	Name and type of virus strain used	Batch number of the vaccine	Name of the vaccine	Manufacturer of the vaccine

]

(e)

underwent serological and/or bacteriological tests (7) within the last 90 days prior to the date of loading of the consignment for dispatch to the Union at a level which gives 95% confidence of detecting infection at 5% prevalence and was found not to be infected or showed any grounds for suspecting any infection, by the following agents

(3) either

[Salmonella Pullorum, Salmonella Gallinarum and Mycoplasma gallisepticum (in case of Gallus gallus);]

(3) or

[Salmonella arizonae (serogroup O:18(k)), Salmonella Pullorum and Salmonella Gallinarum, Mycoplasma meleagridis and Mycoplasma gallisepticum (in case of Meleagris gallopavo);]

(3) or

[Salmonella Pullorum and Salmonella Gallinarum (in case of Numida meleagris, Coturnix coturnix, Phasianus colchicus, Perdix perdix and Anas spp);]

(f)	has been isolated on the establishment of origin for at least 21 days prior to the date of collection of the hatching eggs;

(g)	had no contact with poultry or hatching eggs of a lower health status, or with captive or wild birds for a continuous period of at least 3 weeks immediately prior to the date of loading of the consignment for dispatch to the Union;

(h)	did not show symptoms of transmissible diseases on the date of collection of the hatching eggs;

(i)

II.2.6.

were:

(a)	not vaccinated against highly pathogenic avian influenza;

(b)	not vaccinated against infection with Newcastle disease virus;

(c)	disinfected in accordance with the instructions of the competent authority of the third country or territory of origin;

II.2.7.

were collected [on ___/___/____ (dd/mm/yyyy)] (3) [from ___/___/____ (dd/mm/yyyy) to ___/___/____ (dd/mm/yyyy)] (3); (11)

II.2.8.

are loaded for dispatch to the Union in the containers which:

(a)	are constructed in such a way that the hatching eggs cannot fall out;

(b)	are designed to allow cleaning and disinfection;

(c)	contain only hatching eggs of the same species, category and type coming from the same establishment;

(d)	are closed in accordance with the instructions of the competent authority of the third country or territory of origin to avoid any possibility of substitution of the content;

(e)

are

(3) either

[disposable, clean and used for the first time;]

(3) or

(f)	bear the information set out in Point 5 of Annex XVI to Delegated Regulation (EU) 2020/692 relevant for hatching eggs of poultry;

II.2.9.

are loaded for dispatch to the Union in a means of transport which is constructed in accordance with points II.2.8(a) and (b) and was cleaned and disinfected with a disinfectant authorised by the competent authority of the third country or territory of origin and dried or allowed to dry immediately prior to loading of the consignment for dispatch to the Union;

(3) (12) [II.2.10.

(a)	have not been vaccinated against infection with Newcastle disease virus;

(b)	come from flocks which

(3) either

[have not been vaccinated against infection with Newcastle disease virus.]]

(3) or

[have been vaccinated against infection with Newcastle disease virus with an inactivated vaccine.]]

(3) or

[have been vaccinated against infection with Newcastle disease virus with a live vaccine at the latest 60 days prior to the date of collection of the hatching eggs.]]

Notes:

This animal health/official certificate is intended for the entry into the Union less than 20 hatching eggs of poultry other than ratites, including when the Union is not the final destination of those germinal products.

Part I:

Box reference I.8

Provide the code of the zone as it appears in column 2 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

Box referenceI.27

Description of consignment:

“CN code”: Indicate the appropriate Harmonised System (HS) code(s) of the World Customs Organisation under the following heading: 0407 .

“Category”: Select one of the following: Pure line/grandparents/parents/laying pullets/others.

Part II:

(1)	“Hatching eggs” as defined in Article 4 of Regulation (EU) 2016/429.

(2)	Code of the zone as it appears in column 2 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

(3)	Delete if not applicable.

(4)	Only for the zones with the entry “N” in column 4 of the table in Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404.

(5)

This applies only to the zones in which vaccination against highly pathogenic avian influenza is carried out in accordance with a vaccination programme that complies with the requirements set out in Annex XIII to Delegated Regulation (EU) 2020/692, and which are listed in in the table Part 1, Section B, of Annex V to Implementing Regulation (EU) 2021/404 with an entry “A” in column 6 of that table.

(6)

(7)	Tests shall have been carried out on samples taken by or under the control of the competent authority of the third country or territory of origin and testing shall have been carried out in an official laboratory designated in accordance with Article 37 of Regulation (EU) 2017/625.

(8)	Keep in case the hatching eggs are dispatched from a hatchery.

(9)	To be completed when the birds were vaccinated against infection with Newcastle disease virus.

(10)	The clinical inspection shall have been carried out by an official veterinarian of the third country or territory of origin.

(11)	The date(s) of collection shall not be prior to the date of authorisation of the zone referred to in point II.2.2 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of those hatching eggs from that zone.

(12)	This guarantee is required only for the consignments intended for a Member State or zone thereof which has been granted the status free from infection with Newcastle disease virus without vaccination in accordance with Article 66 of Delegated Regulation (EU) 2020/689.

(13)	This guarantee applies only for hatching eggs belonging to the species of Gallus gallus and turkeys.

(14)	If any of the results were positive for the following serotypes during the life of the parent flock, indicate as positive: Salmonella Hadar, Salmonella Virchow and Salmonella Infantis.

(15)	Delete if consignment is not intended for Finland or Sweden.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 33

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CAPTIVE BIRDS, OTHER THAN RACING PIGEONS IMMEDIATELY RELEASED AFTER ENTRY (MODEL “CAPTIVE BIRDS, OTHER THAN RACING PIGEONS”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Quarantine establishment	☐ Confined establishment

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

Total net weight/gross weight (kg)

Part II: Certification

COUNTRY

Certificate model CAPTIVE BIRDS, OTHER THAN RACING PIGEONS

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

II.1.

Animal health attestation

I, the undersigned official veterinarian, hereby certify, that the captive birds (1) of the consignment described in Part I:

II.1.1.

come from the zone with code __-__ (2) which, at the date of issue of this animal health certificate, is authorised and listed in Part 1, Section A, of Annex VI to Commission Implementing Regulation (EU) 2021/404 for the entry into the Union of captive birds;

II.1.2.

come from the establishment (3), indicated in box I.11 approved by the competent authority of the third country or territory of origin in accordance with requirements which are at least as stringent as those laid down in Article 56 of Commission Delegated Regulation (EU) 2020/692, and:

(a)	the approval of which has not been suspended or withdrawn;

(b)	which is under the control of the competent authority of the third country or territory of origin and has a system in place to maintain and to keep record, in accordance with Article 8 of Delegated Regulation (EU) 2020/692;

(c)

(d)	which was not subject to national restriction measures for animal health reasons, including for the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, on the date of loading of the consignment for dispatch to the Union;

(e)

(4) (5) [(f)

in which

(5) either

[avian chlamydiosis has not been confirmed for at least 6 months prior to the date of loading of the consignment for dispatch to the Union;]]

(5) or

[avian chlamydiosis has been confirmed during the last 6 months prior to the date of loading of the consignment for dispatch to the Union, but not during the last 60 days prior to the date of loading of the consignment for dispatch to the Union, and the measures provided for in Article 55, point (e)(i), of Delegated Regulation (EU) 2020/692 have been applied;]]

(5) or

[the animals have been kept under veterinary supervision for the last 45 days prior to the date of loading of the consignment for dispatch to the Union and were treated against avian chlamydiosis;]]

II.1.3.

come from a flock which has been subjected to a clinical inspection (6) within the last 24 hours prior to the time of loading of the consignment for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.1.4.

the birds:

(a)	have remained in the establishment indicated in box I.11 since the date of hatching or for a continuous period of at least 3 weeks immediately prior to the date of loading of the consignment for dispatch to the Union;

(b)	have not been vaccinated against highly pathogenic avian influenza;

(5) either

[(c)	have not been vaccinated against infection with Newcastle disease virus;]

(5) or

[(c)	have been vaccinated against infection with Newcastle disease virus with vaccines that comply with both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692;]

(d)	have been subjected to a virus detection test (7) for highly pathogenic avian influenza and infection with Newcastle disease virus with negative results within 7 to 14 days prior to the date of loading of the consignment for dispatch to the Union;

(e)	had no contact with other birds of a lower health status since the date of hatching or for a continuous period of at least 3 weeks immediately prior to the date of loading of the consignment for dispatch to the Union;

(f)	are not to be killed under a national programme for the eradication of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

(g)

have been subjected to a clinical inspection (6) on ___/___/____ (dd/mm/yyyy), within the last 24 hours prior to the time of loading of the consignment for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.1.5.

are loaded for dispatch to the Union in the containers which:

(a)

are constructed in such a way that:

(i)	the birds cannot escape or fall out;

(ii)	visual inspection of the space where birds are kept is possible;

(iii)

the escape of bird excrements, litter, feed or feathers is prevented or minimized;

(b)	contain only captive birds of the same species coming from the same establishment;

(c)	are used for the first time;

(d)	are closed in accordance with the instructions of the competent authority of the third country or territory of origin to avoid any possibility of substitution of the content;

(e)	bear the information set out in Point 4 of Annex XVI to Delegated Regulation (EU) 2020/692 relevant for captive birds;

II.1.6.

are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy) (8) in a means of transport which is constructed in accordance with point II.1.5(a) and was cleaned and disinfected prior to loading of the consignment for dispatch to the Union with a disinfectant authorised by the competent authority of the third country or territory of origin;

(5) (9) [II.1.7.

are captive birds of galliformes species intended for a Member State or zone thereof which has been granted the status free from infection with Newcastle disease virus without vaccination in accordance with Article 66 Commission Delegated Regulation (EU) 2020/689, and:

(a)	have not been vaccinated against infection with Newcastle disease virus;

(b)

(i)	no bird was vaccinated against infection with Newcastle disease virus during at least 21 days prior to the date of loading of the consignment for dispatch to the Union;

(ii)	no other birds have entered into the establishment during that period;

(iii)

no vaccination has been carried out;

(c)

Notes:

This animal health certificate is intended for the entry into the Union of captive birds, including when the Union is not the final destination of those animals.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.8

Provide the code of the zone as it appears in column 2 of the table in Part 1, Section A, of Annex VI to Implementing Regulation (EU) 2021/404.

Box reference I.12

In the case of captive birds certified for a quarantine establishment, provide the information on the quarantine establishment approved in accordance with Article 14 of Commission Delegated Regulation (EU) 2019/2035, where the captive birds shall be transported without delay following entry into the Union.

Box reference I.27

Description of consignment:

“CN code”: Indicate the appropriate Harmonised System (HS) code(s) of the World Customs Organisation under the following headings: 0106 31 , 0106 32 or 0106 39 .

“Identification system”: The bird shall be individually identified by means of a unique marked closed leg-ring or an injectable transponder in accordance with Article 53 of Delegated Regulation (EU) 2020/692.

Part II:

(1)	“Captive birds” as defined in Article 4 of Regulation (EU) 2016/429 of the European Parliament and of the Council.

(2)	Code of the zone as it appears in column 2 of the table in Part 1, Section A, of Annex VI to Implementing Regulation (EU) 2021/404.

(3)	The name and unique approval number of the establishment shall appear on the list of establishments drawn up and published by the Commission.

(4)	This guarantee is required only for the consignments of Psittacidae.

(5)	Delete if not applicable.

(6)	The clinical inspection shall have been carried out by an official veterinarian of the third country or territory of origin.

(7)

(8)	The date of loading shall not be prior to the date of authorisation of the zone referred to in point II.1.1 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of those birds from that zone.

(9)

This guarantee is required only for the consignments of captive birds of galliformes species intended for a Member State or zone thereof which has been granted the status free from infection with Newcastle disease virus without vaccination in accordance with Article 66 of Delegated Regulation (EU) 2020/689.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 34

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF RACING PIGEONS IMMEDIATELY RELEASED AFTER ENTRY (MODEL “RACING PIGEONS-IMMEDIATE RELEASE”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No	Seal No
I.20	Certified as or for
		☐ Exhibitions

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

Total net weight/gross weight (kg)

Part II: Certification

COUNTRY

Certificate model RACING PIGEONS-IMMEDIATE RELEASE

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

II.1.

Animal health attestation

I, the undersigned official veterinarian, hereby certify that the racing pigeons (1) of the consignment described in this animal health certificate:

II.1.1.

come from the third country or territory, or zone thereof indicated in box I.7 or box I.8 from where the Member State of destination indicated in box I.9 has accepted their introduction in accordance with Article 230(2) of Regulation (EU) 2016/429 of the European Parliament and of the Council;

II.1.2.

come from the establishment indicated in box I.11 registered by the competent authority of the third country or territory of origin, and:

(a)	within a 10 km radius of which, including, where appropriate, the territory of a neighbouring country, there has been no outbreak of highly pathogenic avian influenza or infection with Newcastle disease virus for at least 30 days prior to the date of loading for dispatch to the Union;

(b)	in which the vaccination against infection with Newcastle disease virus is carried out.

II.1.3.

have not been vaccinated against highly pathogenic avian influenza;

II.1.4.

have been vaccinated against infection with Newcastle disease virus with vaccines that comply with both the general and specific criteria set out in point 1 of Annex XV to Delegated Regulation (EU) 2020/692;

II.1.5.

II.1.6.

are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy) (2) in a means of transport which:

(a)

is constructed in such a way that:

(i)	the birds cannot escape or fall out;

(ii)	visual inspection of the space where birds are kept is possible;

(iii)

the escape of bird excrements, litter, feed or feathers is prevented or minimised;

(b)	contains only racing pigeons;

(c)	was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority of the third country or territory of origin.

Notes:

This animal health certificate is intended for the entry into the Union of racing pigeons to be immediately released with the expectation that they will fly back to the third country or territory of origin, or zone thereof indicated in box. I.7 or box. I.8.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

This animal health certificate shall be completed in accordance with the notes for the completion of certificates laid down in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.

Part I:

Box reference I.12

The location, in the Member State indicated in box I.9, from where the racing pigeons will be released.

Box reference I.27

“CN code”: Indicate the appropriate Harmonised System (HS) code(s) of the World Customs Organisation under the following headings: 0106 31 , 0106 32 or 0106 39 .

Part II:

(1)	“Racing pigeons” as referred to in Article 62(2) of Delegated Regulation (EU) 2020/692.

(2)	The date of loading shall not be prior to the date on which the Member State of destination indicated in box I.9 has accepted the introduction of the racing pigeons in accordance with Article 230(2) of Regulation (EU) 2016/429 of the European Parliament and of the Council.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 35

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF HATCHING EGGS OF CAPTIVE BIRDS (MODEL “HE-CAPTIVE-BIRDS”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

Total net weight/gross weight (kg)

I.27	Description of consignment
CN code	Species	Subspecies/Breed/Category	Identification system	Identification number	Quantity

Part II: Certification

COUNTRY

Certificate model HE-CAPTIVE-BIRDS

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

II.1.

Animal health attestation

I, the undersigned official veterinarian, hereby certify, that the hatching eggs of captive birds (1) of the consignment described in Part I:

II.1.1.

II.1.2.

come from the establishment (3) indicated in box I.11, approved by the competent authority of the third country or territory of origin in accordance with requirements which are at least as stringent as those laid down in Article 56 of Commission Delegated Regulation (EU) 2020/692, and:

(a)	the approval of which has not been suspended or withdrawn;

(b)	which is under the control of the competent authority of the third country or territory of origin and has a system in place to maintain and to keep records in accordance with Article 8 of Delegated Regulation (EU) 2020/692;

(c)

(d)	which was not subject to national restriction measures for animal health reasons, including for the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, on the date of loading of the consignment for dispatch to the Union;

(e)

(5) (4) [(f)

in which

(5) either

[avian chlamydiosis has not been confirmed for at least 6 months prior to the date of loading of the consignment for dispatch to the Union;]]

(5) or

[the birds from which the hatching eggs have been obtained, have been kept under veterinary supervision for the last 45 days prior to the date of collection of the hatching eggs and were treated against avian chlamydiosis;]]

II.1.3.

come from captive birds which:

(a)	have remained in the establishment indicated in box I.11 since the date of hatching or for a continuous period of at least 3 weeks immediately prior to the date of loading of the consignment for dispatch to the Union;

(b)	have not been vaccinated against highly pathogenic avian influenza;

(5) either

[(c)	have not been vaccinated against infection with Newcastle disease virus;]

(5) or

[(c)	have been vaccinated against infection with Newcastle disease virus with vaccines that comply with both the general and specific criteria of Annex XV to Delegated Regulation (EU) 2020/692;

(d)	have been subjected to a virus detection test (7) for highly pathogenic avian influenza and infection with Newcastle disease virus with negative results within 7 to 14 days prior to the date of collection of the hatching eggs;

(e)	had no contact with other birds of a lower health status since the date of hatching or for a continuous period of at least 3 weeks immediately prior to the date of collection of the hatching eggs;

(f)	are not to be killed under a national programme for the eradication of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

(g)

II.1.4.

were collected [on ___/___/____ (dd/mm/yyyy)] (5) [from ___/___/____ (dd/mm/yyyy) to ___/___/____ (dd/mm/yyyy)] (5); (8)

II.1.5.

are loaded for dispatch to the Union in the containers which:

(a)	are constructed in such a way that hatching eggs cannot fall out;

(b)	are designed to allow cleaning and disinfection;

(c)	contain only hatching eggs of captive birds of the same species coming from the same establishment;

(d)	are closed in accordance with the instructions of the competent authority of the third country or territory of origin to avoid any possibility of substitution of the content;

(e)

are

(3) either

[disposable, clean and used for the first time;]

(3) or

(f)	bear the information set out in Point 7 of Annex XVI to Delegated Regulation (EU) 2020/692 relevant for hatching eggs of captive birds;

II.1.6.

are loaded for dispatch to the Union in a means of transport which is constructed in accordance with point II.1.5(a) and (b), and was cleaned and disinfected with a disinfectant authorised by the competent authority of the third country or territory of origin and dried or allowed to dry immediately prior to loading of the consignment for dispatch to the Union;

(5) (9) [II.1.7.

(a)	have not been vaccinated against infection with Newcastle disease virus;

(b)

(i)	no bird was vaccinated against infection with Newcastle disease virus during at least 21 days prior to the date of loading of the consignment for dispatch to the Union;

(ii)	no other birds have entered into the establishment during that period;

(iii)

no vaccination has been carried out;

(c)

Notes:

This animal health certificate is intended for the entry into the Union of hatching eggs of captive birds, including when the Union is not the final destination of those products.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

This animal health certificate shall be completed according to the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.

Part I:

Box reference I.8

Provide the code of the zone as it appears in column 2 of the table in Part 1, Section A, of Annex VI to Implementing Regulation (EU) 2021/404.

Box reference I.27

Description of consignment:

‘CN code’: Indicate the appropriate Harmonised System (HS) code(s) of the World Customs Organisation under the following heading: 04.07.

Part II:

(1)	“Captive birds” as defined in Article 4 of Regulation (EU) 2016/429 of the European Parliament and of the Council.

(2)	Code of the zone as it appears in column 2 of the table in Part 1, Section A, of Annex VI to Implementing Regulation (EU) 2021/404.

(3)	The name and unique approval number of the establishment shall appear on the list of establishments drawn up and published by the Commission.

(4)	This guarantee is required only for the consignments of Psittacidae.

(5)	Delete if not applicable.

(6)	The clinical inspection shall have been carried out by an official veterinarian of the third country or territory of origin.

(7)

(8)	The date(s) of collection shall not be prior to the date of authorisation of the zone referred to in point II.1.1 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of those hatching eggs from that zone.

(9)

This guarantee is required only for the consignments of hatching eggs of captive birds of galliformes species intended for a Member State or zone thereof which has been granted the status free from infection with Newcastle disease virus without vaccination in accordance with Article 66 of Delegated Regulation (EU) 2020/689.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 36

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF QUEEN HONEYBEES (MODEL “QUE”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No	Seal No
I.20	Certified as or for
	☐ Further keeping

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

Total net weight/gross weight (kg)

I.27	Description of consignment
CN code	Species	Subspecies/Category	Quantity

Part II: Certification

COUNTRY

Certificate model QUE

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify, that the queen honeybees of the consignment described in Part I:

II.1.

come from the zone with code __-__ (2) which, at the date of issuing this animal health certificate is listed in Part 1 of Annex VII to Commission Implementing Regulation (EU) 2021/404 for the entry into the Union of queen honeybees;

II.2.

have remained continuously:

(a)	in the zone referred to in point II.1 since the date of hatching, and

(b)	in the establishment of origin since the date of hatching;

II.3.

had no contact with honeybees of a lower health status since the date of hatching;

II.4.

II.5.

have been dispatched to the Union in closed cages each containing one single queen honeybee with a maximum 20 accompanying attendants:

II.5.1.

in packaging material which, prior to packing the queen honeybees of the consignment:

(a)

was new;

(b)	had not been in contact with any bees and brood combs;

(c)	has been subject to all precautions to prevent its contamination with pathogens causing diseases of honeybees;

II.5.2.

accompanied by feedingstuff free from pathogens causing their diseases;

II.5.3.

in packaging material and with accompanying products which have undergone a visual examination prior to the date of loading of the consignment for dispatch to the Union to ensure that they do not pose an animal health risk and do not contain Aethina tumida (Small hive beetle) and Tropilaelaps mite in any of their life stages.

II.5.4.

directly from the establishment of origin to the Union without passing through any other establishment without being unloaded in any place that does not comply with the requirements laid down in point II.7 since the date of dispatch from their establishment of origin until the date of loading of the consignment for dispatch to the Union and have not been in contact with bees of a lower health status;

II.6.

have been subjected to a clinical inspection within the last 24 hours prior to the time of loading of the consignment for dispatch to the Union, carried out by an official veterinarian in the third country or territory of origin, or zone thereof, who did not detect signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

II.7.

originate from an apiary:

II.7.1.

in and around which, within an area of 100 km radius, including where appropriate the territory of a neighbouring country:

(a)	infestation with Aethina tumida (Small hive beetle) or infestation with Tropilaelaps spp. has not been reported;

(b)	there are no restrictions in place due to a suspicion, case or outbreak of the diseases referred to point (a);

II.7.2.

in and around which, within an area of 3 km radius, including where appropriate the territory of a neighbouring country:

(a)	American foulbrood has not been reported for at least 30 days prior to the date of loading of the consignment for dispatch to the Union;

(b)	there are no restrictions in place due to a suspicion or a confirmed case of American foulbrood during the period referred to in point (a);

(1) [(c)

there had been a previous confirmed case of American foulbrood prior to the period referred to in point (a), and all hives were subsequently checked by the competent authority of the third country or territory of origin and all infected hives were treated and subsequently inspected with favourable results within 30 days after the date of the last recorded case of that disease;]

II.8.

originate from hives from which samples of the comb have been tested for American foulbrood with negative results within the last 30 days prior to the date of loading of the consignment for dispatch to the Union.

(1) (4) (5) [II.9.1.

(a)	originate from a third country or territory, or zone thereof free from infestation with Varroa spp.;

(b)	in the third country or territory, or zone thereof of origin, infestation with Varroa spp. has not been reported for the last 30 days prior to the date of loading of the consignment for dispatch to the Union;

II.9.2.

have been prepared for loading and dispatch to the Union, taking every precaution to avoid contamination of the consignment with Varroa spp.]

Notes:

This animal health certificate is intended for the entry into the Union of honeybee queens, including when the Union is not the final destination of those animals.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.27

“Category”: Indicate queens with maximum 20 attendants.

Part II:

(1)	Delete if not applicable.

(2)	Code of the zone as it appears in column 2 of the table in Part 1 of Annex VII to Implementing Regulation (EU) 2021/404.

(3)	Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.1 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of those queen honeybees from that zone.

(4)	Only applicable when the Member State or zone thereof of destination either has disease-free status for the relevant category C disease or has an approved eradication programme.

(5)	It may only be certified by third countries or territories with an entry ‘VAR’ in column 6 of the table in Part 1 of Annex VII to Implementing Regulation (EU) 2021/404 recognised free of infestation with Varroa spp. (varroasis).

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 37

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF BUMBLE BEES (MODEL “BBEE”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No	Seal No
I.20	Certified as or for
	☐ Further keeping

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

Total net weight/gross weight (kg)

I.27	Description of consignment
CN code	Species	Subspecies/Category			Quantity
					Net weight

			Nature of commodity	Number of packages

Part II: Certification

COUNTRY

Certificate model BBEE

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify, that the bumble bees of the consignment described in Part I:

II.1.

come from the zone with code __-__ (1)which, at the date of issuing this animal health certificate is listed in Part 1 of Annex VII to Commission Implementing Regulation (EU) 2021/404 for the entry into the Union of bumble bees;

II.2.

have remained continuously:

(i)	in the zone referred to in point II.1 since the date of hatching, and

(ii)	in the establishment of origin since the date of hatching, in which no bumble bees have been introduced into their epidemiological unit of origin during that period;

II.3.

had no contact with bees of a lower health status since the date of hatching;

II.4.

are not to be killed under a national programme for the eradication of diseases, including listed diseases and emerging diseases;

II.5.

have been dispatched in closed containers each containing a colony of maximum 200 adult bumble bees, with or without a queen:

II.5.1.

in packaging material which, prior to packing of the consignment:

(a)

was new;

(b)	had not been in contact with any bees and brood combs;

(c)	has been subject to all precautions to prevent its contamination with pathogens causing diseases of bumble bees.

II.5.2.

accompanied by feedingstuff free from pathogens causing their diseases;

II.5.3.

II.5.4.

directly from the establishment of origin without passing through any other establishment and without being unloaded in any place that does not comply with the requirements laid down in points II.7 and II.8 since the date of dispatch from their establishment of origin until the date of loading of the consignment for dispatch to the Union and have not been in contact with animals of a lower health status.

II.6.

have been subjected to a clinical inspection within the last 24 hours prior to the time of loading (2) of the consignment for dispatch to the Union, carried out by an official veterinarian in the third country or territory of origin, or zone thereof, who did not detect signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases.

II.7.

have been bred and kept in an environmentally isolated bumble bee production establishment which:

II.7.1.

is registered by, and is under the control of, the competent authority of the third country or territory and has a system in place to maintain and to keep records in accordance with Article 8 of Delegated Regulation (EU) 2020/692;

II.7.2.

has facilities which ensure that the production of bumble bees is carried out inside of a flying insect-proof building;

II.7.3.

has facilities and equipment which ensure that the bumble bees are further isolated in separate epidemiological units and each colony in closed containers within the building throughout the whole production;

II.7.4.

the storage and handling of pollen within the facilities is isolated from the bumble bees throughout the whole production of bumble bees until it is fed to them;

II.7.5.

has standard operating procedures to prevent the entry of Aethina tumida (Small hive beetle) into the establishment and to regularly survey for the presence of infestation with Aethina tumida (Small hive beetle) within the establishment.

II.8.

come from an epidemiological unit with the establishment in which infestation with Aethina tumida (Small hive beetle) has not been detected.

Notes:

This animal health certificate is intended for the entry into the Union of bumble bees, including when the Union is not the final destination of those animals.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part II:

(1)	Code of the zone as it appears in column 2 of the table in Part 1 of Annex VII to Implementing Regulation (EU) 2021/404.

(2)	Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.1 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of those bumble bees from that zone.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 38

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF DOGS, CATS AND FERRETS (MODEL “CANIS-FELIS-FERRETS”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
	☐ Further keeping
		☐ Confined establishment
		☐ Quarantine establishment
			☐ Other

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

Total net weight/gross weight (kg)

I.27	Description of consignment
CN code	Species	Subspecies/Category	Sex	Identification system	Identification number	Age	Quantity

				Nature of commodity
						Test

Part II: Certification

COUNTRY

Certificate model CANIS-FELIS-FERRETS

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian hereby certify that the animals of the consignment described in Part I:

II.1.

come from a third country or territory, zone thereof with code __-__ (1)which, on the date of issue of this animal health certificate is authorised for the entry into the Union of dogs, cats and ferrets and is listed in Part 1 of Annex VIII to Commission Implementing Regulation (EU) 2021/404;

(2) either

[II.2.

have been dispatched to the Union directly from the establishment of origin without passing through any other establishment;]

(2) (3) or

[II.2.

have undergone one single assembly operation in the country or territory, or zone thereof of origin which took place for not more than 6 days in an establishment fulfilling the following requirements:

(a)	it is approved for conducting assembly operations of dogs, cats and ferrets by the competent authority in the third country or territory in accordance with Article 10 of Commission Delegated Regulation (EU) 2019/2035;

(b)	it has a unique approval number assigned by the competent authority of the third country or territory;

(c)	it is listed for that purpose by the competent authority of the third country or territory of dispatch to the Union, including the information set out in Article 21 of Delegated Regulation (EU) 2019/2035;

(d)	it complies with the record keeping requirements provided for in Article 73(2), point (a)(iv), of Delegated Regulation (EU) 2020/692;]

(2) (3) or

[II.2.

have been dispatched from an animal shelter fulfilling the following requirements:

(a)	it is approved by the competent authority in the third country or territory in accordance with Article 11 of Delegated Regulation (EU) 2019/2035;

(b)	it has a unique approval number assigned by the competent authority of the third country or territory;

(c)	it is listed for that purpose by the competent authority of the third country or territory of dispatch, including the information provided for in Article 21 of Delegated Regulation (EU) 2019/2035;]

II.3

have been subjected with negative result to a clinical inspection, carried out by an official veterinarian in the third country or territory of origin, or zone thereof within the last 48 hours prior to the time of loading for dispatch to the Union for the detection of signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;

(2) either

[II.4.

are destined for direct entry into the Member State of destination to be isolated in

(2) either

[a confined establishment;]]

(2) or

[an approved quarantine establishment;]]

(2) or

[II.4.

were at least 12 weeks old at the date of vaccination against rabies and at least 21 days have elapsed since the date of completion of the primary anti-rabies vaccination (5) carried out in accordance with the validity requirements set out in Annex III to Regulation (EU) No 576/2013 of the European Parliament and of the Council, and any subsequent revaccination was carried out within the period of validity of the preceding vaccination (6), and

(2) either

[come from, and in the case of transit are scheduled to transit through, a third country or territory listed in Annex II to Commission Implementing Regulation (EU) No 577/2013 and details of the relevant anti-rabies vaccination(s) are provided in columns 1 to 7 in the table below;]]

(2) or

[come from or are scheduled to transit through a third country or territory not listed in Annex II to Commission Implementing Regulation (EU) No 577/2013, and:

(a)	the details of the relevant anti-rabies vaccination(s) are provided in columns 1 to 7 in the table below,

(b)

a rabies antibody titration test (7), carried out on a blood sample taken by the veterinarian authorised by the competent authority not less than 30 days after the date of the preceding vaccination and at least 3 months prior to the date of issue of this animal health certificate, proved an antibody titre equal to or greater than 0,5 IU/ml (8) and any subsequent revaccination was carried out within the period of validity of the preceding vaccination, and the date of sampling for testing the immune response are provided in column 8 in the table below:]]

Transponder		Date of vaccination [dd/mm/yyyy]	Name and manufacturer of vaccine	Batch number	Validity of vaccination		Date of blood sampling [dd/mm/yyyy]
Alphanumeric code of the animal	Date of implantation and/or reading (9) [dd/mm/yyyy]				Validity of vaccination
Alphanumeric code of the animal	Date of implantation and/or reading (9) [dd/mm/yyyy]				From [dd/mm/yyyy]	To [dd/mm/yyyy]
1	2	3	4	5	6	7	8

(2) either

[II.5.

include dogs destined for a Member State listed in the Annex to Commission Implementing Regulation (EU) 2018/878 and those dogs have been treated against infestation with Echinococcus multilocularis, and the details of the treatment carried out by the administering veterinarian in accordance with point 2 of Annex XXI to Delegated Regulation (EU) 2020/692 (10) (11) are provided in the table below:

Transponder or tattoo. Alphanumeric code of the dog	Anti-Echinococcus treatment		Administering veterinarian
Transponder or tattoo. Alphanumeric code of the dog	Name and manufacturer of the product	Date [dd/mm/yyyy] and time of treatment [00:00]	Name in capitals, stamp and signature

]

(2) or

[II.5.

include dogs which have not been treated against infestation with Echinococcus multilocularis.]

(2) or

[II.5.

include dogs destined for direct entry into the Member State of destination to be isolated in

(1) either

[a confined establishment.]]

(1) or

[an approved quarantine establishment.]]

(2) (3) [II.6.

were loaded for dispatch to the Union on ___/___/____(dd/mm/yyyy) (4) in a means of transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority of the third country or territory, and constructed in such a way that:

(a)	animals cannot escape or fall out;

(b)	visual inspection of the space where animals are kept is possible;

(c)	the escape of animal excrements, litter or feed is prevented or minimized.]

Notes:

This animal health certificate is intended for commercial entries into the Union of dogs, cats and ferrets, including when they are destined to a confined establishment or to an approved quarantine establishment and when the Union is not the final destination of the animals and for the entry into the Union of dogs, cats and ferrets moved in accordance with Article 5(4) of Regulation (EU) No 576/2013 of the European Parliament and of the Council.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.20

Certified as or for: Indicate:

—	“Further keeping” where dogs, cats or ferrets are moved in accordance with Title 5 of Part II of Delegated Regulation (EU) 2020/692;

—	Confined establishment: As defined in Article 4, point (48), of Regulation (EU) 2016/429 of the European Parliament and of the Council;

—	Approved quarantine establishment: As defined in Article 3(9) of Commission Delegated Regulation (EU) 2020/688;

—	“Others” where dogs (Canis lupus familiaris), cats (Felis silvestris catus) or ferrets (Mustela putorius furo) are moved in accordance with Article 5(4) of Regulation (EU) No 576/2013 of the European Parliament and of the Council.

Part II:

(1)	Code of the zone as it appears in column 2 of the table in Part 1 of Annex VIII to Implementing Regulation (EU) 2021/404.

(2)	Delete if not applicable.

(3)	Not applicable to the movement of dogs, cats and ferrets other than non-commercial movements, kept as pet animals in households that may not be carried out in accordance with the conditions laid down in Article 245(2) or Articles 246(1) and (2) of Regulation (EU) 2016/429.

(4)	Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.1 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of those animals from that zone.

(5)	Any revaccination shall be considered a primary vaccination if it was not carried out within the period of validity of a previous vaccination.

(6)	A certified copy of the identification and vaccination details of the animals concerned shall be attached to the animal health certificate.

(7)

The rabies antibody titration test referred to in point II.4:

(a)	shall be carried out on a sample collected by a veterinarian authorised by the competent authority, at least 30 days after the date of vaccination and 3 months prior to the date of dispatch to the Union;

(b)	shall measure a level of neutralising antibody to rabies virus in serum equal to or greater than 0,5 IU/ml;

(c)	shall be performed by an official laboratory;

(d)	shall not be renewed on an animal, which following that test with satisfactory results, has been revaccinated against rabies within the period of validity of a previous vaccination.

A certified copy of the official report from the official laboratory on the result of the rabies antibody test referred to in point II.4 shall be attached to the animal health certificate.

(8)

By certifying this result, the official veterinarian confirms that he has verified, to the best of his ability and where necessary with contacts with the laboratory indicated in the report, the authenticity of the laboratory report on the results of the antibody titration test referred to in point II.4.

(9)	In conjunction with note (6), the marking of the animals concerned by the implantation of a transponder shall be verified before any entry is made in this animal health certificate and shall always precede any vaccination, or where applicable, testing carried out on those animals.

(10)

The treatment against infestation with Echinococcus multilocularis referred to in point II.5 shall:

(a)	be administered by a veterinarian within not more than 48 hours and not less than 24 hours prior to the time of the scheduled dispatch of the dogs to one of the Member States or parts thereof listed in the Annex to Commission Implementing Regulation (EU) 2018/878;

(b)

consist of an approved medicinal product which contains the appropriate dose of praziquantel or pharmacologically active substances, which alone or in combination, have been proven to reduce the burden of mature and immature intestinal forms of Echinococcus multilocularis in the host species concerned.

(11)

The table referred to in point II.5 shall be used to document the details of a further treatment if administered after the date the animal health certificate was signed and prior to the scheduled entry into one of the Member States or parts thereof listed in the Annex to Implementing Regulation (EU) 2018/878.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 39

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF SEMEN OF BOVINE ANIMALS COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH REGULATION (EU) 2016/429 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL AND COMMISSION DELEGATED REGULATION (EU) 2020/692 AFTER 20 APRIL 2021, DISPATCHED FROM THE SEMEN COLLECTION CENTRE WHERE THE SEMEN WAS COLLECTED (MODEL “BOV-SEM-A-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17
	☐ Railway	☐ Road vehicle
	Identification

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity

Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model BOV-SEM-A-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify that:

II.1.

The semen of the consignment described in Part I is intended for artificial reproduction and was obtained from donor animals which originate from a third country or territory, or zone thereof:

II.1.1.

authorised for the entry into the Union of semen of bovine animals and listed in Annex IX to Commission Implementing Regulation (EU) 2021/404;

(1) either

[II.1.2.

where foot and mouth disease was not reported for at least 24 months immediately prior to the date of collection of the semen and until its date of dispatch to the Union;]

(1) (2) or

[II.1.2.

where foot and mouth disease was not reported for a period starting on the date ___/___/____ (dd/mm/yyyy) immediately prior to the date of collection of the semen and until the date of dispatch of the consignment to the Union;]

II.1.3.

where infection with rinderpest virus, infection with Rift Valley fever virus, contagious bovine pleuropneumonia and lumpy skin disease were not reported for at least 12 months immediately prior to the date of collection of the semen and until the date of dispatch of the consignment to the Union;

II.1.4.

where no vaccination against infection with rinderpest virus, infection with Rift Valley fever virus and contagious bovine pleuropneumonia has been carried out for at least 12 months immediately prior to the date of collection of the semen and until the date of dispatch of the consignment to the Union, and no vaccinated animals entered into the third country or territory, or zone thereof during that period, and

(1) either

[no vaccination against foot and mouth disease has been carried out for the same period, and no vaccinated animals entered into the third country or territory, or zone thereof during that period.]

(1) or

[vaccination against foot and mouth disease has been carried out for the same period, or vaccinated animals entered into the third country or territory, or zone thereof during that period.]

II.2.

The semen of the consignment described in Part I was obtained from donor animals which, prior to the date of the commencement of the quarantine referred to in point II.4.6, originated from establishments:

II.2.1.

situated in an area where foot and mouth disease has not been reported within a 10-km radius centred on the establishments for at least 30 days and in which foot and mouth disease has not been reported during at least 3 months, and

(1) either

[in which they were not vaccinated against foot and mouth disease;]

(1) or

[in which they were vaccinated against foot and mouth disease during the last 12 months prior to the date of collection of the semen but not of the last 30 days immediately prior to the date of collection of the semen, and in which 5% (with a minimum of five straws) of each quantity of semen taken from a donor animal at any time is submitted to a virus isolation test for foot and mouth disease with negative results;]

II.2.2.

free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) and they have never been kept previously in any establishment of a lower health status;

II.2.3.

free from infection with Brucella abortus, B. melitensis and B. suis and they have never been kept previously in any establishment of a lower health status;

(1) either

[II.2.4.

free from enzootic bovine leukosis and they have never been kept previously in any establishment of a lower health status;]

(1) or

[II.2.4.

not free from enzootic bovine leukosis and they are younger than 2 years of age and they have been produced by dams which have been subjected, with negative results, to a serological test for enzootic bovine leukosis after the date of removal of the animal from the dam;]

(1) or

[II.2.4.

not free from enzootic bovine leukosis and they have reached the age of 2 years, and they have been subjected, with a negative result, to a serological test for enzootic bovine leukosis;]

(1) either

[II.2.5.

free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis and they have never been kept previously in any establishment of a lower health status;]

(1) or

[II.2.5.

not free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis and they have been subjected, with a negative result, to a serological test (whole virus) on a blood sample;]

II.2.6.

in which

(1) either

[surra (Trypanosoma evansi) has not been reported during the last 2 years.]

(1) or

[surra (Trypanosoma evansi) has not been reported for at least 30 days and when the disease was reported in the establishments during the last 2 years, following the last outbreak, the establishments have remained under movement restrictions until the date on which the infected animals have been removed from the establishments, and the remaining animals in the establishments have been subjected to a test for surra with one of the diagnostic methods provided for in Part 3 of Annex I to Commission Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months after the date on which the infected animals have been removed from the establishments.]

II.3.

The semen of the consignment described in Part I has been collected, processed and stored, and dispatched from the semen collection centre (3) which:

II.3.1.

is approved and listed by the competent authority of the third country or territory;

II.3.2.

complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 1 of Annex I to Commission Delegated Regulation (EU) 2020/686.

II.4.

The semen of the consignment described in Part I was obtained from donor animals which:

II.4.1.

were not vaccinated against infection with rinderpest virus, infection with Rift Valley fever virus, contagious bovine pleuropneumonia and lumpy skin disease;

II.4.2.

remained for at least 6 months prior to the date of collection of the semen in a third country or territory, or zone thereof referred to in box I.7;

II.4.3.

did not show symptoms or clinical signs of transmissible animal diseases on the date of their admission to a semen collection centre and on the date of collection of the semen;

II.4.4.

are individually identified as provided for in Article 21(1) of Delegated Regulation (EU) 2020/692;

II.4.5.

for at least 30 days prior to the date of collection of the semen and during the collection period:

II.4.5.1.

were kept in establishments not situated in a restricted zone established due to the occurrence of foot and mouth disease, infection with rinderpest virus, infection with Rift Valley fever virus, contagious bovine pleuropneumonia or lumpy skin disease, or of an emerging disease relevant for bovine animals;

II.4.5.2.

were kept on a single establishment where infection with Brucella abortus, B. melitensis and B. suis, infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis), rabies, anthrax, surra (Trypanosoma evansi), enzootic bovine leukosis, infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, bovine viral diarrhoea, infection with epizootic haemorrhagic disease virus, infection with bluetongue virus (serotypes 1-24), bovine genital campylobacteriosis and trichomonosis have not been reported;

II.4.5.3.

were not in contact with animals from establishments situated in a restricted zone due to the occurrence of diseases referred to in point II.4.5.1 or from establishments which do not meet the conditions referred to in point II.4.5.2;

II.4.5.4.

were not used for natural breeding;

II.4.6.

have been subjected to a quarantine for at least 28 days in quarantine accommodation, where only other cloven-hoofed animals with at least the same health status were present, which on the date of their admission to the semen collection centre complied with the following conditions:

II.4.6.1.

it was not situated in a restricted zone established due to diseases referred to in point II.4.5.1;

II.4.6.2.

none of the diseases referred to in point II.4.5.2 has been reported for at least 30 days;

II.4.6.3.

it was situated in an area where foot and mouth disease has not been reported within a 10-km radius centred on the quarantine accommodation for at least 30 days;

II.4.6.4.

has had no outbreak of foot and mouth disease reported during at least 3 months preceding the date of admission of the animals into the semen collection centre;

II.4.7.

were kept in the semen collection centre:

II.4.7.1.

which was not situated in a restricted zone established due to diseases referred to in point II.4.5.1;

II.4.7.2.

where none of the diseases referred to in point II.4.5.2 has been reported for at least 30 days prior to the date of collection of the semen, and

(1) (4)

[at least 30 days following the date of collection of the semen;]

(1) (5)

[until the date of dispatch of the consignment to the Union;]

II.4.7.3.

situated in an area where foot and mouth disease has not been reported within a 10-km radius centred on the semen collection centre for at least 30 days; and:

(1) (4) either

[free from foot and mouth disease for at least 3 months prior to the date of collection of the semen and 30 days from the date of its collection;]

(1) (5) or

[free from foot and mouth disease for at least 3 months prior to the date of collection of the semen and until the date of dispatch of the consignment to the Union and they have been kept at that semen collection centre for a continuous period of at least 30 days immediately prior to the date of collection of the semen;]

II.4.8.

comply with at least one of the following conditions as regards infection with bluetongue virus (serotypes 1-24):

(1) either

[II.4.8.1.

they have been kept for at least 60 days prior to and during collection of the semen in a third country or territory, or zone thereof free from infection with bluetongue virus (serotypes 1-24) where no case of infection with bluetongue virus (serotypes 1-24) has been confirmed in the targeted animal population during the last 24 months prior to the date of collection of the semen and during the collection period;]

(1) (10) or

[II.4.8.2.

they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for at least 60 days prior to the date of collection of the semen and during the collection period;]

(1) and/or

[II.4.8.4.

they have been kept in a vector-protected establishment for at least 60 days prior to the date of collection of the semen and during the collection period;]

(1) and/or

[II.4.8.5.

they have been subjected to a serological test able to detect specific antibodies against all serotypes (1-24) of bluetongue virus, with negative results, between 28 and 60 days from the date of each collection of the semen;]

(1) and/or

[II.4.8.6.

they have been subjected to an agent identification test for bluetongue virus (serotypes 1-24), with negative results, on blood samples taken at the date of commencement and the date of final collection of the semen and during the collection period at intervals of at least every 7 days, in the case of the virus isolation test, or of at least every 28 days, in the case of PCR;]

II.4.9.

comply with at least one of the following conditions as regards infection with epizootic haemorrhagic disease virus (EHDV):

(1) either

[II.4.9.1.

they have been kept for at least 60 days prior to the date of collection of the semen and during the collection period in a third country or territory, or zone thereof where EHDV has not been reported within a radius of 150 km of the establishments for at least the preceding 2 years;]

(1) (11) or

[II.4.9.2.

they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for at least 60 days prior to the date of collection of the semen and during the collection period;]

(1) and/or

[II.4.9.3.

they have been kept in a vector-protected establishment for at least 60 days prior to the date of collection of the semen and during the collection period;]

(1) and/or

[II.4.9.4.

they were resident in the third country or territory, or zone thereof of dispatch of the semen of the consignment to the Union in which according to official findings the following serotypes of EHDV exist: … and have been subjected with negative results in each case to the following tests carried out in an official laboratory:

(1) either

[II.4.9.4.1.

a serological test able to detect specific antibodies against those serotypes of EHDV, with negative results, at least every 60 days throughout the collection period and between 28 and 60 days from the date of the final collection of the semen.]]

(1) and/or

[II.4.9.4.2.

an agent identification test for EHDV, with negative results, on blood samples taken at the date of commencement and the date of the final collection of the semen and during the collection of the semen at intervals of at least every 7 days, in the case of virus isolation test, or of at least every 28 days, in the case of PCR.]]

II.4.10.

have been subjected to the following tests, carried out on samples taken within the last 30 days prior to the date of commencement of the quarantine referred to in point II.4.6, with negative results, except for the bovine viral diarrhoea antibody test referred to in point II.4.10.5.2, required in accordance with Part 1, Chapter I, point 1(b), of Annex II to Delegated Regulation (EU) 2020/686:

II.4.10.1.

for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis), an intradermal tuberculin test referred to in Part 2, point 1, of Annex I to Delegated Regulation (EU) 2020/688;

II.4.10.2.

for infection with Brucella abortus, B. melitensis and B. suis, a serological test referred to in Part 1, point 1, of Annex I to Delegated Regulation (EU) 2020/688;

(1) (6) [II.4.10.3.

for enzootic bovine leukosis, a serological test referred to in Part 4, point (a) of Annex I to Delegated Regulation (EU) 2020/688;]

II.4.10.4.

for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, a serological test (whole virus) on a blood sample if the animals do not come from an establishment free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis;

II.4.10.5.

for bovine viral diarrhoea:

II.4.10.5.1.

a virus isolation test, a test for virus genome or a test for virus antigen, and

II.4.10.5.2.

a serological test to determine the presence or absence of antibodies;

II.4.11.

have been subjected to the following tests, carried out on samples taken at least 21 days, or 7 days in the case of the tests referred to in points II.4.11.4 and II.4.11.5, after the date of commencement of the quarantine referred to in point II.4.6, with negative results, except for the bovine viral diarrhoea antibody test referred to in point II.4.11.3.2, required in accordance with Part 1, Chapter I, point 1(c), of Annex II to Delegated Regulation (EU) 2020/686:

II.4.11.1.

for infection with Brucella abortus, B. melitensis and B. suis, a serological test referred to in Part 1, point 1, of Annex I to Delegated Regulation (EU) 2020/688;

II.4.11.2.

for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, a serological test (whole virus) on a blood sample;

II.4.11.3.

for bovine viral diarrhoea:

II.4.11.3.1.

a virus isolation test, a test for virus genome or a test for virus antigen, and

II.4.11.3.2.

a serological test to determine the presence or absence of antibodies;

II.4.11.4.

for bovine genital campylobacteriosis (Campylobacter fetus ssp. venerealis):

(1) either

[II.4.11.4.1.

a single test carried out on a sample of artificial vagina washings or preputial specimen, in the case of animals less than 6 months old or kept since that age in a single sex group without contact with females prior to the quarantine referred to in point II.4.6;]

(1) and/or

[II.4.11.4.2.

tests carried out on samples of artificial vagina washings or preputial specimens taken on three occasions at intervals of at least 7 days;]

II.4.11.5.

for trichomonosis (Trichomonas foetus):

(1) either

[II.4.11.5.1.

a single test carried out on a sample of preputial specimen, in the case of animals less than 6 months old or kept since that age in a single sex group without contact with females prior to the quarantine referred to in point II.4.6;]

(1) and/or

[II.4.11.5.2.

tests carried out on preputial specimens taken on three occasions at intervals of at least 7 days;]

II.4.12.

have been subjected at semen collection centre, at least once a year, to the following compulsory routine tests, required in accordance with Part 1, Chapter I, point 2, of Annex II to Delegated Regulation (EU) 2020/686:

II.4.12.1.

II.4.12.2.

for infection with Brucella abortus, B. melitensis and B. suis, a serological test referred to in Part 1, point 1, of Annex I to Delegated Regulation (EU) 2020/688;

II.4.12.3.

for enzootic bovine leukosis, a serological test referred to in Part 4, point (a), of Annex I to Delegated Regulation (EU) 2020/688;

II.4.12.4.

for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, a serological test (whole virus) on a blood sample;

(1) (7) [II.4.12.5.

for bovine viral diarrhoea, a serological test for detection of an antibody;]

(1) (8) [II.4.12.6.

for bovine genital campylobacteriosis (Campylobacter fetus ssp. venerealis), a test on a sample of preputial specimen;]

(1) (8) [II.4.12.7.

for trichomonosis (Trichomonas foetus), a test on a sample of preputial specimen;]

II.5.

The semen of the consignment described in Part I:

II.5.1.

has been collected, processed and stored in accordance with animal health requirements set out in Annex III to Delegated Regulation (EU) 2020/686;

II.5.2.

is placed in straws or other packages on which the mark is applied in accordance with requirements provided for in Article 83, point (a), of Delegated Regulation (EU) 2020/692 and that mark is indicated in box I.27;

II.5.3.

is transported in a container which:

II.5.3.1.

was sealed and numbered prior to the date of dispatch to the Union from the semen collection centre under responsibility of the centre veterinarian, or by an official veterinarian, and the seal bears the number as indicated in box I.19;

II.5.3.2.

has been cleaned and either disinfected or sterilised before use, or is single-use container;

(1) (4) [II.5.3.3.

has been filled in with a cryogenic agent which has not been previously used for other products.]

(1) [II.6.

Where an antibiotic or a mixture of antibiotics was added to the semen:

II.6.1.

The following antibiotic or mixture of antibiotics has been added to the semen after final dilution, or is contained in the used semen diluents: … (9);

II.6.2.

Immediately after the addition of the antibiotic(s), and before any possible freezing, the diluted semen was kept at a temperature of at least 5 °C, or under a time-temperature regime with a documented equivalent bactericidal activity.]

Notes

This animal health certificate is intended for the entry into the Union of semen of bovine animals, including when the Union is not the final destination of the semen.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

This animal health certificate shall be completed according to the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.

Part I:

Box reference I.11	:	“Place of dispatch”: Indicate the unique approval number and the name and address of the semen collection centre of dispatch of the consignment to the Union. Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/index_en.htm.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Type”: Indicate semen. “Species”: Select amongst “ Bos taurus ”, “ Bison bison ” or “ Bubalus bubalis ” as appropriate. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where semen of the consignment is placed. “Date of collection/production”: Indicate the date on which semen of the consignment was collected. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected. “Quantity”: Indicate the number of straws or other packages with the same mark. “Test”: For BTV-test, indicate “point II.4.8.5” or “point II.4.8.6”, or both, and for EHD-test, indicate “point II.4.9.4.1” or “point II.4.9.4.2”, or both, if relevant.

Part II:

(1)	Delete if not applicable.

(2)	Only for a third country or territory, or zone thereof with an opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(3)	Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/index_en.htm.

(4)	Applicable to frozen semen.

(5)	Applicable to fresh and chilled semen.

(6)	Not applicable to animals which come from an establishment not free from enzootic bovine leukosis and which are less than 2 years of age as referred to in Article 20(2), point (a), of Delegated Regulation (EU) 2020/686.

(7)	Applicable only to seronegative animals.

(8)	Applicable only to bulls in semen production or having contact with bulls in semen production. Bulls returning to collection after a lay-off period of more than 6 months shall be tested during the last 30 days prior to resuming production.

(9)	Insert the name(s) of the antibiotic(s) added and its (their) concentration or the commercial name of the semen diluent containing antibiotics.

(10)	Applicable only for the zones with an entry “SF-BTV” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(11)	Applicable only for the zones with an entry “SF-EHD” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 40

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF STOCKS OF SEMEN OF BOVINE ANIMALS COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH COUNCIL DIRECTIVE 88/407/EEC AS AMENDED BY COUNCIL DIRECTIVE 2003/43/EC, AFTER 31 DECEMBER 2004 AND BEFORE 21 APRIL 2021, DISPATCHED AFTER 20 APRIL 2021 FROM THE SEMEN COLLECTION CENTRE WHERE THE SEMEN WAS COLLECTED (MODEL “BOV-SEM-B-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17
	☐ Railway	☐ Road vehicle
	Identification

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity

Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model BOV-SEM-B-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify that:

II.1.

…

(name of exporting country or part thereof) (1)

was free from rinderpest and foot-and-mouth disease during the 12 month period immediately prior to collection of the semen for export and until its date of dispatch to the Union and no vaccination against these diseases has taken place during the same period.

II.2.

The centre (2) described in box I.11. at which the semen to be exported was collected:

II.2.1.

met the conditions laid down in Chapter I(1) of Annex A to Directive 88/407/EEC;

II.2.2.

was operated and supervised in accordance with the conditions laid down in Chapter II(1) of Annex A to Directive 88/407/EEC.

II.3.

The centre at which the semen to be exported was collected was free from rabies, tuberculosis, brucellosis, anthrax and contagious bovine pleuropneumonia during 30 days prior to the date of collection of the semen to be exported and the 30 days after collection (in the case of fresh semen until the day of dispatch to the Union).

II.4.

The bovine animals standing at the semen collection centre:

(3) II.4.1.

come from herds which satisfy the conditions of paragraph 1(b) of Chapter I of Annex B to Directive 88/407/EEC;

II.4.2.

come from herds or were born to dams which comply with the conditions of paragraph 1(c) of Chapter I of Annex B to Directive 88/407/EEC, or were tested at the age of at least 24 months in accordance with paragraph 1(c) of Chapter II of Annex B to that Directive;

II.4.3.

underwent the tests required in accordance with paragraph 1(d) of Chapter I of Annex B to Directive 88/407/EEC in the 28 days preceding the quarantine isolation period;

II.4.4.

have satisfied the quarantine isolation period and testing requirements laid down in paragraph 1(e) of Chapter I of Annex B to Directive 88/407/EEC;

II.4.5.

have undergone, at least once a year, the routine tests referred to in Chapter II of Annex B to Directive 88/407/EEC.

II.5.

The semen to be exported was obtained from donor bulls which:

II.5.1.

satisfy the conditions laid down in Annex C to Directive 88/407/EEC;

(4) either

[II.5.2.

have remained in the exporting country for at least 6 months prior to collection of the semen to be exported;

(4) or

[II.5.2.

have remained in the exporting country for at least 30 days prior to the collection of the semen since entry and they were imported from … (1)during the period of less than 6 months prior to the collection of the semen and satisfied the animal health conditions applying to donors of the semen which is intended for export to the Union;]

II.5.3.

comply with at least one of the following conditions as regards bluetongue, as detailed in the table in box I.27:

(4) either

[II.5.3.1.

were kept in a bluetongue virus-free country or zone for at least 60 days prior to, and during, collection of the semen;]

(4) and/or

[II.5.3.2.

were kept during a bluetongue virus seasonally-free period in a seasonally-free zone for at least 60 days prior to, and during, collection of the semen;]

(4) and/or

[II.5.3.3.

were kept in a vector-protected establishment for at least 60 days prior to, and during, collection of the semen;]

(4) and/or

[II.5.3.4.

were subjected to a serological test for the detection of antibody to the bluetongue virus serogroup, carried out in accordance with the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, with negative results, at least every 60 days throughout the collection period and between 21 and 60 days after the final collection for this consignment of semen;]

(4) and/or

[II.5.3.5.

were subjected to an agent identification test for bluetongue virus, carried out in accordance with the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, with negative results, on blood samples taken at commencement and final collection for this consignment of semen and at least every 7 days (virus isolation test) or at least every 28 days, if carried out as polymerase chain reaction (PCR), during collection for this consignment of semen;]

II.5.4.

comply with at least one of the following conditions as regards epizootic haemorrhagic disease (EHD), as detailed in the table in box I.27:

(4) either

[II.5.4.1.

were resident in the exporting country which according to official findings is free from epizootic haemorrhagic disease (EHD);]

(4) (5) and/or

[II.5.4.2.

were resident in the exporting country in which according to official findings the following serotypes of epizootic haemorrhagic disease (EHD) exist: … and were subjected with negative results in each case to the following tests carried out in an approved laboratory:

(4) either

[II.5.4.2.1.

a serological test (6) for the detection of antibody to the EHD virus serogroup, carried out on samples of blood taken on 2 occasions not more than 12 months apart prior to and not less than 21 days following collection for this consignment of semen;]]

(4) and/or

[II.5.4.2.2.

a serological test (6) for the detection of antibody to the EHD virus serogroup, carried out on samples taken at intervals of not more than 60 days throughout the collection period and between 21 and 60 days after the final collection for this consignment of semen.]]

(4) and/or

[II.5.4.2.3.

an agent identification test (6) carried out on blood samples collected at commencement and conclusion of, and at least every 7 days (virus isolation test) or at least every 28 days, if carried out as PCR, during collection for this consignment of semen.]]

II.6.

The semen to be exported was collected after the date on which the centre was approved by the competent national authorities of the exporting country.

II.7.

The semen to be exported was processed, stored and transported under conditions which satisfy the terms of Directive 88/407/EEC.

Notes

This animal health certificate is intended for the entry into the Union of semen of bovine animals, including when the Union is not the final destination of the semen.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	“Place of dispatch” Indicate the unique approval number and the name and address of the semen collection centre of dispatch of the consignment to the Union. Only semen collection centre listed in accordance with Article 9(2) of Directive 88/407/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/index_en.htm.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Species”: Select amongst “ Bos taurus ”, “ Bison bison” or “Bubalus bubalis ” as appropriate. “Type”: Indicate semen. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where semen of the consignment is placed. “Date of collection/production” Indicate the date on which semen of the consignment was collected. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected. “Quantity”: Indicate the number of straws of semen collected on a particular date from an identified donor bull complying with particular conditions for bluetongue and EHD.

Part II:

(1)	Only third country or territory, or zone thereof listed in Annex IX to Commission Implementing Regulation (EU) 2021/404 for semen of bovine animals.

(2)	Only semen collection centres listed in accordance with Article 9(2) of Directive 88/407/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/index_en.htm.

(3)

For New Zealand, appearing with an entry “XII” in column 6 of the table in Part 1 of Annex I to Commission Regulation (EU) No 206/2010 (OJ L 73, 20.3.2010, p.1), officially tuberculosis-free bovine herds shall be considered equivalent to officially tuberculosis-free bovine herds in the Member States recognised based on the conditions laid down in paragraphs 1 and 2 of Annex A.I to Council Directive 64/432/EEC.

(4)	Delete if not applicable.

(5)	Compulsory for Australia, Canada and the United States.

(6)	The standards for EHD virus diagnostic tests are described in the Bluetongue Chapter of the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 41

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF STOCKS OF SEMEN OF BOVINE ANIMALS COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH COUNCIL DIRECTIVE 88/407/EEC AS AMENDED BY COUNCIL DIRECTIVE 93/60/EEC, BEFORE 1 JANUARY 2005, DISPATCHED AFTER 20 APRIL 2021 FROM THE SEMEN COLLECTION CENTRE WHERE THE SEMEN WAS COLLECTED (MODEL “BOV-SEM-C-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17
	☐ Railway	☐ Road vehicle
	Identification

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity

Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model BOV-SEM-C-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify that:

II.1.

…

(name of exporting country) (1)

has been free from rinderpest and foot-and-mouth disease during the 12-month period immediately prior to collection of the semen for export and until its date of dispatch and no vaccination against these diseases has taken place during the same period.

II.2.

The semen described above was collected before 31 December 2004 at the semen collection centre (2) which:

II.2.1.

met the conditions laid down in Chapter I of Annex A to Directive 88/407/EEC;

II.2.2.

was operated and supervised in accordance with the conditions laid down in Chapter II of Annex A to Directive 88/407/EEC.

II.3.

The centre at which the semen to be exported was collected was free from rabies, tuberculosis, brucellosis, anthrax and contagious bovine pleuropneumonia during the period commencing 30 days prior to the date of collection of the semen to be exported and the 30 days after collection.

II.4.

At the time semen described above was collected, all bovine animals standing at the semen collection centre:

II.4.1.

came from herds and/or were born to dams which satisfy the conditions of paragraph 1(b) and (c) of Chapter I of Annex B to Directive 88/407/EEC;

II.4.2.

had tested negative, within the 30 days preceding the quarantine isolation period, to:

—	the tests referred to in points 1(d)(i), (ii) and (iii) of Chapter I of Annex B to Directive 88/407/EEC, and

—	a serum neutralization test or an ELISA test for infectious bovine rhinotracheitis/infectious pustular vulvo-vaginitis, and

—	a virus isolation test (fluorescent antibody test or immunoperoxidase test) for bovine viral diarrhoea, deferred until the animal reached the age of 6 months in the case of younger animals;

II.4.3.

had undergone the 30-day quarantine isolation period and had tested negative to the following health tests:

—	a serological test for brucellosis carried out in accordance with the procedure described in Annex C to Directive 64/432/EEC;

—	either an immunofluorescent antibody test or a culture test for Campylobacter fetus infection on a sample of preputial material or artificial vagina washings, or, in the case of a female animal, a vaginal mucus agglutination test;

—	a microscopic examination and culture test for Trichomonas foetus on a sample of preputial material or artificial vagina washings, or in the case of a female animal a vaginal mucus agglutination test;

II.4.4.

had tested negative, at least once a year, to the routine tests referred to in points 1(a), (b) and (c) of Chapter II of Annex B to Directive 88/407/EEC.

II.5.

At the time the semen described in Part I was collected,

II.5.1.

all female bovine animals in the centre had tested negative at least once a year to a vaginal mucus agglutination test for Campylobacter fetus infection, and

II.5.2.

all bulls used for semen production had tested negative either to an immunofluorescent antibody test or to a culture test for Campylobacter fetus infection on a sample of preputial material or artificial vagina washings carried out in 12 months prior to collection.

II.6.

The semen to be exported was obtained from donor bulls which:

II.6.1.

satisfy the conditions laid down in Annex C to Directive 88/407/EEC;

(3) either

[II.6.2.

were resident in the exporting country during the 6 months immediately prior to collection of the semen for export;]

(3) or

[II.6.2.

were imported from … (1) after spending less than 6 months in the exporting country and at the time of import satisfied the animal health conditions applying to donors of the semen which is intended for export to the Union;]

II.6.3.

stand in a semen collection centre at which:

(3) either

[all bovine animals were not vaccinated against infectious bovine rhinotracheitis and tested negative at least once a year to a serum neutralisation test or an ELISA test for infectious bovine rhinotracheitis/infectious pustular vulvo-vaginitis;]

(3) or

[bovine animals not vaccinated against infectious bovine rhinotracheitis tested negative, at least once a year, to a serum neutralisation test or an ELISA test for infectious bovine rhinotracheitis/infectious pustular vulvo-vaginitis, at which testing for infectious bovine rhinotracheitis was not carried out on bulls which had received their first vaccination against infectious bovine rhinotracheitis at the insemination centre after they had tested negative to a serum neutralisation test or an ELISA test for infectious bovine rhinotracheitis/infectious pustular vulvo-vaginitis and which had been regularly re-vaccinated at intervals of not more than 6 months since the first vaccination;]

(3) either

[II.6.4.

have not been vaccinated against infectious bovine rhinotracheitis,]

(3) or

[II.6.4.

have been vaccinated against infectious bovine rhinotracheitis in accordance with point II.6.3,]

II.6.5.

fulfil the import conditions for bovine semen laid down in the Bluetongue Chapter of the Terrestrial Animal Health Code of the OIE, depending on the status of the country or zone of residence;****

II.6.6.

were resident in the country of export in which the following serotypes of epizootic haemorrhagic disease (EHD) exist: … and tested negative on two occasions not more than 12 months apart to an agar-gel immuno-diffusion test (4) and to a virus neutralization test for all above-listed serotypes of EHD, carried out in approved laboratory on samples of blood taken prior to and not less than 21 days following collection of the semen;***

II.6.7.

were resident in the country of export in which the following serotypes of epizootic haemorrhagic disease (EHD) exist: … and tested negative, prior to entry and at 6-monthly intervals, to an agar-gel immuno-diffusion test(4) and a virus neutralization test for all above-listed serotypes of EHD, carried out in approved laboratory;**

II.6.8.

tested negative on two occasions not more than 12 months apart to a serum neutralization test for Akabane virus carried out in approved laboratory on samples of blood taken prior to and not less than 21 days following collection of the semen.*

II.7.

The semen to be exported was collected after the date on which the centre was approved by the competent national authorities of the exporting country.

II.8.

The semen to be exported was processed, stored and transported under conditions which satisfy the terms of Directive 88/407/EEC prior to its amendment by Directive 2003/43/EC.

Notes

This animal health certificate is intended for the entry into the Union of semen of bovine animals, including when the Union is not the final destination of the semen.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	“Place of dispatch” Indicate the unique approval number and the name and address of the semen collection centre of dispatch of the consignment to the Union. Only semen collection centre listed in accordance with Article 9(2) of Directive 88/407/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/index_en.htm.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Species”: Select amongst “ Bos taurus ”, “ Bison bison” or “Bubalus bubalis ” as appropriate. “Type”: Indicate semen. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where semen of the consignment is placed. “Date of collection/production” shall be prior to 31 December 2004 and indicated in the following format: dd/mm/yyyy. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected. “Quantity”: Indicate the number of straws of semen collected on a particular date from an identified donor bull complying with particular conditions for bluetongue and EHD.

Part II:

(1)	Only third country or territory, or zone thereof listed in Annex IX to Commission Implementing Regulation (EU) 2021/404 for semen of bovine animals.

(2)	Only semen collection centres listed in accordance with Article 9(2) of Directive 88/407/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/index_en.htm.

(3)	Delete if not applicable.

(4)	The standards for EHD virus diagnostic tests are described in the Bluetongue Chapter of the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals.

****	To be used only by Australia, Canada and the United States.

***	To be used only by Australia and the United States.

**	To be used only by Canada.

*	To be used only by Australia.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 42

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF OOCYTES AND EMBRYOS OF BOVINE ANIMALS COLLECTED OR PRODUCED, PROCESSED AND STORED IN ACCORDANCE WITH REGULATION (EU) 2016/429 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL AND COMMISSION DELEGATED REGULATION (EU) 2020/692 AFTER 20 APRIL 2021, DISPATCHED BY THE EMBRYO COLLECTION OR PRODUCTION TEAM BY WHICH THE OOCYTES OR EMBRYOS WERE COLLECTED OR PRODUCED (MODEL “BOV-OOCYTES-EMB-A-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17
	☐ Railway	☐ Road vehicle
	Identification

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity
Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model BOV-OOCYTES-EMB-A-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify that:

II.1.

The [oocytes] (1) [in vivo derived embryos] (1) [in vitro produced embryos] (1) [micromanipulated embryos] (1) of the consignment described in Part I are intended for artificial reproduction and were obtained from donor animals which originate from a third country or territory, or zone thereof:

II.1.1.

authorised for the entry into the Union of [oocytes] (1) [embryos] (1) of bovine animals and listed in Annex IX to Commission Implementing Regulation (EU) 2021/404;

(1) either

[II.1.2.

where foot and mouth disease was not reported for at least 24 months immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) and until the date of their dispatch;]

(1) (2) or

[II.1.2.

where foot and mouth disease was not reported for a period starting on the date ___/___/____ (dd/mm/yyyy) immediately prior to the date of collection of the [oocytes] (1) [embryos] (1) and until the date of their dispatch;]

II.1.3.

where infection with rinderpest virus, infection with Rift Valley fever virus, contagious bovine pleuropneumonia and lumpy skin disease were not reported for at least 12 months immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) and until the date of their dispatch;

II.1.4.

where no vaccination against infection with rinderpest virus, infection with Rift Valley fever virus and contagious bovine pleuropneumonia has been carried out for at least 12 months immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1), and until the date of their dispatch, and no vaccinated animals entered into the third country or territory, or zone thereof during that period, and

(1) either

[no vaccination against foot and mouth disease has been carried out for the same period, and no vaccinated animals entered into the third country or territory, or zone thereof during that period.]

(1) or

[vaccination against foot and mouth disease has been carried out for the same period, or vaccinated animals entered into the third country or territory, or zone thereof during that period.]

(1) [II.2.

The [oocytes] (1) [in vivo derived embryos] (1) of the consignment described in Part I have been collected, processed and stored, and dispatched by the embryo collection team (3) which:

II.2.1.

is approved and listed by the competent authority of the third country or territory;

II.2.2.

complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 2 of Annex I to Commission Delegated Regulation (EU) 2020/686.]

(1) [II.2.

The [oocytes] (1) [in vitro produced embryos] (1) of the consignment described in Part I have been collected or produced, processed and stored, and dispatched by the embryo production team (3) which:

II.2.1.

is approved and listed by the competent authority of the third country or territory;

II.2.2.

complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Parts 2 and 3 of Annex I to Delegated Regulation (EU) 2020/686.]

II.3.

The [oocytes] (1) [embryos] (1) of the consignment described in Part I were obtained from donor animals which originate from establishments:

II.3.1.

free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis), and they have never been kept previously in any establishment of a lower health status;

II.3.2.

free from infection with Brucella abortus, B. melitensis and B. suis and they have never been kept previously in any establishment of a lower health status;

(1) either

[II.3.3.

free from enzootic bovine leukosis and they have never been kept previously in any establishment of a lower health status;]

(1) or

[II.3.3.

not free from enzootic bovine leukosis and the official veterinarian responsible for the establishment of origin has certified that there has been no clinical case of enzootic bovine leukosis during at least the preceding 3 years prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) and during the collection period;]

(1) either

[II.3.4.

free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis and they have never been kept previously in any establishment of a lower health status;]

(1) or

[II.3.4.

not free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis and the official veterinarian responsible for the establishment of origin has certified that there has been no clinical case of infectious bovine rhinotracheitis/infectious pustular vulvovaginitis during at least the preceding 12 months prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) and during the collection period;]

II.3.5.

in which

(1) either

[surra (Trypanosoma evansi) has not been reported during the last 2 years prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1).]

(1) or

[surra (Trypanosoma evansi) has not been reported during the preceding 30 days prior to the date of [collection] (1) [production] (1)of the [oocytes] (1) [embryos] (1), and when the disease was reported in the establishments during the preceding 2 years prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1), following the last outbreak, the establishments have remained under movement restrictions until the date on which the infected animals have been removed from the establishments, and the remaining animals in the establishments have been subjected to a test for surra with one of the diagnostic methods provided for in Part 3 of Annex I to Commission Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months after the date on which the infected animals have been removed from the establishments.]

II.4.

The [oocytes] (1) [embryos] (1) of the consignment described in Part I were obtained from donor animals which:

II.4.1.

were not vaccinated against infection with rinderpest virus, infection with Rift Valley fever virus, contagious bovine pleuropneumonia and lumpy skin disease;

II.4.2.

remained for at least the preceding 6 months prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) in a third country or territory, or zone thereof referred to in box I.7;

II.4.3.

for at least the preceding 30 days prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) and during the collection period:

II.4.3.1.

II.4.3.2.

were kept in a single establishment where infection with Brucella abortus, B. melitensis and B. suis, infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis), rabies, anthrax, surra (Trypanosoma evansi), enzootic bovine leukosis, infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, bovine viral diarrhoea, infection with epizootic haemorrhagic disease virus and infection with bluetongue virus (serotypes 1-24) have not been reported;

II.4.3.3.

were not in contact with animals from establishments situated in a restricted zone due to the occurrence of diseases referred to in point II.4.3.1 or from establishments which do not meet the conditions referred to in point II.4.3.2;

II.4.3.4.

were not used for natural breeding;

II.4.4.

were examined by the team veterinarian or a team member and did not show symptoms or clinical signs of transmissible animal diseases on the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1);

II.4.5.

are individually identified as provided for in Article 21(1) of Delegated Regulation (EU) 2020/692;

II.4.6.

comply with the following conditions as regards foot and mouth disease:

II.4.6.1.

they come from establishments:

(a)	situated in an area where foot and mouth disease has not been reported within a 10-km radius centred on the establishments for at least 30 days immediately prior to the date of [collection] (1) [production] (1)of the [oocytes] (1) [embryos] (1);

(b)	in which foot and mouth disease has not been reported during at least 3 months immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1);

(1) either

[II.4.6.2.

they were not vaccinated against foot and mouth disease;]

(1) (4) or

[II.4.6.2.

they were vaccinated against foot and mouth disease during the last 12 months prior to the date of collection of the embryos, and:

II.4.6.2.1.

have not been vaccinated against foot and mouth disease within at least 30 days immediately prior to the date of collection of the embryos;

II.4.6.2.2.

the semen used for fertilisation was collected from a male donor that complies with the conditions set out in Part 5, Chapter I, point 1(b), of Annex II to Delegated Regulation (EU) 2020/686 or the semen complies with the conditions set out in Part 5, Chapter I, point 2, of Annex II to Delegated Regulation (EU) 2020/686;

II.4.6.2.3.

prior to the date of freezing, the embryos have been subjected to trypsin washing carried out in accordance with the recommendations of the IETS Manual (5);

II.4.6.2.4.

the embryos were stored deep frozen for at least 30 days from the date of collection, and during that period the donor animal has not shown clinical signs of foot and mouth disease;]

(1) (6) [II.4.7.

comply with at least one of the following conditions as regards infection with bluetongue virus (serotypes 1-24):

(1) either

[II.4.7.1.

they have been kept for at least 60 days prior to the date of and during collection of the oocytes in a third country or territory, zone thereof free from infection with bluetongue virus (serotypes 1-24) where no case of infection with bluetongue virus (serotypes 1-24) has been confirmed in the targeted animal population during the last 24 months;]

(1) (12) or

[II.4.7.2.

they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for at least 60 days prior to and during collection of the oocytes;]

(1) and/or

[II.4.7.3.

they have been kept in a vector-protected establishment for at least 60 days prior to the date of and during collection of the oocytes;]

(1) and/or

[II.4.7.4.

(1) and/or

[II.4.7.5.

they have been subjected to an agent identification test for bluetongue virus (serotypes 1-24), with negative results, on a blood sample taken on the date of collection of the oocytes;]]

II.4.8.

comply with at least one of the following conditions as regards infection with epizootic haemorrhagic disease virus (EHDV):

(1) either

[II.4.8.1.

they have been kept for at least 60 days prior to the date of and during collection of the [oocytes] (1)[embryos] (1) in a third country or territory, or zone thereof where EHDV has not been reported for at least the preceding 2 years within a radius of 150 km of the establishments;]

(1) (13) or

[II.4.8.2.

they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for at least 60 days prior to the date of and during collection of the [oocytes] (1)[embryos] (1);]

(1) and/or

[II.4.8.3.

they have been kept in a vector-protected establishment for at least 60 days prior to the date of and during collection of the [oocytes] (1)[embryos] (1);]

(1) or

[II.4.8.4.

were resident in the third country or territory or zone thereof of dispatch of the [oocytes] (1) [embryos] (1) of the consignment to the Union in which according to official findings the following serotypes of EHDV exist: … and have been subjected with negative results in each case to the following tests carried out in an official laboratory:

(1) either

[II.4.8.4.1.

a serological test able to detect specific antibodies against those serotypes of EHDV, with negative results, on blood samples taken between 28 and 60 days from the date of collection of the [oocytes] (1)[embryos] (1);]]

(1) and/or

[II.4.8.4.2.

an agent identification test for EHDV, with negative results, on blood samples taken on the date of collection of the [oocytes] (1)[embryos] (1).]]

(1) (6) [II.4.9.

comply with animal health requirements laid down in Part 1, Chapter III, of Annex II to Delegated Regulation (EU) 2020/686;]

II.5.

The [oocytes] (1) [embryos] (1) described in Part I:

II.5.1.

have been collected, processed and stored in accordance with animal health requirements set out in [Part 2] (1)[Part 3] (1) [Part 4] (1) [Part 5] (1)and Part 6 of Annex III to Delegated Regulation (EU) 2020/686;

II.5.2.

are placed in straws or other packages on which the mark is applied in accordance with requirements provided for in Article 83, point (a), of Delegated Regulation (EU) 2020/692 and that mark is indicated in box I.27;

II.5.3.

are transported in a container which:

II.5.3.1.

was sealed and numbered prior to the date of dispatch to the Union by the embryo collection or production team under responsibility of the team veterinarian, or by an official veterinarian, and the seal bears the number as indicated in box I.19;

II.5.3.2.

has been cleaned and either disinfected or sterilised before use, or is single-use container;

(1) (7) [II.5.3.3.

has been filled in with a cryogenic agent which has not been previously used for other products;]

(1) (8) [II.5.4.

are placed in straws or other packages which are securely and hermetically sealed;

II.5.5.

are transported in a container where the different types are separated from each other by physical compartments or by being placed in secondary protective bags.]

(1) (9) [II.6.

The [in vivo derived embryos] (1) [in vitro produced embryos] (1) [micromanipulated embryos] (1) of the consignment described in Part I were conceived by artificial insemination using semen coming from a semen collection centre, germinal product processing establishment or germinal product storage centre approved for the collection, processing and storage of semen by the competent authority of a third country or territory, or zone thereof listed in Annex IX to Implementing Regulation (EU) 2021/404 for semen of bovine animals or by the competent authority of a Member State, and were collected, processed and stored in accordance with the requirements of Part 1, Chapter I and Part 5, Chapters II and III, of Annex II, and Part 1 of Annex III to Delegated Regulation (EU) 2020/686.]

(1) (10) [II.7.

The following antibiotic or mixture of antibiotics (11) has been added to the collection, processing, washing or storage media: … .]

Notes

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	“Place of dispatch”: Indicate the unique approval number and the name and address of the embryo collection or production team of dispatch of the consignment of oocytes or embryos. Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of oocytes or embryos.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Species”: Select amongst “ Bos taurus ”, “ Bison bison ” or “ Bubalus bubalis ” as appropriate. “Type”: Specify if oocytes, in vivo derived embryos, in vitro produced embryos or micromanipulated embryos. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where oocytes or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which oocytes or embryos of the consignment were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the embryo collection or production team by which the oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate the number of straws or other packages with the same mark. “Test”: For BTV-test, indicate: “point II.4.7.4” or “point II.4.7.5”, or both; for EHD-test, indicate: “point II.4.8.4.1” or “point II.4.8.4.2”, or both, if relevant.

Part II:

(1)	Delete if not applicable.

(2)	Only for a third country or territory, or zone thereof with an opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(3)	Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.

(4)	Option available only for the consignment of in vivo derived embryos.

(5)

Manual of the International Embryo Technology Society — A procedural guide and general information for the use of embryo transfer technology emphasising sanitary procedures, published by the International Embryo Technology Society, 1 111 North Dunlap Avenue, Savoy, Illinois 61 874, USA (http://www.iets.org/).

(6)	Applicable for the consignment of oocytes and in vitro produced embryos.

(7)	Applicable for frozen oocytes or embryos.

(8)	Applicable for consignments where oocytes, in vivo derived embryos, in vitro produced embryos and micromanipulated embryos of bovine animals are placed and transported in one container.

(9)	Does not apply to oocytes.

(10)	Mandatory attestation in case antibiotics were added.

(11)	Insert the name(s) of the antibiotic(s) added and its (their) concentration.

(12)	For the zones with an entry “SF-BTV” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(13)	For the zones with an entry “SF-EHD” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 43

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF STOCKS OF IN VIVO DERIVED EMBRYOS OF BOVINE ANIMALS COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH COUNCIL DIRECTIVE 89/556/EEC BEFORE 21 APRIL 2021, DISPATCHED AFTER 20 APRIL 2021 BY THE EMBRYO COLLECTION TEAM BY WHICH THE EMBRYOS WERE COLLECTED (MODEL “BOV-in-vivo-EMB-B-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17
	☐ Railway	☐ Road vehicle
	Identification

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity

Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model BOV-in-vivo-EMB-B-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned, official veterinarian of the … certify that:

(exporting country) (1)

II.1.

The embryos to be exported:

II.1.1.

were collected in the exporting country, which according to official findings:

II.1.1.1.

was free from rinderpest during the 12 month period immediately prior to their collection;

(2) either

[II.1.1.2.

was free from foot-and-mouth disease and lumpy skin disease during the 12 month period immediately prior to their collection and did not carry out vaccination against foot-and-mouth disease or lumpy skin disease during that period.]

(2) or

[II.1.1.2.

was not free from foot-and-mouth disease or lumpy skin disease during the 12 months immediately prior to their collection or carried out vaccination against foot-and-mouth disease or lumpy skin disease during that period, and:

—	the embryos were not subjected to penetration of the zona pellucida,

—	the embryos were stored under approved conditions for at least 30 days immediately after their collection,

—

the donor females come from holdings on which no animal was vaccinated against foot-and-mouth disease or lumpy skin disease during the 30 days prior to collection and no animal of a susceptible species showed clinical signs of foot-and-mouth disease or lumpy skin disease during the 30 days prior to, and at least the 30 days after, the embryos were collected.]

II.1.2.

were collected by the embryo collection team (3) which:

—	had been approved in accordance with Chapter I of Annex A to Directive 89/556/EEC;

—	which carried out the collection, processing, storing and transport of the embryos in accordance with Chapter II of Annex A to Directive 89/556/EEC;

—	was subject to inspection by an official veterinarian at least twice a year.

II.1.3.

were collected and processed on premises situated in an area of at least 10 km radius centred on them, on which according to official findings there was no occurrence of foot-and-mouth disease, epizootic haemorrhagic disease, vesicular stomatitis, Rift Valley fever, contagious bovine pleuropneumonia or lumpy skin disease in the 30 days immediately prior to their collection and until dispatch to the Union, in the case of fresh embryos, or during the 30 days after collection, in the case of embryos subject to a mandatory storage for at least 30 days in accordance with point II.1.1.2.

II.1.4.

from the time of collection until 30 days thereafter or, in the case of fresh embryos until the day of their dispatch to the Union, they were stored on premises situated in an area of at least 10 km radius centred on them, on which according to official findings there was no occurrence of foot-and-mouth disease, vesicular stomatitis, Rift Valley fever, contagious bovine pleuropneumonia or lumpy skin disease.

II.1.5.

were collected from the donor females, which:

II.1.5.1.

were located, during the 30 days immediately prior to collection, on premises situated in an area of at least 10 km radius centred on them, on which, according to official findings, there was no occurrence of foot-and-mouth disease, bluetongue, epizootic haemorrhagic disease, vesicular stomatitis, Rift Valley fever, contagious bovine pleuropneumonia or lumpy skin disease;

II.1.5.2.

showed no clinical signs of disease on the day of collection;

II.1.5.3.

spent the 6 months immediately prior to collection within the territory of the exporting country in no more than two herds:

—	which, according to official findings, were free from tuberculosis during that time,

—	which, according to official findings, were free from brucellosis during that time,

—	which were free from enzootic bovine leukosis or in which no bovine animal showed clinical signs of enzootic bovine leukosis during the previous 3 years,

—	in which no bovine animal showed clinical signs of infectious bovine rhinotracheitis/infectious pustular vulvo-vaginitis during the previous 12 months.

II.1.6.

The embryos to be exported were conceived by artificial insemination using semen coming from semen collection or storage centres approved for the collection, processing and/or storage of semen by the competent authority of a third country or part thereof listed in Annex I to Implementing Decision 2011/630/EU (4) or by the competent authority of a Member State.

Notes

This animal health certificate is intended for the entry into the Union of embryos of bovine animals, including when the Union is not the final destination of the embryos.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	“Place of dispatch”: Indicate the unique approval number and the name and address of the embryo collection or production team of dispatch of the consignment of embryos. Only embryo collection or production teams listed in accordance with Article 8(2) of Directive 89/556/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of embryos.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Species”: Select amongst “ Bos taurus ”, “ Bison bison” or “Bubalus bubalis ” as appropriate. “Type”: Select " in vivo derived embryos". “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which embryos of the consignment were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the embryo collection team by which the embryos of the consignment were collected, processed and stored; and listed in accordance with Article 8(2) of Directive 89/556/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm. “Quantity”: Indicate the number of straws or other packages with the same mark.

Part II:

(1)	Only third country or territory, or zone thereof listed in Annex IX to Commission Implementing Regulation (EU) 2021/404 for embryos of bovine animals.

(2)	Delete if not applicable.

(3)	Only embryo collection teams listed in accordance with Article 8(2) of Directive 89/556/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.

(4)	OJ L 247, 24.9.2011, p. 32.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 44

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF STOCKS OF IN VITRO PRODUCED EMBRYOS OF BOVINE ANIMALS PRODUCED, PROCESSED AND STORED IN ACCORDANCE WITH COUNCIL DIRECTIVE 89/556/EEC BEFORE 21 APRIL 2021, CONCEIVED USING SEMEN COMPLYING WITH REQUIREMENTS OF COUNCIL DIRECTIVE 88/407/EEC, DISPATCHED AFTER 20 APRIL 2021 BY THE EMBRYO PRODUCTION TEAM BY WHICH THE EMBRYOS WERE PRODUCED (MODEL “BOV-in-vitro-EMB-C-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17
	☐ Railway	☐ Road vehicle
	Identification

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity

Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model BOV-in-vitro-EMB-C-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned, official veterinarian of … certify that:

(exporting country) (1)

II.1.

The embryos to be exported:

II.1.1.

were produced in the exporting country, which according to official findings:

II.1.1.1.

was free from rinderpest during the 12 month period immediately prior to their production;

(2) either

[II.1.1.2.

was free from foot-and-mouth disease and lumpy skin disease during the 12 month period immediately prior to their production and did not carry out vaccination against foot-and-mouth disease or lumpy skin disease during that period.]

(2) or

[II.1.1.2.

was not free from foot-and-mouth disease or lumpy skin disease during the 12 month period immediately prior to their production or carried out vaccination against foot-and-mouth disease or lumpy skin disease during that period, and:

—	the embryos were produced without penetration of the zona pellucida,

—	the embryos were stored under approved conditions for at least 30 days immediately after their production,

—

II.1.2.

were produced by the embryo production team (3) which:

—	had been approved in accordance with Chapter I of Annex A to Directive 89/556/EEC,

—	carried out the production, processing, storing and transport in accordance with Chapter II of Annex A to Directive 89/556/EEC,

—	was subject to inspection by an official veterinarian at least twice a year.

II.2.

The oocytes used in the production of the embryos to be exported were collected on premises situated in an area of at least 10 km radius centred on them, on which according to official findings there was no occurrence of foot-and-mouth disease, epizootic haemorrhagic disease, vesicular stomatitis, Rift Valley fever, contagious bovine pleuropneumonia or lumpy skin disease in the 30 days immediately prior to their collection and until their dispatch to the Union, in the case of fresh embryos, or during the 30 days after collection, in the case of embryos subject to a mandatory storage for at least 30 days in accordance with point II.1.1.2.

II.3.

From the time of collection of the oocytes until 30 days thereafter or, in the case of fresh embryos, until the day of dispatch, the embryos to be exported were stored on premises situated in an area of at least 10 km radius centred on them, on which according to official findings there was no occurrence of foot-and-mouth disease, vesicular stomatitis, Rift Valley fever, contagious bovine pleuropneumonia or lumpy skin disease.

II.4.

The donors of oocytes used in the production of the embryos to be exported:

II.4.1.

were located, during the 30 days immediately prior to collection of the oocytes, on premises situated in an area of at least 10-km radius on which, according to official findings, there was no occurrence of foot-and-mouth disease, bluetongue, epizootic haemorrhagic disease, vesicular stomatitis, Rift Valley fever, contagious bovine pleuropneumonia or lumpy skin disease;

II.4.2.

showed no clinical signs of disease on the day of collection;

II.4.3.

spent the 6 months immediately prior to collection within the territory of the exporting country in no more than two herds:

—	which, according to official findings, were free from tuberculosis during that time,

—	which, according to official findings, were free from brucellosis during that time,

—	which were free from enzootic bovine leukosis or in which no bovine animal showed clinical signs of enzootic bovine leukosis during the previous 3 years,

—	in which no bovine animal showed clinical signs of infectious bovine rhinotracheitis/infectious pustular vulvo-vaginitis during the previous 12 months;

(2) either

[II.4.4.

were kept in a bluetongue virus-free country or zone for at least 60 days prior to, and during, collection of the oocytes.]

(2) or

[II.4.4.

were kept during a seasonally free period or protected from the vector for at least 60 days prior to, and during, the collection of the oocytes, and the embryos were produced without penetration of the zona pellucida, except if the donors underwent a serological test to detect antibodies to the bluetongue virus group, carried out in accordance with the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals between 21 and 60 days after collection and giving negative results and the embryos were stored for at least 30 days.]

(2) or

[II.4.4.

underwent a serological test to detect antibodies to the bluetongue virus group, carried out in accordance with the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals between 21 and 60 days after collection and giving negative results, and the embryos were stored for at least 30 days.]

(2) or

[II.4.4.

underwent an agent identification test, carried out in accordance with the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals on a blood sample taken on the day of collection or the day of slaughtering and giving negative results – the embryos having been produced, in the latter case, without penetration of the zona pellucida.]

II.5.

The embryos to be exported were conceived by in vitro fertilisation using semen coming from semen collection or storage centres (4):

(2) either

[II.5.1.

approved in accordance with Article 5(1) of Directive 88/407/EEC and located in a Member State of the European Union, and the semen complies with the requirements of Directive 88/407/EEC.]

(2) or

[II.5.1.

approved in accordance with Article 9(1) of Directive 88/407/EEC and located in a third country or part thereof listed in Annex I to Implementing Decision 2011/630/EU, and the semen complies with the requirements set out in Section A of Part 1 of Annex II to that Decision.]

Notes

This animal health certificate is intended for the entry into the Union of embryos of bovine animals, including when the Union is not the final destination of the embryos.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	“Place of dispatch”: Indicate the unique approval number and the name and address of the embryo collection or production team of dispatch of the consignment of embryos. Only embryo collection or production teams listed in accordance with Article 8(2) of Directive 89/556/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of embryos.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Species”: Select amongst “ Bos taurus ”, “ Bison bison” or “Bubalus bubalis ” as appropriate. “Type”: Select " in vitro produced embryos". “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which embryos of the consignment were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the embryo production team by which the embryos of the consignment were produced, processed and stored; and listed in accordance with Article 8(2) of Directive 89/556/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm. “Quantity”: Indicate the number of straws or other packages with the same mark.

Part II:

(1)	Only third country or territory, or zone thereof listed in Annex IX to Commission Implementing Regulation (EU) 2021/404 for embryos of bovine animals.

(2)	Delete if not applicable.

(3)	Only embryo production teams listed in accordance with Article 8(2) of Directive 89/556/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.

(4)	Only semen collection centres approved by the competent authority of a third country or territory, or zone thereof listed in Annex IX to Implementing Regulation (EU) 2021/404 for semen of bovine animals or by the competent authority of a Member State.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 45

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF STOCKS OF IN VITRO PRODUCED EMBRYOS OF BOVINE ANIMALS PRODUCED, PROCESSED AND STORED IN ACCORDANCE WITH COUNCIL DIRECTIVE 89/556/EEC BEFORE 21 APRIL 2021, CONCEIVED USING SEMEN COMING FROM SEMEN COLLECTION OR STORAGE CENTRES APPROVED BY THE COMPETENT AUTHORITY OF THE EXPORTING THIRD COUNTRY OR TERRITORY, DISPATCHED AFTER 20 APRIL 2021 BY THE EMBRYO PRODUCTION TEAM BY WHICH THE EMBRYOS WERE PRODUCED (MODEL “BOV-in-vitro-EMB-D-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17
	☐ Railway	☐ Road vehicle
	Identification

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity
Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model BOV-in-vitro-EMB-D-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned, official veterinarian of … certify that:

(exporting country) (1)

II.1.

The embryos to be exported:

II.1.1.

were produced in the exporting country, which according to official findings:

II.1.1.1

was free from rinderpest during the 12 month period immediately prior to their production;

(2) either

[II.1.1.2.

(2) or

[II.1.1.2.

—	the embryos were produced without penetration of the zona pellucida,

—	the embryos were stored under approved conditions for at least 30 days immediately after their production,

—

II.1.2.

were produced by the embryo production team (3) which:

—	had been approved in accordance with Chapter I of Annex A to Directive 89/556/EEC;

—	carried out the production, processing, storing and transport of the embryos in accordance with Chapter II of Annex A to Directive 89/556/EEC;

—	was subject to inspection by an official veterinarian at least twice a year.

II.2.

The oocytes used in the production of the embryos to be exported were collected on premises situated in an area of at least 10 km radius centred on them, on which according to official findings there was no occurrence of foot-and-mouth disease, epizootic haemorrhagic disease, vesicular stomatitis, Rift Valley fever, contagious bovine pleuropneumonia or lumpy skin disease in the 30 days immediately prior to their collection and until their dispatch to the Union, in case of fresh embryos, or during the 30 days after collection, in case of embryos subject to a mandatory storage for at least 30 days in accordance with point II.2.2.

II.3.

II.4.

The donors of oocytes used in the production of the embryos to be exported:

II.4.1.

were located, during the 30 days immediately prior to collection of the oocytes, on premises within a 10-km radius of which, according to official findings, there was no occurrence of foot-and-mouth disease, bluetongue, epizootic haemorrhagic disease, vesicular stomatitis, Rift Valley fever, contagious bovine pleuropneumonia or lumpy skin disease;

II.4.2.

showed no clinical signs of disease on the day of collection;

II.4.3.

spent the 6 months immediately prior to collection within the territory of the exporting country in no more than two herds:

—	which, according to official findings, were free from tuberculosis during that time,

—	which, according to official findings, were free from brucellosis during that time,

—	which were free from enzootic bovine leukosis or in which no animal showed clinical signs of enzootic bovine leukosis during the previous 3 years,

—	in which no bovine animal showed clinical signs of infectious bovine rhinotracheitis/infectious pustular vulvo-vaginitis during the previous 12 months.

(2) either

[II.4.4.

were kept in a bluetongue virus-free country or zone for at least 60 days prior to, and during, collection of the oocytes.]

(2) or

[II.4.4.

were kept during a seasonally-free period or protected from the vector for at least 60 days prior to, and during, the collection of the oocytes, and the embryos were produced without penetration of the zona pellucida, except if the donors underwent a serological test to detect antibodies to the bluetongue virus group, carried out in accordance with the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals between 21 and 60 days after collection and giving negative results and the embryos were stored for at least 30 days.]

(2) or

[II.4.4.

(2) or

[II.4.4.

II.5.

The embryos to be exported were conceived by in vitro fertilisation using semen coming from semen collection or storage centres approved for the collection, processing and/or storage of semen by the competent authority of a third country or a part thereof listed in Annex I to Implementing Decision 2011/630/EU (4) or by the competent authority of a Member State.

Notes

This animal health certificate is intended for the entry into the Union of embryos of bovine animals, including when the Union is not the final destination of the embryos.

In accordance with Article 3, point (a), of Directive 89/556/EEC, the in vitro produced bovine embryos using semen from semen centres approved by the exporting third country or territory, entered into the Union subject to the conditions laid down in this animal health certificate are excluded from intra-Union trade.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	“Place of dispatch”: Indicate the unique approval number and the name and address of the embryo collection or production team of dispatch of the consignment of embryos. Only embryo collection or production teams listed in accordance with Article 8(2) of Directive 89/556/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of embryos.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Species”: Select amongst “ Bos taurus ”, “ Bison bison ” or “ Bubalus bubalis ” as appropriate. “Type”: Select “ in vitro produced embryos”. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which embryos of the consignment were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the embryo production team by which the embryos of the consignment were produced, processed and stored; and listed in accordance with Article 8(2) of Directive 89/556/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm. “Quantity”: Indicate the number of straws or other packages with the same mark.

Part II:

(1)	Only third country or territory, or zone thereof listed in Annex IX to Commission Implementing Regulation (EU) 2021/404 for embryos of bovine animals.

(2)	Delete if not applicable.

(3)	Only embryo production teams listed in accordance with Article 8(2) of Directive 89/556/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.

(4)	Only third country or territory, or zone thereof listed in Annex IX to Implementing Regulation (EU) 2021/404 for semen of bovine animals.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 46

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF GERMINAL PRODUCTS LISTED BELOW, DISPATCHED AFTER 20 APRIL 2021 FROM THE GERMINAL PRODUCT PROCESSING ESTABLISHMENT:

—	semen of bovine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of semen of bovine animals collected, processed and stored in accordance with Council Directive 88/407/EEC as amended by Council Directive 2003/43/EC, after 31 December 2004 and before 21 April 2021;

—	stocks of semen of bovine animals collected, processed and stored in accordance with Directive 88/407/EEC as amended by Council Directive 93/60/EEC, before 1 January 2005;

—	oocytes and embryos of bovine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of in vivo derived embryos of bovine animals collected, processed and stored in accordance with Council Directive 89/556/EEC before 21 April 2021;

—	stocks of in vitro produced embryos of bovine animals produced, processed and stored in accordance with Directive 89/556/EEC before 21 April 2021, and conceived using semen complying with requirements of Directive 88/407/EEC;

—

(MODEL “BOV-GP-PROCESSING-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity
Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model BOV-GP-PROCESSING-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify that:

II.1.

The germinal product processing establishment (1) described in box I.11 at which the [semen] (2) [oocytes] (2) [in vivo derived embryos] (2) [in vitro produced embryos] (2) [micromanipulated embryos] (2) to be dispatched to the Union was/were processed and stored:

II.1.1.

is located in a third country or territory, or zone thereof:

II.1.1.1.

authorised for the entry into the Union of [semen] (2) [oocytes] (2) [embryos] (2) of bovine animals and listed in Annex IX to Commission Implementing Regulation (EU) 2021/404;

(2) either

[II.1.1.2.

where foot and mouth disease was not reported for at least 24 months immediately prior to the date of [collection] (2/ [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch;]

(2) (3) or

[II.1.1.2.

where foot and mouth disease was not reported for a period starting on the date ___/___/____ (dd/mm/yyyy) immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch;]

II.1.1.3.

where infection with rinderpest virus, infection with Rift Valley fever virus, contagious bovine pleuropneumonia and lumpy skin disease were not reported for at least 12 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch;

II.1.1.4.

where no vaccination against infection with rinderpest virus, infection with Rift Valley fever virus and contagious bovine pleuropneumonia has been carried out for at least 12 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch, and no vaccinated animals entered into the third country or territory, or zone thereof during that period, and

(2) either

[no vaccination against foot and mouth disease has been carried out for the same period, and no vaccinated animals entered into the third country or territory, or zone thereof during that period;]

(2) or

[vaccination against foot and mouth disease has been carried out for the same period, or vaccinated animals entered into the third country or territory, or zone thereof during that period;]

II.1.2.

is approved and listed by the competent authority of the third country or territory;

II.1.3.

complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 4 of Annex I to Commission Delegated Regulation (EU) 2020/686.]

II.2.

The [semen] (2) [oocytes] (2) [embryos] (2) described in Part I is/are intended for artificial reproduction, and:

II.2.1.

has/have been [collected] (2) [produced] (2), [processed] (2) [stored] (2) [in a semen collection centre] (2) (4) [by an embryo collection team] (2) (4) [by an embryo production team] (2) (4) and [processed] (2) [stored] (2) in a germinal product processing establishment (4) [and stored in a germinal product storage centre] (2) (4) complying with requirements set out in [Part 1] (2) [Part 2] (2) [Part 3] (2) [Part 4] (2) [Part 5] (2) of Annex I to Delegated Regulation (EU) 2020/686, and:

(2) either

[located in the third country or territory of dispatch into the Union;]

(2) (5) and/or

[located in …, and has/have been introduced into the third country or territory of dispatch to the Union under conditions at least as strict as for the entry into the Union of [semen] (2) [oocytes] (2) [embryos] (2) of bovine animals in accordance with Regulation (EU) 2016/429 and Commission Delegated Regulation(EU) 2020/692;]

II.2.2.

was/were moved to the germinal product processing establishment described in box I.11 under conditions at least as strict as described in:

(2) either

[Model BOV-SEM-A-ENTRY (6);]

(2) and/or

[Model BOV-SEM-B-ENTRY (6);]

(2) and/or

[Model BOV-SEM-C-ENTRY (6);]

(2) and/or

[Model BOV-OOCYTES-EMB-A-ENTRY (6);]

(2) and/or

[Model BOV-in-vivo-EMB-B-ENTRY (6);]

(2) and/or

[Model BOV-in-vitro-EMB-C-ENTRY (6);]

(2) and/or

[Model BOV-in-vitro-EMB-D-ENTRY (6);]

(2) and/or

[Model BOV-GP-PROCESSING-ENTRY (6);]

(2) and/or

[Model BOV-GP-STORAGE-ENTRY (6);]]

II.2.3.

has/have been collected, processed and stored in accordance with animal health requirements set out in Annex III to Delegated Regulation (EU) 2020/686;

II.2.4.

is/are placed in straws or other packages on which the mark is applied in accordance with requirements provided for in Article 83, point (a), of Delegated Regulation (EU) 2020/692 and that mark is indicated in box I.27;

II.2.5.

is/are transported in a container which:

II.2.5.1.

was sealed and numbered prior to the date of dispatch from the germinal product processing establishment under responsibility of the centre veterinarian, or by an official veterinarian, and the seal bears the number as indicated in box I.19;

II.2.5.2.

has been cleaned and either disinfected or sterilised before use, or is single-use container;

(2) (7) [II.2.5.3.

has been filled in with a cryogenic agent which has not been previously used for other products.]

(2) (8) [II.2.6.

is/are placed in straws or other packages which are securely and hermetically sealed;

II.2.7.

is/are transported in a container where the different types are separated from each other by physical compartments or by being placed in secondary protective bags.]

Notes

This animal health certificate is intended for the entry into the Union of semen, oocytes and embryos of bovine animals, including when the Union is not the final destination of the semen, oocytes and embryos.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	“Place of dispatch”: Indicate the unique approval number and the name and address of the germinal product processing establishment of dispatch of the consignment of semen, oocytes and/or embryos. Only germinal product processing establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of semen, oocytes and/or embryos.
Box reference I.17	:	“Accompanying documents”: Number(s) of related original certificate(s) shall correspond to the serial number of the individual official document(s) or animal health certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I from the semen collection centre where the semen was collected, and/or from the embryo collection team and/or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment where the semen, oocytes or embryos were processed and stored, and/or from the germinal product storage centre where the semen, oocytes or embryos were stored, to the germinal product processing establishment described in box I.11. The original(s) of those document(s) or those certificate(s) or the officially endorsed copies thereof shall be attached to this animal health certificate.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Species”: Select amongst “ Bos taurus ”, “ Bison bison ” or “ Bubalus bubalis ” as appropriate. “Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Identification number”: Indicate identification number of each donor animal. “Identification mark”: Indicate mark on the straw or other packages where semen, oocytes and/or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which semen, oocytes and/or embryos of the consignment was/were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre, where the semen of the consignment was collected, and/or of the embryo collection team and/or the embryo production team by which oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate number of straws or other packages with the same mark.

Part II:

(1)	Only germinal product processing establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.

(2)	Delete if not applicable.

(3)	Only for a third country or territory, or zone thereof with an opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(4)	Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/index_en.htm.

(5)	Only a third country or territory, or zone thereof listed in Annex IX to Implementing Regulation (EU) 2021/404 and the Member States.

(6)

The original(s) of the document(s) or the animal health certificate(s) or the officially endorsed copies thereof that accompanied the semen, oocytes or embryos described in Part I from the semen collection centre where the semen was collected, and/or from the embryo collection team or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment where the semen, oocytes or embryos were processed and stored, and/or from the germinal product storage centre where the semen, oocytes or embryos were stored, to the germinal product processing establishment of dispatch of the semen, oocytes and/or embryos described in box I.11 shall be attached to this animal health certificate.

(7)	Applicable for frozen semen, oocytes or embryos.

(8)	Applicable for consignments where semen, oocytes, in vivo derived embryos, in vitro produced embryos and micromanipulated embryos of bovine animals are placed and transported in one container.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 47

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF GERMINAL PRODUCTS LISTED BELOW, DISPATCHED AFTER 20 APRIL 2021 FROM THE GERMINAL PRODUCT STORAGE CENTRE:

—	semen of bovine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of semen of bovine animals collected, processed and stored in accordance with Council Directive 88/407/EEC as amended by Council Directive 2003/43/EC, after 31 December 2004 and before 21 April 2021;

—	stocks of semen of bovine animals collected, processed and stored in accordance with Directive 88/407/EEC as amended by Council Directive 93/60/EEC, before 1 January 2005;

—	oocytes and embryos of bovine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of in vivo derived embryos of bovine animals collected, processed and stored in accordance with Council Directive 89/556/EEC before 21 April 2021;

—	stocks of in vitro produced embryos of bovine animals produced, processed and stored in accordance with Directive 89/556/EEC before 21 April 2021, and conceived using semen complying with requirements of Directive 88/407/EEC;

—

(MODEL “BOV-GP-STORAGE-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity
Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model BOV-GP-STORAGE-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify that:

II.1.

The germinal product storage centre (1) described in box I.11 at which the [semen] (2) [oocytes] (2) [in vivo derived embryos] (2) [in vitro produced embryos] (2) [micromanipulated embryos] (2) to be dispatched to the Union was/were stored:

II.1.1.

is located in a third country or territory, or zone thereof:

II.1.1.1.

authorised for the entry into the Union of [semen] (2) [oocytes] (2) [embryos] (2) of bovine animals and listed in Annex IX to Commission Implementing Regulation (EU) 2021/404;

(2) either

[II.1.1.2.

where foot and mouth disease was not reported for at least 24 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch;]

(2) (3) or

[II.1.1.2.

II.1.1.3.

where infection with rinderpest virus, infection with Rift Valley fever virus, contagious bovine pleuropneumonia and lumpy skin disease were not reported for at least 12 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch;

II.1.1.4.

where no vaccination against infection with rinderpest virus, infection with Rift Valley fever virus and contagious bovine pleuropneumonia has been carried out for at least 12 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch, and no vaccinated animals entered into the third country or territory, or zone thereof during that period, and

(2) either

[no vaccination against foot and mouth disease has been carried out for the same period, and no vaccinated animals entered into the third country or territory, or zone thereof during that period;]

(2) or

[vaccination against foot and mouth disease has been carried out for the same period, or vaccinated animals entered into the third country or territory, or zone thereof during that period;]

II.1.2.

is approved and listed by the competent authority of the third country or territory;

II.1.3.

complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 5 of Annex I to Commission Delegated Regulation (EU) 2020/686.

II.2.

The [semen] (2) [oocytes] (2) [embryos] (2) described in Part I is/are intended for artificial reproduction and:

II.2.1.

has/have been [collected] (2) [produced] (2) [processed] (2) [stored] (2) [in a semen collection centre] (2) (4) [by an embryo collection team] (2) (4) [by an embryo production team] (2) (4), [and] (2) [processed] (2) [stored] (2) [in a germinal product processing establishment] (2) (4) and stored in a germinal product storage centre (4) complying with requirements set out in [Part 1] (2) [Part 2] (2) [Part 3] (2) [Part 4] (2) [Part 5] (2) of Annex I to Delegated Regulation (EU) 2020/686, and:

(2) either

[located in the third country or territory of dispatch to the Union;]

(2) (5) and/or

[located in …, and has/have been introduced into the third country or territory of dispatch to the Union under conditions at least as strict as for the entry into the Union of [semen] (2) [oocytes] (2) [in vivo derived embryos] (2) [in vitro produced embryos] (2) of bovine animals in accordance with Regulation (EU) 2016/429 and Commission Delegated Regulation (EU) 2020/692;]

II.2.2.

was/were moved to the germinal product storage centre described in box I.11 under conditions at least as strict as described in:

(2) either

[Model BOV-SEM-A-ENTRY (6);]

(2) and/or

[Model BOV-SEM-B-ENTRY (6);]

(2) and/or

[Model BOV-SEM-C-ENTRY (6);]

(2) and/or

[Model 1 in Section A of Part 1 of Annex II to Commission Implementing Decision 2011/630/EU (6);]

(2) and/or

[Model 2 in Section B of Part 1 of Annex II to Implementing Decision 2011/630/EU (6);]

(2 ) and/or

[Model 3 in Section C of Part 1 of Annex II to Implementing Decision 2011/630/EU (6);]

(2) and/or

[Model BOV-OOCYTES-EMB-A-ENTRY (6);]

(2) and/or

[Model BOV-in-vivo-EMB-B-ENTRY (6);]

(2) and/or

[Model BOV-in-vitro-EMB-C-ENTRY (6);]

(2) and/or

[Model BOV-in-vitro-EMB-D-ENTRY (6);]

(2) and/or

[Model BOV-GP-PROCESSING-ENTRY (6);]

(2) and/or

[Model BOV-GP-STORAGE-ENTRY (6);]]

II.2.3.

has/have been collected, processed and stored in accordance with animal health requirements set out in Annex III to Delegated Regulation (EU) 2020/686;

II.2.4.

II.2.5.

is/are transported in a container which:

II.2.5.1.

was sealed and numbered prior to the date of dispatch from the germinal product storage centre under responsibility of the centre veterinarian, or by an official veterinarian, and the seal bears the number as indicated in box I.19;

II.2.5.2.

has been cleaned and either disinfected or sterilised before use, or is single-use container;

(2) (7) [II.2.5.3.

has been filled in with a cryogenic agent which has not been previously used for other products.]

(2) (8) [II.2.6.

is/are placed in straws or other packages which are securely and hermetically sealed;

II.2.7.

is/are transported in a container where the different types are separated from each other by physical compartments or by being placed in secondary protective bags.]

Notes

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	“Place of dispatch”: Indicate the unique approval number and the name and address of the germinal product storage centre of dispatch of the consignment of semen, oocytes and/or embryos. Only germinal product storage centre listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of semen, oocytes and/or embryos.
Box reference I.17	:	“Accompanying documents”: Number(s) of related original animal health certificate(s) shall correspond to the serial number of the individual official document(s) or animal health certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I from the semen collection centre, where the semen was collected, and/or from the embryo collection team and/or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment where the semen, oocytes or embryos were processed and stored, and/or from the germinal product storage centre where the semen, oocytes or embryos were stored, to the germinal product storage centre described in box I.11. The original(s) of those document(s) or those animal health certificate(s) or the officially endorsed copies thereof shall be attached to this animal health certificate.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Species”: Select amongst “ Bos taurus ”, “ Bison bison ” or “ Bubalus bubalis ” as appropriate. “Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Identification number”: Indicate identification number of each donor animal. “Identification mark”: Indicate mark on the straw or other packages where semen, oocytes and/or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which semen, oocytes and/or embryos of the consignment was/were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre, where the semen of the consignment was collected, and/or of the embryo collection team and/or the embryo production team by which oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate number of straws or other packages with the same mark.

Part II:

(1)	Only germinal product storage centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.

(2)	Delete if not applicable.

(3)	Only for a third country or territory, or zone thereof with an opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(4)	Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/index_en.htm.

(5)	Only a third country or territory, or zone thereof listed in Annex IX to Implementing Regulation (EU) 2021/404 and the Member States.

(6)

The original(s) of the document(s) or the animal health certificate(s) or the officially endorsed copies of thereof that accompanied the semen, oocytes or embryos described in Part I from the semen collection centre, where the semen was collected, and/or from the embryo collection team or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment where the semen, oocytes or embryos were processed and stored, and/or from the germinal product storage centre where the semen, oocytes or embryos were stored, to the germinal product storage centre of dispatch of the semen, oocytes and/or embryos described in box I.11 shall be attached to this animal health certificate.

(7)	Applicable for frozen semen, oocytes or embryos.

(8)	Applicable for consignments where semen, oocytes, in vivo derived embryos, in vitro produced embryos and micromanipulated embryos of bovine animals are placed and transported in one container.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 48

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF SEMEN OF OVINE AND CAPRINE ANIMALS COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH REGULATION (EU) 2016/429 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL AND COMMISSION DELEGATED REGULATION (EU) 2020/692 AFTER 20 APRIL 2021, DISPATCHED FROM THE SEMEN COLLECTION CENTRE WHERE THE SEMEN WAS COLLECTED (MODEL “OV/CAP-SEM-A-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17
	☐ Railway	☐ Road vehicle
	Identification

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity

Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model OV/CAP-SEM-A-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify that:

II.1.

The semen of the consignment described in Part I is intended for artificial reproduction and was obtained from donor animals which originate from a third country or territory, or zone thereof:

II.1.1.

authorised for the entry into the Union of semen of [ovine] (1) [caprine] (1) animals and listed in Annex X to Commission Implementing Regulation (EU) 2021/404;

(1) either

[II.1.2.

where foot and mouth disease was not reported for at least 24 months immediately prior to the date of collection of the semen and until the date of dispatch of the consignment to the Union;]

(1) (2) or

[II.1.2.

II.1.3.

where infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia were not reported for at least 12 months immediately prior to the date of collection of the semen and until the date of dispatch of the consignment to the Union;

II.1.4.

where no vaccination against infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia has been carried out for at least 12 months immediately prior to the date of collection of the semen and until the date of dispatch of the consignment to the Union, and no vaccinated animals entered into the third country or territory, or zone thereof during that period, and

(1) either

[no vaccination against foot and mouth disease has been carried out for the same period, and no vaccinated animals entered into the third country or territory, or zone thereof during that period;]

(1) or

[vaccination against foot and mouth disease has been carried out for the same period, or vaccinated animals entered into the third country or territory, or zone thereof during that period;]

II.2.

The semen described in Part I was obtained from donor animals which originated, prior to the date of commencement of the quarantine referred to in point II.4.6, from establishments:

II.2.1.

(1) either

[they were not vaccinated against foot and mouth disease;]

(1) or

[they were vaccinated against foot and mouth disease during the last 12 months prior to the date of collection of the semen but not during the last 30 days immediately prior to the date of collection of the semen, and 5% (with a minimum of five straws) of each quantity of semen taken from a donor animal at any time is submitted to a virus isolation test for foot and mouth disease with negative results;]

II.2.2.

free from infection with Brucella abortus, B. melitensis and B. suis and they have never been kept previously in any establishment of a lower health status;

(1) (3) [II.2.3.

in which infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has not been reported during the last 42 days;]

(1) (5) [II.2.3.

which are subjected to surveillance to detect infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in caprine animals in accordance with procedures provided for in Part 1, points 1 and 2, of Annex II to Commission Delegated Regulation (EU) 2020/688 during at least 12 months and during that period:

(i)	only caprine animals from establishments applying such surveillance have been introduced therein;

(1) either

[(ii)

infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has not been reported in the animals of the same species kept therein.]]

(1) or

[(ii)

infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has been reported in caprine animals kept therein and measures were taken in accordance with Part 1, point 3, of Annex II to Delegated Regulation (EU) 2020/688;]]

II.2.4.

in which

(1) either

[surra (Trypanosoma evansi) has not been reported during the last 2 years;]

(1) or

[surra (Trypanosoma evansi) has not been reported during the last 30 days and when the disease was reported in the establishments during the last 2 years, following the last outbreak, the establishments have remained under movement restrictions until the date on which the infected animals have been removed from the establishments, and the remaining animals in the establishments have been subjected to a test for surra with one of the diagnostic methods provided for in Part 3 of Annex I to Commission Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months after the date on which the infected animals have been removed from the establishments;]

(1) (3) [II.2.5.

where they have remained for a continuous period of at least 30 days and where ovine epididymitis (Brucella ovis) has not been reported during the last 12 months;]

(1) (4) [II.2.6.

where, during the last 30 days prior to their stay in the quarantine accommodation referred to in point II.4.6, they have been subjected to a serological test for ovine epididymitis (Brucella ovis) or any other test with an equivalent documented sensitivity and specificity, with negative results, required in accordance with Part 3, Chapter I, point 1(b), of Annex II to Delegated Regulation (EU) 2020/686;]

(1) (5) [II.2.7.

where infection with Burkholderia mallei (glanders) was not reported during the last 6 months.]

II.3.

The semen described in Part I has been collected, processed and stored, and dispatched from the semen collection centre (6) which:

II.3.1.

is approved and listed by the competent authority of the third country or territory;

II.3.2.

complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 1 of Annex I to Delegated Regulation (EU) 2020/686.

II.4.

The semen described in Part I was obtained from donor animals which:

II.4.1.

were not vaccinated against infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia;

II.4.2.

remained for at least 6 months prior to the date of collection of the semen in a third country or territory, or zone thereof referred to in box I.7.;

II.4.3.

did not show symptoms or clinical signs of transmissible animal diseases on the date of their admission to a semen collection centre and on the date of collection of the semen;

II.4.4.

are individually identified as provided for in Article 21(1) of Delegated Regulation (EU) 2020/692;

II.4.5.

for at least 30 days prior to the date of collection of the semen and during the collection period:

II.4.5.1.

were kept in establishments not situated in a restricted zone established due to the occurrence of foot and mouth disease, infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox or contagious caprine pleuropneumonia, or of an emerging disease relevant for ovine and caprine animals;

II.4.5.2.

were kept in a single establishment where infection with Brucella abortus, B. melitensis and B. suis, infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis), rabies, anthrax, surra (Trypanosoma evansi), infection with epizootic haemorrhagic disease virus, infection with bluetongue virus (serotypes 1-24) and, in the case of ovine animals and those caprine animals which are kept together with the ovine animals, ovine epididymitis (Brucella ovis) have not been reported;

II.4.5.3.

II.4.5.4.

were not used for natural breeding;

II.4.6.

have been subjected to a quarantine for at least 28 days in a quarantine accommodation, where only other cloven-hoofed animals with at least the same health status were present, which on the date of their admission to the semen collection centre complied with the following conditions:

II.4.6.1.

it was not situated in a restricted zone established due to diseases referred to in point II.4.5.1;

II.4.6.2.

none of the diseases referred to in point II.4.5.2 has been reported for at least 30 days;

II.4.6.3.

it was situated in an area where foot and mouth disease has not been reported within a 10-km radius centred on the quarantine accommodation for at least 30 days;

II.4.6.4.

has had no outbreak of foot and mouth disease reported during at least 3 months preceding the date of admission of the animals into the semen collection centre;

II.4.7.

were kept in the semen collection centre:

II.4.7.1.

which was not situated in a restricted zone established due to diseases referred to in point II.4.5.1;

II.4.7.2.

where none of the diseases referred to in point II.4.5.2 has been reported for at least 30 days prior to the date of collection of the semen, and

(1) (7) either

[at least 30 days following the date of collection of the semen;]

(1) (8) or

[until the date of dispatch of the consignment to the Union;]

II.4.7.3.

situated in an area where foot and mouth disease has not been reported within a 10-km radius centred on the semen collection centre for at least 30 days, and

(1) (7) either

[free from foot and mouth disease for at least 3 months prior to the date of collection of the semen and 30 days following the date of collection of the semen;]

(1) (8) or

II.4.8.

comply with at least one of the following conditions as regards infection with bluetongue virus (serotypes 1-24):

(1) either

[II.4.8.1.

they have been kept for at least 60 days prior to the date of and during collection of the semen in a third country or territory, or zone thereof free from infection with bluetongue virus (serotypes 1-24) where no case of infection with bluetongue virus (serotypes 1-24) has been confirmed in the targeted animal population during the last 24 months;]

(1) (13) or

[II.4.8.2.

they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for at least 60 days prior to the date of and during collection of the semen;]

(1) and/or

[II.4.8.3.

they have been kept in a vector-protected establishment for at least 60 days prior to the date of and during collection of the semen;]

(1) and/or

[II.4.8.4.

(1) and/or

[II.4.8.5.

they have been subjected to an agent identification test for bluetongue virus (serotypes 1-24), with negative results, on blood samples taken at the date of commencement and the date of final collection of the semen and during collection of the semen at intervals of at least every 7 days, in the case of the virus isolation test, or of at least every 28 days, in the case of PCR;]

II.4.9.

comply with at least one of the following conditions as regards infection with epizootic haemorrhagic disease virus (EHDV):

(1) either

[II.4.9.1.

they have been kept for at least 60 days prior to the date of and during collection of the semen in a third country or territory, or zone thereof where EHDV has not been reported within a radius of 150 km of the establishment for at least 2 years;]

(1) (14) or

[II.4.9.2.

they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for at least 60 days prior to the date of and during collection of the semen;]

(1) and/or

[II.4.9.3.

they have been kept in a vector-protected establishment for at least 60 days prior to and during collection of the semen;]

(1) or

[II.4.9.4.

were resident in the third country or territory of dispatch to the Union in which according to official findings the following serotypes of EHDV exist: … and have been subjected with negative results in each case to the following tests carried out in an official laboratory:

(1) either

[II.4.9.4.1.

(1) and/or

[II.4.9.4.2.

an agent identification test for EHDV, with negative results, on blood samples taken at the commencement and final collection of the semen and during the collection of the semen at intervals of at least every 7 days, in the case of virus isolation test, or of at least every 28 days, in the case of PCR.]]

II.4.10.

have been subjected to the following tests, carried out on samples taken within the of the last 30 days prior to the date of commencement of the quarantine referred to in point II.4.6, with negative results, required in accordance with Part 3, Chapter I, point 1(c), of Annex II to Delegated Regulation (EU) 2020/686:

II.4.10.1.

for infection with Brucella abortus, B. melitensis and B. suis, a serological test referred to in Part 1, point 1, of Annex I to Delegated Regulation (EU) 2020/688;

(1) (9) [II.4.10.2.

for ovine epididymitis (Brucella ovis), a serological test or any other test with an equivalent documented sensitivity and specificity;]

II.4.11.

have been subjected to the following tests, carried out on samples taken at least 21 days after the commencement of the quarantine referred to in point II.4.6, with negative results, required in accordance with Part 3, Chapter I, point 1(d), of Annex II to Delegated Regulation (EU) 2020/686:

II.4.11.1.

for infection with Brucella abortus, B. melitensis and B. suis, a serological test referred to in Part 1, point 1, of Annex I to Delegated Regulation (EU) 2020/688;

(1) (9) [II.4.11.2.

for ovine epididymitis (Brucella ovis), a serological test or any other test with an equivalent documented sensitivity and specificity;]

II.4.12.

have been subjected at semen collection centre, at least once a year, to the following compulsory routine tests, required in accordance with Part 3, Chapter I, point 2, of Annex II to Delegated Regulation (EU) 2020/686:

II.4.12.1.

for infection with Brucella abortus, B. melitensis and B. suis, a serological test referred to in Part 1, point 1, of Annex I to Delegated Regulation (EU) 2020/688;

(1) (9) [II.4.12.2.

for ovine epididymitis (Brucella ovis), a serological test or any other test with an equivalent documented sensitivity and specificity.]]

(10) [II.4.13.

comply with the following conditions as regards classical scrapie:

II.4.13.1.

they have been kept continuously since birth in a third country or territory where the following conditions are fulfilled:

II.4.13.1.1.

classical scrapie is compulsorily notifiable;

II.4.13.1.2.

an awareness, surveillance and monitoring system is in place;

II.4.13.1.3.

ovine and caprine animals affected with classical scrapie are killed and completely destroyed;

II.4.13.1.4.

the feeding to ovine and caprine animals of meat-and-bone meal, or greaves of ruminant origin, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health, has been banned and effectively enforced in the whole third country or territory for at least 7 years;

(1) either

[II.4.13.2.

they have been kept continuously for the last 3 years prior to the date of collection of the semen to be dispatched to the Union in a holding or holdings which has/have fulfilled during that period all the requirements set out Chapter A, Section A, points 1.3.(a) to (f), of Annex VIII to Regulation (EC) No 999/2001, except during the period when they were kept at a semen collection centre that complied during that period with the conditions set out in Chapter A, Section A, point 1.3.(c)(iv), of Annex VIII to that Regulation.]]

(1) or

[II.4.13.2.

they are ovine animals of the ARR/ARR prion protein genotype.]]

(1) (15) or

[II.4.13.2.

they are caprine animals carrying at least one of the K222, D146 or S146 alleles.]]

II.5.

The semen of the consignment described in Part I:

II.5.1.

has been collected, processed and stored in accordance with animal health requirements set out in Part 1, points 1 and 2, of Annex III to Delegated Regulation (EU) 2020/686;

II.5.2.

II.5.3.

is transported in a container which:

II.5.3.1.

was sealed and numbered prior to the date of dispatch from the semen collection centre under responsibility of the centre veterinarian, or by an official veterinarian, and the seal bears the number as indicated in box I.19;

II.5.3.2.

has been cleaned and either disinfected or sterilised before use, or is single-use container;

(1) (7) [II.5.3.3.

has been filled in with a cryogenic agent which has not been previously used for other products.]

(1) (11) [II.6.

Where an antibiotic or a mixture of antibiotics was added to the semen:

II.6.1.

The following antibiotic or mixture of antibiotics has been added to the semen after final dilution, or is contained in the used semen diluents: … (12),

II.6.2.

Notes

This animal health certificate is intended for the entry into the Union of semen of ovine and caprine animals, including when the Union is not the final destination of the semen.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	“Place of dispatch”: Indicate the unique approval number and the name and address of the semen collection centre of dispatch of the consignment of semen. Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of semen.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Species”: Select amongst “ Ovis aries ” or “ Capra hircus ” as appropriate. “Type”: Indicate semen. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where semen of the consignment is placed. “Date of collection/production”: Indicate the date on which semen of the consignment was collected. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected. “Quantity”: Indicate the number of straws or other packages with the same mark. “Test”: For BTV-test, indicate: “point II.4.8.4” or “point II.4.8.5”, or both, for EHD-test, indicate: “point II.4.9.4.1” or “point II.4.9.4.2”, or both, if relevant.

Part II:

(1)	Delete if not applicable.

(2)	Only for a third country or territory, or zone thereof with an opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(3)	Applicable for ovine animals.

(4)	Applicable for ovine animals and for those caprine animals which are kept together with ovine animals.

(5)	Applicable for caprine animals.

(6)	Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm.

(7)	Applicable for frozen semen.

(8)	Applicable for fresh and chilled semen.

(9)	Applicable for ovine animals and for those caprine animals which are kept together with ovine animals.

(10)	Delete if the Union is not the final destination of the semen.

(11)	Mandatory attestation in case antibiotics were added.

(12)	Insert the name(s) of the antibiotic(s) added and its(their) concentration or the commercial name of the semen diluent containing antibiotic(s).

(13)	For the zones with an entry “SF-BTV” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(14)	For the zones with an entry “SF-EHD” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(15)	Alternative applicable from 14 April 2024.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 49

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF STOCKS OF SEMEN OF OVINE AND CAPRINE ANIMALS COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH COUNCIL DIRECTIVE 92/65/EEC BEFORE 21 APRIL 2021, DISPATCHED AFTER 20 APRIL 2021 FROM THE SEMEN COLLECTION CENTRE WHERE THE SEMEN WAS COLLECTED (MODEL “OV/CAP-SEM-B-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17
	☐ Railway	☐ Road vehicle
	Identification

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity
Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model OV/CAP-SEM-B-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned, official veterinarian, hereby certify that:

II.1.

The exporting country …

(name of exporting country) (1)

II.1.1.

has been free from rinderpest, infection with peste des petits ruminants virus, sheep and goat pox, contagious caprine pleuropneumonia and Rift Valley fever during the 12 month period immediately prior to collection of the semen to be exported and until its date of dispatch to the Union and no vaccination against these diseases took place during that period;

II.1.2.

has been free from foot-and-mouth disease during the 12 month period immediately prior to collection of the semen to be exported and until its date of dispatch to the Union and no vaccination against this disease took place during that period.

II.2.

The semen collection centre (2) described in box I.11. and at which the semen to be exported was collected and stored:

II.2.1.

met the conditions for the approval of semen collection centres laid down in Chapter I(I)(1) of Annex D to Directive 92/65/EEC;

II.2.2.

was operated and supervised in accordance with the conditions applicable to semen collection centres and storage centres laid down in Chapter I(II)(1) of Annex D to Directive 92/65/EEC.

II.3.

The [ovine] (3) [caprine] (3) animals standing at the semen collection centre:

II.3.1.

prior to their stay in the quarantine accommodation described in point II.3.3,

(3) (4) either

[II.3.1.1.

originate from the region described in box I.8, which has been recognised as officially brucellosis (B. melitensis)-free,]

(3) or

[II.3.1.1.

have belonged to a holding which has obtained and maintained its officially brucellosis (B. melitensis)-free status in accordance with Directive 91/68/EEC,]

(3) or

[II.3.1.1.

originate from a holding, where in respect of brucellosis (B. melitensis) all susceptible animals have been free from clinical or any signs of this disease for the last 12 month period, none of the ovine and caprine animals have been vaccinated against this disease, save those vaccinated with Rev. 1 vaccine more than 2 years ago, and all ovine and caprine animals over 6 months of age have been subjected to at least two tests (5), carried out with negative results on samples taken on … (date) and on … (date) at least 6 months apart, the latter being within 30 days before entry into the quarantine accommodation,]

and

have not been kept previously in a holding of a lower status;

II.3.1.2.

have been kept continuously for at least 60 days on a holding where no case of contagious epididymitis (Brucella ovis) has been diagnosed in the last 12 month period,

(3) and

[they are animals of the ovine species and have undergone during the 60 days prior to their stay in the quarantine accommodation described in point II.3.3 a complement fixation test, or any other test with an equivalent documented sensitivity and specificity, to detect contagious epididymitis with result of less than 50 ICFTU/ml;]

II.3.1.3.

to the best of my knowledge do not come from holdings and have not been in contact with animals of a holding, in which, based on the official notification system and according to the written declaration made by the owner, any of the following diseases has been clinically detected within the periods referred to in points (a) to (d) prior to their stay in the quarantine accommodation described in point II.3.3:

(a)	contagious agalactia of sheep or goats (Mycoplasma agalactiae, Mycoplasma capricolum, Mycoplasma mycoides var. mycoides “ large colony”), within the last 6 months,

(b)	paratuberculosis and caseous lymphadenitis, within the last 12 month period,

(c)	pulmonary adenomatosis, within the last 3 years;

(3) either

[(d)	Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last 3 years;]

(3) or

[(d)	Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last 12 month period, and all the infected animals were slaughtered and remaining animals subsequently reacted negatively to two tests carried out at least 6 months apart;]

II.3.2.

have undergone the following tests carried out on a blood sample collected within the 28 days preceding the commencement of the period of quarantine specified in point II.3.3 for:

—	brucellosis (B. melitensis), with negative results in each case in accordance with Annex C to Directive 91/68/EEC;

—	contagious epididymitis (Brucella. ovis), in the case of sheep only, with negative results in each case in accordance with Annex D to Directive 91/68/EEC, or any other test with an equivalent documented sensitivity and specificity;

—	border disease in accordance with point 1.4(c) of Chapter II(II) of Annex D to Directive 92/65/EEC;

II.3.3.

have satisfied the quarantine isolation period of at least 28 days in a quarantine accommodation specifically approved for the purpose by the competent authority and during that period:

II.3.3.1.

only animals of at least the same health status were present in the quarantine accommodation;

II.3.3.2.

the animals have undergone the following tests, carried out by the laboratory approved by the competent authority of the exporting country on samples taken not earlier than 21 days after the animals were admitted to the quarantine accommodation, for:

—	brucellosis (B. melitensis) with negative results in each case in accordance with Annex C to Directive 91/68/EEC;

—	contagious epididymitis (Brucella ovis), in the case of sheep only, with negative results in each case in accordance with Annex D to Directive 91/68/EEC, or any other test with an equivalent documented sensitivity and specificity;

—	border disease in accordance with point 1.6 of Chapter II(II) of Annex D to Directive 92/65/EEC;

II.3.4.

have undergone at least once a year the routine tests for:

—	brucellosis (B. melitensis) with negative results in each case in accordance with Annex C to Directive 91/68/EEC;

—	contagious epididymitis (Brucella ovis), in the case of sheep only, with negative results in each case in accordance with Annex D to Directive 91/68/EEC, or any other test with an equivalent documented sensitivity and specificity;

—	border disease in accordance with point 5(c) of Chapter II(II) of Annex D to Directive 92/65/EEC.

II.4.

The semen to be exported was obtained from donor [rams] (3) [bucks] (3) which:

II.4.1.

were admitted to the approved semen collection centre with the express permission of the centre veterinarian;

II.4.2.

show no clinical signs of disease on the day of admission to the approved semen collection centre and on the day the semen was collected;

(3) either

[II.4.3.

have not been vaccinated against foot-and-mouth disease during the 12 month period prior to collection of the semen;]

(3) or

[II.4.3.

have been vaccinated against foot-and-mouth disease at least 30 days prior to the collection, and 5% (with a minimum of five straws) of each collection have been submitted to a virus isolation test for foot-and-mouth disease with negative results;]

II.4.4.

have been kept at an approved semen collection centre for a continuous period of at least 30 days immediately prior to collection of the semen, in the case of collections of fresh semen;

II.4.5.

have not served naturally after their entry to the quarantine accommodation described in point II.3.3 and up to and including the day of semen collection;

II.4.6.

have been kept at approved semen collection centres:

II.4.6.1.

which have been free from foot-and-mouth disease for at least 3 months prior to collection of the semen and 30 days after collection or, in the case of fresh semen, until the date of dispatch, and which are situated in the centre of an area of 10 kilometres radius in which there has been no case of foot-and-mouth disease for at least 30 days prior to collection of the semen;

II.4.6.2.

which have been free, during the period commencing 30 days prior to collection and ending 30 days after collection of the semen or, in the case of fresh semen, until the date of dispatch, from brucellosis (B. melitensis), contagious epididymitis (Brucella. ovis), anthrax and rabies;

(3) either

[II.4.7.

have remained in the exporting country for at least the past 6 months prior to collection of the semen to be exported;]

(3) or

[II.4.7.

during the last 6 months prior to collection of the semen they complied with the animal health conditions applying to donors of the semen which is intended for export to the Union and they have been imported into the exporting country at least 30 days prior to collection of the semen from … (1);]

(3) either

[II.4.8.

were kept in a bluetongue virus-free country or zone for at least 60 days prior to, and during, collection of the semen;]

(3) or

[II.4.8.

were kept during a bluetongue virus seasonally-free period in a seasonally-free zone for at least 60 days prior to, and during collection of the semen;]

(3) or

[II.4.8.

were kept in a vector-protected establishment for at least 60 days prior to, and during collection of the semen;]

(3) or

[II.4.8.

were subjected to a serological test for the detection of antibody to the bluetongue virus group, carried out in accordance with the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, with negative results, on blood samples taken at least every 60 days throughout the collection period and between 21 and 60 days after the final collection for this consignment of semen;]

(3) or

[II.4.8.

were subjected to an agent identification test for bluetongue virus, carried out in accordance with the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals with negative results on blood samples taken at commencement and final collection for this consignment of semen and at least every 7 days (virus isolation test) or at least every 28 days (PCR test) during collection for this consignment of semen;]

(3) (6) either

[II.4.9.

were resident in the exporting country which according to official findings is free from epizootic haemorrhagic disease (EHD);]

(3) or

[II.4.9.

(3) either

[a serological test (7) for the detection of antibody to the EHDV group carried out in an approved laboratory on samples of blood taken on two occasions not more than 12 months apart prior to and not less than 21 days after the final collection for this consignment of semen.]]

(3) or

[a serological test (7) for the detection of antibody to the EHDV group, carried out in an approved laboratory on samples of blood taken at intervals of not more than 60 days throughout the collection period and between 21 and 60 days after the final collection for this consignment of semen.]]

(3) or

[an agent identification test (7) carried out in an approved laboratory on samples of blood taken at commencement and conclusion of, and at least every 7 days (virus isolation test) or at least every 28 days (PCR test) during collection for this consignment of semen.]]

II.4.10.

comply with the following conditions as regards classical scrapie:

II.4.10.1.

they have been kept continuously since birth in a country where the following conditions are fulfilled:

II.4.10.1.1.

classical scrapie is compulsorily notifiable;

II.4.10.1.2.

an awareness, surveillance and monitoring system is in place;

II.4.10.1.3.

ovine and caprine animals affected with classical scrapie are killed and completely destroyed;

II.4.10.1.4.

the feeding to ovine and caprine animals of meat-and-bone meal, or greaves of ruminant origin has been banned and effectively enforced in the whole country for a period of at least 7 years;

And

(3) either

[II.4.10.2.

they have been kept continuously for the last 3 years preceding the date of the collection of the semen to be exported in a holding or holdings which has/have been complying for the last 3 years before the collection of the semen to be exported with the requirements set out in points 1.3. (a) to (f) of Section A of Chapter A of Annex VIII to Regulation (EC) No 999/2001;]

(3) or

[II.4.10.2.

they are ovine animals of the ARR/ARR prion protein genotype.]

II.5.

The semen to be exported:

II.5.1.

was collected after the date on which the semen collection centre was approved by the competent authority of the exporting country;

II.5.2.

was collected, processed, preserved, stored and transported in accordance with the requirements applicable to semen laid down in Chapter III(I) of Annex D to Directive 92/65/EEC;

II.5.3.

was sent to the place of loading in a sealed container in accordance with the requirements for semen to be subject to trade laid down in point 1.4 of Chapter III(I) of Annex D to Directive 92/65/EEC and bearing the number indicated in box I.19.

(3) either

[II.6.

No antibiotics were added to the semen.]

(3) or

[II.6.

The following antibiotic or combination of antibiotics was added to produce a concentration in the final diluted semen of not less than (8): …

… .]

Notes

This animal health certificate is intended for the entry into the Union of semen of ovine and caprine animals, including when the Union is not the final destination of the semen.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

This animal health certificate shall be completed according to the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235.

Part I:

Box reference I.11	:	“Place of dispatch” Indicate the unique approval number and the name and address of the semen collection centre of dispatch of the consignment of semen. Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Species”: Select amongst “ Ovis aries ” or “ Capra hircus ” as appropriate. “Type”: Indicate semen. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where semen of the consignment is placed. “Date of collection/production” Indicate the date on which semen of the consignment were collected. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre in which the semen of the consignment was collected. “Quantity”: Indicate the number of straws or other packages with the same mark.

Part II:

(1)	Only third country or territory, or zone thereof listed in Annex X to Commission Implementing Regulation (EU) 2021/404 for semen of ovine and caprine animals.

(2)	Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm.

(3)	Delete if not applicable.

(4)	Only for the third country or territory, or zone thereof appearing with an entry "V" in column 6 of the table in Part 1 of Annex I to Commission Regulation (EU) No 206/2010 (OJ L 73, 20.3.2010, p. 1.).

(5)	Tests shall be carried out in accordance with Annex C to Directive 91/68/EEC.

(6)	See remarks for exporting country concerned in Annex I to Decision 2010/472/EU.

(7)	The standards for EHD virus diagnostic tests are described in the Bluetongue Chapter of the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals.

(8)	Insert names and concentrations.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 50

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF OOCYTES AND EMBRYOS OF OVINE AND CAPRINE ANIMALS COLLECTED OR PRODUCED, PROCESSED AND STORED IN ACCORDANCE WITH REGULATION (EU) 2016/429 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL AND COMMISSION DELEGATED REGULATION (EU) 2020/692 AFTER 20 APRIL 2021, DISPATCHED BY THE EMBRYO COLLECTION OR PRODUCTION TEAM BY WHICH THE OOCYTES OR EMBRYOS WERE COLLECTED OR PRODUCED (MODEL “OV/CAP-OOCYTES-EMB-A-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17
	☐ Railway	☐ Road vehicle
	Identification

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity

Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model OV/CAP-OOCYTES-EMB-A-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify that:

II.1.

The [oocytes] (1) [in vivo derived embryos] (1) [in vitro produced embryos] (1) [micromanipulated embryos] (1) described in Part I are intended for artificial reproduction and were obtained from donor animals which originate from a third country or territory, or zone thereof:

II.1.1.

authorised for the entry into the Union of [oocytes] (1) [embryos] (1) of [ovine] (1) [caprine] (1) animals and listed in Annex X to Commission Implementing Regulation (EU) 2021/404;

(1) either

[II.1.2.

(1) (2) or

[II.1.2.

II.1.3.

where infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia were not reported for at least 12 months immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) and until the date of their dispatch;

II.1.4.

where no vaccination against infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia has been carried out for at least 12 months immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) and until the date of their dispatch, and no vaccinated animals entered into the third country or territory, or zone thereof during that period, and

(1) either

[no vaccination against foot and mouth disease has been carried out for the same period and no vaccinated animals entered into the third country or territory, or zone thereof during that period;]

(1) or

[vaccination against foot and mouth disease has been carried out for the same period, or vaccinated animals entered into the third country or territory, or zone thereof during that period.]

(1) [II.2.

The [oocytes] (1) [in vivo derived embryos] (1) described in Part I have been collected, processed and stored, and dispatched by the embryo collection team (3) which:

II.2.1.

is approved and listed by the competent authority of the third country or territory;

II.2.2.

complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 2 of Annex I to Commission Delegated Regulation (EU) 2020/686.]

(1) [II.2.

The [oocytes] (1) [in vitro produced embryos] (1) [micromanipulated embryos] (1) described in Part I have been collected or produced, processed and stored, and dispatched by the embryo production team (3) which:

II.2.1.

is approved and listed by the competent authority of the third country or territory;

II.2.2.

complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Parts 2 and 3 of Annex I to Delegated Regulation (EU) 2020/686.]

II.3.

The [oocytes] (1) [embryos] (1) described in Part I were obtained from donor animals which originate from establishments:

II.3.1.

free from infection with Brucella abortus, B. melitensis and B. suis and they have never been kept previously in any establishment of a lower health status.

(1) (4) [II.3.2.

in which infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has not been reported during the last 42 days;]

(1) (5) [II.3.2.

which is subjected to surveillance to detect infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in caprine animals kept therein in accordance with procedures provided for in Part 1, points (1) and (2), of Annex II to Commission Delegated Regulation (EU) 2020/688 during at least 12 months and during that period:

(i)	only caprine animals from establishments applying such surveillance have been introduced therein;

(1) either

[(ii)

infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has not been reported in the animals of the same species kept therein.]]

(1) or

[(ii)

II.3.3.

in which

(1) either

[surra (Trypanosoma evansi) has not been reported in the establishments during the last 2 years.]

(1) or

II.4.

The [oocytes] (1) [embryos] (1) described in Part I were obtained from donor animals which:

II.4.1.

II.4.2.

remained for at least 6 months immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) in a third country or territory, or zone thereof referred to in box I.7;

II.4.3.

for at least 30 days immediately prior to the date of [collection] (1) [production] (1)of the [oocytes] (1) [embryos] (1) and during the [collection] (1) [production] (1) period:

II.4.3.1.

were kept in establishments not situated in a restricted zone established due to the occurrence of foot and mouth disease, infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox or contagious caprine pleuropneumonia, or of an emerging disease relevant for ovine and caprine animals;

II.4.3.2.

were kept in a single establishment where infection with Brucella abortus, B. melitensis and B. suis, infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis), rabies, anthrax, surra (Trypanosoma evansi), infection with epizootic haemorrhagic disease virus, infection with bluetongue virus (serotypes 1-24) and, in case of ovine animals and those caprine animals which are kept together with ovine animals, ovine epididymitis (Brucella ovis) have not been reported;

II.4.3.3.

II.4.3.4.

were not used for natural breeding;

II.4.4.

II.4.5.

are individually identified as provided for in Article 21(1) of Delegated Regulation (EU) 2020/692;

II.4.6.

comply with the following conditions as regards foot and mouth disease:

II.4.6.1.

they come from establishments:

(a)	situated in an area where foot and mouth disease has not been reported within a 10-km radius centred on the establishments for at least 30 days immediately prior to the date of [collection] (1) [production] (1)of the [oocytes] (1) [embryos] (1);

(b)	in which foot and mouth disease has not been reported during at least 3 months immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1);

(1) either

[II.4.6.2.

they were not vaccinated against foot and mouth disease;]

(1) (6) or

[II.4.6.2.

they were vaccinated against foot and mouth disease during 12 months immediately prior to the date of collection of the embryos and

II.4.6.2.1.

have not been vaccinated against foot and mouth disease within at least 30 days immediately prior to the date of collection of the embryos;

II.4.6.2.2.

II.4.6.2.3.

prior to freezing, the embryos have been subjected to trypsin washing carried out in accordance with the recommendations of the IETS Manual (7);

II.4.6.2.4.

the embryos were stored deep frozen for at least 30 days from the date of collection, and during this period the donor animal has not shown clinical signs of foot and mouth disease;]

II.4.7.

comply with at least one of the following conditions as regards infection with bluetongue virus (serotypes 1-24):

(1) either

[II.4.7.1.

they have been kept for at least 60 days immediately prior to the date of and during collection of the [oocytes] (1) [embryos] (1)in a third country or territory, or zone thereof free from infection with bluetongue virus (serotypes 1-24) where no case of infection with bluetongue virus (serotypes 1-24) has been confirmed in the targeted animal population during the last 24 months;]

(1) (14) or

[II.4.7.2.

they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for at least 60 days immediately prior to the date of and during collection of the [oocytes] (1) [embryos] (1);]

(1) and/or

[II.4.7.3.

they have been kept in a vector-protected establishment for at least 60 days immediately prior to the date of and during collection of the [oocytes] (1) [embryos] (1)]

(1) and/or

[II.4.7.4.

(1) and/or

[II.4.7.5.

they have been subjected to an agent identification test for bluetongue virus (serotypes 1-24), with negative results, on a blood sample taken on the date of collection of the [oocytes] (1) [embryos] (1);]

II.4.8.

comply with at least one of the following conditions as regards infection with epizootic haemorrhagic disease virus (EHDV):

(1) either

[II.4.8.1.

they have been kept for at least 60 days prior to the date of and during collection of the [oocytes] (1) [embryos] (1) in a third country or territory, or zone thereof where EHDV has not been reported within a radius of 150 km of the establishment for at least the preceding 2 years;]

(1) (15) or

[II.4.8.2.

they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for at least 60 days prior to the date of and during collection of the [oocytes] (1) [embryos] (1);]

(1) and/or

[II.4.8.3.

they have been kept in a vector-protected establishment for at least 60 days prior to the date of and during collection of the [oocytes] (1) [embryos] (1);]

(1) or

[II.4.8.4.

(1) either

[II.4.8.4.1.

a serological test able to detect specific antibodies against those serotypes of EHDV, with negative results, on a blood sample taken between 28 and 60 days from the date of the collection of the [oocytes] (1) [embryos] (1);]]

(1) and/or

[II.4.8.4.2.

an agent identification test for EHDV, with negative results, on a blood sample taken on the date of collection of the [oocytes] (1) [embryos] (1).]]

(1) (8) [II.4.9.

comply with the following conditions as regards classical scrapie:

II.4.9.1.

have been kept continuously since birth in a third country or territory where the following conditions are fulfilled:

II.4.9.1.1.

classical scrapie is compulsorily notifiable;

II.4.9.1.2.

an awareness, surveillance and monitoring system is in place;

II.4.9.1.3.

ovine and caprine animals affected with classical scrapie are killed and completely destroyed;

II.4.9.1.4.

(1) either

[II.4.9.2.

have been kept continuously for the last 3 years preceding the date of the collection of the embryos to be dispatch to the Union in a holding or holdings which has/have fulfilled during that period all the requirements set out in Chapter A, Section A, points 1.3.(a) to (f), of Annex VIII to Regulation (EC) No 999/2001, except during the period when they were kept at a semen collection centre that complied during that period with the conditions set out in in Chapter A, Section A, point 1.3.(c)(iv), of Annex VIII to that Regulation;]]

(1) or

[II.4.9.2.

they are ovine animals and the embryos carry at least one ARR allele.]]

(1) (16) or

[II.4.9.2.

they are caprine animals and the embryos carry at least one of the K222, D146 or S146 alleles.]]

II.5.

The [oocytes] (1) [embryos] (1) described in Part I

II.5.1.

have been collected, processed and stored in accordance with animal health requirements set out in [Part 2] (1) [Part 3] (1) [Part 4] (1) [Part 5] (1)and Part 6 of Annex III to Delegated Regulation (EU) 2020/686;

II.5.2.

II.5.3.

are transported in a container which:

II.5.3.1.

was sealed and numbered prior to the date of dispatch by the embryo collection or production team under responsibility of the team veterinarian, or by an official veterinarian, and the seal bears the number as indicated in box I.19;

II.5.3.2.

has been cleaned and either disinfected or sterilised before use, or is single-use container;

(1) (8) [II.5.3.3.

has been filled in with a cryogenic agent which has not been previously used for other products;

(1) (10) [II.5.4.

are placed in straws or other packages which are securely and hermetically sealed;

II.5.5.

are transported in a container where the different types are separated from each other by physical compartments or by being placed in secondary protective bags.]

(1) (11) [II.6.

The [in vivo derived embryos] (1) [in vitro produced embryos] (1) [micromanipulated embryos] (1) described in Part I were conceived by artificial insemination using semen coming from a semen collection centre, germinal product processing establishment or germinal product storage centre approved for the collection, processing or storage of semen by the competent authority of a third country or territory, or zone thereof listed in Annex X to Implementing Regulation (EU) 2021/404 for semen of ovine and caprine animals or by the competent authority of a Member State, and were collected, processed and stored in accordance with the requirements of Part 3, Chapter I and Part 5, Chapters II and III, of Annex II, and Part 1 of Annex III to Delegated Regulation (EU) 2020/686.]

(1) (12) [II.7.

The following antibiotic or mixture of antibiotics (13) has been added to the collection, processing, washing or storage media: … .]

Notes

This animal health certificate is intended for the entry into the Union of oocytes and embryos of ovine and caprine animals, including when the Union is not the final destination of the oocytes and embryos.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	“Place of dispatch”: Indicate the unique approval number and the name and address of the embryo collection or production team of dispatch of the consignment of oocytes or embryos. Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of oocytes or embryos.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Type”: Specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Species”: Select amongst “ Ovis aries ” or “ Capra hircus ” as appropriate. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where oocytes or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which oocytes or embryos of the consignment were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the embryo collection or production team by which the oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate the number of straws or other packages with the same mark. “Test”: For BTV-test, indicate: “point II.4.7.4” or “point II.4.7.5”, or both, for EHD-test, indicate: “point II.4.8.4.1” or “point II.4.8.4.2”, or both, if relevant.

Part II:

(1)	Delete if not applicable.

(2)	Only for a third country or territory, or zone thereof with an opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(3)	Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm.

(4)	Applicable for ovine animals.

(5)	Applicable for caprine animals.

(6)	Option available only for the consignment of in vivo derived embryos.

(7)

(8)	Delete if the Union is not the final destination of the oocytes and embryos.

(9)	Applicable for frozen oocytes or embryos.

(10)	Applicable for consignments where oocytes, in vivo derived embryos, in vitro produced embryos and micromanipulated embryos of ovine or caprine animals are placed and transported in one container.

(11)	Does not apply to oocytes.

(12)	Mandatory attestation in case antibiotics were added.

(13)	Insert the name(s) of the antibiotic(s) added and its (their) concentration.

(14)	For the zones with an entry “SF-BTV” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(15)	For the zones with an entry “SF-EHD” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(16)	Alternative applicable from 14 April 2024.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 51

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF OOCYTES AND EMBRYOS OF OVINE AND CAPRINE ANIMALS COLLECTED OR PRODUCED, PROCESSED AND STORED IN ACCORDANCE WITH COUNCIL DIRECTIVE 92/65/EEC BEFORE 21 APRIL 2021, DISPATCHED AFTER 20 APRIL 2021 BY THE EMBRYO COLLECTION OR PRODUCTION TEAM BY WHICH THE OOCYTES OR EMBRYOS WERE COLLECTED OR PRODUCED (MODEL “OV/CAP-OOCYTES-EMB-B-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17
	☐ Railway	☐ Road vehicle
	Identification

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity

Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model OV/CAP-OOCYTES-EMB-B-ENTRY -

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned, official veterinarian, hereby certify that:

II.1.

The exporting country …

(name of exporting country) (1)

II.1.1.

has been free from rinderpest, infection with peste des petits ruminants virus, sheep and goat pox, contagious caprine pleuropneumonia, and Rift Valley fever during the 12 month period immediately prior to collection of the [ova] (2) [embryos] (2) to be exported and until their date of dispatch to the Union and no vaccination against these diseases took place during that period;

(2) either

[II.1.2.

has been free from foot-and-mouth disease during the 12 month period immediately prior to collection of the [ova] (2) [embryos] (2) and did not carry out vaccination against foot-and-mouth disease during that period;]

(2) or

[II.1.2.

has not been free from foot-and-mouth disease during the 12 month period immediately prior to collection of the [ova] (2) [embryos] (2) and/or carried out vaccination against foot-and-mouth disease during that period and the donor females come from holdings on which no animal was vaccinated against foot-and-mouth disease during 30 days prior to collection and no animal of susceptible species showed clinical signs of foot-and-mouth disease during the 30 days prior to, and at least 30 days after, the [ova] (2) [embryos] (2) were collected and the [ova] (2) [embryos] (2) were not subjected to penetration of zona pellucida;]

II.2.

The [ova] (2) [embryos] (2) to be exported:

II.2.1.

were [collected] (2) [produced] (2) and processed on premises within a 10-km radius of which there was no incidence of foot-and-mouth disease, vesicular stomatitis, Rift Valley fever in the 30 days immediately prior to their collection;

II.2.2.

were stored at all times on approved premises within a 10-km radius of which there was no incidence of foot-and-mouth disease, vesicular stomatitis or Rift Valley fever from the time of their collection until 30 days thereafter;

II.2.3.

were [collected] (2) [produced] (2) by the team described in box I.11., which had been approved and supervised in accordance with the conditions for the approval and supervision of embryo collection teams and embryo production teams (3) laid down in Chapter I(III) of Annex D to Directive 92/65/EEC;

II.2.4.

meet the conditions for ova and embryos laid down in Chapter III(II) of Annex D to Directive 92/65/EEC;

II.2.5.

come from the donor females of [ovine] (2) [caprine] (2) species which:

(2) either

[II.2.5.1.

were kept in a bluetongue virus-free country or zone for at least 60 days prior to, and during collection of the [ova] (2) [embryos] (2);]

(2) or

[II.2.5.1.

were kept during a bluetongue virus seasonally free period in a seasonally free zone;]

(2) or

[II.2.5.1.

were kept protected from the vector for at least 60 days prior to, and during the collection of the [ova] (2) [embryos] (2);]

(2) or

[II.2.5.1.

underwent a serological test for the detection of antibody to the bluetongue virus serogroup, carried out in accordance with the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals between 21 and 60 days after collection of the [ova] (2) [embryos] (2) and giving negative results;]

(2) or

[II.2.5.1.

underwent an agent identification test for bluetongue virus, carried out in accordance with the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals on a blood sample taken on the day of the [ova] (2) [embryos] (2) collection or the day of slaughtering and giving negative results;]

II.2.5.2.

to the best of my knowledge do not come from holdings and have not been in contact with animals of a holding, in which, based on the official notification system and according to the written declaration made by the owner, any of the following diseases has been clinically detected within the periods referred to in points (a) to (d) prior to collection of the [ova] (2)[embryos] (2) to be exported:

(a)	contagious agalactia of sheep or goats (Mycoplasma agalactiae, Mycoplasma capricolum, Mycoplasma mycoides var. mycoides"large colony"), within the last 6 months;

(b)	paratuberculosis and caseous lymphadenitis, within the last 12 month period;

(c)	pulmonary adenomatosis, within the last 3 years;

(2) either

[(d)	Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last 3 years;]

(2) or

[(d)	Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last 12 month period, and all the infected animals were slaughtered and remaining animals subsequently reacted negatively to two tests carried out at least 6 months apart;]

II.2.5.3.

showed no clinical signs of disease on the day of the [ova] (2) [embryos] (2) collection;

(2) (4) either

[II.2.5.4.

originate from the region described in box I.8, which has been recognised as officially brucellosis (B. melitensis)-free, and]

(2) or

[II.2.5.4.

have belonged to a holding which has obtained and maintained its officially brucellosis (B. melitensis)-free status in accordance with Directive 91/68/EEC, and]

(2) or

[II.2.5.4.

originate from a holding, where in respect of brucellosis (B. melitensis) all susceptible animals have been free from any clinical or any signs of this disease for the last 12 month period, none of the ovine and caprine animals have been vaccinated against this disease, save those vaccinated with Rev. 1 vaccine more than 2 years ago, and all ovine and caprine animals over 6 months of age have been subjected to at least two tests (5), carried out with negative results on samples taken on … (date) and on … (date) at least 6 months apart, the latter being within 30 days prior to collection of the [ova] (2) [embryos] (2),]

and	have not been kept previously in a holding of a lower status;

(2) either

[II.2.5.5.

have remained in the exporting country for at least the past 6 months prior to collection of the [ova] (2) [embryos] (2) to be exported;]

(2) or

[II.2.5.5.

during the past 6 months prior to collection of the [ova] (2) [embryos] (2) they complied with the animal health conditions applying to donors of the [ova] (2) [embryos] (2) which are intended for export to the Union and they have been imported into the exporting country at least 30 days prior to collection of the [ova] (2) [embryos] (2) from … (1);]

II.2.5.6.

comply with the following conditions as regards classical scrapie:

II.2.5.6.1

they have been kept continuously since birth in a country where the following conditions are fulfilled:

II.2.5.6.1.1.

classical scrapie is compulsorily notifiable;

II.2.5.6.1.2.

an awareness, surveillance and monitoring system is in place;

II.2.5.6.1.3.

ovine and caprine animals affected with classical scrapie are killed and completely destroyed;

II.2.5.6.1.4.

the feeding to ovine and caprine animals of meat-and-bone meal or greaves of ruminant origin has been banned and effectively enforced in the whole country for a period of at least 7 years;

And

(2) either

[II.2.5.6.2

they have been kept continuously for the last 3 years before the collection of the embryos to be exported in a holding or holdings which has/have been complying for the last 3 years before the collection of the embryos to be exported with the requirements laid down in points (a) to (f) of point 1.3. of Section A of Chapter A of Annex VIII to Regulation (EC) No 999/2001;]

(2) or

[II.2.5.6.2

they are ovine animals and the embryos

(2) either

[are of the ARR/ARR prion protein genotype;]

(2) or

[carry at least one ARR allele and were collected after the date of 1 January 2015.]]

[II.2.6.

were [collected] (2) [produced] (2) in the exporting country,

(2) either

[II.2.6.1.

which according to official findings is free from epizootic haemorrhagic disease (EHD);]]

(2) (6) or

[II.2.6.1.

in which according to official findings the following serotypes of epizootic haemorrhagic disease (EHD) exist: … and the donor females of [ovine] (2) [caprine] (2) species were subjected with negative results in each case to the following tests carried out in an approved laboratory:

(2) either

[a serological test (7) for the detection of antibody to the EHD virus serogroup, carried out on samples of blood taken on two occasions not more than 12 months apart prior to and not less than 21 days following collection for this consignment of [ova] (2) [embryos] (2);]]

(2) or

[a serological test (7) for the detection of antibody to the EHD virus serogroup, carried out on samples of blood taken at intervals of not more than 60 days throughout the collection period and between 21 and 60 days after the final collection for this consignment of [ova] (2) [embryos] (2);]]

(2) or

[an agent identification test (7), carried out on samples of blood collected at commencement and conclusion of, and at least every 7 days, if carried out as virus isolation test, or at least every 28 days, if carried out as polymerase chain reaction, during collection for this consignment of [ova] (2)[embryos] (2);]]

II.2.7.

were [collected] (2) [produced] (2) after the date on which the embryo collection team was approved by the competent authority of the exporting country;

II.2.8.

were processed and stored under approved conditions for at least 30 days immediately after their [collection] (2) [production] (2) and transported under conditions for ova and embryos laid down in Chapter III(II) of Annex D to Directive 92/65/EEC;

II.2.9.

were sent to the place of loading in a sealed container in accordance with the requirements for the transport of embryos laid down in point 6 of Chapter III(II) of Annex D to Directive 92/65/EEC and bearing the number detailed in box I.19.

(2) [II.2.10.

the consignment consists of embryos of the ovine or caprine species which were conceived [by artificial insemination] (2) [as a result of in vitro fertilisation] (2) using semen coming from semen collection centres approved (8) in accordance with:

(2) either

[II.2.10.1.

Article 11(2) of Directive 92/65/EEC and located in a Member State of the European Union; and the semen complies with the requirements of Directive 92/65/EEC.]]

(2) or

[II.2.10.1.

Article 17(3)(b) of Directive 92/65/EEC and located in a third country or part thereof listed in Annex I to Decision 2010/472/EU, and the semen complies with the requirements set out in Part 2 of Annex II to that Decision.]]

Notes

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	“Place of dispatch”: Indicate the unique approval number and the name and address of the embryo collection or production team of dispatch of the consignment of oocytes or embryos. Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Species”: Select amongst “ Ovis aries ” or “ Capra hircus ” as appropriate. “Type”: Specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where oocytes or embryos of the consignment are placed. “Date of collection/production” shall be indicated for in vivo derived embryos and in the following format: dd.mm.yyyy. “Approval or registration number of plant/establishment/centre” Indicate the unique approval number of the embryo collection or production team by which the oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate the number of straws or other packages with the same mark.

Part II:

(1)	Only third country or territory, or zone thereof listed in Annex X to Commission Implementing Regulation (EU) 2021/404 for oocytes/embryos of ovine and caprine animals.

(2)	Delete as appropriate.

(3)	Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm.

(4)	Only for the territory appearing with the entry "V" in column 6 of the table in Part 1 of Annex I to Commission Regulation (EU) No 206/2010 (OJ L 73, 20.3.2010, p. 1).

(5)	Tests shall be carried out in accordance with Annex C to Directive 91/68/EEC.

(6)	See remarks for exporting third country or territory, or part thereof concerned in Annex III to Decision 2010/472/EU.

(7)	Standards for EHD virus diagnostic tests are described in the Bluetongue Chapter of the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals.

(8)	Only semen collection centres approved by the competent authority of a third country or territory, or zone thereof listed in Annex X to Implementing Regulation (EU) 2021/404 for semen of ovine and caprine animals or by the competent authority of a Member State.

Official veterinarian
Name (in capital letters)
Date		Qualification and title
Stamp		Signature

CHAPTER 52

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF GERMINAL PRODUCTS LISTED BELOW, DISPATCHED AFTER 20 APRIL 2021 FROM THE GERMINAL PRODUCT PROCESSING ESTABLISHMENT:

—	semen of ovine and caprine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of semen of ovine and caprine animals collected, processed and stored in accordance with Council Directive 92/65/EEC before 21 April 2021;

—	oocytes and embryos of ovine and caprine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of oocytes and embryos of ovine and caprine animals collected or produced, processed and stored in accordance with Directive 92/65/EEC before 21 April 2021.

(MODEL “OV/CAP-GP-PROCESSING-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity

Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model OV/CAP-GP-PROCESSING-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify that:

II.1.

II.1.1.

is located in a third country or territory, or zone thereof:

II.1.1.1.

authorised for the entry into the Union of [semen] (2) [oocytes] (2) [embryos] (2) of [ovine] (2) [caprine] (2) animals and listed in Annex X to Commission Implementing Regulation (EU) 2021/404;

(2) either

[II.1.1.2.

(2) (3) or

[II.1.1.2.

II.1.1.3.

where infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia were not reported for at least 12 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch;

II.1.1.4.

where no vaccination against infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia has been carried out for at least 12 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch, and no vaccinated animals entered into the third country or territory, or zone thereof during that period, and

(2) either

[no vaccination against foot and mouth disease has been carried out for the same period, and no vaccinated animals entered into the third country or territory, or zone thereof during that period;]

(2) or

[vaccination against foot and mouth disease has been carried out for the same period, or vaccinated animals entered into the third country or territory, or zone thereof during that period;]

II.1.2.

is approved and listed by the competent authority of the third country or territory;

II.1.3.

complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 4 of Annex I to Commission Delegated Regulation (EU) 2020/686.]

II.2.

The [semen] (2) [oocytes] (2) [embryos] (2) described in Part I is/are intended for artificial reproduction, and:

II.2.1.

(2) either

[located in the third country or territory of dispatch to the Union;]

(2) (5) and/or

[located in …, and has/have been introduced into the third country or territory of dispatch to the Union under conditions at least as strict as for the entry into the Union of [semen] (2) [oocytes] (2) [embryos] (2) of [ovine] (2) [caprine] (2) animals in accordance with Regulation (EU) 2016/429 and Commission Delegated Regulation (EU) 2020/692;]

II.2.2.

was/were moved to the germinal product processing establishment described in box I.11 under conditions at least as strict as described in:

(2) either

[Model OV/CAP-SEM-A-ENTRY (6);]

(2) and/or

[Model OV/CAP-SEM-B-ENTRY (6);]

(2) and/or

[Model OV/CAP-OOCYTES-EMB-A-ENTRY (6);]

(2) and/or

[Model OV/CAP-OOCYTES-EMB-B-ENTRY (6);]

(2) and/or

[Model OV/CAP-GP-PROCESSING-ENTRY (6);]

(2) and/or

[Model OV/CAP-GP-STORAGE-ENTRY (6);]

II.2.3.

has/have been collected, processed and stored in accordance with animal health requirements set out in Annex III to Delegated Regulation (EU) 2020/686;

II.2.4.

II.2.5.

is/are transported in a container which:

II.2.5.1.

II.2.5.2.

has been cleaned and either disinfected or sterilised before use, or is single-use container;

(2) (7) [II.2.5.3.

has been filled in with a cryogenic agent which has not been previously used for other products;]

(2) (8) [II.2.6.

is/are placed in straws or other packages which are securely and hermetically sealed;

II.2.7.

is/are transported in a container where the different types are separated from each other by physical compartments or by being placed in secondary protective bags.]

Notes

This animal health certificate is intended for the entry into the Union of semen, oocytes and embryos of ovine and caprine animals, including when the Union is not the final destination of the semen, oocytes and embryos.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	“Place of dispatch”: Indicate the unique approval number and the name and address of the germinal product processing establishment of dispatch of the consignment of semen, oocytes and/or embryos. Only germinal product processing establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of semen, oocytes and/or embryos.
Box reference I.17	:	“Accompanying documents”: Number(s) of related original animal health certificate(s) shall correspond to the serial number of the individual official document(s) or animal health certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I from the semen collection centre where the semen was collected, and/or from the embryo collection team and/or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment, where the semen, oocytes and/or embryos were processed and stored, and/or from the germinal product storage centre, where the semen, oocytes and/or embryos were stored, to the germinal product processing establishment described in box I.11. The original(s) of those document(s) or those animal health certificate(s) or the officially endorsed copies thereof shall be attached to this animal health certificate.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Species”: Indicate “ Ovis aries ” and/or “ Capra hircus ” as appropriate. “Identification number”: Indicate identification number of each donor animal. “Identification mark”: Indicate mark on the straw or other packages where semen, oocytes and/or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which semen, oocytes and/or embryos of the consignment was/were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre, where the semen of the consignment was collected, and/or of the embryo collection team and/or the embryo production team by which oocytes and/or embryos of the consignment were collected or produced. “Quantity”: Indicate number of straws or other packages with the same mark.

Part II:

(1)	Only germinal product processing establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm .

(2)	Delete if not applicable.

(3)	Only for a third country or territory, or zone thereof with opening date in accordance with column 9 in the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(4)	Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm.

(5)	Only a third country or territory, or zone thereof listed in Annex X to Implementing Regulation (EU) 2021/404 and Member States.

(6)

The original(s) of the document(s) or the animal health certificate(s) or the officially endorsed copies of thereof that accompanied the semen, oocytes and/or embryos described in Part I from the semen collection centre where the semen was collected, and/or from the embryo collection team or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment where the semen, oocytes and/or embryos were processed and stored, and/or from the germinal product storage centre where the semen, oocytes and/or embryos were stored, to the germinal product processing establishment of dispatch of the semen, oocytes and/or embryos described in box I.11 shall be attached to this animal health certificate.

(7)	Applicable for frozen semen, oocytes or embryos.

(8)	Applicable for consignments where semen, oocytes, in vivo derived embryos, in vitro produced embryos and micromanipulated embryos of ovine and/or caprine animals are placed and transported in one container.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 53

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF GERMINAL PRODUCTS LISTED BELOW, DISPATCHED AFTER 20 APRIL 2021 FROM THE GERMINAL PRODUCT STORAGE CENTRE:

—	semen of ovine and caprine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of semen of ovine and caprine animals collected, processed and stored in accordance with Council Directive 92/65/EEC before 21 April 2021;

—	oocytes and embryos of ovine and caprine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of oocytes and embryos of ovine and caprine animals collected or produced, processed and stored in accordance with Directive 92/65/EEC before 21 April 2021.

(MODEL “OV/CAP-GP-STORAGE-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity

Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model OV/CAP-GP-STORAGE-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify that:

II.1.

II.1.1.

is located in a third country or territory, or zone thereof:

II.1.1.1.

authorised for the entry into the Union of [semen] (2) [oocytes] (2) [embryos] (2) of [ovine] (2) [caprine] (2) animals and listed in Annex X to Commission Implementing Regulation (EU) 2021/404;

(2) either

[II.1.1.2.

(2) (3) or

[II.1.1.2.

II.1.1.3.

where infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia were not reported for at least 12 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch;

II.1.1.4.

where no vaccination against infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia has been carried out for at least 12 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch, and no vaccinated animals entered into the third country or territory, or zone thereof during that period, and

(2) either

[no vaccination against foot and mouth disease has been carried out for the same period, and no vaccinated animals entered into the third country or territory, or zone thereof during that period;]

(2) or

[vaccination against foot and mouth disease has been carried out for the same period, or vaccinated animals entered into the third country or territory, or zone thereof during that period;]

II.1.2.

is approved and listed by the competent authority of the third country or territory;

II.1.3.

complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 5 of Annex I to Commission Delegated Regulation (EU) 2020/686.]

II.2.

The [semen] (2) [oocytes] (2) [embryos] (2) described in Part I is/are intended for artificial reproduction and

II.2.1.

has/have been [collected] (2) [produced] (2), [processed] (2) [stored] (2) [in a semen collection centre] (2) (4) [by an embryo collection team] (2) (4) [by an embryo production team] (2) (4) [and] (2) [processed] (2) [stored] (2) [in a germinal product processing establishment] (2) (4) and stored in a germinal product storage centre (4) complying with requirements set out in [Part 1] (2) [Part 2] (2) [Part 3] (2) [Part 4] (2) [Part 5] (2)Annex I to Delegated Regulation (EU) 2020/686, and:

(2) either

[located in the third country or territory of dispatch to the Union;]

(2) (5) and/or

[located in …, and has/have been introduced into the third country or territory of dispatch to the Union under conditions at least as strict as for the entry into the Union of [semen] (2) [oocytes] (2) [embryos] (2) of [ovine] (2) [caprine] (2) animals in accordance with Regulation (EU) 2016/429 and Commission Delegated Regulation (EU) 2020/692;]

II.2.2.

was/were moved to the germinal product storage centre described in box I.11 under conditions at least as strict as described in:

(2) either

[Model OV/CAP-SEM-A-ENTRY (6);]

(2) and/or

[Model OV/CAP-SEM-B-ENTRY (6);]

(2) and/or

[Model 1 in Section A of Part 2 of Annex II to Decision 2010/472/EU (6);]

(2) and/or

[Model 2 in Section B of Part 2 of Annex II to Decision 2010/472/EU (6);]

(2) and/or

[Model OV/CAP-OOCYTES-EMB-A-ENTRY (6);]

(2) and/or

[Model OV/CAP-OOCYTES-EMB-B-ENTRY (6);]

(2) and/or

[Model OV/CAP-GP-PROCESSING-ENTRY (6);]

(2) and/or

[Model OV/CAP-GP-STORAGE-ENTRY (6);]

II.2.3.

has/have been collected, processed and stored in accordance with animal health requirements set out in Annex III to Delegated Regulation (EU) 2020/686;

II.2.4.

II.2.5.

is/are transported in a container which:

II.2.5.1.

II.2.5.2.

has been cleaned and either disinfected or sterilised before use, or is single-use container;

(2) (7) [II.2.5.3.

has been filled in with a cryogenic agent which has not been previously used for other products;]

(2) (8) [II.2.6.

is/are placed in straws or other packages which are securely and hermetically sealed;

II.2.7.

is/are transported in a container where the different types are separated from each other by physical compartments or by being placed in secondary protective bags.]

Notes

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	“Place of dispatch”: Indicate the unique approval number and the name and address of the germinal product storage centre of dispatch of the consignment of semen, oocytes and/or embryos. Only germinal product storage centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of semen, oocytes and/or embryos.
Box reference I.17	:	“Accompanying documents”: Number(s) of related original animal health certificate(s) shall correspond to the serial number of the individual official document(s) or animal health certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I from the semen collection centre where the semen was collected, and/or from the embryo collection team and/or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment where the semen, oocytes and/or embryos were processed and stored, and/or from the germinal product storage centre where the semen, oocytes and/or embryos were stored, to the germinal product storage centre described in box I.11. The original(s) of those document(s) or those animal health certificate(s) or the officially endorsed copies thereof shall be attached to this animal health certificate.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Species”: indicate “ Ovis aries ” and/or “ Capra hircus ” as appropriate. “Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Identification number”: Indicate identification number of each donor animal. “Identification mark”: Indicate mark on the straw or other packages where semen, oocytes and/or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which semen, oocytes and/or embryos of the consignment was/were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre, where the semen of the consignment was collected, and/or of the embryo collection team or the embryo production team by which oocytes, in vivo derived embryos or in vitro produced embryos of the consignment were collected or produced. “Quantity”: Indicate number of straws or other packages with the same mark.

Part II:

(1)	Only germinal product storage centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm.

(2)	Delete if not applicable.

(3)	Only for a third country or territory, or zone thereof with an opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(4)	Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm.

(5)	Only a third country or territory, or zone thereof listed in Annex X to Implementing Regulation (EU) 2021/404 and Member States.

(6)

The original(s) of the document(s) or the animal health certificate(s) or the officially endorsed copies of thereof that accompanied the semen, oocytes and/or embryos described in Part I from the semen collection centre where the semen was collected, and/or from the embryo collection team or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment where the semen, oocytes and/or embryos were processed and stored, and/or from the germinal product storage centre where the semen, oocytes and/or embryos were stored, to the germinal product storage centre of dispatch of the semen, oocytes and/or embryos described in box I.11 shall be attached to this animal health certificate.

(7)	Applicable for frozen semen, oocytes or embryos.

(8)	Applicable for consignments where semen, oocytes, in vivo derived embryos, in vitro produced embryos and micromanipulated embryos of ovine and/or caprine animals are placed and transported in one container.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 54

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF SEMEN OF PORCINE ANIMALS COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH REGULATION (EU) 2016/429 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL AND COMMISSION DELEGATED REGULATION (EU) 2020/692 AFTER 20 APRIL 2021, DISPATCHED FROM THE SEMEN COLLECTION CENTRE WHERE THE SEMEN WAS COLLECTED (MODEL “POR-SEM-A-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17
	☐ Railway	☐ Road vehicle
	Identification

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity

Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model POR-SEM-A-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify that:

II.1.

The semen described in Part I is intended for artificial reproduction and was obtained from donor animals which originate from a third country or territory, or zone thereof:

II.1.1.

authorised for the entry into the Union of semen of porcine animals and listed in Annex XI to Commission Implementing Regulation (EU) 2021/404;

(1) either

[II.1.2.

where foot and mouth disease was not reported for at least 24 months immediately prior to the date of collection of the semen and until the date of its dispatch;]

(1) (2) or

[II.1.2.

where foot and mouth disease was not reported for a period starting on the date ___/___/____ (dd/mm/yyyy) immediately prior to the date of collection of the semen and until the date of its dispatch;]

(1) either

[II.1.3.

where classical swine fever was not reported for at least 12 months immediately prior to the date of collection of the semen and until the date of its dispatch;]

(1) (2) or

[II.1.3.

where classical swine fever was not reported for a period starting on the date ___/___/____ (dd/mm/yyyy) immediately prior to the date of collection of the semen and until the date of its dispatch;]

II.1.4.

where infection with rinderpest virus and African swine fever were not reported for at least 12 months immediately prior to the date of collection of the semen and until the date of its dispatch;

II.1.5.

where no vaccination against infection with rinderpest virus and classical swine fever has been carried out for at least 12 months immediately prior to the date of collection of the semen and until the date of its dispatch, and no vaccinated animals entered into the third country or territory, or zone thereof during that period, and

(1) either

[no vaccination against foot and mouth disease has been carried out for the same period, and no vaccinated animals entered into the third country or territory, or zone thereof during that period.]

(1) or

[vaccination against foot and mouth disease has been carried out for the same period, or vaccinated animals entered into the third country or territory, or zone thereof during that period.]

II.2.

The semen described in Part I was obtained from donor animals which originated, prior to the date of commencement of the quarantine referred to in point II.4.6, from establishments:

II.2.1.

situated in an area where foot and mouth disease has not been reported within a 10-km radius centred on the establishments for at least the preceding 30 days and in which foot and mouth disease has not been reported during at least the preceding 3 months,

(1) either

[in which they were not vaccinated against foot and mouth disease;]

(1) or

[in which they were vaccinated against foot and mouth disease during 12 months immediately prior to the date of collection of the semen but not during the last 30 days immediately prior to the date of collection of the semen, and in which 5% (with a minimum of five straws) of each quantity of semen taken from a donor animal at any time is submitted to a virus isolation test for foot and mouth disease with negative results;]

II.2.2.

which are free from infection with Brucella abortus, B. melitensis and B. suis in accordance with the requirements laid down in Part 5, Chapter IV, of Annex II to Commission Delegated Regulation (EU) 2020/686;

II.2.3.

where no clinical, serological, virological or pathological evidence of infection with Aujeszky’s disease virus had been detected during at least the preceding 12 months;

II.2.4.

where, during at least 3 months immediately prior to the date of entry into the quarantine accommodation, no animal was vaccinated against infection with porcine reproductive and respiratory syndrome virus and no infection with porcine reproductive and respiratory syndrome virus was detected.

II.3.

The semen described in Part I has been collected, processed and stored, and dispatched from the semen collection centre (3) which:

II.3.1.

is approved and listed by the competent authority of the third country or territory;

II.3.2.

complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 1 of Annex I to Delegated Regulation (EU) 2020/686.

II.4.

The semen described in Part I was obtained from donor animals which:

II.4.1.

were not vaccinated against infection with rinderpest virus, classical swine fever and infection with porcine reproductive and respiratory syndrome virus;

II.4.2.

remained for at least 3 months immediately prior to the date of collection of the semen in a third country or territory or zone thereof referred to in box I.7;

II.4.3.

did not show symptoms or clinical signs of transmissible animal diseases on the day of their admission to a semen collection centre and on the day of collection of the semen;

II.4.4.

are individually identified as provided for in Article 21(1) of Delegated Regulation (EU) 2020/692;

II.4.5.

for at least 30 days immediately prior to the date of collection of the semen and during the collection period:

II.4.5.1.

were kept in establishments not situated in a restricted zone established due to the occurrence of foot and mouth disease, infection with rinderpest virus, classical swine fever or African swine fever, or of an emerging disease relevant for porcine animals;

II.4.5.2.

were kept in a single establishment where infection with Brucella abortus, B. melitensis and B. suis, infection with rabies virus, anthrax, infection with Aujeszky’s disease virus and infection with porcine reproductive and respiratory syndrome virus have not been reported;

II.4.5.3.

II.4.5.4.

were not used for natural breeding;

II.4.6.

have been subjected to a quarantine for at least 28 days in quarantine accommodation, where only other cloven-hoofed animals with at least the same health status were present, which on the day of their admission to the semen collection centre complied with the following conditions:

II.4.6.1.

it was not situated in a restricted zone established due to diseases referred to in point II.4.5.1;

II.4.6.2.

none of the diseases referred to in point II.4.5.2 has been reported for at least the preceding 30 days;

II.4.6.3.

it was situated in an area where foot and mouth disease has not been reported within a 10-km radius centred on the quarantine accommodation for at least the preceding 30 days;

II.4.6.4.

has had no outbreak of foot and mouth disease reported during at least 3 months immediately preceding the date of admission of the animals to the semen collection centre;

II.4.6.5.

it was free from infection with Brucella abortus, Brucella melitensis and Brucella suis for at least the preceding 3 months;

II.4.7.

were kept in semen collection centres:

II.4.7.1.

which were not situated in a restricted zone established due to diseases referred to in point II.4.5.1;

II.4.7.2.

where none of the diseases referred to in point II.4.5.2 has been reported for at least 30 days immediately prior to the date of collection of the semen, and

(1) (4) either

[at least 30 days following the date of the collection;]

(1) (5) or

[until the date of dispatch of the consignment of semen to the Union;]

II.4.7.3.

situated in an area where foot and mouth disease has not been reported within a 10-km radius centred on the semen collection centres for at least the preceding 30 days; and

(1) (4) either

[were free from foot and mouth disease for at least 3 months immediately prior to the date of collection of the semen and 30 days from the date of collection;]

(1) (5) or

[were free from foot and mouth disease for at least 3 months immediately prior to the date of collection of the semen and until the date of dispatch of the consignment of semen to the Union and they have been kept at that semen collection centre for at least 30 days immediately prior to the date of collection of the semen;]

II.4.7.4.

where no clinical, serological, virological or pathological evidence of infection with Aujeszky’s disease virus had been reported for a period comprising at least 30 days immediately prior to the date of admission and at least 30 days immediately prior to the date of collection of the semen;

II.4.8.

have been subjected to the following tests, carried out within 30 days immediately prior to the date of commencement of the quarantine referred to in point II.4.6, with negative results, required in accordance with Part 2, Chapter I, point 1(b), of Annex II to Delegated Regulation (EU) 2020/686:

II.4.8.1.

as regards infection with Brucella abortus, B. melitensis and B. suis, a buffered Brucella antigen test (rose Bengal test), a competitive ELISA or an indirect ELISA for the detection of antibodies to smooth Brucella species;

II.4.8.2.

as regards infection with Aujeszky’s disease virus,

(1) either

[in the case of non-vaccinated animals, an ELISA to detect antibodies to the whole Aujeszky’s disease virus or to glycoprotein B (ADV-gB) or glycoprotein D (ADV-gD) of the virus or a serum neutralisation test;]

(1) or

[in the case of animals vaccinated with a gE deleted vaccine, an ELISA to detect antibodies to glycoprotein E (ADV-gE) of Aujeszky’s disease virus;]

(1) [II.4.8.3.

as regards classical swine fever, an antibody ELISA or serum neutralisation test, in the case of animals coming from a third country or territory, or zone thereof where classical swine fever has been reported or vaccination against this disease has been practised for the preceding 12 months;]

II.4.8.4.

as regards infection with porcine reproductive and respiratory syndrome virus, a serological test (the immunoperoxidase monolayer assay (IPMA), immunofluorescence assay (IFA), or ELISA);

II.4.9.

have been subjected to the following tests, carried out on samples taken at least 21 days after the commencement of the quarantine referred to in point II.4.6, with negative results, required in accordance with Part 2, Chapter I, point 1(c), of Annex II to Delegated Regulation (EU) 2020/686:

II.4.9.1.

II.4.9.2.

as regards infection with Aujeszky’s disease virus

(1) either

(1) or

[in the case of animals vaccinated with a gE deleted vaccine, an ELISA to detect antibodies to glycoprotein E (ADV-gE) of Aujeszky’s disease virus;]

II.4.9.3.

as regards infection with porcine reproductive and respiratory syndrome virus, a serological test (IPMA, IFA, or ELISA) and a test for virus genome (reverse-transcription polymerase chain reaction (RT-PCR), nested set RT-PCR, real-time RT-PCR);

II.4.10.

have been subjected, at semen collection centre, to the following compulsory routine tests, required in accordance with Part 2, Chapter I, point 2(a), of Annex II to Delegated Regulation (EU) 2020/686:

II.4.10.1.

II.4.10.2.

as regards infection with Aujeszky’s disease virus

(1) either

(1) or

[in the case of animals vaccinated with a gE deleted vaccine, an ELISA to detect antibodies to glycoprotein E (ADV-gE) of Aujeszky’s disease virus;]

(1) [II.4.10.3.

II.4.10.4.

as regards infection with porcine reproductive and respiratory syndrome virus, a serological test (IPMA, IFA, or ELISA);

II.4.11.

have been subjected to the tests referred to in point II.4.10 carried out, in accordance with Part 2, Chapter I, point 2(b), of Annex II to Delegated Regulation (EU) 2020/686, on samples taken from

(1) either

[all animals immediately prior to the date of dispatch from the semen collection centre, or upon the date of arrival at the slaughterhouse, and in no case later than 12 months from the date of admission to the semen collection centre.]

(1) or

[at least 25% of the animals in the semen collection centre every 3 months to test for infection with Brucella abortus, Brucella melitensis and Brucella suis, infection with Aujeszky’s disease virus and classical swine fever, and at least 10% of the animals in the semen collection centre every month to test for infection with porcine reproductive and respiratory syndrome virus.]

(1) or

[at least 10% of the animals in the semen collection centre every month to test for infection with Brucella abortus, Brucella melitensis and Brucella suis, infection with Aujeszky’s disease virus, classical swine fever and infection with porcine reproductive and respiratory syndrome virus.]

II.5.

The semen described in Part I:

II.5.1.

has been collected, processed and stored in accordance with animal health requirements set out in Part 1, points 1 and 2, of Annex III to Delegated Regulation (EU) 2020/686;

II.5.2.

II.5.3.

is transported in a container which:

II.5.3.1.

II.5.3.2.

has been cleaned and either disinfected or sterilised before use, or is single-use container;

(1) (4) [II.5.3.3.

has been filled in with a cryogenic agent which has not been previously used for other products.]

(1) [II.6.

Where an antibiotic or a mixture of antibiotics was added to the semen:

II.6.1.

The following antibiotic or mixture of antibiotics has been added to the semen after final dilution, or is contained in the used semen diluents: … ; (6)

II.6.2.

Immediately after the addition of the antibiotic(s), and before any possible freezing, the diluted semen was kept at a temperature of at least 15 °C for not less than 45 minutes, or under a time-temperature regime with a documented equivalent bactericidal activity.]

Notes

“Porcine animal” means a porcine animal as defined in Article 2, point (4), of Delegated Regulation (EU) 2020/686.

This animal health certificate is intended for the entry into the Union of semen of porcine animals, including when the Union is not the final destination of the semen.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	“Place of dispatch”: Indicate the unique approval number and the name and address of the semen collection centre of dispatch of the consignment of semen. Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/porcine_en.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of semen.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Type”: indicate semen. “Identification number”: Indicate identification number of each donor animal. “Identification mark”: Indicate mark on the straw or other packages where semen of the consignment is placed. “Date of collection/production”: Indicate the date on which semen of the consignment was collected. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected. “Quantity”: Indicate number of straws or other packages with the same mark.

Part II:

(1)	Delete if not applicable.

(2)	Only for a third country or territory, or zone thereof with an opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(3)	Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/porcine_en.

(4)	Applicable for frozen semen.

(5)	Applicable for fresh and chilled semen.

(6)	Insert the name(s) of the antibiotic(s) added and its (their) concentration or the commercial name of the semen diluent containing antibiotic(s).

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 55

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF STOCKS OF SEMEN OF PORCINE ANIMALS COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH COUNCIL DIRECTIVE 90/429/EEC BEFORE 21 APRIL 2021, DISPATCHED AFTER 20 APRIL 2021 FROM THE SEMEN COLLECTION CENTRE WHERE THE SEMEN WAS COLLECTED (MODEL “POR-SEM-B-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17
	☐ Railway	☐ Road vehicle
	Identification

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity

Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model POR-SEM-B-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned, official veterinarian, hereby certify that:

II.1.

the exporting country …

(name of exporting country) (1)

(2) either

[II.1.1.

has during the past 12 months been free of foot-and-mouth disease, classical swine fever and African swine fever,

and	that no vaccinations have been carried out against any of these diseases during the past 12 months;]

(2) or

[II.1.1.

is recognised as free of foot-and-mouth disease without vaccination by the World Organisation for Animal Health (OIE) and free of classical swine fever and African swine fever, in accordance with the recommendations laid down in the OIE Terrestrial Animal Health Code;]

II.2.

the semen collection centre (3) in which the semen in this consignment was collected:

II.2.1.

was approved for export to the Union by the veterinary services of … (name of third country (2)) and complied on date of collection with the conditions for approval and supervision set out in Chapter I and Chapter II of Annex A to Directive 90/429/EEC;

II.2.2.

was, during the period commencing 3 months prior to the date of collection of the semen in this consignment until the date of its dispatch, situated in an area not restricted due to an outbreak of foot-and-mouth disease, classical swine fever, African swine fever, swine vesicular disease, and vesicular stomatitis;

II.2.3.

was, during the period commencing 30 days prior to the date of collection of the semen in this consignment until the date of its dispatch, free from brucellosis and Aujeszky's disease;

(2) either

[II.2.4.

contained only animals that have not been vaccinated against Aujeszky's disease and met the requirements of Annex B to Directive 90/429/EEC.]

(2) (4) and/or

[II.2.4.

was a centre in which some or all of the animals have been vaccinated against Aujeszky's disease using a gE deleted vaccine and met the requirements of Annex B to Directive 90/429/EEC.]

Conditions for the admission of animals to the semen collection centre

II.3.

Prior to be admitted to the semen collection centre, all animals:

II.3.1.

were subjected to a period of quarantine of at least 30 days in accommodation specifically approved for the purpose by the competent authority, and where only animals having at least the same health status were present (quarantine accommodation);

II.3.2.

prior to entering the quarantine accommodation, were chosen from herds or holdings:

II.3.2.1.

which were free of brucellosis in accordance with the Chapter on porcine brucellosis of the Terrestrial Animal Health Code of the World Organisation for Animal Health (OIE);

II.3.2.2.

in which no animal vaccinated against foot and-mouth disease was present in the preceding 12 months;

II.3.2.3.

which were not situated in a restricted area defined under the provisions of the national legislation due to an outbreak of foot-and-mouth disease, classical swine fever, African swine fever, swine vesicular disease, vesicular stomatitis and Aujeszky's disease;

II.3.2.4.

in which no clinical, serological, virological or pathological evidence of Aujeszky's disease was detected in the preceding 12 months;

II.3.3.

prior to entering the quarantine accommodation, were not previously kept in any herd of a lower health status than described in II.3.2.;

II.3.4.

within 30 days prior to entering the quarantine accommodation referred to in point II.3.1, were subjected to the following tests, performed in accordance with international standards, with negative results:

II.3.4.1.

as regards brucellosis, a buffered Brucella antigen test (rose Bengal test), or a cELISA or an iELISA;

II.3.4.2.

as regards Aujeszky’s disease,

(2) either

[II.3.4.2.1.

in the case of non-vaccinated animals, a serum neutralisation test or an ELISA for detecting antibodies to the whole Aujeszky’s disease virus or to its glycoprotein B (ADV-gB) or glycoprotein D (ADV-gD);]

(2) or

[II.3.4.2.1.

in the case of animals vaccinated with a gE deleted vaccine, an ELISA for detecting antibodies to glycoprotein E (ADV-gE);]

(2) either

[II.3.5.

were admitted to the centre after all of the animals had reacted with negative result to a buffered Brucella antigen test (rose Bengal test), or a cELISA or an iELISA carried out on samples collected during the last 15 days of the period of quarantine specified in point II.3.1;]

(2) or

[II.3.5.

were admitted to the centre after not all of the animals had reacted with negative result to a buffered Brucella antigen test (rose Bengal test), or a cELISA or an iELISA carried out on samples collected during the last 15 days of the period of quarantine specified in point II.3.1 and the suspicion of brucellosis was ruled out in accordance with point 1.5. of Chapter I of Annex B to Directive 90/429/EEC;]

II.3.6.

were subjected to the following tests for Aujeszky's disease carried out on samples collected during the last 15 days of the period of quarantine specified in point II.3.1:

(2) either

[II.3.6.1.

(2) or

[II.3.6.1.

in the case of animals vaccinated with a gE deleted vaccine, an ELISA for detecting antibodies to glycoprotein E (ADV-gE);]

(2) either

[II.3.6.2.

the tests referred to in point II.3.6.1 were carried out with negative result in each case;]

(2) or

[II.3.6.2.

the animals that proved positive in a test referred to in point II.3.6.1 were removed immediately from the quarantine accommodation and the competent authority took all necessary measures to ensure that the remaining animals had a satisfactory health status before being admitted to the collection centre in accordance with point II.3;]

II.3.7.

All tests were carried out in a laboratory approved by the competent authority;

II.3.8.

Animals were only admitted to the semen collection centre with the express permission of the centre veterinarian and all animal movements, entering and exiting the semen collection centre, are recorded;

II.3.9.

No animal admitted to the semen collection centre showed any clinical sign of disease on the day of admission; all animals came directly from the quarantine accommodation which, on the day of consignment and during the period of residency of the animals, officially fulfilled the following conditions:

II.3.9.1.

it was not situated in a restricted area defined under the provisions of national legislation due to an outbreak of foot-and-mouth disease, classical swine fever, African swine fever, swine vesicular disease, vesicular stomatitis and Aujeszky's disease;

II.3.9.2.

no clinical, serological, virological or pathological evidence of foot-and-mouth disease, classical swine fever, African swine fever, swine vesicular disease, vesicular stomatitis and Aujeszky's disease had been recorded for the past 30 days.

Compulsory routine tests for animals kept at the semen collection centre

II.4.

All animals kept at the semen collection centre are subjected to the following routine tests carried out in a laboratory approved by the competent authority:

II.4.1.

as regards brucellosis, a buffered Brucella antigen test (rose Bengal test), or a cELISA or an iELISA;

II.4.2.

as regards Aujeszky’s disease virus,

(1) either

[II.4.2.1.

(1) or

[II.4.2.1.

in the case of animals vaccinated with a gE deleted vaccine, an ELISA for detecting antibodies to glycoprotein E (ADV-gE).]

II.4.3.

The routine tests referred to in points II.4.1 and II.4.2 are carried out on samples taken in accordance with point 1.2. of Chapter II of Annex B to Directive 90/429/EEC in order to ensure that all animals in the centre have been tested at least once during their stay at that centre and at least every 12 months from the date of admission, if their stay exceeds 12 months;

(2) either

[II.4.4.

All of the animals have reacted with negative results in the routine tests referred to in points II.4.1 and II.4.2 carried out on samples referred to in point II.4.3.]

(2) or

[II.4.4.

Not all of the animals have reacted with negative results in the tests referred to in points II.4.1 and II.4.2., which were carried out on samples referred to in point II.4.3:

(a)	the animals which proved positive were isolated,

(b)

the semen collected from each animal at the centre since the date of that animal's last negative test was held in separate storage from semen eligible for export to the European Union which was collected before the animal's last negative test or after the health status of the centre had been re-established under responsibility of the competent authority of the exporting country.]

Conditions for semen collected at a semen collection centre and intended for export to the Union

II.5.

The semen in this consignment was obtained from animals which:

II.5.1.

have been resident in … (name of third country (1)) for a minimum period of 3 months immediately prior to collection;

II.5.2.

showed no clinical signs of disease on the day the semen was collected;

II.5.3.

had not been vaccinated against foot-and-mouth disease;

II.5.4.

satisfy the requirements referred to in point II.3;

II.5.5.

have not been allowed to serve naturally;

II.5.6.

were kept in semen collection centres which were not situated in a restricted area designated under the provisions of the national legislation relating to foot-and-mouth disease, classical swine fever, African swine fever, swine vesicular disease, vesicular stomatitis and Aujeszky's disease;

II.5.7.

were kept in semen collection centres in which no clinical, serological, virological or pathological evidence of foot-and-mouth disease, classical swine fever, African swine fever, swine vesicular disease, vesicular stomatitis and Aujeszky's disease has been detected in the 30-day period immediately prior to collection.

II.6.

An effective combination of antibiotics, in particular against leptospires, was added to the semen in this consignment after final dilution or to the diluent. In the case of frozen semen, antibiotics were added before the semen was frozen.

II.6.1.

The combination of antibiotics referred to in point II.6 produced an effect at least equivalent to the following concentration in the final diluted semen:

(a)	not less than 500 μg streptomycin per ml final dilution,

(b)	not less than 500 IU penicillin per ml final dilution,

(c)	not less than 150 μg lincomycin per ml final dilution,

(d)	not less than 300 μg spectinomycin per ml final dilution;

II.6.2.

Immediately after the addition of the antibiotics the diluted semen was kept at a temperature of at least 15 °C for a period of not less than 45 minutes.

II.7.

The semen in this consignment:

II.7.1.

has been stored as laid down in point 2(d) of Chapter I and point 6(a), (b), (e) and (f) of Chapter II of Annex A to Directive 90/429/EEC prior to dispatch;

II.7.2.

is being transported to the country of destination in flasks which were cleaned and disinfected or sterilised before use and which have been sealed prior to dispatch from the approved storage facilities.

Notes

“Porcine animal” means a porcine animal as defined in Article 2, point (4), of Delegated Regulation (EU) 2020/686.

This animal health certificate is intended for the entry into the Union of semen of porcine animals, including when the Union is not the final destination of the semen.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	“Place of dispatch” Indicate the unique approval number and the name and address of the semen collection centre of dispatch of the consignment to the Union. Only semen collection centre listed in accordance with Article 8(2) of Directive 90/429/EEC on the Commission website: http://ec.europa.eu/food/animal/semen_ova/porcine/index_en.htm.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Type”: Indicate semen. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where semen of the consignment is placed. “Date of collection/production” Indicate the date on which semen of the consignment was collected. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected.

Part II:

(1)	Only third country or territory, or zone thereof listed in Annex XI to Commission Implementing Regulation (EU) 2021/404 for semen of porcine animals.

(2)	Delete if not applicable.

(3)	Only semen collection centres listed in accordance with Article 8(2) of Directive 90/429/EEC on the Commission website: https://ec.europa.eu/food/animals/semen/porcine_en.

(4)

This option shall be deleted in case the Member State or region thereof of destination is free of Aujeszky’s disease in accordance with Article 10 of Directive 64/432/EEC, has informed the Commission in accordance with point 4 of Annex C to Directive 90/429/EEC and is listed on the following Commission website: https://ec.europa.eu/food/animals/semen/porcine_en.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 56

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF OOCYTES AND EMBRYOS OF PORCINE ANIMALS COLLECTED OR PRODUCED, PROCESSED AND STORED IN ACCORDANCE WITH REGULATION (EU) 2016/429 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL AND COMMISSION DELEGATED REGULATION (EU) 2020/692 AFTER 20 APRIL 2021, DISPATCHED BY THE EMBRYO COLLECTION OR PRODUCTION TEAM BY WHICH THE OOCYTES OR EMBRYOS WERE COLLECTED OR PRODUCED (MODEL “POR-OOCYTES-EMB-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17
	☐ Railway	☐ Road vehicle
	Identification

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity

Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model POR-OOCYTES-EMB-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify that:

II.1.

The [oocytes] (1) [in vivo derived embryos] (1) [in vitro produced embryos] (1) described in Part I are intended for artificial reproduction and were obtained from donor animals which originate from a third country or territory, or zone thereof:

II.1.1.

authorised for the entry into the Union of [oocytes] (1) [in vivo derived embryos] (1) [in vitro produced embryos] (1) [micromanipulated embryos] (1) of porcine animals and listed in Annex XI to Commission Implementing Regulation (EU) 2021/404;

(1) either

[II.1.2.

where foot and mouth disease was not reported for at least 24 months immediately prior to the date of collection of the [oocytes] (1) [embryos] (1) and until the date of their dispatch;]

(1) (2) or

[II.1.2.

(1) either

[II.1.3.

where classical swine fever was not reported for at least 12 months immediately prior to the date of collection of the [oocytes] (1) [embryos] (1) and until the date of their dispatch;]

(1) (2) or

[II.1.3.

where classical swine fever was not reported for a period starting on the date ___/___/____ (dd/mm/yyyy) immediately prior to the date of collection of the [oocytes] (1) [embryos] (1) and until the date of their dispatch;]

II.1.4.

where infection with rinderpest virus and African swine fever were not reported for at least 12 months immediately prior to the date of collection of the [oocytes] (1) [embryos] (1) and until the date of their dispatch;

II.1.5.

where no vaccination against infection with rinderpest virus and classical swine fever has been carried out for at least 12 months immediately prior to the date of collection of the [oocytes] (1) [embryos] (1) and until the date of their dispatch, and no vaccinated animals entered into the third country or territory, or zone thereof during that period, and

(1) either

[no vaccination against foot and mouth disease has been carried out for the same period, and no vaccinated animals entered into the third country or territory, or zone thereof during that period;]

(1) or

[vaccination against foot and mouth disease has been carried out for the same period, or vaccinated animals entered into the third country or territory, or zone thereof during that period.]

(1) (3) [II.1.6.

free from infection with Aujeszky’s disease virus.]

II.2.

The [oocytes] (1) [embryos] (1) described in Part I were obtained from donor animals which originate from establishments:

II.2.1.

in which infection with Brucella abortus, B. melitensis and B. suis in porcine animals has not been reported during 42 days immediately prior to the date of collection of the [oocytes] (1) [embryos] (1), and in which during at least 12 months immediately prior to the date of collection of the [oocytes] (1) [embryos] (1):

(1) either

[II.2.2.1.

biosecurity and risk mitigating measures, including housing conditions and feeding systems, have been applied as necessary to prevent transmission of infection with Brucella abortus, B. melitensis and B. suis from wild animals of listed species to porcine animals kept in the establishments and only porcine animals from establishments applying equivalent biosecurity measures have been introduced.]

(1) and/or

[II.2.2.2.

surveillance for infection with Brucella abortus, B. melitensis and B. suis has been carried out on the porcine animals kept in the establishments in accordance with Annex III to Commission Delegated Regulation (EU) 2020/688, and during the same period:

(a)

(b)	in the case where infection with Brucella abortus, B. melitensis and B. suis has been reported in porcine animals kept therein, measures were taken in accordance with Part 1, point 3, of Annex II to Delegated Regulation (EU) 2020/688;]

II.2.2.

where no clinical, serological, virological or pathological evidence of infection with Aujeszky’s disease virus has been detected during at least 12 months immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1).

(1) [II.3.

The [oocytes] (1)[in vivo derived embryos] (1) described in Part I have been collected, processed and stored, and dispatched by the embryo collection team (4) which:

II.3.1.

is approved and listed by the competent authority of the third country or territory;

II.3.2.

complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 2 of Annex I to Delegated Regulation (EU) 2020/686.]

(1) [II.3.

II.3.1.

is approved and listed by the competent authority of the third country or territory;

II.3.2.

complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Parts 2 and 3 of Annex I to Commission Delegated Regulation (EU) 2020/686.]

II.4.

The [oocytes] (1) [embryos] (1) described in Part I were obtained from donor animals which:

II.4.1.

were not vaccinated against infection with rinderpest virus, classical swine fever and infection with porcine reproductive and respiratory syndrome virus;

II.4.2.

remained for at least 3 months immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) in a third country or territory, or zone thereof referred to in box I.7;

II.4.3.

for at least 30 days immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) and during the collection period:

II.4.3.1.

II.4.3.2.

II.4.3.3.

II.4.3.4.

were not used for natural breeding;

II.4.4.

have been clinically examined by the team veterinarian or a team member and did not show symptoms of transmissible diseases on the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1);

II.4.5.

are individually identified as provided for in Article 21(1) of Delegated Regulation (EU) 2020/692;

II.4.6.

comply with the following conditions as regards foot and mouth disease:

II.4.6.1.

they come from establishments:

(a)	situated in an area where foot and mouth disease has not been reported within a 10-km radius centred in the establishments for at least 30 days immediately prior to the date of [collection] (1) [production] (1)of the [oocytes] (1) [embryos] (1);

(b)	in which foot and mouth disease has not been reported during at least 3 months immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1);

(1) either

[II.4.6.2.

they were not vaccinated against foot and mouth disease;]

(1) (5) or

[II.4.6.2.

they were vaccinated against foot and mouth disease during the 12 months immediately prior to the date of collection of the embryos, and:

II.4.6.2.1.

have not been vaccinated against foot and mouth disease within at least 30 days immediately prior to the date of collection of the embryos;

II.4.6.2.2.

II.4.6.2.3.

prior to freezing, the embryos have been subjected to trypsin washing carried out in accordance with the recommendations of the IETS Manual (6);

II.4.6.2.4.

the embryos were stored deep frozen for at least 30 days from the date of collection, and during that period the donor animal has not shown clinical signs of foot and mouth disease;]

(1) (7) [II.4.7.

were subjected to a serological test for infection with porcine reproductive and respiratory syndrome virus, with negative results, on two occasions, at an interval of not less than 21 days, the second test being performed within 15 days immediately prior to the date of collection of the [oocytes] (1) [embryos] (1).]

II.5.

The [oocytes] (1) [embryos] (1) described in Part I:

II.5.1.

have been collected, processed and stored in accordance with animal health requirements set out in [Part 2] (1) [Part 3] (1) [Part 4] (1) [Part 5] (1)and Part 6 of Annex III to Delegated Regulation (EU) 2020/686;

II.5.2.

II.5.3.

are transported in a container which:

II.5.3.1.

II.5.3.2.

has been cleaned and either disinfected or sterilised before use, or is single-use container;

(1) (8) [II.5.3.3.

has been filled in with a cryogenic agent which has not been previously used for other products;]

(1) (9) [II.5.4.

are placed in straws or other packages which are securely and hermetically sealed;

II.5.5.

are transported in a container where the different types are separated from each other by physical compartments or by being placed in secondary protective bags.]

(1) (10) [II.6.

The [in vivo derived embryos] (1) [in vitro produced embryos] (1) [micromanipulated embryos] (1) described in Part I were conceived by artificial insemination using semen coming from a semen collection centre, germinal product processing establishment or germinal product storage centre approved for the collection, processing or storage of semen by the competent authority of a third country or territory, or zone thereof listed in Annex XI to Implementing Regulation (EU) 2021/404 for semen of porcine animals or by the competent authority of a Member State, and were collected, processed and stored in accordance with the requirements of Part 2, Chapter I, of Annex II, and of Part 1 of Annex III to Delegated Regulation (EU) 2020/686.]

(1) (11) [II.7.

The following antibiotic or mixture of antibiotics (12) has been added to the collection, processing, washing or storage media: … .]

Notes

“Porcine animal” means a porcine animal as defined in Article 2, point (4), of Delegated Regulation (EU) 2020/686.

This animal health certificate is intended for the entry into the Union of oocytes and embryos of porcine animals, including when the Union is not the final destination of the oocytes and embryos.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	“Place of dispatch”: Indicate the unique approval number and the name and address of the embryo collection or production team of dispatch of the consignment of oocytes or embryos. Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/porcine_en.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of oocytes or embryos.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Type”: Specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Identification number”: Indicate identification number of each donor animal. “Identification mark”: Indicate mark on the straw or other packages where oocytes or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which oocytes or embryos of the consignment were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the embryo collection or production team by which the oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate number of straws or other packages with the same mark.

Part II:

(1)	Delete if not applicable.

(2)	Only for a third country or territory, or zone thereof with opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(3)	Not applicable for in vivo derived embryos subject to trypsin treatment.

(4)	Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/porcine_en.

(5)	Option available only for the consignment of in vivo derived embryos.

(6)

(7)	Applicable for in vivo derived embryos.

(8)	Applicable for frozen oocytes or embryos.

(9)	Applicable for consignments where oocytes, in vivo derived embryos, in vitro produced embryos and micromanipulated embryos of porcine animals are placed and transported in one container.

(10)	Does not apply to oocytes.

(11)	Mandatory attestation in case antibiotics were added.

(12)	Insert the name(s) of the antibiotic(s) added and its (their) concentration.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 57

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF GERMINAL PRODUCTS LISTED BELOW, DISPATCHED AFTER 20 APRIL 2021 FROM THE GERMINAL PRODUCT PROCESSING ESTABLISHMENT:

—	semen of porcine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of semen of porcine animals collected, processed and stored in accordance with Council Directive 90/429/EEC before 21 April 2021;

—	oocytes and embryos of porcine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021.

(MODEL “POR-GP-PROCESSING-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity
Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model POR-GP-PROCESSING-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify that:

II.1.

II.1.1.

is located in a third country or territory, or zone thereof:

II.1.1.1.

authorised for the entry into the Union of [semen] (2) [oocytes] (2) [in vivo derived embryos] (2) [in vitro produced embryos] (2) [micromanipulated embryos] (2) of porcine animals and listed in Annex XI to Commission Implementing Regulation (EU) 2021/404;

(2) either

[II.1.1.2.

(2) (3) or

[II.1.1.2.

(2) either

[II.1.1.3.

where classical swine fever was not reported for at least 12 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch;]

(2) (3) or

[II.1.1.3.

where classical swine fever was not reported for a period starting on the date ___/___/____ (dd/mm/yyyy) immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch;]

II.1.1.4.

where infection with rinderpest virus and African swine fever were not reported for at least 12 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch;

II.1.1.5.

where no vaccination against infection with rinderpest virus and classical swine fever has been carried out for at least 12 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch, and no vaccinated animals entered into the third country or territory, or zone thereof during that period, and

(2) either

[no vaccination against foot and mouth disease has been carried out for the same period, and no vaccinated animals entered into the third country or territory, or zone thereof during that period;]

(2) or

[vaccination against foot and mouth disease has been carried out for the same period, or vaccinated animals entered into the third country or territory, or zone thereof during that period;]

II.1.2.

is approved and listed by the competent authority of the third country or territory;

II.1.3.

complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 4 of Annex I to Commission Delegated Regulation (EU) 2020/686.]

II.2.

The [semen] (2) [oocytes] (2) [embryos] (2) described in Part I is/are intended for artificial reproduction, and:

II.2.1.

(2) either

[located in the third country or territory of dispatch to the Union;]

(2) (5) and/or

[located in …, and has/have been introduced into the third country or territory of dispatch to the Union under conditions at least as strict as for the entry into the Union of [semen] (2) [oocytes] (2) [embryos] (2) of porcine animals in accordance with Regulation (EU) 2016/429 and Commission Delegated Regulation (EU) 2020/692;]

II.2.2.

was/were moved to the germinal product processing establishment described in box I.11 under conditions at least as strict as described in:

(2) either

[Model POR-SEM-A-ENTRY (6);]

(2) and/or

[Model POR-SEM-B-ENTRY (6);]

(2) and/or

[Model POR-OOCYTES-EMB-ENTRY (6);]

(2) and/or

[Model POR-GP-PROCESSING-ENTRY (6);]

(2) and/or

[Model POR-GP-STORAGE-ENTRY (6);]

II.2.3.

has/have been collected, processed and stored in accordance with animal health requirements set out in Annex III to Delegated Regulation (EU) 2020/686;

II.2.4.

II.2.5.

is/are transported in a container which:

II.2.5.1.

II.2.5.2.

has been cleaned and either disinfected or sterilised before use, or is single-use container;

(2) (7) [II.2.5.3.

has been filled in with a cryogenic agent which has not been previously used for other products.]

(2) (8) [II.2.6.

is/are placed in straws or other packages which are securely and hermetically sealed;

II.2.7.

is/are transported in a container where the different types are separated from each other by physical compartments or by being placed in secondary protective bags.]

Notes

”Porcine animal” means a porcine animal as defined in Article 2, point (4), of Delegated Regulation (EU) 2020/686.

This animal health certificate is intended for the entry into the Union of semen, oocytes and embryos of porcine animals, including when the Union is not the final destination of the semen, oocytes and embryos.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	“Place of dispatch”: Indicate the unique approval number and the name and address of the germinal product processing establishment of dispatch of the consignment of semen, oocytes and/or embryos. Only germinal product processing establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of semen, oocytes and/or embryos.
Box reference I.17	:	“Accompanying documents”: Number(s) of related original animal health certificate(s) shall correspond to the serial number of the individual official document(s) or animal health certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I from the semen collection centre where the semen was collected, and/or from the embryo collection team and/or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment where the semen, oocytes or embryos were processed and stored, and/or from the germinal product storage centre where the semen, oocytes or embryos were stored, to the germinal product processing establishment described in box I.11. The original(s) of those document(s) or those animal health certificate(s) or the officially endorsed copies thereof shall be attached to this animal health certificate.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Identification number”: Indicate identification number of each donor animal. “Identification mark”: Indicate mark on the straw or other packages where semen, oocytes and/or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which semen, oocytes and/or embryos of the consignment was/were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected, and/or the embryo collection team and/or the embryo production team by which oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate number of straws or other packages with the same mark.

Part II:

(1)	Only germinal product processing establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/porcine_en.

(2)	Delete if not applicable.

(3)	Only for a third country or territory, or zone thereof with opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(4)	Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/porcine_en.

(5)	Only a third country or territory, or zone thereof listed in Annex XI to Implementing Regulation (EU) 2021/404 and the Member States.

(6)

The original(s) of the document(s) or the animal health certificate(s) or the officially endorsed copies of thereof that accompanied the semen, oocytes or embryos described in Part I from the semen collection centre where the semen was collected, and/or from the embryo collection team or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment where the semen, oocytes or embryos were processed and stored, and/or from the germinal product storage centre where the semen, oocytes or embryos were stored, to the germinal product processing establishment of dispatch of the semen, oocytes and/or embryos described in box I.11 shall be attached to this animal health certificate.

(7)	Applicable for frozen semen, oocytes or embryos.

(8)	Applicable for consignments where semen, oocytes, in vivo derived embryos, in vitro produced embryos and micromanipulated embryos of porcine animals are placed and transported in one container.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 58

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF GERMINAL PRODUCTS LISTED BELOW, DISPATCHED AFTER 20 APRIL 2021 FROM THE GERMINAL PRODUCT STORAGE CENTRE:

—	semen of porcine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of semen of porcine animals collected, processed and stored in accordance with Council Directive 90/429/EEC before 21 April 2021;

—	oocytes and embryos of porcine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021.

(MODEL “POR-GP-STORAGE-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity
Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model POR-GP-STORAGE-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify that:

II.1.

The germinal product storage centre (1) described in box I.11 at which the [semen] (2) [oocytes] (2) [in vivo derived embryos] (2) [in vitro produced embryos] (2) to be dispatched to the Union was/were stored:

II.1.1.

is located in a third country or territory, or zone thereof

II.1.1.1.

(2) either

[II.1.1.2.

(2) (3) or

[II.1.1.2.

(2) either

[II.1.1.3.

(2) (3) or

[II.1.1.3.

II.1.1.4.

II.1.1.5.

(2) either

[no vaccination against foot and mouth disease has been carried out for the same period, and no vaccinated animals entered into the third country or territory, or zone thereof during that period;]

(2) or

[vaccination against foot and mouth disease has been carried out for the same period, or vaccinated animals entered into the third country or territory, or zone thereof during that period;]

II.1.2.

is approved and listed by the competent authority of the third country or territory;

II.1.3.

complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 5 of Annex I to Commission Delegated Regulation (EU) 2020/686.]

II.2.

The [semen] (2) [oocytes] (2) [embryos] (2) described in Part I is/are intended for artificial reproduction, and:

II.2.1.

has/have been [collected] (2) [produced] (2), [processed] (2) [stored] (2) [in a semen collection centre] (2) (4) [by an embryo collection team] (2) (4) [by an embryo production team] (2) (4) [and] (2) [processed] (2) [stored] (2) [in a germinal product processing establishment] (2) (4) and stored in a germinal product storage centre (4) complying with requirements set out in [Part 1] (2) [Part 2] (2) [Part 3] (2) [Part 4] (2) [Part 5] (2) of Annex I to Delegated Regulation (EU) 2020/686, and:

(2) either

[located in the third country or territory of dispatch to the Union;]

(2) (5) and/or

[located in …, and has/have been introduced into the third country or territory of dispatch to the Union under conditions at least as strict as for the entry into the Union of [semen] (2) [oocytes] (2) [embryos] (2) of porcine animals in accordance with Regulation (EU) 2016/429 and Commission Delegated Regulation (EU) 2020/692;]

II.2.2.

was/were moved to the germinal product storage centre described in box I.11 under conditions at least as strict as described in:

(2) either

[Model POR-SEM-A-ENTRY (6);]

(2) and/or

[Model POR-SEM-B-ENTRY (6);]

(2) and/or

[Model POR-OOCYTES-EMB-ENTRY (6);]

(2) and/or

[Model POR-GP-PROCESSING-ENTRY (6);]

(2) and/or

[Model POR-GP-STORAGE-ENTRY (6);]

II.2.3.

has/have been collected, processed and stored in accordance with animal health requirements set out in Annex III to Delegated Regulation (EU) 2020/686;

II.2.4.

II.2.5.

is/are transported in a container which:

II.2.5.1.

II.2.5.2.

has been cleaned and either disinfected or sterilised before use, or is single-use container;

(2) (7) [II.2.5.3.

has been filled in with a cryogenic agent which has not been previously used for other products;]

(2) (8) [II.2.6.

is/are placed in straws or other packages which are securely and hermetically sealed;

II.2.7.

is/are transported in a container where the different types are separated from each other by physical compartments or by being placed in secondary protective bags.]

Notes

”Porcine animal” means a porcine animal as defined in Article 2, point (4), of Delegated Regulation (EU) 2020/686.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	“Place of dispatch”: Indicate the unique approval number and the name and address of the germinal product storage centre of dispatch of the consignment of semen, oocytes and/or embryos. Only germinal product storage centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/porcine_en
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of semen, oocytes and/or embryos.
Box reference I.17	:	“Accompanying documents”: Number(s) of related original animal health certificate(s) shall correspond to the serial number of the individual official document(s) or animal health certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I from the semen collection centre where the semen was collected, and/or from the embryo collection team and/or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment where the semen, oocytes or embryos were processed and stored, and/or from the germinal product storage centre where the semen, oocytes or embryos were stored, to the germinal product storage centre described in box I.11. The original(s) of those document(s) or those animal health certificate(s) or the officially endorsed copies thereof shall be attached to this animal health certificate.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Identification number”: Indicate identification number of each donor animal. “Identification mark”: Indicate mark on the straw or other packages where semen, oocytes and/or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which semen, oocytes and/or embryos of the consignment was/were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected, and/or of the embryo collection team and/or the embryo production team by which oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate number of straws or other packages with the same mark.

Part II:

(1)	Only germinal product storage centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/porcine_en.

(2)	Delete if not applicable.

(3)	Only for a third country or territory, or zone thereof with opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404.

(4)	Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/porcine_en.

(5)	Only a third country or territory, or zone thereof listed in Annex XI to Implementing Regulation (EU) 2021/404 for semen of porcine animals and Member States.

(6)

The original(s) of the document(s) or the animal health certificate(s) or the officially endorsed copies of thereof that accompanied the semen, oocytes or embryos described in Part I from the semen collection centre where the semen was collected, and/or from the embryo collection team and/or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment where the semen, oocytes or embryos were processed and stored, and/or the from germinal product storage centre where the semen, oocytes or embryos were stored, to the germinal product storage centre of dispatch of the semen, oocytes and/or embryos described in box I.11 shall be attached to this animal health certificate.

(7)	Applicable for frozen semen, oocytes or embryos.

(8)	Applicable for consignments where semen, oocytes, in vivo derived embryos, in vitro produced embryos and micromanipulated embryos of porcine animals are placed and transported in one container.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 59

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF SEMEN OF EQUINE ANIMALS COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH REGULATION (EU) 2016/429 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL AND COMMISSION DELEGATED REGULATION (EU) 2020/692 AFTER 20 APRIL 2021, DISPATCHED FROM THE SEMEN COLLECTION CENTRE WHERE THE SEMEN WAS COLLECTED (MODEL “EQUI-SEM-A-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17
	☐ Railway	☐ Road vehicle
	Identification

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity

Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model EQUI-SEM-A-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify that:

II.1.

The semen described in Part I is intended for artificial reproduction and was obtained from donor animals which originate:

II.1.1.

from a third country or territory, or zone thereof

II.1.1.1.

authorised for the entry into the Union of semen of equine animals and listed in Annex XII to Commission Implementing Regulation (EU) 2021/404;

II.1.1.2.

free from African horse sickness for at least 24 months immediately prior to the date of collection of the semen and until the date of its dispatch in accordance with Article 22(2), point (a), of Delegated Regulation (EU) 2020/692, and where no systematic vaccination against African horse sickness has been carried out for at least 12 months immediately prior to the date of collection of the semen and until the date of its dispatch in accordance with Article 22(4), point (b), of that Delegated Regulation;

II.1.1.3.

where Venezuelan equine encephalomyelitis was not reported for at least 24 months immediately prior to the date of collection of the semen and until the date of its dispatch;

II.1.2.

from an establishment in a third country or territory, or zone thereof:

(1) either

[II.1.2.1.

where infection with Burkholderia mallei (glanders) was not reported for at least 36 months immediately prior to the date of collection of the semen and until the date of its dispatch;]

(1) or

[II.1.2.1.

where infection with Burkholderia mallei (glanders) was not reported for at least 6 months immediately prior to the date of collection of the semen and until the date of its dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period;]

(1) either

[II.1.2.2.

where dourine was not reported for at least 24 months immediately prior to the date of collection of the semen and until the date of its dispatch;]

(1) or

[II.1.2.2.

where dourine was not reported for at least 6 months immediately prior to the date of collection of the semen and until the date of its dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period;]

(1) either

[II.1.2.3.

where surra (Trypanosoma evansi) was not reported for at least 24 months immediately prior to the date of collection of the semen and until the date of its dispatch.]

(1) or

[II.1.2.3.

where surra (Trypanosoma evansi) was not reported for at least 6 months immediately prior to the date of collection of the semen and until the date of its dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period.]

II.2.

The semen described in Part I was obtained from donor animals which originate, prior to the date of entering the semen collection centre, from establishments:

II.2.1.

in which

(1) either

[surra (Trypanosoma evansi) has not been reported during the preceding 2 years prior to the date of collection of the semen;]

(1) or

[surra (Trypanosoma evansi) has not been reported during the preceding 30 days prior to the date of collection of the semen and when the disease was reported in the establishments during the preceding 2 years prior to the date of collection of the semen, following the last outbreak, the establishments have remained under movement restrictions

(1) either

[until the date on which the remaining animals in the establishments have been subjected to a test for surra with one of the diagnostic methods provided for in Part 3 of Annex I to Commission Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months after the date on which the last infected animal has been removed from the establishments;]]

(1) or

[for at least 30 days from the date of cleaning and disinfection after the date on which the last animal of listed species in the establishments was either killed and destroyed or slaughtered.]]

II.2.2.

in which dourine has not been reported during the preceding 6 months prior to the date of collection of the semen, and

(1) either

[dourine has not been reported in the establishments during the preceding 2 years prior to the date of collection of the semen;]

(1) or

[dourine has been reported in the establishments during the preceding 2 years prior to the date of collection of the semen and following the last outbreak, the establishments have remained under movement restrictions

(1) either

[until the date on which the remaining equine animals in the establishments, except castrated male equine animals, have been subjected to a test for dourine with the diagnostic method provided for in Part 8 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months after the date on which the infected animals have been killed and destroyed or slaughtered, or the infected entire male equine animals have been castrated;]]

(1) or

[for at least 30 days after the date on which the last equine animal in the establishments was either killed and destroyed or slaughtered, and the premises were cleaned and disinfected;]]

II.2.3.

in which

(1) either

[equine infectious anaemia has not been reported in the establishments during the preceding 12 months prior to the date of collection of the semen;]

(1) or

[equine infectious anaemia has been reported in the establishments during the preceding 12 months prior to the date of collection of the semen and following the last outbreak, the establishments have remained under movement restrictions

(1) either

[until the date on which the remaining equine animals in the establishments have been subjected to a test for equine infectious anaemia with the diagnostic method provided for in Part 9 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken on two occasions with a minimum interval of 3 months after the date on which the infected animals have been killed and destroyed or slaughtered and the establishments were cleaned and disinfected;]]

(1) or

[for at least 30 days after the date on which the last equine animal in the establishments was either killed and destroyed or slaughtered, and the establishments were cleaned and disinfected;]]

II.2.4.

in which during 30 days immediately prior to the date of collection of the semen no equine animal has shown signs of infection with equine arteritis virus and of contagious equine metritis.

II.3.

The semen described in Part I has been collected, processed and stored, and dispatched from the semen collection centre (2) which:

II.3.1.

is approved and listed by the competent authority of the third country or territory;

II.3.2.

complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 1 of Annex I to Commission Delegated Regulation (EU) 2020/686.

II.4.

The semen described in Part I was obtained from donor animals which;

II.4.1.

were not vaccinated against African horse sickness at least in 40 days immediately prior to the date of collection of the semen;

II.4.2.

were not vaccinated against Venezuelan equine encephalomyelitis at least in 60 days immediately prior to the date of collection of the semen;

II.4.3.

remained for at least 3 months immediately prior to the date of collection of the semen in a third country or territory, or zone thereof referred to in box I.7;

II.4.4.

for at least 30 days immediately prior to the date of collection of the semen and during the collection period:

II.4.4.1.

were kept in establishments not situated in a restricted zone established due to the occurrence of African horse sickness, infection with Burkholderia mallei (glanders) or of an emerging disease relevant for equine animals;

II.4.4.2.

were kept in establishments where Venezuelan equine encephalomyelitis, dourine, surra (Trypanosoma evansi), equine infectious anaemia, contagious equine metritis (Taylorella equigenitalis), infection with rabies virus and anthrax have not been reported;

II.4.4.3.

were not in contact with animals from establishments situated in a restricted zone due to the occurrence of diseases referred to in point II.4.4.1 or from establishments which do not meet the conditions referred to in point II.4.4.2;

II.4.5.

were not used for natural breeding during at least 30 days immediately prior to the date of the first semen collection and between the dates of the first sample referred to in points II.4.8.1, II.4.8.2 and/or II.4.8.3. and until the end of the collection period;

II.4.6.

did not show symptoms of transmissible diseases on the date of admission to the semen collection centre and on the date of collection of the semen;

II.4.7.

are individually identified as provided for in Article 21(2) of Delegated Regulation (EU) 2020/692;

II.4.8.

have been subjected to the following tests, referred to in Part 4, Chapter I, point 1(a), of Annex II, to Delegated Regulation (EU) 2020/686, as follows:

(3) II.4.8.1.

for infection with equine infectious anaemia (EIA), an agar-gel immuno-diffusion test (AGID or Coggins test) or an enzyme-linked immunosorbent assay (ELISA) with a negative result;

II.4.8.2.

for infection with equine arteritis virus (EVA),

(1) either

[II.4.8.2.1.

a serum neutralisation test with a negative result at a serum dilution of one in four;]

(1) and/or

[II.4.8.2.2.

a virus isolation test, polymerase chain reaction (PCR) or real-time PCR with a negative result on an aliquot of the entire semen of the donor stallion;]

II.4.8.3.

for contagious equine metritis (CEM), an agent identification test carried out on three specimens (swabs) taken from the donor stallion on two occasions with an interval of not less than 7 days at least from the penile sheath (prepuce), the urethra and the fossa glandis;

The samples were in no case taken earlier than 7 days (systemic treatment) or 21 days (local treatment) after antimicrobial treatment of the donor stallion and were placed in a transport medium with activated charcoal, such as Amies medium, before dispatch to the laboratory where they were subjected with a negative result to a test for:

(1) either

[II.4.8.3.1.

the isolation of Taylorella equigenitalis after cultivation under microaerophilic conditions for at least 7 days, set up within 24 hours after taking the specimens from the donor animal, or 48 hours where the specimens are kept cool during transport;]

(1) and/or

[II.4.8.3.2.

the detection of the genome of Taylorella equigenitalis by PCR or real-time PCR, carried out within 48 hours after taking the specimens from the donor animal;]

II.4.9.

were subjected with the results specified in point II.4.8 in each case to at least one of the following testing programmes detailed in Part 4, Chapter I, points 1(b)(i), (ii) and (iii), of Annex II, to Delegated Regulation (EU) 2020/686:

(4) [II.4.9.1.

The donor stallion was continuously resident at the semen collection centre for at least 30 days immediately prior to the date of the first collection and during the period of collection of the semen described in Part I, and no equine animal in the semen collection centre came during that time into direct contact with equine animals of lower health status than the donor stallion.

(4) [II.4.9.2.

The donor stallion was resident at the semen collection centre for at least 30 days immediately prior to the date of the first collection and during the period of collection of the semen described in Part I, but left the semen collection centre under the responsibility of the centre veterinarian for a continuous period of less than 14 days during the collection period, or other equine animals in the semen collection centre came into direct contact with equine animals of a lower health status than the donor stallion.

The tests described in point II.4.8 were carried out on samples taken (5) from the donor stallion at least once a year at the beginning of the breeding season or prior to the date of the first collection of the semen intended for the entry into the Union of fresh, chilled or frozen semen and not less than 14 days following the date of the commencement of the residence period of at least 30 days immediately prior to the date of the first collection, and during the period of collection of the semen intended for the entry into the Union of fresh, chilled or frozen semen, the donor stallion was subjected to the tests described in point II.4.8, as follows:

(a)	for equine infectious anaemia, one of the tests described in point II.4.8.1 was last carried out on a sample of blood taken (5) not more than 90 days prior to the date of collection of the semen described in Part I;

(b)	for infection with equine arteritis virus, one of the tests described

(1) either

[in point II.4.8.2 was last carried out on a sample taken (5) not more than 30 days immediately prior to the date of collection of the semen described in Part I;]

(1) or

[in point II.4.8.2.2, in case the non-shedder state of a donor stallion seropositive for infection with equine arteritis virus is confirmed, was carried out on an aliquot of the entire semen of the donor stallion taken (5) not more than 6 months prior to the date of collection of the semen described in Part I, and a blood sample taken (5) from the donor stallion during the last 6 months reacted with a positive result in a serum neutralisation test for infection with equine arteritis virus at a serum dilution of more than one in four;]

(c)	for contagious equine metritis, the tests described in point II.4.8.3 were last carried out on three specimens (swabs) taken (5) not more than 60 days immediately prior to the date of the collection of the semen described in Part I

(1) either

[on two occasions.]]

(1) or

[on a single occasion and subjected to a PCR or real-time PCR.]]

(4) [II.4.9.3.

The donor stallion did not meet the conditions set out in Part 4, Chapter I, points 1(b)(i) and (ii), of Annex II to Delegated Regulation (EU) 2020/686 and the semen was collected for the entry into the Union as frozen semen.

The tests described in points II.4.8.1, II.4.8.2 and II.4.8.3 were carried out on samples taken (5) from the donor stallion at least once a year at the beginning of the breeding season, and the tests described in points II.4.8.1 and II.4.8.3 were carried out on samples taken (5) from the donor stallion during the storage period of the semen of a minimum period of 30 days from the date of the collection of the semen and prior to the date of removal of the semen from the semen collection centre, not less than 14 days and not more than 90 days after the date of collection of the semen described in Part I, and

(1) either

[the tests for infection with equine arteritis virus described in point II.4.8.2 were carried out on samples taken (5) during the storage period of the semen of a minimum of 30 days from the date of the collection of the semen and prior to the date of removal of the semen from the semen collection centre or used, not less than 14 days and not more than 90 days after the date of the collection of the semen described in Part I.]]

(1) or

[the non-shedder state of a donor stallion seropositive for infection with equine arteritis virus was confirmed by virus isolation test, PCR or real-time PCR carried out with a negative result on samples of an aliquot of the entire semen of the donor stallion taken (5) twice a year at an interval of at least 4 months, and the donor stallion reacted with a positive result at a serum dilution of at least one in four in a serum neutralisation test for infection with equine arteritis virus.]]

II.4.10.

underwent the testing provided for in point II.4.9 on samples taken on the following dates:

Identification of semen	Test programme	Start date (5)		Date of sampling for health tests (5)
		Donor residence	Semen collection	EIA II.4.8.1	EVA II.4.8.2		CEM II.4.8.3
					Blood sample	Semen sample	1. sample	2. sample

II.5.

The semen described in Part I:

II.5.1.

has been collected, processed and stored in accordance with animal health requirements set out in Part 1, points 1 and 2, of Annex III to Delegated Regulation (EU) 2020/686;

II.5.2.

II.5.3.

is transported in a container which:

II.5.3.1.

II.5.3.2.

has been cleaned and either disinfected or sterilised before use, or is single-use container;

(1) (6) [II.5.3.3.

has been filled in with a cryogenic agent which has not been previously used for other products.]

(1) (7) [II.6.

Where antibiotic(s) were added to the semen:

II.6.1.

The following antibiotic or mixture of antibiotics has been added to the semen after final dilution, or is contained in the used semen diluents: (8) … ;

II.6.2.

Notes

This animal health certificate is intended for the entry into the Union of semen of equine animals, including when the Union is not the final destination of the semen.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	“Place of dispatch”: Indicate the unique approval number and the name and address of the semen collection centre of dispatch of the consignment of semen. Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of semen.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Type”: Indicate semen. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where semen of the consignment is placed. “Date of collection/production”: Indicate the date on which semen of the consignment was collected in the following format: dd.mm.yyyy. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected. “Quantity”: Indicate the number of straws or other packages with the same mark. “Test”: Indicate “Yes, see points II.4.9 and II.4.10”.

Part II:

Guidance for the completion of the table in point II.4.10:

Abbreviations:

EIA-1	Equine infectious anaemia (EIA) testing first occasion
EIA-2	EIA testing second occasion
EVA-B1	Infection with equine arteritis virus (EVA) testing on a blood sample first occasion
EVA-B2	EVA testing on a blood sample second occasion
EVA-S1	EVA testing on a semen sample first occasion
EVA-S2	EVA testing on a semen sample second occasion
CEM-11	Contagious equine metritis (CEM) testing first occasion first sample
CEM-12	CEM testing first occasion second sample taken 7 days after CEM-11
CEM-21	CEM testing second occasion first sample
CEM-22	CEM testing second occasion second sample taken 7 days after CEM-21

Instructions:

For each semen identified in column A of the table and indicated in box I.27, the test programme (point II.4.9.1, II.4.9.2 and/or II.4.9.3) shall be specified in column B of the table, and columns C and D of the table shall be completed with the dates required.

The dates when samples were taken for laboratory testing prior to the first collection of the semen described in Part I as required by points II.4.9.1, II.4.9.2 and II.4.9.3, shall be entered in the upper line of columns 5 to 9 of the table, this being the boxes marked with EIA-1, EVA-B1 or EVA-S1 and CEM-11 and CEM-12 in the example below.

The dates when samples were taken for repeat laboratory testing as required in accordance with point II.4.9.2 or II.4.9.3 shall be entered in the lower line of columns 5 to 9 of the table, this being the boxes EIA-2, EVA-B2 or EVA-S2 and CEM-21 and CEM-22 in the example below.

Identification of semen	Test programme	Start date		Date of sampling for health tests
		Donor residence	Semen collection	EIA II.4.8.1	EVA II.4.8.2		CEM II.4.8.3
					Blood sample	Semen sample	1.sample	2.sample
A	B	C	D	EIA-1	EVA-B1	EVA-S1	CEM-11	CEM-12
				EIA-2	EVA-B2	EVA-S2	CEM-21	CEM-22

(1)	Delete if not applicable.

(2)	Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en.

(3)

The agar gel immunodiffusion test (AGID or Coggins test) or the ELISA for equine infectious anaemia are not required for donor equine animals which continuously resided in Iceland since birth, provided that Iceland remained officially free of equine infectious anaemia and no equine animals and their semen, oocytes and embryos were introduced into Iceland from outside prior to and during the period the semen was collected.

(4)	Cross out the programmes that do not apply to the consignment.

(5)	Insert date in table in point II.4.10 (follow guidance in Part II of the Notes).

(6)	Applicable for frozen semen.

(7)	Mandatory attestation in case antibiotic(s) were added.

(8)	Insert the name(s) of the antibiotic(s) added and its (their) concentration or the commercial name of the semen diluent containing antibiotic(s).

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 60

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF STOCKS OF SEMEN OF EQUINE ANIMALS COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH COUNCIL DIRECTIVE 92/65/EEC AFTER 30 SEPTEMBER 2014 AND BEFORE 21 APRIL 2021, DISPATCHED AFTER 20 APRIL 2021 FROM THE SEMEN COLLECTION CENTRE WHERE THE SEMEN WAS COLLECTED (MODEL “EQUI-SEM-B-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17
	☐ Railway	☐ Road vehicle
	Identification

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity

Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model EQUI-SEM-B-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned, official veterinarian, of the exporting country (1) … hereby certify that:

(name of exporting country)

II.1.

The semen collection centre (2), in which the semen described in Part I was collected, processed and stored for export to the Union was approved and supervised by the competent authority in accordance with the conditions of Chapters I(I)(1) and I(II)(1) of Annex D to Directive 92/65/EEC (3);

II.2.

During the period commencing 30 days prior to the date of first collection of the semen described in Part I until the date the fresh or chilled semen was dispatched or until the 30 days storage period for frozen semen elapsed, the semen collection centre:

II.2.1.

was situated in the exporting country or, in the case of regionalisation according to Article 13 of Directive 2009/156/EC (4), in that part of the territory of the exporting country which was:

—	not considered to be infected with African horse sickness in accordance with Article 5(2)(a) and (b) of Directive 2009/156/EC,

—	free from Venezuelan equine encephalomyelitis for a period of at least 2 years,

—	free from glanders and dourine for a period of at least 6 months;

II.2.2.

fulfilled the conditions for a holding laid down in Article 4(5) of Directive 2009/156/EC and in particular:

(5) either

[II.2.2.1.

following a case of a disease mentioned below not all the animals of species susceptible to that disease located in the holding were slaughtered or killed and the holding has been free:

—	from any type of equine encephalomyelitis for a period of at least 6 months, beginning on the day on which the equidae suffering from the disease are slaughtered,

—	from equine infectious anaemia (EIA) for at least the period required to obtain a negative result in an agar gel immunodiffusion test (AGID or Coggins test) carried out on samples taken after the infected animals were slaughtered on two occasions 3 months apart from each of the remaining animals,

—	from vesicular stomatitis (VS) for a period of at least 6 months from the last recorded case,

—	from rabies for a period of at least one month from the last recorded case,

—	from anthrax for a period of at least 15 days from the last recorded case,]

(5) or

[II.2.2.1.

following a case of a disease mentioned below all the animals of species susceptible to that disease located in the holding have been slaughtered or killed and the premises disinfected, and the holding was free for a period of at least 30 days from any type of equine encephalomyelitis, equine infectious anaemia, vesicular stomatitis and rabies or 15 days in the case of anthrax, beginning on the day on which following the destruction of the animals the disinfection of the premises was satisfactorily completed;]

II.2.3.

contained only equidae which were free of clinical signs of equine viral arteritis and contagious equine metritis,

II.3.

Prior to entering the semen collection centre the donor stallions and any other equidae located in the centre:

II.3.1.

were continuously resident for a period of 3 months (or since entry if they were directly imported from a Member State during the 3 months period) in the exporting country or, in the case of regionalisation in accordance with Article 13 of Directive 2009/156/EC, in that part of the territory of the exporting country which was during that period:

—	not considered to be infected with African horse sickness in accordance with Article 5(2)(a) and (b), of Directive 2009/156/EC,

—	free from Venezuelan equine encephalomyelitis for a period of at least 2 years,

—	free from glanders and dourine for a period of at least 6 months;

(5) either

[II.3.2.

originated from the country of export which was on the day of admission into the centre free from vesicular stomatitis (VS) for a period of at least 6 months,]

(5) or

[II.3.2.

were subjected to a virus neutralisation test for vesicular stomatitis (VS) carried out with a negative result at a serum dilution of 1 in 32 or a VS ELISA carried out with a negative result in accordance with the relevant Chapter of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the OIE on a blood sample taken (6) within 14 days prior to entering the centre;]

II.3.3.

originated from holdings which on the day of admission onto the centre fulfilled the requirements of point II.2.2;

II.4.

The semen described in Part I was collected from donor stallions which:

II.4.1.

did not show any clinical sign of an infectious or contagious disease at the time of admission onto the semen collection centre and on the day the semen was collected;

II.4.2.

were kept for a period of at least 30 days prior to the date of semen collection in holdings where no equine animal has shown any clinical sign of equine viral arteritis or contagious equine metritis during that period;

II.4.3.

were not used for natural mating during a period of at least 30 days prior to the date of first semen collection and between the dates of the first sample referred to in points II.4.5.1, II.4.5.2 and/or II.4.5.3 and until the end of the collection period;

II.4.4.

underwent the following tests, which meet at least the requirements of the relevant Chapter of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the OIE, carried out in a laboratory which is recognised by the competent authority and has the tests referred to hereinafter included in its accreditation equivalent to that provided for in Article 12 of Regulation (EC) No 882/2004 (7), as follows:

(8) [II.4.4.1.

for equine infectious anaemia (EIA), an agar-gel immuno-diffusion test (AGID or Coggins test) or an enzyme-linked immunosorbent assay (ELISA) with a negative result;]

II.4.4.2.

for equine viral arteritis (EVA),

(5) either

[II.4.4.2.1.

a serum neutralisation test with a negative result at a serum dilution of one in four;]

(5) and/or

[II.4.4.2.2.

a virus isolation test, polymerase chain reaction (PCR) or real-time PCR with a negative result on an aliquot of the entire semen of the donor stallion;]

II.4.4.3.

The samples were in no case taken earlier than 7 days (systemic treatment) or 21 days (local treatment) after antimicrobial treatment of the donor stallion and were placed in transport medium with activated charcoal, such as Amies medium, before dispatch to the laboratory where they were subjected with a negative result to a test for:

(5) either

[II.4.4.3.1.

the isolation of Taylorella equigenitalis after cultivation under microaerophilic conditions for a period of at least 7 days, set up within 24 hours after taking the specimens from the donor animal, or 48 hours where the specimens are kept cool during transport;]

(5) and/or

[II.4.4.3.2.

the detection of the genome of Taylorella equigenitalis by PCR or real-time PCR, carried out within 48 hours after taking the specimens from the donor animal;]

II.4.5.

were subjected with the results specified in point II.4.4 in each case to at least one of the test programmes detailed respectively in points 1.6(a), (b) and (c) of Chapter II of Annex D to Directive 92/65/EEC as follows:

(9) [II.4.5.1.

The donor stallion was continuously resident on the semen collection centre for a period of at least 30 days prior to the date of the first collection and during the period of collection of the semen described in Part I, and no equidae on the semen collection centre came during that time into direct contact with equidae of lower health status than the donor stallion.

The tests described in point II.4.4 were carried out on samples taken (6) from the donor stallion at least once a year at the beginning of the breeding season or prior to the first collection of semen intended for imports into the Union of fresh, chilled or frozen semen and not less than 14 days following the date of the commencement of the residence period of at least 30 days prior to the first semen collection.]

(9) [II.4.5.2.

The donor stallion was resident on the semen collection centre for a period of at least 30 days prior to the date of the first collection and during the period of collection of the semen described in Part I, but left the semen collection centre under the responsibility of the centre veterinarian for a continuous period of less than 14 days, and/or other equidae on the semen collection centre came into direct contact with equidae of a lower health status.

The tests described in point II.4.4 were carried out on samples taken (6) from the donor stallion at least once a year at the beginning of the breeding season or prior to the date of the first collection of semen intended for imports into the Union of fresh, chilled or frozen semen and not less than 14 days following the date of the commencement of the residence period of at least 30 days prior to the first semen collection,

and

during the period of collection of the semen intended for imports into the Union of fresh, chilled or frozen semen the donor stallion was subjected to the tests described in point II.4.4, as follows:

(a)	for equine infectious anaemia, one of the tests described in point II.4.4.1 was last carried out on a sample of blood taken (6) not more than 90 days prior to the collection of the semen described in Part I;

(b)	for equine viral arteritis, one of the tests described

(5) either

[in point II.4.4.2 was last carried out on a sample taken (6) not more than 30 days prior to the date of the collection of the semen described In Part I;]

(5) or

[in point II.4.4.2.2 was carried out on an aliquot of the entire semen of the donor stallion taken (6) not more than 6 months prior to the date of the collection of the semen described in Part I and a blood sample taken (6) from the donor stallion during the 6 months period reacted with a positive result in a serum neutralisation test for equine viral arteritis at a serum dilution of more than one in four;]

(c)	for contagious equine metritis, the test described in point II.4.4.3 was last carried out on three specimens (swabs) taken (6) not more than 60 days prior to the date of the collection of semen described in Part I

(5) either

[on two occasions;]

(5) or

[on a single occasion and subjected to a PCR or real-time PCR.]]

(9) [II.4.5.3.

The donor stallion does not meet the conditions set out in points 1.6(a) and (b) of Chapter II of Annex D to Directive 92/65/EEC and the semen is collected for imports into the Union of frozen semen.

The tests described in points II.4.4.1, II.4.4.2 and II.4.4.3 were carried out on samples taken (6) from the donor stallion at least once a year at the beginning of the breeding season,

and

the tests described in points II.4.4.1 and II.4.4.3 were carried out on samples taken (6) from the donor stallion during the storage period of the semen of a minimum period of 30 days from the date of the collection of the semen and before the semen is removed from the semen collection centre, not less than 14 days and not more than 90 days after the collection of the semen described in Part I,

and

(5) either

[the tests for equine viral arteritis described in point II.4.4.2 were carried out on samples taken (6) during the storage period of the semen of a minimum period of 30 days from the date of the collection of the semen and before the semen is removed from the semen collection centre or used, not less than 14 days and not more than 90 days after the date of the collection of the semen described in Part I.]

(5) or

[the non-shedder state of a donor stallion seropositive for equine viral arteritis was confirmed by virus isolation test, PCR or real-time PCR carried out with a negative result on samples of an aliquot of the entire semen of the donor stallion taken (6) twice a year at an interval of at least 4 months and the donor stallion has reacted with a positive result at a serum dilution of at least one in four in a serum neutralisation test for equine viral arteritis.]]

II.4.6.

underwent the testing provided for in points II.3.2 (5) and II.4.5 on samples taken on the following dates:

Identification of semen	Test programme	Start date (6)		Date of sampling for health tests (6)
		Donor residence	Semen collection	VS (5) II.3.2	EIAII.4.4.1	EVA II.4.4.2		CEM II.4.4.3
						Blood sample	Semen sample	1. sample	2. sample

(5) either

[II.5.

No antibiotics were added to the semen;]

(5) or

[II.5.

The following antibiotic or combination of antibiotics was added to produce a concentration in the final diluted semen of not less than (10): …

… ;]

II.6.

The semen described in Part I was:

II.6.1.

collected, processed, stored and transported under conditions which comply with the requirements of Chapters II(I)(1) and III(I) of Annex D to Directive 92/65/EEC;

II.6.2.

sent to the place of loading in a sealed container in accordance with point 1.4 of Chapter III(I) of Annex D to Directive 92/65/EEC and bearing the number indicated in box I.19.

Notes

This animal health certificate is intended for the entry into the Union of semen of equine animals, including when the Union is not the final destination of the semen.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	”Place of dispatch” shall correspond to the semen collection centre of the semen origin.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of semen.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Type”: Indicate semen. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where semen of the consignment is placed. “Date of collection/production”: Indicate the date on which semen of the consignment was collected in the following format: dd.mm.yyyy. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected. “Quantity”: Indicate the number of straws or other packages with the same mark.

Part II:

Guidance for the completion of the table in point II.4.6

Abbreviations:

VS	Vesicular stomatitis (VS) testing if required in accordance with point II.3.2
EIA-1	Equine infectious anaemia (EIA) testing first occasion
EIA-2	EIA testing second occasion
EVA-B1	Equine viral arteritis (EVA) testing on a blood sample first occasion
EVA-B2	EVA testing on a blood sample second occasion
EVA-S1	EVA testing on a semen sample first occasion
EVA-S2	EVA testing on a semen sample second occasion
CEM-11	Contagious equine metritis (CEM) testing first occasion first sample
CEM-12	CEM testing first occasion second sample taken 7 days after CEM-11
CEM-21	CEM testing second occasion first sample
CEM-22	CEM testing second occasion second sample taken 7 days after CEM-21

Instructions:

For each semen identified in column A of the table and indicated in box I.27, the test programme (points II.4.5.1, II.4.5.2 and/or II.4.5.3) shall be specified in column B of the table, and columns C and D of the table shall be completed with the dates required.

The dates when samples were taken for laboratory testing prior to the first collection of the semen described in Part I as required by points II.4.5.1, II.4.5.2 and II.4.5.3, shall be entered in the upper line of columns 5 to 9 of the table, this being the boxes marked with EIA-1, EVA-B1 or EVA-S1 and CEM-11 and CEM-12 in the example below.

The dates when samples were taken for repeat laboratory testing as required in accordance with point II.4.5.2 or II.4.5.3 shall be entered in the lower line of columns 5 to 9 of the table, this being the boxes EIA-2, EVA-B2 or EVA-S2 and CEM-21 and CEM-22 in the example below.

Identification of semen	Test programme	Start date		Date of sampling for health tests
		Donor residence	Semen collection	VSII.3.2	EIAII.4.4.1	EVA II.4.4.2		CEM II.4.4.3
						Blood sample	Semen sample	1.sample	2.sample
A	B	C	D	VS	EIA-1	EVA-B1	EVA-S1	CEM-11	CEM-12
					EIA-2	EVA-B2	EVA-S2	CEM-21	CEM-22

(1)

Entry into the Union of equine semen is authorised from a third country or territory listed in column 1 of the table in Part 1 of Annex XII to Commission Implementing Regulation (EU) 2021/404 provided that the semen was collected in the zone detailed in column 2 of the table in Part 1 of that Annex from a donor stallion of the category of equine animals indicated in column 3 of the table in Part 1 of that Annex.

(2)	Only semen collection centres listed in accordance with Article 17(3), point (b), of Directive 92/65/EEC on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en.

(3)

Council Directive 92/65/EEC of 13 July 1992 laying down animal health requirements governing trade in and imports into the Community of animals, semen, ova and embryos not subject to animal health requirements laid down in specific Community rules referred to in Annex A (I) to Directive 90/425/EEC (OJ L 268, 14.9.1992, p. 54).

(4)	Council Directive 2009/156/EC of 30 November 2009 on animal health conditions governing the movement and importation from third countries of equidae (OJ L 192, 23.7.2010, p. 1).

(5)	Delete if not applicable.

(6)	Insert date in table in point II.4.6 (follow guidance in Part II of the Notes).

(7)	Regulation (EC) No 882/2004 of the European Parliament and of the Council of 29 April 2004 on official controls performed to ensure the verification of compliance with feed and food law, animal health and animal welfare rules (OJ L 165, 30.4.2004, p. 1).

(8)

The agar gel immunodiffusion test (AGID or Coggins test) or the ELISA for equine infectious anaemia are not required for donor equine animals which continuously resided in Iceland since birth, provided that Iceland remained officially free of equine infectious anaemia and no equine animals and their semen, ova and embryos were introduced into Iceland from outside prior to and during the period the semen was collected.

(9)	Cross out the programmes that do not apply to the consignment.

(10)	Insert names and concentrations.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 61

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF STOCKS OF SEMEN OF EQUINE ANIMALS COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH COUNCIL DIRECTIVE 92/65/EEC AFTER 31 AUGUST 2010 AND BEFORE 1 OCTOBER 2014, DISPATCHED AFTER 20 APRIL 2021 FROM THE SEMEN COLLECTION CENTRE WHERE THE SEMEN WAS COLLECTED (MODEL “EQUI-SEM-C-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17
	☐ Railway	☐ Road vehicle
	Identification

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity

Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model EQUI-SEM-C-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned, official veterinarian, of the exporting country (1) … hereby certify that:

(name of exporting country)

II.1.

The semen collection centre (2), in which the semen described in Part I was collected, processed and stored for export to the Union was approved and supervised by the competent authority in accordance with the conditions of Chapter I(I)(1) and Chapter I(II)(1) of Annex D to Directive 92/65/EEC,

II.2.

during the period commencing 30 days prior to the date of first collection of the semen described in Part I until the 30 days storage period for frozen semen elapsed, the semen collection centre:

II.2.1.

was situated in the exporting country or, in the case of regionalisation according to Article 13 of Directive 2009/156/EC (3), in that part of the territory of the exporting country which was:

—	not considered to be infected with African horse sickness in accordance with Article 5(2)(a) and (b) of Directive 2009/156/EC (3),

—	free from Venezuelan equine encephalomyelitis for 2 years,

—	free from glanders and dourine for 6 months;

II.2.2.

fulfilled the conditions for a holding laid down in Article 4(5) of Directive 2009/156/EC (3) and in particular:

(4) either

[II.2.2.1.

following a case of a disease mentioned below not all the animals of species susceptible to the disease located on the holding were slaughtered or killed and the holding has been free:

—	from any type of equine encephalomyelitis for at least 6 months, beginning on the day on which the equidae suffering from the disease are slaughtered,

—	from equine infectious anaemia for at least the period required to obtain a negative result in an agar gel immunodiffusion test (Coggins test) carried out on samples taken after the infected animals were slaughtered on two occasions 3 months apart from each of the remaining animals,

—	from vesicular stomatitis for at least 6 months from the last recorded case,

—	from rabies for at least one month from the last recorded case,

—	from anthrax for at least 15 days from the last recorded case,]

(4) or

[II.2.2.1.

following a case of a disease mentioned below all the animals of species susceptible to the disease located on the holding have been slaughtered or killed and the premises disinfected, the holding has been free for at least 30 days from any type of equine encephalomyelitis, equine infectious anaemia, vesicular stomatitis and rabies or 15 days in the case of anthrax, beginning on the day on which following the destruction of the animals the disinfection of the premises was satisfactorily completed;]

II.2.3.

contained only equidae which were free of clinical signs of equine viral arteritis and contagious equine metritis,

II.3.

Prior to entering the semen collection centre the donor stallions and any other equidae located in the centre:

II.3.1.

were continuously resident for 3 months (or since entry if they were directly imported from a Member State of the European Union during the 3 months period) in the exporting country or, in the case of regionalisation according to Article 13 of Directive 2009/156/EC (3), in that part of the territory of the exporting country which was during that period

—	not considered to be infected with African horse sickness in accordance with Article 5(2)(a) and (b) of Directive 2009/156/EC (3),

—	free from Venezuelan equine encephalomyelitis for at least 2 years,

—	free from glanders and dourine for at least 6 months;

(4) either

[II.3.2.

originated from the country of export which was on the day of admission into the centre free of vesicular stomatitis (VS) for at least 6 months,]

(4) or

[II.3.2.

were subjected to a virus neutralisation test for vesicular stomatitis (VS) carried out with negative result at a serum dilution of 1 in 12 on a blood sample taken (5) within 14 days prior to entering the centre;]

II.3.3.

originated from holdings which on the day of admission onto the centre fulfilled the requirements of point II.2.2;

II.4.

The semen described in Part I was collected from donor stallions, which:

II.4.1.

have not shown any clinical sign of an infectious or contagious disease at the time of admission onto the centre and on the day the semen was collected;

II.4.2.

have been kept for 30 days prior to the date of semen collection on holdings where no equine animal has shown any clinical sign of equine viral arteritis or contagious equine metritis during that period;

II.4.3.

have not been used for natural mating during at least 30 days prior to the date of first semen collection and between the dates of the first sample referred to in points II.4.5.1, II.4.5.2 and/or II.4.5.3. and until the end of the collection period;

II.4.4.

have undergone the following tests, which meet at least the requirements of the relevant Chapter of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the OIE, carried out on samples taken in accordance with one of the programmes specified in point II.4.5 in a laboratory recognised by the competent authority:

(4) (6) either

[II.4.4.1.

an agar-gel immuno-diffusion test (Coggins test) for equine infectious anaemia (EIA) with negative result;]

(4) (6) or

[II.4.4.1.

an ELISA for equine infectious anaemia (EIA) with negative result;]

and

(4) either

[II.4.4.2.

a serum neutralisation test for equine viral arteritis (EVA) with negative result at a serum dilution of one in four;]

(4) or

[II.4.4.2.

a virus isolation test for equine viral arteritis (EVA) carried out with negative result on an aliquot of the entire semen of the donor stallion;]

and

II.4.4.3.

an agent identification test for contagious equine metritis (CEM) carried out on two occasions on samples collected with an interval of 7 days by isolation of Taylorella equigenitalis after a cultivation of 7 to 14 days from pre-ejaculatory fluid or a semen sample and from genital swabs taken at least from the penile sheath, urethra and urethral fossa with negative result in each case;

II.4.5.

have been subjected with the results specified in II.4.4 in each case to at least one of the test programmes (7) detailed in points II.4.5.1, II.4.5.2 and II.4.5.3 as follows:

(4) [II.4.5.1.

The donor stallion was continuously resident on the semen collection centre for at least 30 days prior to the date of the first collection and during the period of collection of the semen described in Part I, and no equidae on the semen collection centre came during that time into direct contact with equidae of lower health status than the donor stallion.

The tests described in point II.4.4 have been carried out on samples taken (5) prior to the first semen collection and at least 14 days following the date of the commencement of the residence period of at least 30 days.]

(4) [II.4.5.2.

The donor stallion was resident on the semen collection centre for at least 30 days prior to the date of the first collection and during the period of collection of the semen described in Part I, but has left the centre under the responsibility of the centre veterinarian for a continuous period of less than 14 days, or other equidae on the collection centre came into direct contact with equidae of lower health status.

The tests described in point II.4.4 have been carried out on samples taken (5) prior to the date of the first semen collection of the breeding season or collection period in the year the semen described in Part I was collected and at least 14 days following the date of the commencement of the residence period of at least 30 days,

and	the test described in point II.4.4.1 for equine infectious anaemia was last carried out on a sample of blood taken (5) not more than 90 days before the semen described in Part I was collected;

and

(4) either

[one of the tests described in point II.4.4.2 for equine viral arteritis was last carried out on a sample taken (5) not more than 30 days before the semen described in Part I was collected,]

(4) or

[a virus isolation test for equine viral arteritis was carried out with negative result on an aliquot of the entire semen of the donor stallion taken (5) not more than 6 months before the semen described in Part I was collected and a blood sample taken on the same date (5) reacted positive in a serum neutralisation test for equine viral arteritis at a serum dilution of more than one in four,]

and	the test described in point II.4.4.3 for contagious equine metritis was last carried out on samples taken (5), not more than 60 days before the semen described in Part I was collected.]

(4) [II.4.5.3.

and	the tests described in point II.4.4 have been carried out on samples taken (5) between 14 and 90 days after the collection of the semen described in Part I.]

II.4.6.

have undergone the testing provided for in points II.3.2 (4) and II.4.5 on samples taken on the following dates:

Identification of semen	Test programme	Start date (5)		Date of sampling for health tests (5)
		Donor residence	Semen collection	VS (4) II.3.2	EIII.4.4.1	EVA II.4.4.2		CEM II.4.4.3
						Blood sample	Semen sample	1. sample	2. sample

(4) either

[II.5.

No antibiotics were added to the semen;]

(4) or

[II.5.

The following antibiotic or combination of antibiotics was added to produce a concentration in the final diluted semen of not less than (8): …

… ;]

II.6.

The semen described in Part I was:

II.6.1.

collected, processed, stored and transported under conditions which comply with the requirements of Chapters II(I)(1) and III(I) of Annex D to Directive 92/65/EEC;

II.6.2.

sent to the place of loading in a sealed container in accordance with point 1.4 of Chapter III(I) of Annex D to Directive 92/65/EEC and bearing the number indicated in box I.19.

Notes

This animal health certificate is intended for the entry into the Union of semen of equine animals, including when the Union is not the final destination of the semen.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	”Place of dispatch” shall correspond to the semen collection centre of the semen origin.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of semen.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Type”: Indicate semen. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where semen of the consignment is placed. “Date of collection/production”: Indicate the date on which semen of the consignment was collected in the following format: dd.mm.yyyy. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected. “Quantity”: Indicate the number of straws or other packages with the same mark.

Part II:

Guidance for the completion of the table in point II.4.6.

Abbreviations:

VS	Vesicular stomatitis (VS) testing if required in accordance with point II.3.2
EIA-1	Equine infectious anaemia (EIA) testing first occasion
EIA-2	EIA testing second occasion
EVA-B1	Equine viral arteritis (EVA) testing on a blood sample first occasion
EVA-B2	EVA testing on a blood sample second occasion
EVA-S1	EVA testing on a semen sample first occasion
EVA-S2	EVA testing on a semen sample second occasion
CEM-11	Contagious equine metritis (CEM) testing first occasion first sample
CEM-12	CEM testing first occasion second sample taken 7 days after CEM-11
CEM-21	CEM testing second occasion first sample
CEM-22	CEM testing second occasion second sample taken 7 days after CEM-21

Instructions:

For each semen identified in column A of the table and indicated in box I.27, the test programme (II.4.5.1, II.4.5.2 and/or II.4.5.3) shall be specified in column B of the table, and columns C and D of the table shall be completed with the dates required.

The dates when samples were taken for laboratory testing prior to the first collection of the semen described in Part I as required by II.4.5.1, II.4.5.2 and II.4.5.3, are entered in the upper line of columns 5 to 9 of the table, this being the boxes marked with EIA-1, EVA-B1 or EVA-S1 and CEM-11 and CEM-12 in the example below.

The dates when samples were taken for repeat laboratory testing as required in accordance with II.4.5.2 or II.4.5.3 are entered in the lower line of columns 5 to 9 of the table, this being the boxes EIA-2, EVA-B2 or EVA-S2 and CEM-21 and CEM-22 in the example below.

Identification of semen	Test programme	Start date		Date of sampling for health tests
		Donor residence	Semen collection	VS II.3.2	EIAII.4.4.1	EVA II.4.4.2		CEM II.4.4.3
						Blood sample	Semen sample	1.sample	2.sample
A	B	C	D	VS	EIA-1	EVA-B1	EVA-S1	CEM-11	CEM-12
					EIA-2	EVA-B2	EVA-S2	CEM-21	CEM-22

(1)

Entry into the Union of equine semen is authorised from a third country or territory listed in column 1 of the table in Part 1 of Annex XII to Commission Implementing Regulation (EU) 2021/404 provided the semen was collected in the zone detailed in column 2 of the table in Part 1 of that Annex from a donor stallion of the category of equine animals indicated in column 3 of the table in Part 1 of that Annex.

(2)	Only semen collection centres listed in accordance with Article 17(3), point (b), of Directive 92/65/EEC on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en .

(3)	OJ L 192, 23.7.2010, p. 1.

(4)	Delete if not applicable.

(5)	Insert date in table in point II.4.6 (follow guidance in Part II of the Notes)

(6)

The agar gel immunodiffusion test (Coggins test) or the ELISA for equine infectious anaemia are not required for donor equine animals which have continuously resided in Iceland since birth, provided that Iceland has remained officially free of equine infectious anaemia and no equine animals and their semen, ova and embryos have been introduced into Iceland from outside prior to and during the period the semen was collected.

(7)	Cross out the programmes that do not apply to the consignment.

(8)	Insert names and concentrations.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 62

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF STOCKS OF SEMEN OF EQUINE ANIMALS COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH COUNCIL DIRECTIVE 92/65/EEC BEFORE 1 SEPTEMBER 2010, DISPATCHED AFTER 20 APRIL 2021 FROM THE SEMEN COLLECTION CENTRE WHERE THE SEMEN WAS COLLECTED (MODEL “EQUI-SEM-D-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17
	☐ Railway	☐ Road vehicle
	Identification

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity

Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model EQUI-SEM-D-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned, official veterinarian, of the exporting country (1) … hereby

(name of exporting country)

certify that:

II.1.

The semen collection centre (2) in which the semen described in Part I was collected, processed and stored for export to the Union:

II.1.1.

was approved and supervised by the competent authority according to the conditions of Chapter I, Annex D to Directive 92/65/EEC,

II.1.2.

is situated in the territory or in the case of regionalisation according to Article 13 of Directive 2009/156/EC (3) in a part of the territory of the country of export which was on the day the semen was collected until the date of dispatch free of:

—	African horse sickness, in accordance with EU legislation,

—	Venezuelan equine encephalomyelitis for 2 years,

—	glanders and dourine for 6 months;

II.1.3.

was during the period commencing 30 days prior to the date of collection of the semen until the day of its dispatch not subject to a prohibition order for animal health reasons which laid down one of the following conditions:

II.1.3.1.

if not all the animals of species susceptible to the disease located in the holding were slaughtered or killed, the prohibition lasted for:

—	6 months, beginning on the day on which the equidae suffering from the disease are slaughtered, in the case of equine encephalomyelitis,

—	a period required to carry out with negative result two Coggins tests 3 months apart in the animals remaining after the infected animals have been slaughtered, in the case of infectious equine anaemia,

—	6 months, in the case of vesicular stomatitis,

—	one month from the last recorded case, in the case of rabies,

—	15 days from the last recorded case, in the case of anthrax.

II.1.3.2.

if all the animals of species susceptible to the disease located in the holding have been slaughtered or killed and the premises disinfected, the prohibition lasted for 30 days, or 15 days in the case of anthrax, beginning on the day on which following the destruction of the animals the disinfection of the premises was satisfactorily completed;

II.1.4.

contained during the period commencing 30 days prior to semen collection and lasting until the date of its dispatch only equidae which were free of clinical signs of equine viral arteritis and contagious equine metritis,

II.2.

Prior to entering the semen collection centre the donor stallions and any other equidae located in the centre:

II.2.1.

were continuously resident for 3 months (or since entry if they were directly imported from a Member State during the 3 months period) in the territory or in the case of regionalisation in a part of the territory (4) of the country of export which was during that period free of:

—	African horse sickness, in accordance with EU legislation,

—	Venezuelan equine encephalomyelitis for 2 years,

—	glanders for 6 months,

—	dourine for 6 months;

(4) either

[II.2.2.

originated from the territory of the country of export which was on the day of admission into the centre free of vesicular stomatitis for 6 months,]

(4) or

[II.2.2.

were tested by a virus neutralisation test for vesicular stomatitis in a blood sample taken on … (5), this being within 14 days prior to entering the centre, with negative result at a serum dilution of 1 in 12;]

II.2.3.

originated from holdings which on the day of admission onto the centre fulfilled the requirements of point II.1.3;

II.3.

The semen described in part I was collected from donor stallions, which:

II.3.1.

on the day the semen was collected have not shown clinical signs of an infectious or contagious disease,

II.3.2.

during at least 30 days prior to collection of the semen have not been used for natural service,

II.3.3.

during the last 30 day period prior to collection of the semen have been kept on holdings where no equine animal showed clinical signs of equine viral arteritis,

II.3.4.

during the last 60 day period prior to collection of the semen have been kept on holdings where no equine animal showed clinical signs of contagious equine metritis,

II.3.5.

to the best of my knowledge and as far as I could ascertain have not been in contact with equidae suffering from an infectious or contagious disease the 15 days immediately preceding the collection of the semen;

II.3.6.

have undergone the following animal health tests carried out in a laboratory recognised by the competent authority, in accordance with a test programme as specified in point II.3.7:

II.3.6.1.

an agar-gel immuno-diffusion test (Coggins test) for equine infectious anaemia with negative result (6);

(4) either

[II.3.6.2.

a serum neutralisation test for equine viral arteritis with negative result at a serum dilution of 1 in 4;]

(4) or

[II.3.6.2.

a virus isolation test for equine viral arteritis carried out with negative result on an aliquot of the entire semen;]

II.3.6.3.

a test for contagious equine metritis carried out on two occasions with an interval of 7 days by isolation of Taylorella equigenitalis from pre-ejaculatory fluid or a semen sample and from genital swabs taken at least from the penile sheath, urethra and from the urethral fossa with negative result in each case;

II.3.7.

have been subjected to one of the following test programmes (7):

(4) [II.3.7.1.

The donor stallion was continuously resident on the collection centre for at least 30 days prior to the semen collection, and during the collection period, and no equidae in the collection centre came during that time into direct contact with equidae of lower health status than the donor stallions.

The tests required in point II.3.6 have been carried out on samples taken on … (5) and on … (5) at least 14 days after the commencement of the above residence period and at least at the beginning of the breeding season.]

(4) [II.3.7.2.

The donor stallion was not continuously resident on the collection centre or other equidae on the collection centre came into direct contact with equidae of lower health status than the donor stallions.

The tests required in point II.3.6 have been carried out on samples taken on … (5) and on … (5), within the 14 days period before the first semen collection and at least at the beginning of breeding season.

The test required in point II.3.6.1 was last carried out on a sample of blood taken not more than 120 days before the semen was collected on … (5);

(4) either

[The test required in point II.3.6.2 was last carried out not more than 30 days before the semen was collected on … (5).]]

(4) or

[The non-shedder state of the seropositive stallion for equine viral arteritis was confirmed by a virus isolation test which was carried out not more than one year before the semen was collected on … (5).]]

(4) [II.3.7.3.

The tests required in point II.3.6 have been carried out during the 30 days mandatory storage period of frozen semen and not less than 14 days after the collection of the semen on samples taken on … (5) and on … (5).]

II.4.

The semen described in Part I was collected, processed, stored and transported under conditions which comply with the requirements of Chapters II and III of Annex D of Directive 92/65/EEC.

Notes

This animal health certificate is intended for the entry into the Union of semen of equine animals, including when the Union is not the final destination of the semen.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	”Place of dispatch” shall correspond to the semen collection centre of the semen origin.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of semen.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Type”: Indicate semen. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where semen of the consignment is placed. “Date of collection/production”: Indicate the date on which semen of the consignment was collected in the following format: dd.mm.yyyy. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected. “Quantity”: Indicate the number of straws or other packages with the same mark.

Part II:

(1)

Entry into the Union of equine semen is authorised from a third country or territory listed in column 1 of the table in Part 1 of Annex XII to Commission Implementing Regulation (EU) 2021/404 provided the semen was collected in the zone detailed in column 2 of the table in Part 1 of that Annex from a donor stallion of the category of equine animals indicated in column 3 of the table in Part 1 of that Annex.

(2)	Only semen collection centres listed in accordance with Article 17(3), point (b), of Directive 92/65/EEC on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en .

(3)	OJ L 192, 23.7.2010, p. 1.

(4)	Delete if not applicable.

(5)	Insert date.

(6)

(7)	Cross out the programmes that do not apply to the consignment.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 63

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF OOCYTES AND EMBRYOS OF EQUINE ANIMALS COLLECTED OR PRODUCED, PROCESSED AND STORED IN ACCORDANCE WITH REGULATION (EU) 2016/429 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL AND COMMISSION DELEGATED REGULATION (EU) 2020/692 AFTER 20 APRIL 2021, DISPATCHED BY THE EMBRYO COLLECTION OR PRODUCTION TEAM BY WHICH THE OOCYTES OR EMBRYOS WERE COLLECTED OR PRODUCED (MODEL “EQUI-OOCYTES-EMB-A-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17
	☐ Railway	☐ Road vehicle
	Identification

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity

Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model EQUI-OOCYTES-EMB-A-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify that:

II.1.

II.1.1.

from a third country or territory, or zone thereof:

II.1.1.1.

authorised for the entry into the Union of [oocytes] (1) [embryos] (1) of equine animals and listed in Annex XII to Commission Implementing Regulation (EU) 2021/404;

II.1.1.2.

free from African horse sickness for at least 24 months immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) and until the date of their dispatch in accordance with Article 22(2), point (a), of Commission Delegated Regulation (EU) 2020/692, and where no systematic vaccination against African horse sickness has been carried out for at least 12 months immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) and until the date of their dispatch in accordance with Article 22(4), point (b), of that Delegated Regulation;

II.1.1.3.

where Venezuelan equine encephalomyelitis was not reported for at least 24 months immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) and until the date of their dispatch;

II.1.2.

from an establishment in a third country or territory, or zone thereof:

(1) either

[II.1.2.1.

where infection with Burkholderia mallei (glanders) was not reported for at least 36 months immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) and until the date of their dispatch;]

(1) or

[II.1.2.1.

where infection with Burkholderia mallei (glanders) was not reported for at least 6 months immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) and until the date of their dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period;]

(1) either

[II.1.2.2.

where dourine was not reported for at least 24 months immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) and until the date of their dispatch;]

(1) or

[II.1.2.2.

where dourine was not reported for at least 6 months immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) and until the date of their dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period;]

(1) either

[II.1.2.3.

where surra (Trypanosoma evansi) was not reported for at least 24 months immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) and until the date of their dispatch;]

(1) or

[II.1.2.3.

where surra (Trypanosoma evansi) was not reported for at least 6 months immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) and until the date of their dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period.]

II.2.

The [oocytes] (1) [embryos] (1) described in Part I were obtained from donor animals which originate from establishments:

II.2.1.

in which

(1) either

[surra has not been reported during 2 years immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1);]

(1) or

[surra has not been reported during the period of the preceding 30 days prior to [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1), and when the disease was reported in the establishments during the preceding 2 years prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) following the last outbreak, the establishments have remained under movement restrictions

(1) either

(1) or

[for at least 30 days from the date of cleaning and disinfection and after the date on which the last animal of listed species in the establishments was either killed and destroyed or slaughtered.]]

II.2.2.

in which

(1) either

[dourine has not been reported during the preceding 2 years prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1);]

(1) or

[dourine has not been reported during the preceding 6 months prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1), and when the disease was reported in the establishments during the preceding 2 years prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) following the last outbreak, the establishments have remained under movement restrictions

(1) either

(1) or

[for at least 30 days after the date on which the last equine animal in the establishments was either killed and destroyed or slaughtered, and the premises were cleaned and disinfected;]]

II.2.3.

in which

(1) either

[equine infectious anaemia has not been reported during the preceding 12 months prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1);]

(1) or

[equine infectious anaemia has not been reported during the preceding 90 days prior to the date of [collection] (1) [production] (1)of the [oocytes] (1) [embryos] (1), and when the disease was reported in the establishments during the preceding 12 months prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) following the last outbreak, the establishments have remained under movement restrictions

(1) either

[until the date on which the remaining equine animals in the establishments have been subjected to a test for equine infectious anaemia with the diagnostic method provided for in Part 9 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken on two occasions with a minimum interval of 3 months after the date on which the infected animals have been killed and destroyed or slaughtered, and the establishments were cleaned and disinfected.]]

(1) or

[for at least 30 days after the date on which the last equine animal in the establishments was either killed and destroyed or slaughtered, and the establishments were cleaned and disinfected.]]

(1) [II.3.

The [oocytes] (1) [in vivo derived embryos] (1) described in Part I have been collected, processed and stored, and dispatched by the embryo collection team (2) which:

II.3.1.

is approved and listed by the competent authority of the third country or territory;

II.3.2.

complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 2 of Annex I to Commission Delegated Regulation (EU) 2020/686.]

(1) [II.3.

II.3.1.

is approved and listed by the competent authority of the third country or territory;

II.3.2.

complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Parts 2 and 3 of Annex I to Delegated Regulation (EU) 2020/686.]

II.4.

The [oocytes] (1) [embryos] (1) described in Part I were obtained from donor animals which:

II.4.1.

were not vaccinated against African horse sickness at least in the last 40 days immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1);

II.4.2.

were not vaccinated against Venezuelan equine encephalomyelitis at least in the last 60 days immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1);

II.4.3.

II.4.4.

for at least 30 days immediately prior to the date of [collection] (1) [production] (1) of the [oocytes] (1) [embryos] (1) and during the collection period:

II.4.4.1.

II.4.4.2.

II.4.4.3.

II.4.5.

were not used for natural breeding during at least 30 days immediately prior to the date of the collection of the [oocytes] (1) [embryos] (1) and between the date on which the first samples referred to in points II.4.8.1 and II.4.8.2 were taken and the date of collection of the [oocytes] (1) [embryos] (1);

II.4.6.

II.4.7.

are individually identified as provided for in Article 21(2) of Delegated Regulation (EU) 2020/692;

II.4.8.

were subjected to the following tests, referred to in Part 4, Chapter II, points 2(b) and (c), of Annex II to Delegated Regulation (EU) 2020/686, as follows:

(3) [II.4.8.1.

for equine infectious anaemia (EIA), an agar-gel immuno-diffusion test (AGID or Coggins test) or an enzyme-linked immunosorbent assay (ELISA) with a negative result carried out on a blood sample taken on … (4), being not less than 14 days following the date of commencement of the period referred to in point II.4.5 and not more than 90 days prior to the date of collection of the [oocytes] (1)[embryos] (1) intended for entry into the Union;]

II.4.8.2.

for contagious equine metritis (CEM), an agent identification test carried out with a negative result on at least two specimens (swabs) taken during the period referred to in point II.4.5 from at least the mucosal surfaces of the clitoral fossa and the clitoral sinuses of the donor mare:

(1) either

[II.4.8.2.1.

on two occasions with an interval of not less than 7 days on … (4) and on … (4), in the case of isolation of Taylorella equigenitalis after cultivation under microaerophilic conditions for at least 7 days, set up within 24 hours after taking the specimens from the donor animal, or 48 hours where the specimens are kept cool during transport.]

(1) and/or

[II.4.8.2.2.

on one occasion on __________ (4), in the case of detection of the genome of Taylorella equigenitalis by a polymerase chain reaction (PCR) or real-time PCR, carried out within 48 hours immediately after taking the specimens from the donor animal.]

The samples referred to in points II.4.8.2.1 and II.4.8.2.2 were in no case taken earlier than 7 days (systemic treatment) or 21 days (local treatment) after antimicrobial treatment of the donor mare and were placed in a transport medium with activated charcoal, such as Amies medium, before dispatch to the laboratory.

II.5.

The [oocytes] (1) [embryos] (1) described in Part I:

II.5.1.

have been collected, processed and stored in accordance with animal health requirements set out in [Part 2] (1) [Part 3] (1) [Part 4] (1) [Part 5] (1)and Part 6 of Annex III to Delegated Regulation (EU) 2020/686;

II.5.2.

II.5.3.

are transported in a container which:

II.5.3.1.

was sealed and numbered prior to the dispatch by the embryo collection or production team under responsibility of the team veterinarian, or by an official veterinarian, and the seal bears the number as indicated in box I.19;

II.5.3.2.

has been cleaned and either disinfected or sterilised before use, or is single-use container;

(1) (5) [II.5.3.3.

has been filled in with a cryogenic agent which has not been previously used for other products.]

(1) (6) [II.5.4.

are placed in straws or other packages which are securely and hermetically sealed;

II.5.5.

are transported in a container where the different types are separated from each other by physical compartments or by being placed in secondary protective bags.]

(1) (7) [II.6.

The [in vivo derived embryos] (1) [in vitro produced embryos] (1) [micromanipulated embryos] (1) described in Part I were conceived by artificial insemination using semen coming from a semen collection centre, germinal product processing establishment or germinal product storage centre approved for the collection, processing or storage of semen by the competent authority of a third country or territory, or zone thereof listed in Annex XII to Implementing Regulation (EU) 2021/404 for semen of equine animals or by the competent authority of a Member State (8), and were collected, processed and stored in accordance with the requirements of Part 4, Chapter I and Part 1 of Annex III to Delegated Regulation (EU) 2020/686.]

(1) (9) [II.7.

The following antibiotic or mixture of antibiotics (10) has been added to the collection, processing, washing or storage media: … .]

Notes

This animal health certificate is intended for the entry into the Union of oocytes and embryos of equine animals, including when the Union is not the final destination of the oocytes and embryos.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	“Place of dispatch”: Indicate the unique approval number and the name and address of the embryo collection or production team of dispatch of the consignment of oocytes or embryos. Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of oocytes or embryos.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Type”: Specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where oocytes or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which oocytes or embryos of the consignment were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the embryo collection or production team by which the oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate the number of straws or other packages with the same mark.

Part II:

(1)	Delete if not applicable.

(2)	Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en.

(3)

The agar gel immunodiffusion test (AGID or Coggins test) or the ELISA for equine infectious anaemia are not required for donor equine animals which continuously resided in Iceland since birth, provided that Iceland remained officially free of equine infectious anaemia and no equine animals and their semen, ova and embryos were introduced into Iceland from outside prior to and during the period the ova or embryos were collected and the semen was used for fertilisation.

(4)	Insert date in the following format: dd.mm.yyyy.

(5)	Applicable for frozen oocytes or embryos.

(6)	Applicable for consignments where oocytes, in vivo derived embryos, in vitro produced embryos and micromanipulated embryos of equine animals are placed and transported in one container.

(7)	Does not apply to oocytes.

(8)

Only a semen collection centre, germinal product processing establishment or germinal product storage centre listed on the Commission websites for:

(a)	third countries or territories, or zones thereof: https://ec.europa.eu/food/animals/live_animals/approved-establishments_en;

(b)	Member States: https://ec.europa.eu/food/animals/semen/equine_en.

(9)	Mandatory attestation in case antibiotic(s) were added.

(10)	Insert the name(s) of the antibiotic(s) added and its (their) concentration.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 64

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF STOCKS OF OOCYTES AND EMBRYOS OF EQUINE ANIMALS COLLECTED OR PRODUCED, PROCESSED AND STORED IN ACCORDANCE WITH COUNCIL DIRECTIVE 92/65/EEC AFTER 30 SEPTEMBER 2014 AND BEFORE 21 APRIL 2021, DISPATCHED AFTER 20 APRIL 2021 BY THE EMBRYO COLLECTION OR PRODUCTION TEAM BY WHICH THE OOCYTES OR EMBRYOS WERE COLLECTED OR PRODUCED (MODEL “EQUI-OOCYTES-EMB-B-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17
	☐ Railway	☐ Road vehicle
	Identification

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity

Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model EQUI-OOCYTES-EMB-B-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned, official veterinarian, of the exporting country (1) … hereby certify that:

(name of exporting country)

II.1.

The [ova] (2) [embryos] (2) described in Part I:

II.1.2.

were [collected] (2) [produced] (2) by the team (3) described in box I.11, which had been approved and supervised in accordance with Chapter I(III) of Annex D to Directive 92/65/EEC (4) and was subject to inspection by an official veterinarian at least once every calendar year;

II.1.3.

were [collected] (2) [produced] (2), processed and stored in accordance with the requirements of Chapter III(II) of Annex D to Directive 92/65/EEC;

II.1.4.

were collected at a place separated from other parts of the premises or holding which is in good repair and was cleaned and disinfected prior to the collection;

II.1.5.

were examined, processed and packed in laboratory facilities which are not situated in a zone subject to prohibition or quarantine measures as set out in point II.1.6., in a section which is separated from the section for storing equipment and materials used in contact with donor animals and from the area where the donor animals are handled;

II.1.6.

come from donor mares which:

II.1.6.1.

were continuously resident for a period of 3 months (or since entry if they were directly imported from a Member State during the 3 months period) in the exporting country or, in the case of regionalisation in accordance with Article 13 of Directive 2009/156/EC (5), in that part of the territory of the exporting country which was during that period:

—	not considered to be infected with African horse sickness in accordance with Article 5(2)(a) and (b) of Directive 2009/156/EC,

—	free from Venezuelan equine encephalomyelitis for a period of at least 2 years,

—	free from glanders and dourine for a period of at least 6 months;

(2) either

[II.1.6.2.

originated from a country of export which was on the day of collection free from vesicular stomatitis (VS) for a period of at least 6 months from that date;]

(2) or

[II.1.6.2.

(2) either

[II.1.6.3.

during a period of the past 30 days prior to the date of the collection were located in holdings under veterinary supervision which fulfilled from the day of the collection of the [ova] (2)/ [embryos] (2) until the date of their dispatch the conditions for a holding laid down in Article 4(5) of Directive 2009/156/EC, and in particular:]

(2) or

[II.1.6.3.

in the case of frozen [ova] (2) [embryos] (2), during a period of the past 30 days prior to the date of the collection were kept in holdings under veterinary supervision which fulfilled, from the day of the collection of the [ova] (2) [embryos] (2) until the end of the period of 30 days mandatory storage at approved premises, the conditions for a holding laid down in Article 4(5) of Directive 2009/156/EC, and in particular:]

(2) either

[II.1.6.3.1.

following a case of a disease mentioned below not all the animals of species susceptible to that disease located in the holding were slaughtered or killed and the holding has been free:

—	from any type of equine encephalomyelitis for a period of at least 6 months, beginning on the day on which the equidae suffering from the disease are slaughtered,

—	from equine infectious anaemia for at least the period required to obtain a negative result in an agar gel immunodiffusion test (AGID or Coggins tests) carried out on samples taken after the infected animals were slaughtered on two occasions 3 months apart from each of the remaining equidae,

—	from vesicular stomatitis for a period of at least 6 months from the last recorded case,

—	from rabies for a period of at least one month from the last recorded case,

—	from anthrax for a period of at least 15 days from the last recorded case,]

(2) or

[II.1.6.3.1.

following a case of a disease mentioned below all the animals of species susceptible to that disease located in the holding were slaughtered or killed and the premises disinfected, the holding was free for a period of at least 30 days from any type of equine encephalomyelitis, equine infectious anaemia, vesicular stomatitis and rabies or a period of at least 15 days in the case of anthrax, beginning on the day on which following the destruction of the animals the disinfection of the premises was satisfactorily completed;]

II.1.6.4.

during a period of the past 30 days prior to the collection the [ova] (2) [embryos] (2) were kept in holdings in which none of the equidae has shown clinical signs of contagious equine metritis for a period of at least 60 days;

II.1.6.5.

were not used for natural breeding during a period of at least 30 days prior to the date of the collection of the [ova] (2) [embryos] (2) and between the date of the first samples referred to in points II.1.6.6.1 and II.1.6.6.2 and the date of the collection of the [ova] (2) [embryos] (2);

II.1.6.6.

have undergone the tests, which meet at least the requirements of the relevant Chapters of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the OIE, carried out in a laboratory which is recognised by the competent authority and has the tests referred to hereinafter included in its accreditation equivalent to that provided for in Article 12 of Regulation (EC) No 882/2004 (7), as follows:

(8) [II.1.6.6.1.

for equine infectious anaemia (EIA), an agar-gel immuno-diffusion test (AGID or Coggins test) or an enzyme-linked immunosorbent assay (ELISA) with a negative result carried out on a blood sample taken on … (6), being not less than 14 days following the date of commencement of the period referred to in point II.1.6.5 and not more than 90 days prior to the date of the collection of the [ova] (2) [embryos] (2) intended for imports into the Union;]

II.1.6.6.2.

for contagious equine metritis (CEM), an agent identification test carried out with a negative result on at least two specimens (swabs) taken during the period referred to in point II.1.6.5 from at least the mucosal surfaces of the clitoral fossa and the clitoral sinuses of the donor mare:

(2) either

[II.1.6.6.2.1.

on two occasions with an interval of not less than 7 days on … (6) and on … (6), in the case of isolation of Taylorella equigenitalis after cultivation under microaerophilic conditions for a period of at least 7 days, set up within 24 hours after taking the specimens from the donor animal, or 48 hours where the specimens are kept cool during transport,]

(2) and/or

[II.1.6.6.2.2.

on one occasion on … (6), in the case of detection of the genome of Taylorella equigenitalis by a polymerase chain reaction (PCR) or real-time PCR, carried out within 48 hours after taking the specimens from the donor animal,]

The samples referred to in points II.1.6.6.2.1 and II.1.6.6.2.2 were in no case taken earlier than 7 days (systemic treatment) or 21 days (local treatment) after antimicrobial treatment of the donor mare and were placed in transport medium with activated charcoal, such as Amies medium, before dispatch to the laboratory.

II.1.6.7.

to the best of my knowledge and as far as I could ascertain, were not in contact with equidae suffering from an infectious or contagious disease during the period of 15 days immediately preceding the collection;

II.1.6.8.

on the day of the collection of the [ova] (2) [embryos] (2) did not show clinical signs of an infectious or contagious disease;

II.1.7.

were [collected] (2) [produced] (2) after the date on which the embryo [collection] (2) [production] (2) team described in box I.11 was approved by the competent authority of the exporting country;

II.1.8.

were processed and stored under approved conditions for a period of at least 30 days immediately after their [collection] (2) [production] (2), and were transported under conditions which satisfy the terms laid down in Chapter III(II) of Annex D to Directive 92/65/EEC;

II.2.

The embryos described in Part I were conceived [by artificial insemination] (1) [as a result of in vitro fertilisation] (2) using semen meeting the requirements of Directive 92/65/EEC and coming from semen collection centres approved in accordance with Article 11(2) or 17(3)(b) of Directive 92/65/EEC (9) and located respectively in a Member State of the Union or in a third country or parts of the territory of a third country listed in columns 2 and 4 of the table in Annex I to Commission Implementing Regulation (EU) 2018/659 from which the import of equine semen collected from registered horses, registered equidae or equidae for breeding and production is authorised in accordance with Article 4 of Commission Implementing Regulation (EU) 2018/659 and indicated in columns 11, 12 and 13 of Annex I thereto. (10) (11)

(12) [II.3.

The ova used for in vitro production of the embryos described in Part I comply with the requirements of Annex D to Directive 92/65/EEC and in particular the requirements set up in points II.1.1 to II.1.8 of this animal health certificate.]

Notes

This animal health certificate is intended for the entry into the Union of oocytes and embryos of equine animals, including when the Union is not the final destination of the oocytes and embryos.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	”Place of dispatch”: Indicate the unique approval number and the name and address of the embryo collection or production team of dispatch of the consignment of oocytes or embryos. Only embryo collection or production teams approved in accordance with Article 17(3), point (b), of Directive 92/65/EEC and listed on the Commission website: http://ec.europa.eu/food/animal/semen_ova/equine/index_en.htm.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of oocytes or embryos.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Type”: Specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where oocytes or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which oocytes or embryos of the consignment of were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the embryo collection or production team by which the oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate the number of straws or other packages with the same mark.

Part II:

(1)

Only third countries or territories, or zones thereof listed in column 1 of the table in Part 1 of Annex XII to Commission Implementing Regulation (EU) 2021/404 from which the entry into Union of equine animals, other than for slaughter, is also authorised and as indicated in column 3 the table in Part 1 of that Annex.

(2)	Delete if not applicable.

(3)	Only embryo collection or production teams listed in accordance with Article 17(3), point (b), of Directive 92/65/EEC on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en.

(4)

(5)	Council Directive 2009/156/EC of 30 November 2009 on animal health conditions governing the movement and importation from third countries of equidae (OJ L 192, 23.7.2010, p. 1).

(6)	Insert date. (follow Guidance in Part II of the Notes).

(7)	Regulation (EC) No 882/2004 of the European Parliament and of the Council of 29 April 2004 on official controls performed to ensure the verification of compliance with feed and food law, animal health and animal welfare rules (OJ L 165, 30.4.2004, p. 1).

(8)

The agar gel immunodiffusion test (AGID or Coggins test) or the ELISA for equine infectious anaemia are not required for donor equidae which continuously resided in Iceland since birth, provided that Iceland remained officially free of equine infectious anaemia and no equidae and their semen, ova and embryos have were introduced into Iceland from outside prior to and during the period the ova or embryos were collected and the semen was used for fertilisation.

(9)	Only semen collection centres approved by the competent authority of a third country or territory, or zone thereof listed in Annex XII to Commission Implementing Regulation (EU) 2021/404 for semen of equine animals or by the competent authority of a Member State.

(10)

Entry into the Union of equine semen is authorised from third countries listed in column 2 of the table in Part 1 of Annex I to Commission Implementing Regulation (EU) 2018/659 provided that the semen was collected in the part of the territory of the third country detailed in column 4 of the table in Part 1 of that Annex from a donor stallion of the category of equidae positively indicated in column 11, 12 or 13 of the table in Part 1 of that Annex.

(11)	Does not apply to ova.

(12)	Delete if none of the embryos in the consignment was produced by in vitro fertilisation of ova.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 65

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF STOCKS OF OOCYTES AND EMBRYOS OF EQUINE ANIMALS COLLECTED OR PRODUCED, PROCESSED AND STORED IN ACCORDANCE WITH COUNCIL DIRECTIVE 92/65/EEC AFTER 31 AUGUST 2010 AND BEFORE 1 OCTOBER 2014, DISPATCHED AFTER 20 APRIL 2021 BY THE EMBRYO COLLECTION OR PRODUCTION TEAM BY WHICH THE OOCYTES OR EMBRYOS WERE COLLECTED OR PRODUCED (MODEL “EQUI-OOCYTES-EMB-C-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17
	☐ Railway	☐ Road vehicle
	Identification

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity

Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model EQUI-OOCYTES-EMB-C-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned, official veterinarian, of the exporting country (1) … hereby certify that:

(name of exporting country)

II.1.

The [ova] (2) [embryos] (2) described in Part I:

II.1.2.

were [collected] (2) [produced] (2) by the team (3) described in box I.11, which had been approved and supervised in accordance with Chapter I(III) of Annex D to Directive 92/65/EEC and was subject to inspection by an official veterinarian at least once every calendar year;

II.1.3.

were [collected] (2) [produced] (2), processed and stored in accordance with the requirements of Chapter III(II) of Annex D to Directive 92/65/EEC;

II.1.4.

were collected at a place separated from other parts of the premises or holding which is in good repair and was cleaned and disinfected prior to the collection;

II.1.5.

were examined, processed and packed in laboratory facilities which are not situated in a zone subject to prohibition or quarantine measures as set out in box II.1.6., in a section which is separated from the section for storing equipment and materials used in contact with donor animals and from the area where the donor animals are handled;

II.1.6.

come from donor mares which:

II.1.6.1.

were continuously resident for 3 months (or since entry if they were directly imported from a Member State during the 3 months period) in the exporting country or, in the case of regionalisation according to Article 13 of Directive 2009/156/EC (4), in that part of the territory of the exporting country which was during that period:

—	not considered to be infected with African horse sickness in accordance with Article 5(2)(a) and (b), of Directive 2009/156/EC,

—	free from Venezuelan equine encephalomyelitis for at least 2 years,

—	free from glanders and dourine for at least 6 months;

(2) either

[II.1.6.2.

originated from a country of export which was on the day of collection free of vesicular stomatitis for at least 6 months;]

(2) or

[II.1.6.2.

were tested by a virus neutralisation test for vesicular stomatitis on a blood sample taken on … (5) within 30 days prior to collection, with negative result at a serum dilution of 1 in 12;]

(2) either

[II.1.6.3.

during the past 30 day period prior to collection have been located in holdings under veterinary supervision which fulfilled from the day of collection of [ova] (2) [embryos] (2) until the date of their dispatch the conditions for a holding laid down in Article 4(5) of Directive 2009/156/EC, and in particular:]

(2) or

[II.1.6.3.

during the past 30 day period prior to collection have been located in holdings under veterinary supervision which fulfilled from the day of collection of [ova] (2) [embryos] (2) until, in the case of frozen [ova] (2) [embryos] (2), the period of 30 days mandatory storage at approved premises elapsed, the conditions for a holding laid down in Article 4(5) of Directive 2009/156/EC and in particular:]

(2) either

[II.1.6.3.1.

following a case of a disease mentioned below not all the animals of species susceptible to the disease located on the holding were slaughtered or killed and the holding has been free:

—	from any type of equine encephalomyelitis for at least 6 months, beginning on the day on which the equidae suffering from the disease are slaughtered,

—	from equine infectious anaemia for at least the period required to obtain a negative result in an agar gel immunodiffusion test (Coggins tests) carried out on samples taken after the infected animals were slaughtered on two occasions 3 months apart from each of the remaining equidae;

—	from vesicular stomatitis for at least 6 months from the last recorded case,

—	from rabies for at least one month from the last recorded case,

—	from anthrax for at least 15 days from the last recorded case,]

(2) or

[II.1.6.3.1.

following a case of a disease mentioned below all the animals of species susceptible to the disease located in the holding have been slaughtered or killed and the premises disinfected, the holding has been free for at least 30 days from any type of equine encephalomyelitis, equine infectious anaemia, vesicular stomatitis and rabies or 15 days in the case of anthrax, beginning on the day on which following the destruction of the animals the disinfection of the premises was satisfactorily completed;]

II.1.6.4.

during the past 30 days prior to collection have been kept in holdings each of them having been free from clinical signs of contagious equine metritis for at least 60 days;

II.1.6.5.

have not been used for natural breeding during at least 30 days prior to the date of collection of ova or embryos and between the date of the first samples referred to in points II.1.6.6 and II.1.6.7 and the date of the collection of ova and embryos;

II.1.6.6.

have been subjected with negative result to an agar-gel immuno-diffusion test (Coggins test) or an ELISA for equine infectious anaemia carried out on a blood sample taken on … (5) being during the past 30 days prior to the date of the first collection of ova or embryos and not more than 90 days before the ova or embryos were collected (6);

II.1.6.7.

have been subjected to an agent identification test for contagious equine metritis by isolation of Taylorella equigenitalis after a cultivation of 7 to 14 days carried out with negative results in each case on samples taken during the past 30 days prior to the date of the first collection of ova or embryos from mucosal surfaces of the clitoral fossa and clitoral sinuses on two consecutives oestrus periods on … (5) and on … (5), and on an additional culture specimen taken during one of the oestrus periods from the endometrial cervix on … (5);

II.1.6.8.

to the best of my knowledge and as far as I could ascertain, have not been in contact with equidae suffering from an infectious or contagious disease during the 15 days immediately preceding the collection;

II.1.6.9.

have on the day of collection of [ova] (2) [embryos] (2) not shown clinical signs of an infectious or contagious disease;

II.1.7.

were [collected] (2) [produced] (2) after the date on which the embryo [collection] (2) [production] (2) team described in box I.11 was approved by the competent authority of the exporting country;

II.1.8.

were processed and stored under approved conditions for at least 30 days immediately after their [collection] (2) [production] (2), and were transported under conditions which satisfy the terms laid down in Chapter III(II) of Annex D to Directive 92/65/EEC;

II.2.

The embryos described in Part I were conceived [by artificial insemination] (2) [as a result of in vitro fertilisation] (2) using semen meeting the requirements of Directive 92/65/EEC and coming from semen collection centres approved in accordance with Article 11(2) or 17(3)(b) of Directive 92/65/EEC and located respectively in a Member State of the European Union or in a third country or parts of the territory of third country listed in columns 2 and 4 of the table in Annex I to Commission Implementing Regulation (EU) 2018/659 from which the import of equine semen collected from registered horses, registered equidae or equidae for breeding and production is authorised in accordance with Article 4 of Commission Implementing Regulation (EU) 2018/659 and indicated in columns 11, 12 and 13 of Annex I thereto. (7)(8);

II.3.

The ova used for in vitro production of the embryos described above comply with the requirements of Annex D to Directive 92/65/EEC and in particular the requirements set up in points II.1.1 to II.1.8 of this animal health certificate (2).

Notes

This animal health certificate is intended for the entry into the Union of oocytes and embryos of equine animals, including when the Union is not the final destination of the oocytes and embryos.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	”Place of dispatch”: Indicate the unique approval number and the name and address of the embryo collection or production team of dispatch of the consignment of oocytes or embryos. Only embryo collection or production teams approved in accordance with Article 17(3), point (b), of Council Directive 92/65/EEC and listed on the Commission website: http://ec.europa.eu/food/animal/semen_ova/equine/index_en.htm.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of oocytes or embryos.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Type”: specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where oocytes or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which oocytes or embryos of the consignment were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the embryo collection or production team by which the oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate the number of straws or other packages with the same mark.

Part II:

(1)

Only third countries or territories, or zones thereof listed in column 1 of the table in Part 1 of Annex XII to Commission Implementing Regulation (EU) 2021/404 from which the entry into the Union of equine animals, other than for slaughter, is also authorised and as indicated in column 3 of the table in Part 1 of that Annex.

(2)	Delete if not applicable.

(3)	Only embryo collection or production teams listed in accordance with Article 17(3), point (b), of Directive 92/65/EEC on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en.

(4)	OJ L 192, 23.7.2010, p. 1.

(5)	Insert date.

(6)

The agar gel immunodiffusion test (Coggins test) or the ELISA for equine infectious anaemia are not required for donor equine animals which have continuously resided in Iceland since birth, provided that Iceland has remained officially free of equine infectious anaemia and no equidae and their semen, oocytes and embryos have been introduced into Iceland from outside prior to and during the period the semen was collected.

(7)	Only semen collection centres approved by the competent authority of a third country or territory, or zone thereof listed in Part 1 of Annex XII to Implementing Regulation (EU) 2021/404 for semen of equine animals or by the competent authority of a Member State.

(8)	Does not apply to ova.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 66

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF GERMINAL PRODUCTS LISTED BELOW, DISPATCHED AFTER 20 APRIL 2021 FROM THE GERMINAL PRODUCT PROCESSING ESTABLISHMENT:

—	semen of equine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of semen of equine animals collected, processed and stored in accordance with Council Directive 92/65/EEC after 30 September 2014 and before 21 April 2021;

—	stocks of semen of equine animals collected, processed and stored in accordance with Directive 92/65/EEC after 31 August 2010 and before 1 October 2014;

—	stocks of semen of equine animals collected, processed and stored in accordance with Directive 92/65/EEC before 1 September 2010;

—	oocytes and embryos of equine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of oocytes and embryos of equine animals collected or produced, processed and stored in accordance with Directive 92/65/EEC after 30 September 2014 and before 21 April 2021;

—	stocks of oocytes and embryos of equine animals collected, processed and stored in accordance with Directive 92/65/EEC after 31 August 2010 and before 1 October 2014.

(MODEL “EQUI-GP-PROCESSING-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity
Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model EQUI-GP-PROCESSING-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify, that all:

II.1.

II.1.1.

is located in a third country or territory, or zone thereof:

II.1.1.1.

authorised for the entry into the Union of [semen] (2) [oocytes] (2) [embryos] (2) of equine animals and listed in Annex XII to Commission Implementing Regulation (EU) 2021/404;

II.1.1.2.

free from African horse sickness for at least 24 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch in accordance with Article 22(2), point (a), of Commission Delegated Regulation (EU) 2020/692, and where no systematic vaccination against African horse sickness has been carried out for at least 12 months immediately prior to the date of collection of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch in accordance with Article 22(4), point (b), of that Regulation;

II.1.1.3.

where Venezuelan equine encephalomyelitis was not reported for at least 24 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch;

II.1.2.

is an establishment, where:

(2) either

[II.1.2.1.

infection with Burkholderia mallei (glanders) was not reported for at least 36 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch;]

(2) or

[II.1.2.1.

infection with Burkholderia mallei (glanders) was not reported for at least six months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period;]

(2) either

[II.1.2.2.

dourine was not reported for at least 24 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch;]

(2) or

[II.1.2.2.

dourine was not reported for at least 6 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period;]

(2) either

[II.1.2.3.

surra (Trypanosoma evansi) was not reported for at least 24 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch;]

(2) or

[II.1.2.3.

surra (Trypanosoma evansi) was not reported for at least 6 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period.]

II.1.3.

is approved and listed by the competent authority of the third country or territory;

II.1.4.

complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 4 of Annex I to Commission Delegated Regulation (EU) 2020/686.]

II.2.

The [semen] (2) [oocytes] (2) [embryos] (2) described in Part I is/are intended for artificial reproduction, and:

II.2.1.

has/have been [collected] (2) [produced] (2), [processed] (2) [stored] (2) [in a semen collection centre] (2) (3) [by an embryo collection team] (2) (3) [by an embryo production team] (2) (3) and [processed] (2) [stored] (2) in a germinal product processing establishment (3) [and stored in a germinal product storage centre] (2) (3) complying with requirements as regards responsibilities, operational procedures, facilities and equipment set out in [Part 1] (2) [Part 2] (2) [Part 3] (2) [Part 4] (2) [Part 5] (2) of Annex I to Delegated Regulation (EU) 2020/686, and:

(2) either

[located in the third country or territory of dispatch to the Union;]

(2) (4) and/or

[located in …, and has/have been introduced into the third country of dispatch to the Union under conditions at least as strict as for the entry into the Union of [semen] (2) [oocytes] (2) [embryos] (2) of equine animals in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692;]

II.2.2.

was/were moved to the germinal product processing establishment described in box I.11 under conditions at least as strict as described in:

(2) either

[Model EQUI-SEM-A-ENTRY (5);]

(2) and/or

[Model EQUI-SEM-B-ENTRY (5);]

(2) and/or

[Model EQUI-SEM-C-ENTRY (5);]

(2) and/or

[Model EQUI-SEM-D-ENTRY (5);]

(2) and/or

[Model EQUI-OOCYTES-EMB-A-ENTRY (5);]

(2) and/or

[Model EQUI-OOCYTES-EMB-B-ENTRY (5);]

(2) and/or

[Model EQUI-OOCYTES-EMB-C-ENTRY (5);]

(2) and/or

[Model EQUI-GP-PROCESSING-ENTRY (5);]

(2) and/or

[Model EQUI-GP-STORAGE-ENTRY (5);]

II.2.3.

has/have been collected, processed and stored in accordance with animal health requirements set out in Annex III to Delegated Regulation (EU) 2020/686;

II.2.4.

II.2.5.

is/are transported in a container which:

II.2.5.1.

was sealed and numbered prior to the dispatch from the germinal product processing establishment under responsibility of the centre veterinarian, or by an official veterinarian, and the seal bears the number as indicated in box I.19;

II.2.5.2.

has been cleaned and either disinfected or sterilised before use, or is single-use container;

(2) (6) [II.2.5.3.

has been filled in with a cryogenic agent which has not been previously used for other products;]

(2) (7) [II.2.6.

is/are placed in straws or other packages which are securely and hermetically sealed;

II.2.7.

is/are transported in a container where the different types are separated from each other by physical compartments or by being placed in secondary protective bags.]

Notes

This animal health certificate is intended for the entry into the Union of semen, oocytes and embryos of equine animals, including when the Union is not the final destination of the semen, oocytes and embryos.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	“Place of dispatch”: Indicate the unique approval number and the name and address of the germinal product processing establishment of dispatch of the consignment of semen, oocytes or embryos. Only germinal product processing establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of semen, oocytes or embryos.
Box reference I.17	:	“Accompanying documents”: Number(s) of related original animal health certificate(s) shall correspond to the serial number of the individual official document(s) or animal health certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I from the semen collection centre where the semen was collected, and/or from the embryo collection team and/or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment where the semen, oocytes or embryos were processed and stored, and/or from the germinal product storage centre where the semen, oocytes or embryos were stored, to the germinal product processing establishment described in box I.11. The original(s) of those document(s) or those animal health certificate(s) or the officially endorsed copies thereof shall be attached to this animal health certificate.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Identification number”: Indicate identification number of each donor animal. Identification mark: Indicate mark on the straw or other packages where semen, oocytes and/or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which semen, oocytes and/or embryos of the consignment was/were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected, and/or of the embryo collection team and/or the embryo production team by which the oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate number of straws or other packages with the same mark.

Part II:

(1)	Only germinal product processing establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en.

(2)	Delete if not applicable.

(3)	Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en.

(4)	Only a third country or territory, or zone thereof listed in Annex XII to Implementing Regulation (EU) 2021/404 and Member States.

(5)

The original(s) of the document(s) or the animal health certificate(s) or the officially endorsed copies of thereof that accompanied the semen, oocytes or embryos described in Part I from the semen collection centre where the semen was collected, and/or from the embryo collection team or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment where the semen, oocytes or embryos were processed and stored, and/or from the germinal product storage centre where the semen, oocytes or embryos were stored, to the germinal product processing establishment of dispatch of the semen, oocytes and/or embryos described in box I.11 shall be attached to this animal health certificate.

(6)	Applicable for frozen semen, oocytes or embryos.

(7)	Applicable for consignments where semen, oocytes, in vivo derived embryos, in vitro produced embryos and micromanipulated embryos of equine animals are placed and transported in one container.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 67

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF GERMINAL PRODUCTS LISTED BELOW, DISPATCHED AFTER 20 APRIL 2021 FROM THE GERMINAL PRODUCT STORAGE CENTRE:

—	semen of equine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of semen of equine animals collected, processed and stored in accordance with Council Directive 92/65/EEC after 30 September 2014 and before 21 April 2021;

—	stocks of semen of equine animals collected, processed and stored in accordance with Directive 92/65/EEC after 31 August 2010 and before 1 October 2014;

—	stocks of semen of equine animals collected, processed and stored in accordance with Directive 92/65/EEC before 1 September 2010;

—	oocytes and embryos of equine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021;

—	stocks of oocytes and embryos of equine animals collected or produced, processed and stored in accordance with Directive 92/65/EEC after 30 September 2014 and before 21 April 2021;

—	stocks of oocytes and embryos of equine animals collected, processed and stored in accordance with Directive 92/65/EEC after 31 August 2010 and before 1 October 2014.

(MODEL “EQUI-GP-STORAGE-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17	Accompanying documents
	☐ Railway	☐ Road vehicle		Type	Code
	Identification			Country	ISO country code
	Identification			Commercial document reference

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity

Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model EQUI-GP-STORAGE-ENTRY

II.	Health information

II.a

Certificate reference

II.b.

IMSOC reference

I, the undersigned official veterinarian, hereby certify that:

II.1.

The germinal product storage centre (1) described in box I.11. at which the [semen] (2) [oocytes] (2) [in vivo derived embryos] (2) [in vitro produced embryos] (2) [micromanipulated embryos] (2) to be dispatched to the Union was/were stored:

II.1.1.

is located in a third country or territory, or zone thereof:

II.1.1.1.

authorised for the entry into the Union of [semen] (2) [oocytes] (2) [embryos] (2) of equine animals and listed in Annex XII to Commission Implementing Regulation (EU) 2021/404;

II.1.1.2.

II.1.1.3.

II.1.2.

is an establishment:

(2) either

[II.1.2.1.

where infection with Burkholderia mallei (glanders) was not reported for at least 36 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch;]

(2) or

[II.1.2.1.

where infection with Burkholderia mallei (glanders) was not reported for at least 6 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period;]

(2) either

[II.1.2.2.

where dourine was not reported for at least 24 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch;]

(2) or

[II.1.2.2.

where dourine was not reported for at least 6 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period;]

(2) either

[II.1.2.3.

where surra (Trypanosoma evansi) was not reported for at least 24 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch.]

(2) or

[II.1.2.3.

where surra (Trypanosoma evansi) was not reported for at least 6 months immediately prior to the date of [collection] (2) [production] (2) of the [semen] (2) [oocytes] (2) [embryos] (2) and until the date of its/their dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period;]

II.1.3.

is approved and listed by the competent authority of the third country or territory;

II.1.4.

complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 5 of Annex I to Commission Delegated Regulation (EU) 2020/686.]

II.2.

The [semen] (2) [oocytes] (2) [embryos] (2) described in Part I is/are intended for artificial reproduction and:

II.2.1.

has/have been [collected] (2) [produced] (2), [processed] (2) [stored] (2) [in a semen collection centre] (2) (3) [by an embryo collection team] (2) (3) [by an embryo production team] (2) (3) [and] (2) [processed] (2) [stored] (2) [in a germinal product processing establishment] (2) (3) and stored in a germinal product storage centre (3) complying with requirements as regards responsibilities, operational procedures, facilities and equipment set out in [Part 1] (2) [Part 2] (2) [Part 3] (2) [Part 4] (2) [Part 5] (2) of Annex I to Delegated Regulation (EU) 2020/686, and:

(2) either

[located in the third country or territory, or zone thereof of dispatch to the Union (4);]

(2) (4) and/or

[located in …, and has/have been introduced into the third country or territory, or zone thereof of dispatch to the Union under conditions at least as strict as for the entry into the Union of [semen] (2) [oocytes] (2) [embryos] (2) of equine animals in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692;]

II.2.2.

was/were moved to the germinal product storage centre described in box I.11. under conditions at least as strict as described in:

(2) either

[Model EQUI-SEM-A-ENTRY (5);]

(2) and/or

[Model EQUI-SEM-B-ENTRY (5);]

(2) and/or

[Model EQUI-SEM-C-ENTRY (5);]

(2) and/or

[Model EQUI-SEM-D-ENTRY (5);]

(2) and/or

[Model EQUI-OOCYTES-EMB-A-ENTRY (5);]

(2) and/or

[Model EQUI-OOCYTES-EMB-B-ENTRY (5);]

(2) and/or

[Model EQUI-OOCYTES-EMB-C-ENTRY (5);]

(2) and/or

[Model EQUI-GP-PROCESSING-ENTRY (5);]

(2) and/or

[Model EQUI-GP-STORAGE-ENTRY (5);]

(2) and/or

[Model 1 in Section A of Part 1 of Annex III to Implementing Regulation (EU) 2018/659 (5);]

(2) and/or

[Model 2 in Section B of Part 1 of Annex III to Implementing Regulation (EU) 2018/659 (5);]

(2) and/or

[Model 3 in Section C of Part 1 of Annex III to Implementing Regulation (EU) 2018/659 (5);]

(2) and/or

[Model 4 in Section D of Part 1 of Annex III to Implementing Regulation (EU) 2018/659 (5);]

(2) and/or

[Model 1 in Section A of Part 2 of Annex II to Decision 2010/471/EU (5);]

(2) and/or

[Model 2 in Section B of Part 2 of Annex II to Decision 2010/471/EU (5);]

(2) and/or

[Model 3 in Section C of Part 2 of Annex II to Decision 2010/471/EU (5);]

(2) and/or

[Model in Annex to Commission Decision 96/539/EC (5);]

II.2.3.

has/have been collected, processed and stored in accordance with animal health requirements set out in Annex III to Delegated Regulation (EU) 2020/686;

II.2.4.

II.2.5.

is/are transported in a container which:

II.2.5.1.

II.2.5.2.

has been cleaned and either disinfected or sterilised before use, or is single-use container;

(2) (6) [II.2.5.3.

has been filled in with a cryogenic agent which has not been previously used for other products.]

(2) (7) [II.2.6.

is/are placed in straws or other packages which are securely and hermetically sealed;

II.2.7.

is/are transported in a container where the different types are separated from each other by physical compartments or by being placed in secondary protective bags.]

Notes

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11	:	“Place of dispatch”: Indicate the unique approval number and the name and address of the germinal product storage centre of dispatch of the consignment of semen, oocytes and/or embryos. Only germinal product storage centre listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en.
Box reference I.12	:	“Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of semen, oocytes and/or embryos.
Box reference I.17	:	“Accompanying documents”: Number(s) of related original animal health certificate(s) shall correspond to the serial number of the individual official document(s) or animal health certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I from the semen collection centre where the semen was collected, and/or from the embryo collection team and/or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment where the semen, oocytes or embryos were processed and stored, and/or from the germinal product storage centre where the semen, oocytes or embryos were stored, to the germinal product storage centre described in box I.11. The original(s) of those document(s) or those animal health certificate(s) or the officially endorsed copies thereof shall be attached to this animal health certificate.
Box reference I.19	:	Seal number shall be indicated.
Box reference I.24	:	Total number of packages shall correspond to the number of containers.
Box reference I.27	:	“Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Identification number”: Indicate identification number of each donor animal. “Identification mark”: Indicate mark on the straw or other packages where semen, oocytes and/or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which semen, oocytes and/or embryos of the consignment was/were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected, and/or the embryo collection team and/or embryo production team by which oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate number of straws or other packages with the same mark.

Part II:

(1)	Only germinal product storage centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en

(2)	Delete if not applicable.

(3)	Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en.

(4)	Only a third country or territory, or zone thereof listed in Part 1 of Annex XII to Implementing Regulation (EU) 2021/404 and Member States.

(5)

The original(s) of the document(s) or the animal health certificate(s) or the officially endorsed copies of thereof that accompanied the semen, oocytes or embryos described in Part I from the semen collection centre where the semen was collected, and/or from the embryo collection team and/or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment where the semen, oocytes or embryos were processed and stored, and/or from the germinal product storage centre where the semen, oocytes or embryos were stored, to the germinal product storage centre of dispatch of the semen, oocytes and/or embryos described in box I.11 shall be attached to this animal health certificate.

(6)	Applicable for frozen semen, oocytes or embryos.

(7)	Applicable for consignments where semen, oocytes, in vivo derived embryos, in vitro produced embryos and micromanipulated embryos of equine animals are placed and transported in one container.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 68

MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF SEMEN, OOCYTES AND EMBRYOS OF TERRESTRIAL ANIMALS KEPT AT CONFINED ESTABLISHMENTS WHICH WERE COLLECTED OR PRODUCED, PROCESSED AND STORED IN ACCORDANCE WITH REGULATION (EU) 2016/429 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL AND COMMISSION DELEGATED REGULATION (EU) 2020/692 (MODEL “GP-CONFINED-ENTRY”)

Part I: Description of consignment

COUNTRY

Animal health certificate to the EU

I.1	Consignor/Exporter		I.2	Certificate reference	I.2a	IMSOC reference
	Name		I.2	Certificate reference
	Address		I.3	Central Competent Authority		QR CODE
	Address		I.3	Central Competent Authority
	Country	ISO country code	I.4	Local Competent Authority
I.5	Consignee/Importer		I.6	Operator responsible for the consignment
	Name			Name
	Address			Address
	Country	ISO country code		Country		ISO country code
I.7	Country of origin	ISO country code	I.9	Country of destination		ISO country code
I.8	Region of origin	Code	I.10	Region of destination		Code
I.11	Place of dispatch		I.12	Place of destination
	Name	Registration/Approval No		Name		Registration/Approval No
	Address			Address
	Country	ISO country code		Country		ISO country code
I.13	Place of loading		I.14	Date and time of departure

I.15	Means of transport		I.16	Entry Border Control Post
	☐ Aircraft	☐ Vessel	I.17
	☐ Railway	☐ Road vehicle
	Identification

I.18	Transport conditions	☐ Ambient	☐ Chilled	☐ Frozen
I.19	Container number/Seal number
	Container No		Seal No
I.20	Certified as or for
		☐ Germinal products

I.21	☐ For transit		I.22	☐ For internal market
	Third country	ISO country code	I.23

I.24

Total number of packages

I.25

Total quantity

I.26

I.27	Description of consignment
CN code	Species	Subspecies/Category		Identification number	Quantity

Type		Approval or registration number of plant/establishment/centre	Identification mark	Date of collection/production	Test

Part II: Certification

COUNTRY

Certificate model GP-CONFINED-ENTRY

II.	Health information

II.a

Certificate reference

II.b

IMSOC reference

I, the undersigned official veterinarian, hereby certify, that:

II.1.

The [semen] (1) [in vivo derived embryos] (1) [oocytes] (1) [in vitro produced embryos] (1) [micromanipulated embryos] (1) described in Part I is/are intended for artificial reproduction and was/were obtained from donor animals which:

II.1.1.

originate from a third country or territory, or zone thereof authorised for the entry into the Union of the particular species and category of animals and listed in Annexes II to VII to Commission Implementing Regulation (EU) 2021/404, or authorised pursuant to Article 230(2) of Regulation (EU) 2016/429 by the Member State of destination, depending on the species in question;

II.1.2.

originate from a confined establishment in the third country or territory, or zone thereof of origin, which is included in a list of confined establishments, established by the Member State of destination in accordance with Article 117, point (c), of Commission Delegated Regulation (EU) 2020/692, from which the entry of animals of specific species into the Union may be authorised;

II.1.3.

do not come from an establishment, nor have been in contact with animals from an establishment, situated in a restricted zone established due to the occurrence of a category A disease referred to in the Annex to Commission Implementing Regulation (EU) 2018/1882, or of an emerging disease relevant for species of those kept terrestrial animals;

II.1.4.

come from an establishment where no category D disease, relevant for species of those kept terrestrial animals as referred to in the Annex to Implementing Regulation (EU) 2018/1882, has been reported for at least 30 days immediately prior to the date of collection of the [semen] (1) [oocytes] (1) [embryos] (1)intended for entry into the Union;

II.1.5.

have remained in a single confined establishment of origin for at least 30 days immediately prior to the date of collection of the [semen] (1) [oocytes] (1) [embryos] (1)intended for entry into the Union;

(1) (2) either

[II.1.6.

are bovine, porcine, ovine, caprine or equine animals and are identified in accordance with Article 21 of Delegated Regulation (EU) 2020/692;]

(1) (3) or

[II.1.6.

are terrestrial animals other than bovine, porcine, ovine, caprine or equine animals and are identified and registered in accordance with the rules of the confined establishment;]

II.1.7.

have been clinically examined by the establishment veterinarian responsible for the activities carried out at the confined establishment and showed no disease symptoms on the date of collection of the [semen] (1) [oocytes] (1) [embryos] (1);

II.1.8.

as much as possible, were not used for natural breeding for at least 30 days immediately prior to the date of collection of the [semen] (1) [oocytes] (1) [embryos] (1)and during the collection period.

II.2.

The [semen] (1) [oocytes] (1) [embryos] (1) described in Part I:

II.2.1.

is/are placed in straws or other packages on which the mark is applied in accordance with requirements provided for in

(1) (2)

[Article 83, point (a), of Delegated Regulation (EU) 2020/692 and that mark is indicated in box I.27;]

(1) (3)

[Article 119, point (a), of Delegated Regulation (EU) 2020/692 and that mark is indicated in box I.27;]

II.2.2.

is/are placed in a transport container which:

II.2.2.1.

was sealed and numbered prior to the date of dispatch from the confined establishment by the establishment veterinarian responsible for the activities of the confined establishment and the seal bears the number as indicated in box I.19;

II.2.2.2.

has been cleaned and either disinfected or sterilised before use, or is a single-use container;

(1) (4) [II.2.2.3.

has been filled in with a cryogenic agent which has not been previously used for other products.]

(1) (2) (5) [II.2.3.

is/are placed in straws or other packages which are securely and hermetically sealed;

II.2.4.

is/are transported in a container where the different types are separated from each other by physical compartments or by being placed in secondary protective bags.]

II.3.

The consignment of [semen] (1) [oocytes] (1) [embryos] (1)

II.3.1.

is destined to a confined establishment in the Union, which is approved in accordance with Article 95 of Regulation (EU) 2016/429;

II.3.2.

is transported directly to the confined establishment as indicated in box I.12.

Notes

This animal health certificate is intended for the entry into the Union of semen, oocytes and embryos of terrestrial animals kept at confined establishments, including when the Union is not the final destination of the semen, oocytes and embryos.

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

Part I:

Box reference I.11

“Place of dispatch”: Indicate the unique approval number, if assigned by the competent authority, and the name and address of the confined establishment of dispatch of the consignment of semen, oocytes or embryos.

Box reference I.12

“Place of destination”: Indicate the name, address and unique approval number of the confined establishment of destination in the Union of the consignment of semen, oocytes or embryos.

Box reference I.27

“Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos.

“Identification number”: Indicate identification number of each donor animal.

“Identification mark”: Indicate mark on the straw or other packages where semen, oocytes or embryos of the consignment are placed.

“Date of collection/production”: Indicate the date on which semen, oocytes or embryos of the consignment was/were collected or produced.

“Approval or registration number of plant/establishment/centre”: Indicate the unique approval number, if assigned by the competent authority, and the name and address of the confined establishment of the collection or production of semen, oocytes or embryos of the consignment.

“Quantity”: Indicate number of straws or other packages with the same mark.

Part II:

(1)	Delete if not applicable.

(2)	Applicable for consignments of semen, oocytes or embryos of bovine, porcine, ovine, caprine or equine animals.

(3)	Applicable for consignments of semen, oocytes or embryos of terrestrial animals other than bovine, porcine, ovine, caprine or equine animals.

(4)	Applicable for frozen semen, oocytes or embryos.

(5)	Applicable for consignments where oocytes, in vivo derived embryos, in vitro produced embryos and micromanipulated embryos of bovine, porcine, ovine, caprine or equine animals are placed and transported in one container.

Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

’.

ELI: http://data.europa.eu/eli/reg_impl/2025/544/oj

ISSN 1977-0677 (electronic edition)

Top

Description of consignment

Subspecies/Category

Identification system

Identification number